For Reference 


NOT TO BE TAKEN FROM THIS ROOM 


A STUDY OF THE EFFECTS OF 
THE ADRENOCORTICOTROPIC 
HORMONE (ACTH) AND CORTISONE IN 
CERTAIN SELECTED DISEASES 





Thebi* 

‘951 


i 


HATFIELD — 

mm 





mm 


w& 






























cj e 


be 



ITOBI* 

niswumais 

UMMilMlS 

















Digitized by the Internet Archive 
in 2017 with funding from 
University of Alberta Libraries 


https ://arch i ve. o rg/detai Is/studyofef fectsof OOcI i n 









at t; ,L';. TT ITISHaVITB 

' 

. J ?'C r[ "■qt.'-Ci 




j ‘ f> ; : I / ' > ■ ^ m . 




‘to.-: ;••• 




; . Jf ;. . Vf . ; f XoQi:/Si ■■ I# cT- fxrmrxoe'X 


' 

y.j ; xx ;j- • , !f ; ; • ' .Of: A ■ .*>• A "d T'M) 

• ■: ■ ■ - ■ ■ ‘ : ■ • 

. T) ":.c ’h ■ .te/i^cd. ■■ 


d:m 


■. v 


. , -Vv\ /.. ' 




... 






V >3 ,v.i 





THE UNIVERSITY OF ALBERTA 


A STOUT OF THE EFFECTS OF THE ADRENOCORTXCOTRQPHIC HORMONE (ACTS) 
AND CORTISONE IN CERTAIN SELECTED DISEASES. 


A DISSERTATION 

SUBMITTED TO THE SCHOOL OF GRADUATE STUDIES 
IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DECREE 
OF MASTER OF SCIENCE 


FACULTI OF ARTS AND SCIENCE 


CLINTON BRUCE HATFIELD 


EDMONTON, ALBERTA 
SEPTEMBER, 1951. 



■; ■ 'K-'S''.:. ''h?'«■ -vi ■ T v> r./ T ■ v 

VI" : <:/0 U1 :i >--O..'- 0 :'W 








: riTTTIU - 

x.1 t. tt? ct 

;:r;;(: r vTT '"'IT' f" 'V■ T’!, 

i O- ; ■ \iv ■T< 




■ u ■ . : ' . 





\P> s \ 
ft s7 


ERRATA 


Acknowledgement line 4 "advise" to read "advice". 

Table of Contents, Page 2, Vll (b) (2) "Metabolus" to 

read "Metabolism". 

Page 34, line 26, "fasciculata" to read "glomerulosa". 

Page 47, line 16, !1 suggested to read "suggests* 1 . 

Page 50, line 14, (Eg.2) to read (Fig. 2). 

Page 54, line 19,"stimulatory" to read "stimulating". 

Page 89, line 8,"ocrtisone" to read "cortisone”. 

Page 99, line 9, delete fl on a . 

Pagel39, line 2I,"rate" to read "rats”. 

Appendix I, page i, line 25, "balance 11 to read "balanced". 

Bibliography,Reference #217, delete "Hoffman, M. M., Browne, 

J. S,. L." so as to read "Venning, E. H., 
Kazmin, V. E., and Bell,J. C." 



. 






. . 

<. • 

\ < - i ' 

. I- ■ , : • : . :: ■ ' ■' .* t '■> 1. ■ ' 


. 

• ■ 

... 






ACKNOWLEDGEMENT 


I wish to express my gratitude to the John and Mary R« 
Markle Foundation through whose interest this work was made possible* 
I am deeply indebted to Dr* D. R. Wilson for his guidance, encourage¬ 
ment and advise, and to Dr* H. V. Rice and Dr. R* E. Bell for their 
interest and assistance. I wish to acknowledge the technical aid re¬ 
ceived from the dietitians, laboratory staff and medical personnel 
of the University of Alberta Hospital, and to thank the members of 
the Departments of Medicine, Biochemistry and Psychology of the Uni¬ 
versity of Alberta for their co-operation at all times. 



• • - 7 / ‘ , ' 7 ^ $ l 

■ ' • • ‘ ^ ' 

, ' • V 7 . 

. ' . ; /• " . 7 . . : C ;■ VMS ■ e • ' ' ' * - ‘ ‘ 

j .,+ .: .. . -i.) / ',on I ' y 

i 


TABLE OF CONTENTS 


Section Page 

A. Historical Introduction ...... ..... 1 

B. A Review of the Literature, 

1. The Effects of Adrenalectomy: Adrenal Insufficiency, 9 

(a) Survival Tke...... ..... 9 

(b) Physiological Disturbances • . • ... 10 

(1) Anorexia ......................... 10 

(2) Adynamia . ........ 10 

(3) Temperature Regulation .................... 11 

(4) Circulatory Alterations ................... 11 

(5) Hypersensitivity to Stress ... 12 

(c) Pathological Disturbances ....... 12 

(1) Pigmentation ............ . 12 

(2) Other Autopsy Findings ... 13 

(d) Biochemical Disturbances ....................... 14 

(1) Sodium L©ss .. 14 

(2) Potassium Retention ....................... 15 

(3) Increased Blood Cholesterol & Non-Protein 

Nitrogen .. 16 

(4) Carbohydrate Metabolism ... • 16 

II. The Effects of GortieaX Extract Administration ...... 17 

(a) In Adrenal Insufficiency .. 17 

(b) On Normal Animals .. 18 

III. The Specific Hormone Preparations (The Cortical 

Steroids)........................................... 19 

(a) Introduction .. 19 

(b) The Chemistry of the Cortical Steroids ......... 20 

(1) The Desoxy- Group ......................... 20 

(2) The 11- and 11, 17-Oxysteroid.Group ....... 21 

(3) The Adrenal Androgens ..................... 21 

(c) The Effects of Specific Cortical Steroid Admin¬ 

istration .. 22 

(1) Desouyeortieosterone .. 22 

(2) Cortisone (Xl-dehydro-17-hydroxycorticos¬ 

terone (Compound E) ...................... 25 

4. Effects on Carbohydrate Metabolism ... 25 

b. Effects on Electrolyte Metabolism .... 26 

c» Other Metabolic Effects ... 27 

d. Effects on the Organism .............. 28 

©. Effects on Laboratory Tests .. 29 

f. Other Hormonal Effects ... 30 




























































2. 


Page 


IV* The nature of the Adrenal Hormones . 31 

(a) Introduction . *. ...... .31 

(b) Theories Regarding the Nature of Secretion ...• 31 

(1) The Multisteroid Concept .... ..... 31 

(2) The "N” and the "S” Hormone Concept ...... 32 

(3) The Autonomy Concept ...» . ... . ... 33 

(4) The Unitarian Concept .................... 35 

V. Measurement of Adrenal Cortical Activity............ 37 

(a) Changes in the Adrenal Cortex .. 37 

(1) Gross Changes 37 

(2) Histochemical Changes .................... 38 

(3) Chemical Changes .. 38 

a. Adrehal Cholesterol .. 38 

b. Adrenal Ascorbic Acid .. 39 

(b) Changes in the Organism ....................... 39 

(1) Lymphocytes .. 39 

(2) Eosinophils .. 40 

(c) Urinary Steroids 41 

(1) Urinary Biocorticolds .. 41 

(2) Urinaiy Cheraoeorticoids 42 

(3) Urinary 17-ketosteroids .................. 43 

VI. Regulation of the Rat© of Secretion of the Adreno¬ 
cortical Hormone 45 

(a) Pituitary Regulation of Adrenal Cortical 

Activity .. 45 

(1) Hypophysectomy ........................... 45 

(2) Administration of the Adrenocorticotrophic 

Hormone (AGTH) ........... . 45 

(b) Regulation of Pituitary Adrenocorticotrophic 

Activity 47 

(1) Peripheral Humoral Mechanism •••••••••»••• 48 

(2) Central-Neural or Central Neurohumoral 

Mechanism ............................... 52 

(3) The Role of the Sympatho-Adrenal System .. 54 

VII. Some Physiological Changes 0ccuring in Stress....... 58 

(a) Increased Utilization of the Cortical Hormone » 58 

(b) Metabolic Changes ............................. 58 

(1) Carbohydrate , Protein and Fat Metabolism . 58 

(2) Electrolyte Metabolus .................... 59 

VIII. Resistance to Stress ............................... 61 

(a) Definition .. 61 

(b) Mechanisms Producing Hypocorticism ............ 61 

(1) Inadequate Pituitary Adrenocortical System 61 

(2) Exhaustion of the Adrenal Cortex ......... 62 

(3) Exhaustion of the Pituitary .............. 62 





































SI "• H 






























3- Page 

IX. The Mode of Action of the Cortical Hormone in In- 

creasing Resistance to Stress ... 63 

(a) Detoxification Theory ........... ............... * 63 

(b) Cardiovascular Theory .... 64 

(c) Antibody Mobilization Theory.... 64 

(d) Ubiquity Theory ... 65 

X. Adaptation to Stress........ 65 

(a) Definition .. 65 

(b) The General Adaptation Syndrome ................. 66 

(c) The Clinical Importance of the General Adaptation 

Syndrome 68 

XI. Does Stress Produce Pathological Changes? .... 69 

(a) Toxicity of DOCA_ ............................ 69 

(b) Toxicity of ACE ... 70 

(c) Toxicity of ACTH and Anterior Pituitary Extracts. 70 

(d) Deficiency of 11, 17”Oxysteroids Induced by DOGA 71 

(e) Production of the Diseases of Adaptation ........ 72 

XII. Therapy of the Collagen Diseases with Cortisone and 

ACTS .. ..... 72 

C. Introduction to the Problem .............................. 73 

D. Methods .................._............................ 74 

1*>.Hospitalization 74 

II. Diet .. 74 

III. Fluid Intake ......................................... 74 

I?. Collection of Specimens.. 75 

(a) Urine .. 75 

(b) Blood .. 75 

?. Blood Pressure and Weight Determinations 76 

VI. Chemical Methods ..................................... ^6 

VII. Statistical Methods ...... 77 

1. Case Reports and Results... 77 

I. Cushing 8 s Syndrome Treated with Cortisone ............. 77 

(a) Introduction ..................................... 77 

(b) Case History #96690 79 

(c) Procedure 80 

(d) Results 81 

(1) The Effects of Cortisone on Electrolyte 

Metabolism .. 81 

a. Sodium Balance ......................... 81 

b. Chloride Balance ....................... 81 

c. Potassium Balance 81 

(2) The Effect of Cortisone on Weight and Nitro¬ 

gen Metabolism .......... 9 .................® 82 

(3) The Effects of Cortisone on Gortin, 17-Keto- 

steroids and Eosinophils 82 

(4) Other Effects of Cortisone in Cushing’s Syn¬ 

drome .82 









































o JaKy j : 

.. ■ ■ ;K\ 


>. v ' y ; \ ••• J 


: niT (d'l 
j -u? ;:,) 


i ■ O' 
v.;r “ ... • , 0 'i J 0 
T ( : r) 

' 








- r .. . ■ , . 









• 















, -'Ij 

, 

V * * • 




' ’ * V » 


... -o .rrfIJ-osliicO; 

• f -i 7 i « ) 

. 

t i.H 







■ -uJivvY o : y - 

. 

t 

. : 








♦ 


, 

(j.) 



.... .... . ai 

. ..... , .. : ■: l : . 

, . ., ......... . , . . 

* i . ' : • • : - vv). 7<.o ■ ■■ 

.. " 'T:V' 


■ • ! 








































4 


Page 


( e) Discussion .................................. 83 

(f) Summary and Conclusions .... 85 

II. The Adrenogenital Syndrome Treated -with Cortisone and 

ACTH.... 85 

(a) Introduction .. 85 

(b) The Effects of Cortisone on a Patient with the 

Adrenogenital Syndrome .. 88 

(1) Case History #96696 ........................ 88 

(2) Procedure 89 

(3) Be suits .. 89 

a. The Effects of Methyl Testosterone and 

Cortisone on Electrolyte Metaholism ... 89 

i. Sodium Balance .. 89 

ii. Chloride Balance ................... 90 

iii. Potassium Balance .................. 90 

b. The Effects of Methyl Testosterone and 

Cortisone on Urinary Nitrogen and Weight 90 

c. The Effects of Methyl Testosterone and 

Cortisone on the Urinary Excretion of 
ll-oxysieroids, 17-ketosteroids and cir- 91 
eulating eosinophils ... 

d. Other Effects of Methyl Testosterone and 

Cortisone ............................. 92 

(4) Discussion.. 92 

(5) Summary . 94 

(c) The Effects of ACTH in the Adrenogenital Syndrome 95 

(1) Introduction ............................... 95 

(2) Case History #99205 .. 95 

(3) Procedure .. 96 

(4) Results .................................... 96 

a. The Effects of ACTH and Methyl Testos¬ 

terone on Electrolyte Metabolism ...... % 

i. Sodium Blanc© ...................... 96 

ii. Chloride Balance ................... 97 

iii. Potassium Balance .................. 97 

b. The Effects of ACTH and Methyl festester-■ 

one on Weight and Nitrogen Balance .... 97 

c. The Effects of Methyl Testosterone and 

ACTH on the Urinary Excretion of Corti- 
colds and 17~Ketosteroids, and the Cir¬ 
culating Eosinophils .................. 98 

d. Other Effects of Methyl Testosterone and 

ACTH .................................. 98 

(5) Discussion ................................. 98 

(6) Summary .................................... 102 

(d) Comments on the Investigation of the Adrenogeni¬ 

tal Syndrome ................................... 102 

(e) Conclusions ..................................... 104 































."•* . T 


: 

. :'c» • ‘i v ei:!T 

/■ !>'!.; . ■ ! 7‘> 

• - - , : h 


mu ! 


,,,,,,.. ■!’ • ;■ J 


JT . 

no ■/ 

a 

■ 

i ; ■ ■: - 

u fi'T . 


; h 


o 


■ (o) 

fi C' £v’:' vi > 'O 0 \ ) 

;• 5 .. ; ; . ) • ; 
































5. Page 


III. The Effects of ACTH on Allergic Urticaria.... 104 

(a) Introduction. 104 

(b) Case History #99254 .. 106 

(c) Procedure . 107 

(d) Results . 107 

(1) Clinical Observations .... 107 

(2) The Effects of Neo-Antergan and ACTH on Elec¬ 

trolyte Metabolism. 108 

a. Sodium Balance .... 108 

b. Chloride Balance..... 109 

c. Potassium Balance. 109 

(3) The Effect of N e o~Antergan and ACTH on Weight 

and Nitrogen Balance .. 109 

(4) The Effect of Neo-Antergan and ACTH on the 

Urinary Excretion of Cbrtin and 17-Ketoster- 
oids, and Circulating Eosinophil Levels .... 110 

(5) Other Effects of Neo-Antergan and ACTH ...... 110 

(e) Discussion ....... 110 

(f) Summary .... 113 

IV. The Effects of Cortisone on Idiopathic Epilepsy ...... 113 

(a) Introduction...... 113 

(b) Special Methods ...... 117 

(c) Case History #81123 ..... 118 

(d) Procedure ........ 120 

(e) The Effects of Pitressin on Epilepsy .. 121 

(1) A Note of Explanation ... 121 

(2) Results . 122 

a. The Effects of Pitressin on Electrolyte 

Metabolism ...... ..... 122 

i. Sodium Balance. 122 

ii. Chloride Balance .................... 122 

iii. Potassium Balance .. 123 

b. The Effect of Pitressin on Nitrogen Bal¬ 

ance ................................... 123 

c. The Effect of Pitressin on the Urinary 

Excretion of Cortin and 17-Ketostaroids, 
and Circulating Eosinophil Levels ...... 124 

d. The Effects of Pitressin on the Electro¬ 

encephalogram . 124 

e. Other Effects of Pitressin . 124 

(3) Discussion .. 125 

(f) The Effects of Diminished Water Intake and Pi¬ 

tressin on Epilepsy ..... 126 

(1) Results .. 126 

a. The Effects of Reduced Water Intake and 

Pitressin on Electrolyte Metabolism .... 126 

i, Sodium Balance. 126 

ii. Chloride Balance ... • • • 126 

iii. Potassium Balance .. 127 










































(b) 
\ { ■' / 





































6. Page 

b. The Effects of Diminished Water Intake 

and Pitressin on Nitrogen Balance. 127 

c. The Effect of Diminished Water Intake and 

Pitressin on the Urinary Output of Cortin 
and 17-Ketosteroids, and Circulating 
Eosinophils Levels .... 127 

d. The Effects of Pitressin on Fluid Balance 128 

e. The Effects of Lowered Water Intake and 

Pitressin on the Electroencephalogram ..• 129 

f. Other Effects of Reduced Water Intake and 

Pitressin...... 129 

(2) Discussion .... . 130 

(g) The Effects of Cortisone on Epilepsy ........ . 131 

(1) Procedure ..... 131 

(2) Results .. 132 

a. The Effect of Cortisone on Electrolyte 

Metabolism .... • 132 

i. Sodium Balance ...*.. 132 

ii. Chloride Balance .. 133 

iii. Potassium Balance .. 133 

b. The Effect of Cortisone on Nitrogen and 

Water Balance, and Weight.. 134 

c. The Effect of Cortisone on the Urinary Out¬ 

put of Gorttn and 17-Ketosteroids, and 
Circulating Eosinophils .. 135 

d. The Effect of Cortisone on the Electroen¬ 

cephalogram • ••••••••••••• . 135 

e. Other Effects of Cortisone ... 136 

(3) Comments ...... 136 

(h) Summary ..... .. ...» 140 

F. A Comparison of the Metabolic Effects of ACTS and Cortisone 141 

I. Sodium Balance... 141 

II. Potassium Balance .. 142 

III. Chloride Balance .. 142 

I?, Nitrogen Balance .. 142 

V. Eosinophil Response . 143 

VI. Urinary Output of 17-Eetosteroids .. 143 

VII. Urinary Output of Cortin . 143 

VIII. Blood Pressure .. 144 

IX. Urine Volume and Specific Gravity .. 145 

G. Summary....... 146 

H. Appendices 

I. Flame Photometery (i)............................... i 

II. Factors Affecting the Determination of Urinaiy Cortin vii 

III. Tables of Metabolic Data ix 


































" o 




1c 










n r.t 


•I ’ 10 


























7 


Tables Page 

1. Comparison of the average daily sodium and potassium bal¬ 

ances occuring before, during and after therapy with 

ACTH or Cortisone.... 141 

2. Comparison of the average daily chloride and nitrogen bal¬ 

ances oc curing before, during and after therapy with ACTE 
or Cortisone ........ 142 

3. Comparison of the average daily urinary output of 17-keto- 

steroid, and the mean daily level of circulating eosino¬ 
phils oc curing before, during and after therapy with 
ACTH and Cortisone .. 143 

4* Comparison of mean daily eortin and blood pressure determi¬ 
nations obtained before, during and after therapy with 
ACTE or Cortisone 144 

5. Comparison of mean daily urine values and specific gravity 

before, daring and after treatment with ACTE or Cortisone 144 

6. Sample calibration data for both the Absolute Method and 

the Internal Standard Method..... ®.. iv 

7. Showing comparison of values for serum sodium obtained on 

the Barclay and Beckman Flame Photometers ... v 

8. The effect of freezing on urinary and serum potassium de¬ 

terminations performed with the flame photometer. vi 

9* Table showing the effect of storage temperature on the deter- 
mina tion of urinary eortin .. •••••••••«••••••• vii 

10, Table showing the effect of freezing on the determination 

of urinary eortin. ••••••• .... viii 













i> 


lo .v'.« 

*:-:0 

' 







y< '-o 







r.r r - ; XJ.y:' .01 

■ 








8 . 


Opposite 

Index of Figures, Page 

1. Inter-relations of Adrenal Steroids..... 21 

2. The Peripheral-Humoral Concept .... . 50 

3. The Central-Neural and Central Neurohumoral Concepts. 50 

4. Sympatho-adrenal Relationship. 56 

5. Pituitary-Adrenal Relationships. 56 

6. Cushing’s Syndrome #96690. Photograph showing slight puffi¬ 

ness suggestive of moon face .... 80 

7. Metabolic data on Mrs. R. C. #96690 with Cushing’s Syhdrome 

to show the effect of therapy with Cortisone... 82 

8. Metabolic data on Mrs. R. G. #96690 with Cushing’s Syndrome 

to show the effect <f therapy wth Cortisone .. 82 

9. Metabolic data on Mrs. R. C. #96690 with Gushing’s Syndrome 

showing the effects of Cortisone on urinary 17-ketosteroid 
excretion and circulating eosinophils.. 83 

10. Adrenogenital Syndrome # 96696 . Photograph showing facial 

hirsutism ..... • 87 

11. Adrenogenital Syndrome # 96696 . Photographs showing male 

musculature and body build of the patient... 88 

12. Adrenogenital Syndrome # 96696 . Photographs showing male 

musculature and body build of the patient ... 88 

13* Metabolic data on Miss G. ¥. #96696 with Adrenogenital Syn¬ 
drome to show the effects of Methyl Testosterone and Cor¬ 
tisone ....... 89 

14* Metabolic data on Miss C. #96696 continued. 90 

15. Adrenogenital Syndrome C. W. # 96696 . The effect of Methyl 

Testosterone and Cortisone on the urinary output of 17- 

ketosteroid and eortin, and on circulating eosinophil 

levels ......... 91 

16. Photographs showing appearance of acne before and after cor- -re 

tisone therapy...* 92 

17. Photographs showing appearance of acne before and after cor¬ 

tisone therapy ........ 92 


























; f'O 






f ■ -I''" • ' : .< • : : i •; 



1 





t 











'.r 

Xd‘ V: 


a - o\ \ ' 1 ' 





• :■ 'r: -c <■■■■ • ■ 

\ J>a® -v .-:..mt 






:Jb 


• v .'•■J'iry 

i; r.;;. /> im:' te>.‘ . :j? 

al.t , ;i M oo hiijt hi o*:.:cd , p,od‘&3C 

....... 


^*TO 


at'-O-:: 


' iV: : crK 


ric 


■a 


c 


. 










9. 

Opposite 

Index of Figures Page 


IB. Adrenogenital Syndrome Mr. E. C. #99205. Photograph 

showing male body build and musculature. 95 

19. Adrenogenital Syndrome, Mr. E. C. #99205. Photograph 

showing male phallus and female distribution of pubic 

hair........ 96 

20. Metabolic data on Mr. E. 0. #99205 with Adrenogenital 

Syndrome to show the effects of Methyl Testosterone and 
ACTH ........... 96 

21. Metabolic data on Mr. E. C. #99205 continued .. 93 

22. Metabolic data on Mr. E. C. #99205 continued . 93 

23. Allergic Urticaria, Mrs. J. W. #99254* Photographs show¬ 

ing the effective control of urticaria with Neo-Antergan, 
and the appearance of urticaria with no therapy.. 107 

24. Allergic Urticaria, Mrs. J. W. #99254* Photographs show¬ 

ing the effective control of urticaria with Neo-antergan, 
and the appearance of urticaria with no therapy .. 107 

25. Allergic Urticaria, Mrs. J. W. #99254* Photograph showing 

the urticarial lesions on the back and shoulders !••••»• 103 

26. Allergic Urticaria, Mrs. J. W. #99254 showing the effects 

of Neo-antergan and ACTH therapy ....................... 109 

27. Allergic Urticaria, Mrs. J. ¥. #99254 showing the effects 

of Neo-antergan and ACTH therapy ... 109 

23. Metabolic data on Mr. M. A. #81123 with Epilepsy to show 

the effect of Pltressin ... 123 

29. Idiopathic Epilepsy Mr. M. A. #31123 showing the effect 

of Pitressin on the urinary output of cortin and 17- 
ketosteroids, and on the circulating eosinophils.. 123 

30. Metabolic data on Mr. M. A. #81123 with Epilepsy to 

show the effect of lowered water intake and Pitressin w 127 

31* Idiopathic Epilepsy, Mr. M. A. #81123. Chart showing the 
effect of Pitressin and lowered water intake on cortin 
excretion, aid urine volume and specific gravity ........ 127 

32. Idiopathic Epilepsy, Mr. M. A. #81123. The effect of Pi¬ 
tressin on fluid balance...... 128 


















,0':';PV' 



: ri' ( r 









' I 

: ycd'otc./ c 1 


. 

y : 'V ••--c • yd'' ' :: jyyoyi'y- 



........ 

. . « . 

*««»••• 

■Iwoi ■■ ' ■ , . . Z , 1 ; , - ‘ , 

.., . / . 



0 Xcycdcioo :-v: 'Oy'tdo yfit ?nd 
■■jj.d'TM *lo co.- "■ cod Lit-' 


T, C 





. 

.. 


' 1 . . . d. . 7 . 

• ' i U 

....... ’ . • ' . : ..f-■ '... ' .. : hy ; !’ 


' 


-■yj ;o 



. 


■ y . . cI 


i: cl 











10. 

Opposite 

Index of Figures Page 

33* Idiopathic Epilepsy, Mr, M. A. #81123. The effect of 

reduced water intake and Pitressin on fluid balance .... 133 

34. Metabolic data on Mr. M. A. #81123 with Idiopathic Epi¬ 

lepsy to show the effect of Cortisone .... 133 

35. Idiopathic Epilepsy #81123. Metabolic data showing the 

effect of Cortisone on nitrogen, potassium and water 
balances • ...... 133 

36. Idiopathic Epilepsy #81123. Chart showing the effect of 

Cortisone on the urinazy output of eortin and 17-keto- 
steroids, and circulating eosinophils... 135 

37. Idiopathic Epilepsy #81123. Electroencephalograph!c pic¬ 

ture with no therapy and water ad libitum ... 137 

38. Idiopathic Epilepsy #81123. Electroeneephalographic pic¬ 

ture with no therapy and water ad libitum ... 137 

39* Idiopathic Epilepsy #81123. The effect of Pitressin and 

restricted water intake on the electroencephalogram . 137 

40. Idiopathic Epilepsy #81123. The effect of Pitressin and 

restricted water intake on the electroencephalogram .... 137 

41. Idiopathic Epilepsy #81123. The effect of restricted 

water intake and Cortisone on the Electroencephalogram . 137 

42. Idiopathic Epilepsy #81123. The iffeet of restricted 

water intake and Cortisone on the Electroencephalogram . 137 

43* Idiopathic Epilepsy #81123. The effect of Cortisone on the 

electroencephalogram ........ 137 

44* Chronic rheumatoid arthritis #27645. The effect of Dilantin 
and Mesantoin on the sodium, potassium, chloride and ni¬ 
trogen balances ........ 137 













j0 

- i 









i 

■ 

. ......... ••- ur. .. ’ 







oi • .- My ’v'"^- -T-"^ - '•' • ;v '° 

...... >■■!•:■'■ 


, 

■ : r7 - e-xxd' 


>SXS ■ 


. o ■ 


. CTSli ' • 


IP. 'Vi •: 




■ 

C-r :• 




. „ .. , - .j,y; . ; . . 

..„ .. ; ' ‘ •' 




. 

.. . . . . . 








HISTORICAL INTRODUCTION 


Prior to the middle of the sixteenth century the adrenal 
glands were unknown structures. They were first described by Bartho- 
lomaeus Eustachius in 1563 in his book n 0puscula Anatomica Gentus” 
under the title "De Glandulis Quae Renibus Incumbunt" • Despite the 
clear exposition of Eustachius (1), it took more than three hundred 
years before any indication of their probable action was obtained. 

During the middle of the nineteenth century advances were 
made in the anatomical study of the adrenals. Ecker (2) in 1846 first 
demonstrated the glandular nature of the adrenal cells, and concluded 
that these organs must pour some secretion into the blood either 
directly or by way of the lymphatics. In 1854 Kolliker (3) published 
a description of the microscopic structure of the adrenals and their 
nervous connections. He recognized the medulla and the cortex as func¬ 
tionally different structures and wrote, "The medullary substance of 
the suprarenal gland is not a true secreting gland, but rather is re¬ 
lated to the nervous system, in which the cellular and nervous elements 
are in apposition.” 

The modern study of the physiology of the adrenals may be 
said to have begun with Thomas Addison (4)• His classic description 
in 1855 of the disease of the adrenals, which has since been associated 
with his name, initiated a series of researches which have continued to 
the present day. Not only did Addison recognize the condition as a 
morbid entity, but he also accurately correlated it with a pathological 
state of the adrenals. He wrote, "The leading and characteristic fea- 







. V7G7L 

„ 0 . ■• ■; • .. . ;± c ■■ vi / - ■ ; -■ ' rt 'ins ff .o ' ft 1 T. 3 

.us . ■ ! -see : •' a i• •. f-nxif-- - - nS 

< ' ■} - •• "rc. i;c ' ■ • 

, ; ’ j '(If 'i ' 

y 

L. ' ; o ■■■ 

. 

ucq ' Hlif . O •: .• •id' *X 

. , ■; } • ' '■•••' - ■ ..i..' 7 '■ ^ ^ 

• •' A;. --7 \> -Ik I J7 7 L C <7 0*1’.) v7i -'i J : .C : '"'J J ' i'.n.^vh « 

■ •; . , ..7 ..7; • 7 7 7 1 O-i ,27! \ ••.'7 7 " -ri 7/' 

• ••; ■ •?>’ . 7 “SUJ 'firf-S 3 7Ti.ru , 

, . ./ . .. : •• ' . 7 b rf . - : “ ::**£ : > \ 

■ 

■ 

“ .IK ‘ TS.BC : It'- 

■ 

~ r r, ■■ : ■ T ' . 

:• : • : 7 ■ ' j- , • 

.■■ 7 . ..a 7.C7 :><;■. . , . •- „■ 7 ..• 7 ..I 

• 7 ;. . “ • 

. 7 " H ,7‘1 - l ■ 



2 . 


tures of the morbid state, to which I would direct attention, are 
anemia, a general languor and debility, a remarkable feebleness of 
the heart*s action, irritability of the stomach, and a peculiar change 
of colour of the skin, occurring in connection with a diseased condition 
of the suprarenal capsule•” Addison’s publication (4) prompted Brown- 
Sequard (5) in 1856 to extirpate the adrenals from rabbits, dogs, 
guinea pigs and rats. The uniformly fatal outcome following bilateral 
extirpation led him to conclude that these glands were indispensable 
for life. His conclusions, however, were questioned on the basis that 
death might have been occasioned by the surgical procedure itself. 

Biedl (6) later devised an ingenius operative technique to avoid this 
criticism. He first removed the glands from their normal posiition 
and, with their blood vessels intact, attached them subcutaneously. 
Several days later he removed the glands through a simple skin incision, 
and this resulted in the prompt death of the animals. He noted also 
that animals so treated showed many of the signs characteristic of the 
clinical manifestations of Addison’s Disease. 

The French physiologist fulpian (7),working at about the same 
time as Addison (4) and Brown-Sequard (5), discovered that the cells of 
the medulla and the cortex had different staining characteristics. He 
noted that the medulla was stained green by ferric chloride and that the 
blood of the adrenal vein sometimes gave a similar reaction, (it is now 
known that this reaction is characteristic of the secretion of the 
medulla.) The observations of Oliver and Schafer (8) in 1894 of the re¬ 
markable pressor effects of extracts of the adrenal medulla turned atten- 
tention to the study of epinephrine and the medullary portion of the 



I 







3 


gland. Thereafter, for about thirty years, study of the physiology of 
the cortex was neglected and was overshadowed by the apparent importance 
of the medulla. 

During this interval the medulla was thoroughly investigated. 
Following Vulpian*s description (7) in 1856 of the iron chloride re¬ 
action of the medulla, Henle (9) reported that the medulla assumed a 
brownish coloration when treated with a salt of chromic acid, and this 
reaction later paved the way for the elaboration of the ”Ghromaffian 
System” as we know it today. The relatively high concentration in 
which epinephrine occurs in the adrenals rendered it relatively easy 
for Abel (10) t© isolate the active principle of the medulla in 1899 5 
and it was but two years until Takamine (11) and Aldrich (12) prepared 
the first pure crystalline 1-adrenalin * The discovery of epinephrine, 
its isolation and the demonstration of its powerful pharmacological 
action focused all attention on this substance as the important pro¬ 
duct of the adrenal gland. 

Takamine (11), Jowett (13), Stolz (14), Dakin (15) and 
others, labored to determine the structure of this hormone, and their 
work enabled Friedmann (16) in 1906 t© establish definitely the struc¬ 
tural configuration of this substance. These observations are of con¬ 
siderable historic interest since they represent for the first time 
the isolation and synthesis of a pure crystalline hormone. It is in¬ 
teresting to note that the synthesis of this hormone by Stolz (14) in 
1904, and Dakin (15) in 1905 preceded the determination of its struc¬ 
ture by Friedmann ( 16 ) in 1906 , 






■ 

- :• • ; 

... . rt':; 

:t n.v - i 





) 0 


. 


1 " 


■ 

• i ■ I'xo 


• 

: ' 


• ‘ - • ■ ' 


J 1 ,; -o: ( ; • •• 

' 'a: 


'/> ';f : ’ «, ’• OS 


i< . : ;1 ■ •. .. o' : 

’ rr .{-r y{obUv 'oi o ■ fv 

l 


' 


'} */'■"' \o : ; i" 

■ • 

- 

ni a*o.‘ r -l '*io*'rn o 

' iT 

• ■ rj - r ■ ■ 

' 

f' ' ■; f, 

\n -•; : . v ‘ mi. ' 


y ' ' ' I • '••• '■ ' 

■ 

1 


oof'i " o ■.■ ■ /V:,.oo ..'o J c-i 1.0J ) "f'A 

' 

VV, • : "■ . : -■ ■> ■" V " V ■■■' " ■" 

• . • j.f : i ;■’ «> noli 

.. 0 .,V -cJ-'oi::: /: '. i t'-' ^ - :>iv'.r-r 

„ - ' ' I TO ‘ ' • ■ j o;jD 

- • . ' , ’) ,1 ' , 'V . . ) ’ 

' ; ■ m f -■'•rrn--' v- r { ■ ■[ o >/ r ‘:'v ’ 1 ■ ' 

' 

.-r ‘i;■)!> ! -T u'..K?j. ff J: ( 61 / -'o: ■ y rv ' ,r 

: r . : y,-> • ' ■ v . . r ■ ;■ ‘ • : ' ; '' ' ‘ 

. • ; ■ ; . ■ - ; v 5 ; ■ ■ : '■ ' • " ■ ■ - 

,• vr 'o l: v . ■ ' ; ' ‘ 

■ • ' ' . ■' " ■ ’ ' ' 5 

■ in ■ ■ jo ct 50 W i ( '■ ) ; >t V* .} 

. : ‘ ■ 1 .. r' : • v ■ ‘ ,y 



4. 


Numerous experiments were devised and theories elaborated 
concerning the physiological role of adrenalin. Oliver and Schafer 
(3) in 1395 previously demonstrated the immediate and marked rise of 
blood pressure produced by the injection of a medullary extract. In 
1399 a similar extract was observed by Boruttau (17) to inhibit the 
tonus of the alimentary tract, and Blum (13) in 1901 showed that an in¬ 
jection of epinephrine caused glycosuria. He noted that this was the 
result of a hyperglycemia produced by glycogenolysis in the liver. 

This was confirmed by Mann and Magath (19), who showed that the hyper¬ 
glycemia did not occur after the removal of the liver. It is inter¬ 
esting to note that Cori (20) later showed that the mobilization of 
all the glycogen present in the liver could account for only a part 
of the glucose which appears in the circulation after an injection of 
epinephrine. In fasting rats he found that epinephrine caused a de¬ 
crease in the glycogen content of the muscles with a concurrent in¬ 
crease in the glycogen store of the liver, and postulated that this 
was due to a break-dawn of glycogen in the muscles to lactic acid, 
which in turn was re-synthesized into liver glycogen. The further 
break-down of this newly formed glycogen was thought to result in the 
hyperglycemia seen following the injection of epinephrine. Gannon (21) 
in 1922 attempted to explain the function of the medulla, and pointed 
out that epinephrine was serviceable in lessening muscular fatigue, 
accelerating the coagulation of the blood, and in otherwise aiding the 
organism in an emergency. The preoccupation with all phases of inter¬ 
est in connection with epinephrine diverted attention from the problems 
associated with the cortex. 



.'o. t 

il • r 

£O0dd dro: 

> 



r rJOTf 

< ;;V. 






■) r<nv, v i\ 

ootid) 

lara-dxa do 

• I; 

i 


odd 

' 

L* ■ 

ooo rtoo 



do:;‘i ■!. 

da...: d d .. 

■(' > i. ' ... ' 1 

;n<• d 

• dl;; 

' 



d r 

(; ( •; ) 

. 

do. 

•■•;:d o ■ v\ 


aid ;. 

• • 

bvpl 

: (■ * 

f.a::r 



y oi 

odd. 

' 

d 

r (Vd) ;;;d 


; Y':':a)do a o' 

. ■.. .* 


■ • 



. pop f 

■«« - 

r. d 

■"‘i 

, • •yoo;. ■" 


( d) x-jjld 

;.:; . a ■> 

" ' V. 

’ 



do 

■ oonc/d 

odd CO 


. i.C . t ' 

d £;> d ■" 

♦ 

0"o r d-: 

) Of; 1 

■'d'd/' 

‘ M 1 

!•: 

f 

. <J f) l. • 


-id f •' ' o' : d ' o . ' d ' d^ -d.:ov;a: 

id, ). r< > (. { - , ,! J n > :) 5 a."- i ■ y m ' :t ' " r.: d 


. i :;;i: dX . ' ' . cl d : ‘ ' 

Jo ' ' - c • b to •• X ( ) i '< ■ - < X ; " 

;■ - ■ 5 : £< - o' }00 ;;i - 

- ; ;-f / - • , ; - . . dj r;f : ' < • >i ' - ^ 

; . . xi 

;;<i.yr*rs . 0■. • dddo o .d.r If -•do do •' (7 Cj ':/ 0 fO ’C/0" ' Odd J'vf OuOOMO 

id; ;d !,.;]• o d ,d' :{y . 0 :' f *t "7'1 ' dd dn d.od. fo ' CO \ ‘-dd f.d: coroyfo 

, '• s o.drool cd . ■ ■ : . s <Vi >. rry« -./lap'i s ee ; ?< \ 

•/ ; : .;d.r y,;. . d .. oa-o-y'dd; o; "yd.-d 'ad;-.,/-; -o: : 'd-d ro. o y-v : 

odd ;d: d.dri dd J v;- no" o.y x.iwr. a oil o' to ?y.;r;y-y._.o.. 0:0 

(dd) .dyj/iiud'di'do /!., noddo-d oi odd .ndyolded ;ryoy yiiyrooydyoay/I 



i 'J Jo aC’ld; 

: i c 

cd .Dfdvdrrr-'dj'oi d' d;J.. ici: 

Id o ! .;,o 

J. ; to ; ::: d nd 

; oo.drcoo ■*, »■ ’ 

: d : . ' ' : • r 


: i , ! H ( OL 

' dO I ,.td i £* 

a o,oo odd dfoL.:oo‘ : [:'or:;;0'>'j O 


, c ' 

I • tdyodd ; v t > i c. d . I ■ ) d: .1 tru o ' ■■■ s 


^ . j rj ■ t > 



5 


Soon it became apparent that the medulla was not essen¬ 
tial for life, and increased attention was directed to the cortex. 

When Thomas Addison (4) noted the lesions which accompanied the syn¬ 
drome of adrenal cortical insufficiency, he provided the first tan¬ 
gible proof of the important role played by the endocrines in inter¬ 
nal medicine. Brown-Sequard ( 5 ) soon thereafter reported that the 
adrenals were essential for life. That the substance necessary for 
the maintenance of life actually originates in the cortex was first 
demonstrated on elasmobranch fish, such as the torpedo, in which the 
cortex is separate from the medulla. In 1913 Biedl (6) extirpated 
the cortex in the torpedo and observed muscular weakness, convulsion, 
a decreased respiratory rate, and death in three to seven days. 

Similar observations in 1914 by Crowe (22), Wheeler and Vincent (23) 
in 1917, firmly established the critical need for the adrenal cortex 
in survival. These workers excised one adrenal in mammals, removed 
half of the second adrenal and cauterised the medullary substance in 
the remaining half of the gland. The animals so treated survived for 
long periods in relatively good health, so demonstrating the relative 
unimportance of the medulla. In 1923 Houssay and Lewis (25) split the 
left adrenal of dogs, excised the medulla and ten days later removed 
the right gland. Their animals also appeared to remain entirely 
normal. Hartman et al (26) in 1928 obtained an extract which he 
called "cortin", and which was capable of significantly prolonging the 
survival time of adrenaleeternized animals. Similar results were noted 
by Stewart and Rogoff (24), who one year later showed that the lives 
of completely adrenaleetomized animals could be prolonged by the in- 


(TO, 


■MT:ro To :■ Oi. T-Oli.J 'ijO'r 

' Hj- .70 77.1'.' 7 7. 7. ' 7; ' 7 07' ; . 0 7.7 fO< 7U 

, V. ,;• .;.. ■ • ,. '• . ,■ .-:••» ' '' • 

", : : 7. V, : , V O 0 ", ‘j. • O' O' . . '... .7. •■07 7. 007 

-.Xpr-n Oil .0’ oCOTV lOCOOO 0,0 .0 i 

■• ■■ r; , 7 X;.loO 0.ri;X i.-o 0 7 -os. :TjS: J . 

X u7r ;. , , x'j . .‘:vv i 

, , . 77 0-7 -O'- 70 00i: 7. . V 70 0 .*. 'O' 07 > ’ 1.C 0 r -O 

•tot;!X oo.oc r . r •• 

: ■■ 1 o'. - T " X r ; -"- t 

oJu 1 0. v o 7X00.0 X : 

■ .0 -:oro'i . 0,0.0. 

‘;r• /r ' O'!.: 1 . > 'O' ; •0 ! ' -.‘0 .. O' j ' ' 

.0 ■; 7. „ 0 ;: ■ ■< x : loo -■ - • • ■ :.r o? 77X0 

-W/1X 0,0; .7 1 007 7 00 • 

J' ol .070 ' U '' ■ 1'7 ’ r\ 11 1'C • 7 ■" '• ■' 07: '.['Ml 0.0 X 

f .VX 0.0 0707 o'. t - '>• ; ' f >X 

•.jo, iU.rr-. .(■*.. jo 7 07 77 07. :>' T oo;'• 0 0000 l;y 

j . X ■' ' 0' ' 

TO00,0:0.07.07 ? 0 7 77.7 : O0 : 

TO," 1- V-. 7 0 1. : 70 • GO ' O- .7 O'! .1.7 ’.'C v". <7 0 01,1 

. 707 7 : 71 V 7 7' Co '7.. 0.0.7 

: 1 ./ ■: 00v 7 , 7 07 7’ ' X " 0. 77 1 0. ' 707 7 'b .3- 

(to} .'o V .1 no or.'-lo ooo 

■" ' ■ r 4 \XP ' j. ' C14 :v ■ : *0 7. .7 i 

•7'.. O-'! 1.0/0 07 • : , O 

- ’o' ■ .. ii ■ 70. - 07 - , 

0).. VO. ': ■; :. V i J’ 0 

. O0 0-! '07 ‘ ■ 7 7 1 ... V ■ - 07; : J 

o.i: o:.oo: ooo.Oo ' " 70 ’.a.7.0 • 0.. 

o ; ox ,j.y..O) 7)10 A. 70 ‘"070 - 1 0. > ' : ' ,o-.' 7 0 1-OOii: 

icx o:.v.lv-.';n loo 0 oX 770 7:1 

- 

' 

■ ' 7 7. 7 . 

'0 o'ol ■ i 'O' C ' 777 V . 7: 07 "0. 0 o ■ . v . 70 1 

IT 0He.;77 (XX), obrol 7,0-' vy 

■ „ r ' . . ' . : 7 

boV^-.'C'X TOj. 'X 0T7-1) ft'! 0 

1-0:0 00.1 :-70.07 00 f 0O,..l 1. • .0.7 0 11/1 

, / 

V v f 1 ' ' . ■ ' ' 0 1 

0 0 Xol.o TO 7 777 O’ ffO 1 

.. ' / 7 '■ o, . i 1 1 ( 1 ) 1 ■ - . > o' ,.77 7' 7j] ' 

. 

: VO 7 ' 0 O' V./ fl) 1 1 O 7 . : l./0,0 - ' .0 7.1 L 3.). 

■ tad ■ . • * ‘j i . 

. -.1 ; J 7; 70 i. 77 ' 70 ■ ’ O .J 7 1 J. 'v'TOO 



6 . 


jection of a cortical extract combined with a transfusion of saline. 

It was in 1931, some thirty years after the isolation of the adrenal 
medullary hormone (11)(12), that Swingle and Pfiffner (27) utilized 
lipid solvents in the manner first used in the isolation of estrogenic 
substances, to prepare a highly potent cortical extract. Soon there¬ 
after, in 1933, Grollman (28) introduced a simple method of concentrat¬ 
ing the active principle of the cortical extract by absorption on 
charcoal. 

The isolation of the crystalline steroid hormones from cor¬ 
tical extracts was achieved by a number ©f investigators. In 1934 
Kendall et al (29) announced the isolation of a crystalline substance 
capable of maintaining the life of an adrenalectomized animal. Winter- 
steiner and Pfiffner (30)(31) and Relchstein (32) also obtained active 
crystalline preparations. During the following three years contributions 
from the above laboratories finally led to the elucidation of the chem¬ 
ical structures of many of the cortical steroids ( 33 )( 34 )( 31 )( 35 )• 

The first partial synthesis of a corticoid was announced in 
1937 by Steiger and Relchstein (36), who used stigmasterol as the start¬ 
ing material for the synthesis of 11-desoxycorticosterone. As was the 
case with epinephrine, this compound also was synthesized before it was 
isolated from its source by Relchstein and Euw in 1938 (37). More re¬ 
cently 11-dehydro corticosterone (Gompound A) and corticosterone (Com¬ 
pound B) have been prepared (38)(39)• In 1946 Sarret (40) in co-opera¬ 
tion with Kendall succeeded in synthesizing 17-hydroxy-ll-dehydrocortico¬ 
sterone (Compound l) from desoxycholic acid. To avoid confusion with 
Vitamin E the name of this compound later was changed to Cortisone. 


. 


[ij 


J; o vMidrxo 


: ■ r 











: c 


til h f : . incur- i ;:T,r 




y;i.<.).-) ..,’vi i-.s 


--ICO 


\ 





) (i-Y- ) 


\ 


: : 


- ” i; •• ' i 



7. 


In 1941, some years before these pure hormone preparations 
became available, Hench (41) noted the possibility that rheumatoid 
arthritis was a reversible disease. It had long been known that the 
condition was capable of undergoing a spontaneous remission, particu¬ 
larly during attacks of jaundice and during pregnancy (42)(43)(44) 

(45)(46)* On this basis Hench speculated that the factor which caused 
the remission ms possibly an adrenal cortical hormone. 

In 1930 Smith (47) demonstrated that adrenal cortical func¬ 
tion ms regulated by a secretion of fhe anterior pituitary. Three 
years later Collip ( 48 ) isolated an impure w adrenotropie n hormone which 
contained the adrenocorticotrophic principle in potent amounts. Pure 
forms of this adrenocorticotrophic hormone (AGTH) were subsequently 
isolated in 1943 by Li et al (49) and Sayers et al (50) from sheep and 
swine pituitaries. The addition of AGTH to the growing list of hor¬ 
mones being isolated and synthesised at this time provided still another 
means of studying adrenal physiology. 

Selye ( 51 ) brought forth his theoretical concept of the Gen¬ 
eral Adaptation Syndrome in 1946. His experimental observations led 
him to conclude that many seemingly unrelated diseases were due to an 
imbalanced elaboration of the cortical hormones, which resulted after 
periods of continued stress. Among such ’'diseases of adaptation” as he 
termed them, were included rheumatic fever, rheumatoid arthritis, gout, 
nephrosclerosis, hypertension, periarteritis nodosa and eclampsia. 

In September, 1948, shortly after compound E (Cortisone) was 


synthesized, Hench et al ( 52 ) administered this hormone to a patient with 








VK 









:cri I ' cbioo 








W 0 



3 ' 




ft 







8 


severe rheumatoid arthritis and striking and rapid improvement in clini¬ 
cal and laboratory features of the disease resulted. Subsequently in 
1949 these investigators reported dramatically favorable effects on 
severe or moderately severe rheumatoid arthritis with Cortisone in 
fourteen patients, and with adrenocorticotrophic hormone (ACTH) in 
two patients. 

These observations initiated a series of experimental and 
clinical studies designed to determine the function of these hormones 
in normal adrenal physiology, and their possible usefulness in treat¬ 
ing disease entities® 




. 


d . f : '; 

or:cold'HoO xidio? 
fj. (id’O.) OHO; or: od.. 


^ ■ . i:rr;3 aiJ'I ’ r 

. . i'll o od 

- ~ • ‘ - . ', r, j- j. f; , i id . \ X 

rj j • "H V •/. d oOH ‘‘0 "0 V ■; 

: /idoo.-j""oO' H. -I."j' .iivi:. n: ■ oRd'ro. ilo: r:r d'-ro‘I 


. d :: t ood 

y\.\‘ ‘ 

.j- r > r ; v lo , ' • '• ;>od o'.,o' 'J. oh .ti.•Hi o xsivoii* 

. mh , o ; : od) : i nio 1 .odr.iio 

■. ,, .' : . o i id o *, - f •' ; 1 - 

. o: d f : ;o o'. ■ ' "V-. 





1 











A REVI m OF THE LITERATURE 


1, The Effects of Adrenalectomy : Adrenal Insufficiency. 

Adrenalectomies have been performed on fish (6), frogs (53)> 
birds (54)> rabbits (55 ) 9 dogs (56), cats (57)(58), rats and mice (55) 
(59). The importance of the cortex for the maintenance of the func¬ 
tional integrity of the organism has been demonstrated conclusively. 
There now remains no doubt that the cortical cells of the adrenal 
elaborate hormones of vital importance to the organism, for death 
rapidly follows excision of this part of the gland ( 5 )( 6 )( 53 )( 60 ). 
Attention is directed to the multiple disturbances which follows hypo- 
function or ablation of the gland, 

(a) Survival Time, 

Workers using extirpation techniques have noted that the 
survival time of animals may vary under certain circumstances. Sisson 
and March (6) reported that adult animals survived longer than did 
those of the same species -which were immature. Optimum pre-operative 
care was found to increase the survival time in rats (55). Animals 
subjected to stressful situations, such as poor nutrition or abnormal 
temperatures prior to adrenalectomy, were noted to succumb more rapidly 
than those which had lived in an ideal environment. 

The completness of extirpation was most important in deter¬ 
mining the period of survival. Any fragments of the gland or access¬ 
ory tissue of similar origin may hypertrophy sufficiently to permit in¬ 
definite survival of the animals (62). Some authors (55)(53) reported 
prolongation of the survival time of adrenalectomized animals during 







O y 


' 







%'Q ", ) -' Y 


Y :J n.: 


l . ' • J 





',.c ’v" r ;yj ■ f n.i b 








10 . 


pregnancy, which may be due to fetal cortical hormone passing through 
the placenta to the maternal tissues. Sex, however, has no prolong¬ 
ing effect on the survival time ( 56 ). 

(b) Physiological Disturbances. 

The physiology of adrenalectomiaed animals in adrenal in¬ 
sufficiency is disturbed in many characteristic ways. Some phenomena 
are not observed in animals surviving adrenalectomy for a short time, 
however, after the introduction of cortical extracts (24)(26)(27) the 
survival time of adrenal ec t oral 2 ed animals could be prolonged, per¬ 
mitting observation of these animals for longer intervals. The changes 
which occurred during cortical insufficiency were observed by gradu¬ 
ally discontinuing the administration of these extracts. 

(1) Anorexia 

A loss of appetite is one of the earliest symptoms of adrenal 
cortical insufficiency in dogs ( 56 ), cats (57) (58) and men (4)* If the 
animal survives adrenalectomy for some time a marked inanition is 
usually seen. 

(2) Adynamia 

The increased fatigability noted by Addison ( 4 ) is seen as 
cortical insufficiency progresses. Muscle weakness (6) (53), which is 
evident in smooth as well as in skeletal muscles, is soon replaced by 
paralysis, or convulsions (6)(55) not unlike those seen following an 
overdose of insulin (55)® That the observed prostration and weakness 
were not due to a paralysis of the muscles or their nerves, was demon¬ 
strated by Elliott when he noted that the muscles of moribund animals 


rrfrov J oOro on ornf o-v f lr.:r-Y?6$& eun od ■/ ■■ 

■ ; j • : ■: • ■: . ■ ■ v . , : 3 . J : ‘ ' ■-• O' < ■ ' ' ' 'H 

t . . • ' ' 

• ■ ' 

-ai • d ' > ' ' oioizx 

< : ■( fo r l: ■; : >■; . r 7 .:> " ' . o ' 

) 0 ■ 101 . i ^ 3 rdv r 

(v"?)(m ';5 (V,;) j-. : Jo-iOooo xo ncad'.; u co J..' outd o 0 : ' v; 

,. r ,• t .o.-■•■.■ '-.r.-j’.c'.f 0 Jno rlo. : n • to.::r JornoJtn ‘to or Jo ! -/• 

oooroufo f;xii .olrTi J.nJ 00 nol’ *.col oJ or Jr: r ; <dt 'to nolo* , T': eooo 

• • ‘ J V o : 'I ; r ' . . ' . fclf- - ; 

. - . ; • 93 e x ■ ■ l ■ e nx to 0 : * 

oJ.oronoJ ( 1 ) 

' 1 ' 0 ' ‘ , tO ■ ' - ’ ' 

o <& . .( .. t -- { e! (\ ■ ■ *(< : \ ' o u 0 i ■ •■■■ 

n J.'' r J do.or .0, ’ ; : j ;oo ooti: V- ■ do J. 'O' ‘O; ; 3 '7 -0/- . : 0 * 


. 

\1 . srr > J . 

3; ;' - 9 7 ff,;,--;.'. 'J or h. o \' J J'r Jd.su ■). ■ -o-oOfi;J •: o' 

• O.. :r # ( ' ( ; ; ;j . o' 't 'Or' 

-/ j v o o ' vr I J' J.. : i '■) : ’ o ‘ or o ' ■ • ' -' v ' 

n..: •; ;» : ; ■' ;c,.. 7 oio/r /oo (c:)(o) oof- oo V;'( 3 o'o O.oo; 7 

; :o - :r •, i •. : .I - .' oo o- v oo l to to'.-.o;. J: too ooo: 

o ? : - r - j •; ■ j. J-;- oo o ..to : o. • - ,ot;' J.0 or y v :t.O -XT O' <:;o n . J'oo 

;Jo. J.o ; to-.'lo:o- J.o o o/o ;.07 i-ii& J Jooon or 09;io o. it . '.o Jo J 


' 


• O ■■ 

'/'■ [ r o;.; 

‘ 

•)Joo 

vi: j: ' 

j 003 

r J : 

■ D 

r 

■ r •, f 

":.' 0 ', 


11 


could be stimulated to normal activity. Further the fact that con¬ 
vulsions may occur supports the thesis that adynamia is the result of 
impaired circulation producing a central nervous system anoxia. 

(3) Temperature Regulation 

The ability of the adrenalectomiaed animal to regulate body 
temperature, -when exposed to a normal environment, is markedly im¬ 
paired. Adequate adjustment cannot be made to either excessive heat 
or cold and the temperature gradually drops as the cortical insuffi¬ 
ciency becomes more severe ( 63 )• In effect the adrenalectomized 
animal is poikilothermic -while the non-adrenale ctomized animal is 
hemothermic, in that it retains fee ability to maintain a constant 
body temperature. It is thought feat the inability to regulate body 
temperature is due to the impaired circulation and to fee lowered 
metabolic rate ( 64 ) 9 for it has been observed feat the diminution in 
oxygen consumption and body temperature are directly proportional to 
the degree of adrenal insufficiency ( 65 )» Respiration due to muscular 
and circulatory failure usually becomes slow, and progresses to com¬ 
plete respiratory paralysis (62) and death. 

(4) Circulatory Alterations 

At first the jalse becomes rapid and may be irregular (62), 
but as the insufficiency becomes pronounced the pulse becomes slow and 
the heart may go into a slow auricular fibrillation (66). Cardiac fail¬ 
ure is accentuated by the diminished cardiac output produced by the 
decreased heart rate and fee progressive decrease in blood volume, as 
indicated by increased hematocrit values (67). Hypotension is com- 


■ d do 


. J. . 

X’ YY 


' J ' ) •. X 1 Y ' Y Y : C ,'j' ; 

Y ; UYY'OY! O ’ 

" ■ . + * : ' 


' 



Y77 YY,;- : Ci" T- : Y;' 

6 




-XqX X ’ JXryYf YY' X 

■ 


■ Y 



.•YYYYYYYY7 YY i.:,Y 


" 

- - ;j • ; . 

X YY': • V YY:: 0 :: ' ’ 

i. Y .'Co 

: 

y d-Y—..'- i. yy’ n$ 

.be 




YY ■ -- .* 

:.;Y . . Y ■ Y \D 

be X o;k> . y 



\-;Y : v ■ 

.VYY yy I YGfe- lo 

1 X • YHY bt s± 

(V. o? I'in T: ... 




■ • • X 

'- y *..•->■ 

•Y u'J i - 

ij r.d ‘i o'! 1 i y 

' . -i' 

YYOa YY Y.YY .Y-- c j 



■' M 

" :U"Yf"C i Y : d' ‘'V'C'-'i 

DOGGY/oX • .YY 07 

,';yy:. nc.tt • J Yy7:jy 

J 

i: ■: gy cur/' 

YY YY TY Y 

fti: f .''.i.r.iYi . . ''i i • ■ 

Y 'YY .0 : ..'V YY Y H 


: •.-■■.!. , (-Y) 


< 1 1 '.' i' o ; y 

yJy) :yyy :-y.i:.y amfd 


Y ■ J' ’ YOY • Yf i fY'J; 

,b:[i.Cr ,v :00 n-vye'Q 

i ’iJjSO . YY - 07 Y.Y f f X 

;- v -i y . ( : 

"’YY Y : 

Y ' 

■ :. lo OYT'Yb • r'l 


--Yu'} CJ ■ . yy y/gIg yyyoyy \Y-if.ri'.: ■ ‘77 X. 1 yxy - 'y - 'J -H. > 

_yX y. V «r > ('•; ol. yyyyy ;• c •'/ • 1 gyy; 'y I-yU; 

1 l 1 . I 1: si " v • 

' . . / f • t 1 •?. "■ Y " Y ■ • ' Y ' . ' 

>j , . y - b 9 Y ill t Y : ; Y - ) , t ' ■ i Ci ' ' : 

. I • .. . J \U J‘rb ‘.1 ' n r ; * < .* o ; • ' - X o> 1 

■■ ; y‘ .yy y’ : ; v:.r yy X. y -y ! >y, • ,_y;y\ yyX \y yJ' 'jYi'Y ’ ■' • i. Y.txr 

Y , Y . . Y'. r • . ' : Y YY ...) !.V' : Y Y; X' : YY YXYl YIYG.X ' >0 R:; Y ' Y . X 

■ . J . X 1 ; ;■ . . Y ■: yy 7 >. :y Y “ YY ... 'v y 7 y yyX 



12 . 


monly observed following adrenalectomy ( 64 ) and reflects reduced 
efficiency of the cardiovascular system during insufficiency. 

Differential cell counts are also altered in adrenal in¬ 
sufficiency. It has been shown in cats that there is a relative 
decrease in polymorphonuclear neutrophils and a corresponding In¬ 
crease in the number cf mononuclear lymphocytes (68). 

(5) Hypersensitivity to Stress 

Perhaps one of the most consistant physiological changes 
observed in adrenalectorn!zed animals is the altered sensitivity to 
all forms of stress such as heat, cold, exercise and emotional dis¬ 
turbances. Adrenalectomized animals are unable to maintain their 
body temperature when cooled ( 69 ), and it has been reported that the 
metabolic rise which normally follows subjection to cold does not ocdur 
in adrenal insufficiency (70) • Adrenalectorn!zed animals can be thrown 
into acute and fatal insufficiency by subjecting them for a few hours to 
temperatures which the normal animal can endure 'with impunity (70). 

Such animals are exceedingly sensitive to toxins (71) (72) (S3) and are 
very prone to infections. They succumb to disease processes which 
usually have only trivial effects in normal animals. 

(c) Pathological Disturbances. 

At autopsy adrenalec torn! zed animals and humans show very 
little pathological evidence to account for the diverse symptoms seen 
during cortical insufficiency. 

(1) Pigmentation 

In clinical adrenal insufficiency the patient* s skin becomes 
characteristically bronzed in color. This pigmentation, first des- 







;y. ;,//> AX •; , • ' (•/;.. y< 0:' ' J 'A; ' ‘ 7 X S L.'/l h V 1 rAy yXror 

'■ r y ; , r A O '0 • iA' Ar A' -■ - ’ r r 

. ■ • / ' . ■ t X- ■ 

f. tfii ’ • 

, ■ - . : •? 

. { A) 'V / ' ; X f • '■ •/ -iVif. ' ' -XA i A O 

;• •; ' r v - ' ' V . j \ ’■ 

ycryrb AA/or C.A/ Ayr A - • A ; A; . : ro •:/ ’o ; " r :A Ac ■' , r r. -rA A. 

I ' : ; I C ' \T . > 0 


A j ^ArrAA !•, ‘j r- r. J: 


c. . v . c. 


AX-.;.? , i • a t • '.-0 rn' oX XI.S 


£X> 0 


' ;■ " •• A \ r . ' A ■ i. * : i ‘ v 


£. it : & A toe * i 

il 5 ' . • f Aj j 

’ ' A ' ' / ■ : 

’is.'DOo .tore w,o' A'.ro f --.y 

iK'.'.j'OO AAr; 

y :(■. .A :A yAA '• 

: or i '. A A •' ■ A/. •/ AAA- Art y ■ 

■ n ;o*:c.Ai oA ;t '0 :,.ii • ' 

Aryl/ oA o :1 

y -A • . . A 


ot yyyjoA v/.:; y. *'i;oA -yyA- 

A J o j; 

y' A>1 A 

" j n A. X -A A 1 : • a r A:/o y cJyr; 

. ( . 'A: -A ’ : ■ A 

/. • fry 

; Ay/.y Arr 

■yr; ..]• yAyA'yy - y; •■;;//, /r/r :rrt 

'.'i '. Ayr-;, (y ) ( AV) ( A ! ) 

•"y A. y;,t :r L / 

r/A/y/ryr vSry 

, o X • r t ..r :ff!j 

rial A- DA ‘ 

: rA ’ ( A 

A r/y/r: v yy/A 

• y 'A : i ‘ :> V 

. 

i 

;A: /,A'. •. AAA - J! 

../.A. /A :. 1 vJAn.o f : t v ;A ' Al ;r :;/j 




' i' . - J: 1 . J ( 

•< ;/r v ; X.y ::: Ayyyyy .yy : i ' .. - '. r-S. 7r i rAA V 'A'• ./A 

t ' . • ■ «*i' v lh . j ■ • ' ■ ■ i l f ' o J. _ ' I 

. 

j 

' A A 1 Mt It y.iA v/);:. A/Xy AX r yX A. vy yA:r I y; AAT- rl 

. ■ A ; A . . . -' ■ - ' . • .A • 


13. 


cribed by Addison ( 4 ), has not often been produced in animals. 

Harrop and Weinstein (74) reported pigmentation in an adrenalectora- 
ized monkey, which was kept alive for several weeks with cortical 
hormone, but other attempts to reporoduce this phenomenon in animals 
have been unsuccessful. 

(2) Other Autopsy Findings. 

Perhaps the most outstanding autopsy finding in adrenalectom- 
ized animals is the marked hyperemia ©f the visceral organs, and the 
frequent occurrence of hemorrhages into the gastrointestinal tract 
(75)* Gastric ulcers are often seen and are usually multiple and 
cone shaped. Mann (75) has demonstrated feat these lesions develop 
in the absence of pancreatic secretion and bile, and are, therefore, 
not due to regurgitation ©f these fluids. 

Degenerative changes noted in the liver (76) of dogs have 
been thought perhaps to account for the abnormal carbohydrate metabol¬ 
ism of adrenal cortical insufficiency. 

Hypertrophic changes have been noted in the various compon¬ 
ents of the lymphatic system. Such changes were described by Star (77), 
who recorded the persistance of the thymus in patients dead of Addi¬ 
son’s disease. Jaffe (78) has commented on the similarity of the gen¬ 
eral lymphatic enlargement seen in Addison’s disease, and that seen 
in the so-called "status lymphatieus”. He calls attention to the fact 
that adrenalectomy in young animals stimulates growth of the thymus, 
while in older animals active regeneration of thymic tissue occurs. 
Enlargement of the lymph nodes in adreanlectomized dogs (76) and cats 
(79) has been described. 




. ' ■ ■ at 

-■'•o' 


; ■; • ;■ \ 


rx • 

r.f;. ■ 

{ 

. •• ' ' /• *, 

■-'Ci-ati 

•r D ’ 




r: 

; .;••• f/. ■; ' ; 


r - xx s' •* ; c:' X' 

t:<" a. 

*‘SQ| 


, ' , •; n '• ■' . V ;.rf. 


. - '-c.6 ■} \ -v: 0 ( 

rh. . ‘ • ( > ■ ' " ; ' ' ' ; 

t . M r ..L-;:!■ cst ":t ‘sis tarJ: 

■; $ : ni - ■ • :: " 


■ til!: : 

■ sat.:-r K . t .. • r t -t ■ ,1 m nva : x'fOv- . o ■' * 

' ■ : r ”:. s la 

ot\t . 

. 

o oloV.: I) 

o..v j. ' . A .,/■ r : : :i , v> ■ ’' 

S') 


: 0 

1 

. ■ . • ■ 

■ i ‘ / 

c.O'! ' 

at 


■ . ■ : ■ 


07 ii .o’; xO V'-. ) . o' -• •% O. j f ' ; V' Sj . 

. [ , j i i .1 n ^ 

*■ ■ / .V . r•• ' . ...o ‘ ■ • •• ';.o i x-i.:: 

-•-nouioo srctssv ussa rl ^stva. asst ■ v : ass as us oJil . c/urrasst 

v, ■, v. .. : ; 

£ ; , . . . 'i ror J I ;"C :j ;•£ Oi[w 

- : •;., : •; •.- •. . ; - ( v) ; ■■ .- -' : • ! ■ " : - 

: d - ■- ■ ~. ■ 

. . . , H h -< ■ xifc 

, *:tr . •. : ’.: • J- o T • J'.'uiJ 

, ; r • V.‘ ■ ■' : ;■ . r; f i-.v\: c v. : ,.S ; i: 

( V ; '} •• x-J' •£>„; i.:: y- .jt Vl r-rit io 

' /doJ ( r ?V) 





14 


The heart has been observed to be filled with clots formed 
during life (80), which is probably a direct result of the hemoconcen- 
tration which occurs in adrenal insufficiency. Controversial evidence 
exists as to the effect of adrenal insufficiency on cardiac action. 
Dilatation of the heart has been reported (8), but more recent work 
has shown the heart size to decrease in chronic adrenal insufficiency 
(82)(83)• 

(d) Biochemical Disturbances. 

(1) Sodium Loss 

In adrenal insufficiency there is a marked abnormality in the 
metabolism of sodium resulting in a negative balance of this ion, a 
fall in the total electrolyte content of the extracellular fluid, and 
a shift in the distribution of the body fluids. 

Loeb (84) and Harrop (85) and co-workers have shown that there 
is a negative balance of sodium and chloride, due to the urinary ex¬ 
cretion of these substances in excess of their intake. This condition 
is reflected in a fall in the concentration of sodium and chloride in 
the serum and extracellular fluids. 

The loss of sodium is probably the result of impaired renal 
function caused by the lack of the cortical hormone and is accompanied 
by an increased elimination of water and dehydration. The kidney fails 
to re-absorb a sufficient quantity of sodium to maintain the normal 
osmotic pressure of the extracellular fluid (86). With a fall in the 
concentration of the extracellular electrolyte, the extracellular fluids 
become hypotonic relative to to the intracellular fluid, and consequently 
there is a shift of water into the cells resulting in anhydremia. This 


f : > ■ ' 6 X ' J ■ 

■:; : . v;,l ; • poll ' » ll: j ;n.i • i'SD 

. . ; . 

. - l ‘ ' li$ ■ i : ) 

„ . ; f i i o . * u ’' ‘i j i ill I s > O’ - o. 'Jpi.JHf 

■; •: . ;■ j 1 • ' f: ■>. ' - .»'• r (. 1 ’ 0 VJ.. 

00 )(■■■■ > 

. : " ■ '■ 0 . . { : 

’’ Pi !. LiL : .K >> • \ .• 

’ ' , 1 ; .< 1 ' JT/-. 'i 1 00"! lo - Pill ololom 

• o 11 ' c lirinoo lolol ool ni: Jlult 

.poll!: p". <vf •!! lo roll • ill’ll,, 11 : .11 < 1 : llloo .a 
1<:y. • - p-. (".• ] : c :v r. • ,1 ' (’; -,c ) ■ iVloJ 


lo •: 

'.0/1! 

. ! V. 

' ' ' o i 

Of- 1 


.■o\ol 

lo nc .'l.oo 


: 0 ; ■ :L 1 1 ■! *3 1 £ >'lloll *1 i i 

. -J.: • 1' oo ■' -. I :o a v: ....1 

a: arl ‘Idi-KiT: a! roll>oa lo aid iiii? 

:>1 i -p.■: civ orl lo lo -1 oil pdo a ndliara.lt 

1 .. : : ctJ:d:I« 

; d. ,ca X • aodl aiao l.r. ddd ; ;■ :o”. J cl 

1: ) p.Vp';. Ip.pl 'OX- 1 J.o p'p;v’.; • p. ; oJ.1o.p:jo 

• ■ ’ o 

v/ltii: pH icl pvIIpIc s .,c £>j:j:ic.l'cx ; "P'i icnoopa 

.1.1 p i.ill fi.J: ppl i : lo 11,11 . :> f.L c.l 


. . 't 



15. 


phenomenon is seen in Addison*s disease and in the adrenalectomized 
cat (87) and dog ( 64 ) • In addition the existence of a negative water 
balance has been demonstrated in the adrenalectomized dog (84) ( 85 ). 

It is thought that the water loss is the result of mechanism directly 
related to the excess loss of sodium in adrenal insufficiency. 

The lack of cortical hormone permits excess sodium, to pass 
into the glomerular filtrate making it hypertonic relative to the body 
.extracellular fluids. In order to restore isotonicity, water passes 
from the extracellular compartment into the glomerular filtrate. This 
water loss, however, seems to lag somewhat behind the loss of soditqu 
Because of this the extracellular fluids are always hypotonic to the 
intracellular fluid, and water shifts into the cells in an attempt to 
maintain the isotonic state. With the shift of water into the cells, 
hydration of the specialised osmoreceptors (88), thought t© be located 
in the region of the supraoptic nucleus, occurs. The resultant distur¬ 
bance of the milieux interior of these cells is thought to suppress the 
liberation of pituitary antidiuretie principle, so augmenting the water 
diuresis (89). 

(2) Potassium Retention 

Following extirpation of the adrenals, there is a steady in¬ 
crease in the potassium level of the blood and extracellular fluids (90) 
(87)(91)(92). The concentration of cellular potassium in muscle also 
rises (93) • The retention of potassium also seems to be due to a renal 
defect, for ordinarily the kidney can prevent its accumulation in the 
blood even when very large amounts are administered. Thus, in adrenal 
cortical insufficiency there is a dual disturbance in the renal excretion 






•otfo JL tc: 






•o 


# 


V 



• ; j 




In 






)C 






< :. 'JC! 'lO-I 


Y ->0 



v. r ./ 


.!> 




)0 ?, 






r D ■ II:. d 


> 


' 



•j'O r > 


m j.o , r r ■ I.t r , I'l 


)( 








! t 0 


10 


jLffijj' v.: n.I';;: n 


• > i j.riirJ' ; i: ) 


. 


1/T- f f 


•) 



16 


of electrolyte, Sodium, which is normally re-absorbed in order to 
maintain osmotic equilibrium, is lost in excessive amounts. On the 
other hand potassium, which is normally excreted, is retained. The 
resultant hyperpotassemia may in part account for the cardiac arryth- 
mias seen in the terminal stages of adrenal insufficiency (62), 

(3) Increased Blood Cholesterol and Non-Protein Nitrogen. 

Adrenalectomy is followed by an increase in the blood level 

of cholesterol (94). It is now thought that this increased eholes- 
trol concentration results from failure of the adrenal to utilize it 
in the synthesis of the cortical hormone. 

Disturbed nitrogen excretion, as well as faulty electrolyte 
excretion, has been noted in adrenal insufficiency. A rise in the non¬ 
protein nitrogen concentration in the blood of adrenalectomized cats 
has been demonstrated (95) • After injections of urea ©r creatinine 
much less of these substances were excreted by adrenalecteanized animals 
than by normal animals, Marshall and Davis (95) also observed a dimi¬ 
nution in the excretion of phenolsulphonephthalein in adrenalectomized 
animals, and concluded that normal kidney function was dependent upon 
the integrity ©f the adrenals or a product of their secretion. Many 
subsequent writers have confirmed their results (96) (97) (98) (99) * 

(4) Carbohydrate Metabolism 

Hypoglycemia has been demonstrated in adrenalectomized dogs 
(100) and in patients with Addison 8 s disease (101). The latter also show 
an increased sensitivity to insulin (102). Liver glycogen reduction, 
concomitant with hypoglycemia, has been described (101), and in some 



. ,; - ■ yro ■ ' r >) 1 : avi ■' 


.. 

■ . 


, Vj a ■ oc ' ' ' 







? 


.. •• ■■■• : • 

» 

■ • • :ir: 

, ■ ■ " • ,- r !,:! - :j : r> 


ion ■ ' - . ■. ■ 


' 

' 

;t ’ '• 

. 

J v ■ ■ * : . ' r 

: ■ • -J- V •; " : .t ' V''-'.’ 

■ ■ ■ - • 

, 


: ■ ' 

.'jnc .1; ' f.. .'.‘.St. : "v,; ' 

• if ' ' ’ I ' 

;• r •'' * " ■" r '. > - . : J - ;>/■ ;.;o- !f c >■ 

rt > ' ‘ ' 

' 

• ■ ‘ ,/r:r J^upbacta' 

. ,:•*!’ r o- r ■; 

r ' w ■ r ; ) 


v' • ' r .V.V; 6 ■ '• 'i- ' 'VW V i 


: ■ : : • ■■ * rvo ? r 

; ' / ' ; ' • '' < ■■■ ( ‘' r ' r / 

. j {'•) / • r 'V;,: * l) 


j f ) 1 V '' 

•' • ' ' • 1 1 oo 


17 


instances the liver glycogen has completely disappeared following ad¬ 
renalectomy (103) • That the hypoglycemia was in no way related to ab¬ 
sence of the medullary hormone has been shown by the experiments of 
Houssay and Lewis (25) • In animals in which no medullary tissue was 
demonstrable, they found the blood sugar to be normal* These observa¬ 
tions were later confirmed by Boggild (104) > "who noted no changes in 
the elevated blood sugar levels of depancreatized rats following the 
removal of the adrenal medulla. On the basis of these observations it 
has been concluded that the hypoglycemia and reduced liver glycogen 
content are due to adrenal cortical insufficiency. Further it appears 
that in the normal organism the glucose content of the blood i s main¬ 
tained at relatively constant levels by the antagonism between the cor¬ 
tical hormones and the insulin produced by the pancreas. 

11. The Effects of Cortical Extract Administration. 

(a) In Adrenal Insufficiency. 

When the adrenal cortical hormone is injected into adrenal- 
ectomized animals or patients with Addison's disease, the characteris¬ 
tics of adrenal insufficiency can be prevented, or eliminated if al¬ 
ready developed. 

Stewart and Rogoff (24) and Hartman (26) demonstrated that cor¬ 
tical extracts were capable of prolonging the survival time of adrenal- 
ectomized animals. Swingle and Pfiffner (27) later extracted a potent 
substance from the cortex, which counteracted the effects of adrenal 
deprivation, and permitted adrenalectcmized animals to survive indefinitely. 

Loeb (&4) (105) and Harrop ( 85 ) had demonstrated that patients 
with Addison's disease and adrenale eternized animals lost large quantities 



'0 ! r 


xr 


.< : <i; j . > c >:: x 






' Q:i 


qj %«rzm 


- 


■ 




.O'J" 




.m .a 


1 n 


;:[■ \j QUO". 


d::j:xu: 


, n r . x 

■ 


f KOc;X::o i 
. / : 


. : ( 5 j . V . 




J-; ■ XO - I •;;; 




/'.V ::r': 06 ::1 s*;d 

:.' b o i'.i :.r. 




■j >j. ,n a - 


7 w 


/ ■ . ! - 


18 


of sodium and chlorine in the urine. Although the animals survived 
indefinitely with elevated dietary intake of sodium (84) (85) (106) (107), 
in most instances such a regimen was insufficient to permit resumption 
of normal activities. Thom (108) and co-workers demonstrated that ad¬ 
renal cortical extract was capable of restoring the electrolyte balance 
in patients with Addison 5 s disease. Serum sodium levels returned to 
normal and the concentration of serum potassium was diminished. These 
electrolyte changes were accompanied by an increase in plasma volume 
and extracellular fluid, and a concomitant rise in blood pressure (82). 
Renal function improved and, if elevated, the blood non-protein nitrogen 
returned to normal (108). In addition body weight increased and muscular 
strength improved, but there was little change in pigmentation. 

Cortical extracts have been reported to restore to normal the 
lowered basal metabolic rate of adrenal©eternized animals (109) , and to 
elevate the fasting blood sugar levels (110), vdiieh counteracts the hy¬ 
poglycemia produced by adrenalectomy. The injection of the cortical 
hormone increases glycogen storage in the liver. This and the circula¬ 
tory improvement may account for the postponement ©f fatigue (111) seen 
following these injections. Further it has been reported that the ad¬ 
ministration of the cortical hormone produces a lymphopenia (112). 

(b) On Normal Animals. 

Similar effects with respect to electrolyte metabolism have 
been produced in normal animals and humans following the administration 
of cortical extracts. A retention of sodium and an increased elimination 
of potassium have been demonstrated in normal, human beings and in dogs 
(108) (113) (114) (115). Lymphoid tissue and circulating lymphocytes dimin¬ 
ish following the employment ©f active extracts (116). 





.. X.... . . . '. • m rlhw 

, (7xx )( lX o ■ V., ;X.n.X.'. ';o;.l !■.• .IX rr X XoX o.X.; .ioXX.XiU: 

.' ... .00.0;,. 5 ) :i ;0 . - ..0-,. ■! Oi-.0,) L; \j <\L0 u . OJJ* il.0 

. ' - } I . • XX 

; j ' X . ... >. X XU'. ‘i X : > S0‘ o ' ■■■'■' "j ' •'I '1 

J • ' ■ 

j.ii , XX J. ..XI » .. ; X .’J',,-; i.i; /j:; x Xo ..X n.nnu o o X : •:i ; .'! ox OH 

.,// . ...' o,;xX. ox o; ■ l- Xu :v rcxo o oxx X:o . X., XnXonlo 

o.xox X : o .0 X-X Xi.oon:0S> „G x : XxX.l XGlailoO• OclvCO XX 3 

:'xx.n.x x n .'.'■-.-■j ■:./j .x..;o .x..X. ,. .• .-J :v „xn n. ‘iioxxof .• ''.. : Tol 

, j ) ' ' . .73. ' . 


... ■ . 1 .. . ; . . . / 0 o o o - ) V =: . 0 X : t '.1' } 

• ■1 x ■ ; x, , • V .. ■ of y / ox ' ■.) 

Go “In .3 o&J; m'yiz xoX. ,.n vj '.Innnon XX) Xxr os: loot.XlX XvtnX 

-x gX .-i ; .. xo, > 1 Xx.X X. 0 " X ooU ;o'f. : J'' x . r'J' ■ : / -i.. 

1 ; ’i;o •. ;; /yy: >,.-y. ■>'. : .o /> [ 

■ y.a-.y :yj ...1' ./i ; 01: .1 * ..■■ ■ J.l : : J 0 I: tif.j/; 4 on;':; ol.; v ( '}iV.>r ; ’XOd 

non; {JX; ) -,;r 1 .7: • n >. >l;iK ^ ..oX : >ol .lo;.onn.. ; ,; : v,o .--n v.. y ./ nl 

: ; ■ * 0.0 ' ' 

.. '1 '■ .' ' ' . ■ . OOOOOO" O'. ■ . Ov.’; r.;.,' O'. 'O'X. 1 ulyi 

# 3.1. v. 'Jo'X. ."'■•ooo :: -.o,' ■*:() 

&J .1 1 ' 00 ...< In: J ,•)',.[.» (J 0 0 ll ? 'U X'OXlln 'yjiiyd■/< 

0 . o . • 1 ; .'..0 0.;/.; 'nOiJO . i- j : y>hl > J o;: :o;:n’ /'Of. !'u>OCf 

■’ ; / ■■■ ; ' . . ‘ ; . o , rn ■. . ;J'o : ■■ .!. v. Ilf :,n ' 'no 


>.o ; ...oo. .' ■ jooooo no- m y> :oo- ; o • '>o 

■ r i >no ..X ■ . r • o: j I . ( 1 0;t) 

- ; v . 1.' '..:o : ::o :■# ■ oo, ,o.y X; ;cXX:X li; 


19. 


Striking changes in carbohydrate metabolism have been noted 
following the injection of adrenal cortical extracts. The early con¬ 
tention of Britton (110) that extracts of the cortex elevate the carbo¬ 
hydrate stores of adrenalectomizied animals above normal have been amply 
confirmed. When given to fasting normal rats, these extracts cause an 
elevation of the blood sugar and a marked deposition of liver glycogen. 
Accompanying this action is a marked increase in the excretion of urinary 
nitrogen indicating that the probable source of the carbohydrate is from 
protein (118)(117)(116). 

111. The specific Hormone Preparations (The Cortical Steroids). 

(a) Introduction 

The appearance of fairly potent cortical extracts was quickly 
followed by the isolation from them of a number of steroid hormones (29) 
(30) (31) (32) • Thus far about thirty steroids have been isolated from 
the adrenal cortex in the chemically pure state. Remaining after the 
separation of these compounds is the so-called w amorphous fraction 11 , 
which is relatively more water soluble, and which retains a ve$y high 
proportion of the activity of the original tissue. Many of the steroids 
isolated from the gland may represent intermediates in the synthesis of 
tiie cortical hormone, or may be artifacts arising from the manipulations 
of tiie chemist. The work of Groliman (119) and the more recent work ©f 
Haines (120) demonstrate quite clearly that the method of handling the 
tissue has a marked influence upon the composition and the amounts of 
the steroids in glandular extracts. The latter worker showed that an 
increased yield of 17-hydro3grcorticosterone was obtained from glands 


".or: a s'V-Zii ryy : ;.uxi' -jou /: y yxVx.xyryx: xl yyqy-yy ";nX.:L‘.-..y.1 

• f; i ’ .. . • • T : ' . ••• ■' ' - - *•' - : -- 

-0 r : y.yt yyi'yv:' ‘y y y yy, yy -.o yjyy.J,:, ■:) :.:J 1 o : yy'.t 

qlyyry n,.-,ry.' jyy :yyy ryyy .■> ■yiycu'y 1 .n" l'‘> ■ 'io '.vyyqr ; ■ ‘j ::.% 

y ■: ' <: •. ■:.■ . ■ v ... . • o 

. : 't ■ y \yy.‘... yy I.yJ..x: y ; > y ;yy y . y y yy ■>: x.\ -ti/ 
yy ’ic j :c : ..x x-xx/y/x: .xxx x •• ... -xJ ' "J:. x x x- • ooo -t 

■ ■ : . U ■■ ' ' x - ’ ni i s 1: t 

. y.;v.a.)(•■:. ,. 

ibl ■ . j . jtfT) a nc-i »xfT *X 

noxb'imbo *x yl (x) 

•• yy’yyjrp x:rr yjxxxx Ixx'Jxyy y • xx '•;/: ix-x 1 ,• /Kyyxxxq x cxf,? 

(?'0 /xxioxycx: '..xxx; , lo y x: ; lo n ylr xc.x‘/ aolb --io-ii osi? v/f •• ;y. I .."i 
....y. y :Jyj / ; : ; .? . y J/ x ■:) . qyx y'' ■' f'" " yy.' . ( "'y qx;) qj■;} 

d : y • : .. yy .' . ■ 

: ' ; ' — ,i\ ' j d ' c 

i.hf '1 ;yv ■ xx'xJ' m. : 'xy xyv.'/ '/xx: yyy y xx- y s Jy -y ,■yyy .y- 

• c ' . c 

'y r,y ; J . i .b yy y\ .f - ' . f.>a b &£d& myij. yyj losl 

y.iy.‘y yy .yy/ i'‘:rrV yy/. .‘y- ..yy ' \..i. ■: -y a /. y..yy.:, ; y. yy.yyyy y. ,y 

. . 1C 

/'■j ■ yy/. 1 '. : r io /.c- / ii>/ v ’, v iu "y y ’ yi.o yyy/ ■'yyy ..tv y .* (u...!.y) y'y/y/yi 

’ ' . • • . . ■ . - ; ; 

" ; ! '■ : v. 'ryyiyyyyyc/ /, •••?/ '..o J.i: .yq V,yy..cy. 



20 . 


frozen rapidly after death of the animal than from glands allowed to 
stand at room temperature. 

(b) The Chemistry of the Cortical Steroids. 

The crystalline compounds that have been isolated from the 
adrenal cortex are similar to cholesterol, and all contain a cycle- 
pentenophenanthrene (121) ring system*, It is because ©f this fact 
that they are called steroids. Other steroid compounds are the bile 
acids, cardiac aglueones, sapogenine and some of the sex hormones such 
as testosterone. 

The activity and physiological properties of "fee adrenal ster¬ 
oids vary in accordance with their chemical structure, which is related 
to that of allopregnsn© (figure 1). The parent compounds of all ster¬ 
oids are saturated nuclear hydrocarbons, but the steroids themselves 
usually have double bonds between the fourth and fifth carbons® It has 
been pointed out by S©ly© (122) that a two carbon atom side chain at 
carbon seventeen is essential for corticoid activity. 

Chemically three groups of physiologically active steroids ar© 
recognized. 

(1) The Desosy- Qroup 

This group of steroids are characterized by the absence of 
an oxygen molecule or hydroxyl group at the eleventh carbon. Desoxy- 
corticosterone (figure 1) the most important member of the group has been 
synthesized (36) and is capable ©f maintaining the life of adrenalectorn!zed 
animals and patients with Addison 9 s disease. Another related compound is 
17-hydrosy-ll-desoxycorticosterone (Reichstein 9 s Compound S). The action 



'v ' r j' - c: j r. : .7- 7 V to ...if yOO ' ■ ’ • V' £ V IlWCAlt 

I 

. ■■ : t. vr ■ *; T X ' 1 77 7 

\ fv7 b.Vi :V 77 7, v;:) V7 1 ( i} 


f. , n , . f . - ' .... 

■ 


7 7/7' ■ 

i 

; 


-o.r-.r-; > • J. •• / ; .o . .. ■ v 

. 

! ■ . :• i t . 

l 

J" ■ Oi 

' ■ f 


; > 7 : h; ■ ■. 7 ■ \, *. •• 7 77 ; ■ i ! / i. , 7 *:t v■: • r b on ' a v 

•. : .-I,..v ■ : 777 i ■ 7 0 •. ■ ■ ' Z « " : ■ • - 0 • 1 : ’ ’ ■■"■'OJ 

) r i v .: . . ' J 1 ' 7 o . tV '7" ■ • . ■ ’0 : 1 

« >.*. r • • ■ ■ : i 7 ; 

•' • .r. ■ 7> ' ' ■ *77, C 7 , r ' " - ' ' 7-77 '' ' 


ik)0 . " 

b 7.; -,Jd- 



■. 00 ; 

"7 -Idio 

~ '':c non: on,-o •<. oul 

. ' :: 



' ■ -.7 ■ -J ■ : ' 

: 

inn's ' ■ ' d ■ 

Mh:>7)0X-Y., f 

in,.. 


■ 

nolo 

. ; :V-.' '■ ^ 7 



112^, ;7 


. . non 

• ■}- l. ; - ‘ i < 7 : , 1 .d • 




. i Xi/O >: 

or '?0lvd' 

' 

u ■ ■ 

,t ? f 



ivssinn 

J',7 ©'-/J;vfo/s ^XX-rv >1 ; cJj:-.!; r ;; 


my. 

ni'i 

■■••LlOOh ' 






+ '\V .! 

XnooDuvf 


oponZ 

1 

;; or 

! 9Gl . ' ‘ _ ) 


' 


j'7 


77 .'7, 7.0 dl‘ 



v. I : o v ;v ; : ovo .7 /. t-7 7- .1 • .• X .»•• :y:-rv~zo an 

o ■ ’’ ij -j ■ J 77V t 7 77 77 ( t . : 7V ■ f,.) ' j\;<v> VVf.;, 



•, ",o 



■ 1 an 

00.\l it; 




, 

{ r v " ' ' 7 ■ 

;• :.7 -of mo.' ■ 


f 1 • ■ ; :v: ■ J' . ■ ; 7 -• .. ~-v r ■ / - / 7 







INTER-RELATIONS OF ADRENAL STEROIDS 



Figure 1* Inter-Relations of Adrenal Steroids. 

The chemical structures of some of the adrenal steroids 
are shown in relation to the basic structure of allopregnan©. Its 
individual carbon atoms are numbered as a guide for determining the 
chen&Sal?. differences indicated in the text® The alpha and beta 
hydrogens are given a spatial position by the use of dotted and sol¬ 
id lines respectively. The former is assumed to be behind the plane 
of the paper, while the latter is in front. Metabolic activity of 
the compounds is indicated by the vertical arrow, the compound hav¬ 
ing the greatest activity being alongside of "fee arrow head. 

















21 . 


of the Desoxy group appears to be predominantly concerned with the 
regulation of electrolyte balance, and hence is often referred to as 
the "sodium-retaining” group or "Na" hormones of Albright (123); the 
Na merely being the chemical symbol for the substance retained. Selye 
(122) refers to this same group of steroids as the mineralocorticoids. 

(2) The 11- and 11, 17-0xysteroid Group. 

Structurally, this group of steroids is very closely related 
to the "Na" hormones (see figure 1), differing from the latter in that 
an oxygen or hydroxyl group is present at the eleventh carbon, which 
markedly alters the metabolic activity of these compounds ( 124 )« Early 
investigations have indicated that adrenal steroids having an oxygen 
atom at the eleventh carbon position exerted a definite influence on the 
metabolism of carbohydrate, fat and protein, and over lymphoid tissue 
and circulating eosinophils. Included in this group of hormones are 
17-hydroxy-ll-dehydrocorticosterone (Compound E or Cortisone), and 
17=hydroxycorticosterone (Compound F), and because of their influence 
on "sugar metabolism" they have been designated the "S" hormones by Al¬ 
bright (123). It has been demonstrated recently by Selye (51) that the 
11-oxysteroids and tie 11, 17-cxy steroids (glucocorticoids) are important 
in protecting the organism against stress. 

(3) The Adrenal Androgens. 

It is thought that the adrenal androgens exert an effect on 
nitrogen balance similar to that ©f the testicular androgens (testosterone 
figure 1), hence they have been designated by Albright (123) as the 
"nitrogen retaining" or "N” hormones. Generally speaking a side chain at 
carbon seventeen is detrimental to these compounds (122), and they are 




ono j •• , V; r-'r.oonco 'o. o odd 00.000 ■■ o * .v no n o " -‘.r.; :c ••>'1 : Vr oc 

HO GO O' DOO t>: D ;T W 0 ." ::noV Oi W 00 ; ’ O-'V t .0 ' V riXOjoD 

coo ?(f V ; .tot::, t t ; - • :: o'o ■ v ' tt :t V ••-ooo-.o:” mV 

. 

o • ‘ . ' ■ " ..on o o' • . o'' • V' . V V ;' t ' . to o •. Vo '!' ■ ■; ' o to V 

. . t• o ’ t • , .■ ; t ■ o t o . oo. : t t • ■ o • r. tf, 

. ■ oo -o ; : • , t - - .. . .to , 

t: -;t ?,, ,o r j ••;;;• v o.t o,.t to. o 'to ,.o *0 ot o.n , v tto'o.;ooDT:V ; 

$cr^iio rd orctoVt o;V o- VI o/ntooWo • f _ (t oorroto too,:). onncnocV V>ll n o,V oV 

: :>■ ‘ . 

.ito.oo: t no. r '; -o ov f oo too ; o _ ..t tt t do. n.hvt no? u .; o no 

» . . ' oooJXo 

icoyyO; fo o.t. v. ;..t on'tnntoo tVnont t tj t tonott t v o: toot.;/ vt to ,voot: 

... • net o • •.LV-lt) 

sJ t . ‘ o Vk f ■ . ± to- TL ■ ' - ’ ■ ' ■ • tto J ' t. . 

■ ■•‘XO- ooro.: o :ooxt to ■ too o.t . ...Vot o ■ tt ■ O. tv ", ..t.'v. 'o' . to do:.; 

.too , . no oton.nn) o •" ' t'-t ot ' moot' • o ono ' no Vt - -tt' "; toV "t^--V.t 

oc/r.Kot :o.t j t .tt too •• .'.-to : o>oo, . : ' ro' : ; ( i ; o odd: t' c o ‘o ono, o no'.no-Y.t 




. :i ." . * 1 * I : . t • l t . . 1 o : . o i t : ; j to I Ot o, C 

- 

to. o: t .t . 'to- i t. o ' t ..Do o:.t .} t o t ; ;:o--Vtt , TJ. ot' too; otto •. t't ■; o..--.t.t 




no , .* 




J' ; 



. ■' o ■ . 0 ;t-T o.t 

.oo o o- . ■ " ■. H ( 

d • - It t ct i ' ■ o ■' I 

. 

^ • oo/ -o :,o, . „• no, o'o , ; o. ■.: o i o /r-.oootoor: 

t O' too;." ' ,.t ..0 t>. o :to to :'-'0 ;,:,oo' v .o ; it' /.oroot . Xt '.oTEyOt: x 

. or o.t • :t ' .to. 

' : -to tcof‘100 



22 


characterized by an oxygen at the eleventh carbon* Adrenosterone 
(figure 1) is presumed to be one of this group of hormones, and has 
been isolated from the urine of females as well as males in increased 
quantities in patients with "virilizing” adrenal tumors (125). 

It should be emphasized that such a definite distinction be¬ 
tween groups as indicated apparently does not in fact exist, for it 
has been noted that there is some overlapping of function of these 
steroids* Cortisone, which is an ”S" hormone, has been reported to 
induce sodium retention (126) and is often followed by hirsutism when 
administered to patients with intact glands (127). These effects are 
usually attributed to the "Na” and the ”N" hormones respectively* Fur¬ 
ther, the same cortical steroid may promote, as well as inhibit, glucose 
utiliziation (128), or produce anabolism as well as catabolism (129). 

The chemical configuration which apparently determines the 
predominant actions of a particular crystalline preparation from the 
adrenal cortex is the presence ©r absence of an oxygen atom at carbon 
eleven* When the oxygen is absent the predominant action is on electro¬ 
lyte metabolism, and when it is present on carbohydrate and muscle meta¬ 
bolism (130). 

(c) The Effects of Specific Cortical Steroid Administration* 

The general description given of the action of the relatively 
crude extracts of the adrenal cortex in restoring the health of adrenal- 
ectomized animals may now be supplemented by an account of the effects 
which result from the administration of crystalline fractions of the 
cortical extract. 

(1) Desoxycorticosterone. 

Desoxycorticosterone, prepared synthetically as an acetate 
(hereinafter called DOGE), is a potent and effective regulator of elec- 


■: ■: 1 O . • . • •: .• D : 1 • V V II i 1 : l\ "/ J < 1 ' ■ O,0 0 Y£ 1/.10 

:: : 1 ■ ‘ to ■■ ■ ■ ■ - ■ - ‘ o ~ •’ ’ 1 

. \[ . j,.'. 0..1 lo .•1 •.. • : :X':l: j 1 ‘.lo .1: Lie c K,\ 

*;. i ■ ■ :: i ' ' v' .; o .■■ ; <1 o i:: i - > 

-or; ; i 1 1■ • 0 :i •• j.:: : :‘x; 1 ; ■ 1. • i: .7 ;. '' 1 . ' i '' ■ ....’K ii : o'J. 

11 ool , 1 loo lo 1 '1 .1.1 v o'.; v- 1 -o; ;; ■ :■ J' o *. ; ijv: ; r; oil 

oo-:ll ‘.tv 11 oil lo rl. \ v ol - J ..' ■ .for: 'M-o o.o1 

h 

■ j \ td ' ' ■ ■ - i ' ) I 00 " £ {i 

"V:; . .• J • , : . : . ‘ : ■. 1 1 o j 1 :1 C - ■ 

. v ; ‘■ n ' . -. 


ooo oirli 

, 11 lixkii; 

;;,v o'i'fvf ,C‘.jOj. if- 4 .-: ; o- 

' i 1 . 6 

- .CioJ 

1 0 

. 

< 

■‘roll 

. 

;) 


O'- l.:"vv r: 

o m Mocf 

mh . ■ 

•; • 4 x< 




■11 j 

... 0,11 


i umv u 

v'o; o 

.k. 

' 









Ur 0-0' 


ViiA . ..'.J':) 

0 , -jo i 

)c ': 

1 iO- I'';' 

. ox 

0.0 ; 

• r : r ;~.o i- ’■ : ;o 

90 m- 

. o:o vozcz 



-j - 'ico 


' •cl ' 

-o-xlo ,- f. 



Oiiij’U cZ ZliJuGD 

. 

Ofioulo 


:o 

. ' ; 

« 

VC 1~> 

■ i dr: 

. 0: •01, 

' 

;0 ku-r. 


aviiz : 

f • . ; 

... ic.; • 


o J' ;1 









. 

) i 

llol 


- 



' 

' 

■'< 'to : : 



‘.•O 





lo oc-'joo 

!•; Vi : 









.0 : 

• 



w ; v £; 




l.'.r.ro 




v‘;oj';0 :j: ii ■ 

. ok: o; 

.• fr; ; 


ri.'v.ko. 

j.:.: •- foOSX.ti5 

C-J DO 



; LO- 

:>•> . V,. I 

IC 






.. 1 








. 

■•o,y..o, 

1,00.1 







- 


; o-oo-I 

(-•) ? 






. :: j 

■ L ' ; 

0CCi_ ' 

k:. ooikxoo^cc 










( : -;oc, 

Tr::. ..00 

or. 







23 


trolyte metabolism and has no demonstrable direct effect on protein or 
carbohydrate metabolism in man and little, if any, in experimental 
animals (131)(132). 

The most outstanding action of DOGA is upon sodium, potassium 
and water metabolism (111) (133) • DOGA causes an increased retention of 
sodium and water, and an increased excretion of potassium (134) • Plas¬ 
ma volume and serum sodium levels are increased while tie serum potassium 
levels are reduced (135) • Following administration of DOGA intracellular 
potassium is decreased and that of sodium increased. Chlorine is also 
retained, but the fact that sodium salts other than sodium chloride 
are effective in the treatment of patients with Addison 9 s disease sug¬ 
gests that the retention of sodium is primary, and that the chloride 
changes in general follow those ©f sodium (125)* 

In patients with adrenal insufficiency, DOGA restores the serum 
sodium and potassium, and the plasma volume to normal levels and ele¬ 
vates the blood pressure (136) (137)* The drug is of value in the manage¬ 
ment of adrenal insufficiency (138) ( 139 ) (140) and such patients are often 
able to r esume essentially noimal activity by the administration of DOGA 
and sodium chloride alone. 

Presumably the major site of action of the compound is on the 
renal tubule (ill). However the effects are not all renal for the ster¬ 
oid appears to reduce the permeability of tissue generally (111)(141)• 

The mechanism of the action of DOGA is to restore the ability of the 
tubules to re-absorb sodium salts and to excrete potassium ( 115 )( 102 )® 
Normally the extent of re-absorption of sodium is delicately adjusted by 
the kidney so that a sodium balance is maintained. Because of the amount 



♦to ;\i ,Vv.'. r :0 d:>S.Cl .: .) cv-..-" "io ■'TT.'/ i nb ;..n 1 ...Ovi.r 

■J-r?.*: :n . a.-. r: ' • '• :;J ‘i / “ .u_ r .i zo 

. ; . r . • ■) .. . .? • . 

; j-' . ; ,yor; ' :w s' ‘j.o ul “ ■'* ■ i :• '• o,, f - . %k- 

lc pi 0 tD ... ■- 

;v,/: ; ,.. ,. ,, oc .. r • on 

r ,.j.r. ; yJ'T ; -t: •: . J ' r • ' J. v . ik". m'S '.o~f v : 

; ■ : i . ' .' : ■ v 

. ' - ■ - 

' 

. , ? to.'..,*'.. , ■: ... : J' r\ •’ ' : ’ V.' . 

. 

. , -• .' :Q , . o'.:. . • ; }:i vxl:> 

: y o:.J :/, ' '. /,. - r A)O.L , •; J to • odoo o'.;..'.,:o- : 1 

■ le n ■ ■. . C&Drio ct od- qsvjjXov s t \£c .o 

. . , ( 

; • . ;J rfowi .. . . . . io : ,fii J '$ m 

■ .' u : < .. . ; / ■ . . . ; • ' 

,- ;i- • v; '...... y:. •; ; •;; 

.i no IjmfQi'.Lco t di' Jjj 'j,, . j.:: • -:y‘; aT 

- .V (d ..... - ■ ■ 

)’(.L . , . lo . ' uit'y o ■ j ■ 

^ ... J .. :. ' , ‘..v., fi r.luJM . . .' 'if- . , on"! 

* ' .'.,V ; ; 1 ; : ; '. . i •. . . / v.; : {,. j : :,J .. i i; jJ;. /c:: ^ uJ". LsxI^j 

' 

. ' , . - . . ' . : . i j- 




24. 


of sodium retained determines to a large extent the volume of extra¬ 
cellular fluid, it follows that the regulatory action of the kidney in 
the rejection or re-abeerption of sodium is the main mechanism by means 
of which the body maintains a relatively constant extracellular fluid 
volume. Administration of DOC A, therefore, in causing a retention of 
sodium results in an increased extracellular fluid volume (142). In 
large doses DOCA may produce edema, pulmonary congestion, hypertension 
and cardiac dilatation and failure ( 111 )( 102 )( 133 ) with perhaps sudden 
death (136) (H3). 

The manner in which DOCA induces these ill effects is not 
certain. The rapid increase in plasma volume (137) and, as a result ©f 
this, the extra burden thrown upon the cardiovascular system is suspected 
of being an important factor. 

Depression of the potassium concentration of the body fluids 
may be a lethal factor in some instances (133). It has been shown that 
the adminstration of DOCA to animals may lower the potassium level to 
the point where paralysis develops (ill). Occasionally hypopotassemia 
induced by the drug gives rise to weakness and to electrocardiographic 
changes ( 133 ). 

In addition to itfes effect ©n the renal control of electrolytes, 
DOCA also seems to exert a regulatory effect on the electrolyte compo¬ 
sition of sweat. Conn (144) and his co-workers have demonstrated that 
DOCA induces a sharp fall in the concentration of sodium and chloride 
in the sweat, and an increase in the concentration of potassium. 

Interestingly enough, and contrary to common belief, the ad¬ 
ministration of DOCA to dogs for long periods has been demonstrated to 


ni: ’‘fifth!. folwO - ■ f ■ •' ■ nvo. 

; ■ • ■ .c id* el ■ ' " ■ i'j. *i '!■ 

hi.>:['• i ; £• •) ' ; 0. ' : 

‘io £:£-' )*.: •/ ■. /•■■■■-'■:* ■ ■ . * : •• - - ■ ' • 

r-T . ( y ;) • £ - 3 ■ . ■ ■ ' ■ ■ - . - . .•••' >«■; 

r . . :'j h.i : : ' "; £ '£ :• t •" ‘V: r "■.■■■ V )>.’.! ‘ 

: .j . ' ( . . . . - ' ' • ' • . - ' 0 

' 

“ro j.£jr. hnn (V"\. ) •:< : v v a'ia :,L ■ ni 1 /' t. m;? 

. :son> nv/ : . »: v : . ' t .. •> : / .'.. '• ■■ . • 3 .. - f 'V. : *:.■:/ ♦ . lo 

' ■ ' ' ' > 


ijom.Q n< 1 J'A'f.t ' :> v3>:' 1 ■ t, .3 V.' r ',"3 


; : , . ' ' ' • ■ ■ ; ■; ■■■ • 

cJ, v-1 Crx":. r ■ inr. ■!' • :x xj‘.r.r;' 'rrt;:'; vi", nrli 

. .... . . . ; , 

; •; u.' : • ' c'J*‘ .V■ ; /' ; i r '.cb ;:rJ' v.f : r' 0 :J-rii 


J*0 •- lO . ' ' : > ' 5’ I j X 0 OJl f! I 

_ ■ ■. ■' .'. ; :i . ;•£) r -'.r. 1 ■ *, ,ri : kJ i£2; ! oa o” v, A')OQ 








■!J 


■ ; ; o i > 

'-0 / ■ 
>■; :i u 




> 




'a '-?)■ 


' • ■ ( ••• 0 . i V •' : 

i ' l . '. ■ ■; s ' yr; t !. ,300 

' t 'J '■ a; ; 

,:k.;v - j: :• ;:f.£ 


i )(}! i . ’ : C 


.'OI 


\o, 


.n-a 


. 



25. 


produce a condition resembling diabetes insipidus (145)• The water 
intake, especially if salt is administered, is increased from six to 
tenfold, and the output of a low specific gravity urine rises accord¬ 
ingly (146). 

DOCA does not correct the defect in carbohydrate metabolism 
which is evident in patients with Addison®s disease, and some deaths 
reported associated with the use of DOCA may have been due to hypo¬ 
glycemia ( 139 ) (H3). 

The question might reasonably b© raised as to whether DOCA 
is the substance normally responsible for electrolyte regulation in 
man. Following adrenocorticotrophic hormone stimulation in normal 
human subjects, there is a pronounced retention of sodium and chloride, 
with a rebound following cessation of therapy (14V) • The magnitude of 
these changes is in every way comparable to the action of DOCA. A corres¬ 
ponding change has not been noted with any other adrenal steroid, yet in 
larger amounts compounds E and F do act similarly. The physiological 
role of desoxycortieosterone remains unsettled. 

(2) Cortisone (ll-Dehydro-17-Hydroxycorticosterone or Compound l) 

(a) Effects of Cortisone on Carbohydrate Metabolism. 

Early investigations indicated that Cortisone and other ad¬ 
renal steroids having an oxygen atom at the eleventh carbon position 
exerted a definite influence on carbohydrate metabolism (14S)(149)(150)• 
Cortisone given to normal rats forced fed with a high carbo¬ 
hydrate diet produced a transient hyperglycemia and glycosuria ( 151 ). 

When administered to partially depancreatized animals with intact ad¬ 
renal glands, it intensified the glycosuria, and when given to partially 


Of . ; ■) ;; / ' J' ‘ ■ '• ,0* . 

■ ’<■ ;.■■■ ■ c- ' '.' ■ ■■ • c v »■•!.'. ■ ■*;. O A. 00 '"0. ’ >0 ; ■ * '0. 0';,j 

7 ,XT ' ' 7. v*J * . ' ' ■ 

. . , ;X , i 

;:k 1 Xo 00 v. r? ' J- V! ' ; ■■ 1 m m.m.m.j.m.m- :r,oh :..J r cl 

: O vob o : ' , ; • ..." r :o •'> ■ 0.0; 0 ' ' 0 

. 0"'Y?; oO ; 0) :: m.) .w .'UX/i i.o j:;t -j 0 .-'J',! : -O' V; ^ .••.O' O: ■ •; 

■ ■ 

‘V)0 r { ■ oO v V,- -VO -;0 ■ V-"- 00 0. i, Xvj; > >00 

■ 1 • .'. • ' - . .. ' io 1 . n >j j 

' • l ffoli '! hnoi . ' ■ . • . . 

■ 0 ■ - .. ' ' 


■ ' " ; !- 



. 


■ 'V- •• r - - : >i uU.xiol' .ilO'JiW 

■ A: 

. 

u: 


1.1m . -■ >o 

\ ■ v r ■ 1 0 





■ j : J •>; ' 

. 


5 ' ol • ' • 1 if. ' . ' ;. f JWJ C 

.. '0 c.,-/ - , ■ c ,.. .. Oo oO * 

(\ r J.frcryir.c") ■ ;o s'c 0 -j. \C c/::0v' --V0 -<.n 'oO 00--OO J MM' M‘:l\.i^l ; 

- j. . - j A o : .. < . > ' 0 . '•} 

.■ • . ^ z i !: .') j J , . 

' ' ' • j.»TXl V t ' ‘ ' ; ( i l : V . 1 ' l 

( ’’.* O' I .iv m. -i \ ..' Y .b.. u i.;::.: 

-C' ,r -: f I- V. ins.y /.•*.; o,t r^vl:^ wno^ii.X'loO 

. ' . ' - ■ : . . • • y ' .: • .■ in :: •; . . 

.' '.;i. \Z.l L-'lc o,' - .j , r - n nil 

. vii;) .j : KJ: . '. . :.. 1mm ■■ 



26 


depancreatized, adrenalectomized animals glycosuria reappeared (148) 
(118) (152) • Because of concomitant increases in the excretion of ni¬ 
trogen and ptassium, it was at first reasoned that Cortisone and the 
other 11-oxysteroids stimulated gluconeogenesis by manufacturing the 
glucose at the expense of tissue protein (118), Later studies, how¬ 
ever, suggested hat gluconeogenesis may not be accomplished by the 
catabolism of body protein, but by a process of blocking protein syn¬ 
thesis (anti-anabolic effect) whereby amino acid radicles were diverted 
to pyruvate acid and thence to glucose (123) (152) (153) • When adrenal¬ 
ectomized (154)(155) or hypohesectomized animals (156) were subjected 
to phlorhizin and then injected with cortisone, an increased excretion 
of glucose and nitrogen occurred, indicating that the hormone is cap¬ 
able of replacing the gluconeogenic function of the adrenal gland. The 
hormone was found to counteract effectively the hypoglycemic effect of 
insulin (148) (157) (158) and to promote the deposition of glycogen in the 
liver and the muscles (149)(159)(160)(161)• In patients with Addison*s 
disease in whom electrolyte balance was maintained with DOGA, the ad¬ 
ministration of cortisone corrected the abnormal carbohydrate metabolism 
the fasting blood sugar was raised, the respiratory quotient decreased 
and the threshold for hypoglycemic reactions increased,(162), In sub¬ 
jects with co-existing Addison*s disease and diabetes mellitus, the 
diabetes was intensified following the daily administration of cortisone 
(163). 

(b) Effects of Cortisone on Electrolyte Metabolism, 

Cortisone given to human subjects over long periods has little 
overall effect on electrolyte metabolism (147)(I64)• In moderate dosage 



( . : vr.} b -rbvM'.u;,v,\: 

t H r ■> ; : •, li.vd-^bv; - r - ; > ! rn b «| 

b 

; j r ■ • ' b" ‘ ' . 

O uf on ■ an": bb ■ ■ 

.. : an : • •• a : '■ ,i a 1 ? b b , ■' ’ ' ' v -f«i r. ‘ rn {'Mb 

;.. f i.i' r ' 


-' •oJ jj •:.! 

.. ■' b • ' : :'i ' 'I' ' •' MM M M.: b > M. M' .. 

0 %l* a bvaiob J 

; •' 0 ; \ V ; bo .'0 1 m " *. b'i 1 b 1 " ' ' ' b' r b/. 

- 

MM- ■"( 

; : V ' . • - ' f. 1 

' M ’ ' b ' b' ' 'm ' 

-S. Mb •• ■ '• fi -il 

b : ■ ( ) i ■ - • : 3 M b < 

nnl-O:, l b,T; : (n 

b . 

ncbb.-Mio :n ;jf)r •. an m 

: - >. . : •, b Y <,‘J '• M . : •" Mb'.b ' Ml"' < ' 

b--b. :0 . 

ib ,, ' ;■ " • • f > TMM ' ;' - ■< “ Mb' 'MM: J., ■ bo 

. ■ . ■ ■ -r ■ . ) ; 

o c» ; ■ ) ' > I IX ■ j t f 

?£0 b nib 2. \. 

b b.’ ■' "■ b v ■ '■ b-: • - ,■ ■ nyy .‘tob 

, 

"b -b '-m ;Mbb b,; c;r 'rb (■•'.!}(? bib Pb.’) mm 


• b M; ; (••-.: • (• ) ;b- ;; b br • b:>vbl 

■ ; > f j ■ .b'w’ ; ■ m m. c:;jb; i' M rb ;.L(Mrb;t b'/ m =M. ; 


lou, m; ;b v. i mo .1 \ ■: m;mm -abb ••r.o'.r r r.x& :Griati'h$ r X'6 r u iicJJ nab 


.or, • ,m ■■ •.) J'.m: .■ b. j • 

■. J* : ' M M/ m;m Mr-; : •< Mb : : M M b T'fb 

. 

■ ) ' M 1 "' ' . bb ; l ) . : ' ■ bb , ; : ' ■" ■ 

M ; ■. ■) ' . ; ■* -■ ; . , , • m m.' J' ' — 0'} J V '' ' : 'b! 

b m'm.a'M r;' 

■ ' > S' I . I 

. 

■ M : - b ' ' ‘ M* ' ' ;o bf'TO'bi-bnob ;, bO" Mb M r'brb {.,■ f ) |j| 


'/ , ::: 1 * V'.'s : bn . b .a fi,b; Jib <b!’ f ifC'! ib* • Ob b 

<j 1 . ( ( .vb,b,b) rnbUbbu ;n d; .nr; Jbnbbr .Lbribvc 


27 


(100 mg. daily), cortisone induced minimal or no alterations in bal¬ 
ances for nitrogen, calcium, phosphorus, sodium, chloride and potassium, 
and in the concentrations of electrolytes in the extracellular fluid 
as measured in the plasma. Larger doses regularly induced a negative 
balance for nitrogen and ptassium, whereas augmentation of nitrogen 
excretion was slight or absent when the dose of cortisone was moderate 
(52)(147). Large doses had variable effects on the excretion of sodium 
and chloride. The most common effect was a retention of these ions at 
first followed later by increased excretion (149)• According to Thom 
(152) cortisone and the related ll-oxy steroids exert a weak sodium re¬ 
taining effect, about one-thirtieth of that produced by DOGA. However 
under certain conditions, as in the presence of excessiT© sodium reten¬ 
tion induced by DOGA, cortisone may act in competition with DOGA and 
cause increased sodium excretion (153) • Cortisone was found t> increase 
the excretion of potassium and phosphorus in partially depancreatized 
adrenalectomiaed rats. Its administration to normal subjects and patients 
with gout produced increased renal clearance of uric acid resulting in 
the excretion of large quantities of urates (152)• Also young rats re¬ 
ceiving Idle hormone exhibited a decrease in the phosphatase activity of 
the bone epiphyses (I65)• 

(c) Other Metabolic Effects of Cortisone. 

Urine concentrations of corticosteroids were increased initial¬ 
ly with large doses of cortisone, but with continued administration, the 
amount excreted remained elevated or declined toward normal values (52) 
(147) . Administration of cortisone was followed by a prompt and striking 
fall in urinary 17-ketosteroid values. This suggested that the hormone 
depressed some of the functions of the adrenal cortex (52) (147)* 


* :' x - " - . •' : 

: . .... j , .xxt tt; t ; xoxx. • xX xi , • r ‘ : ‘ ' ' 

bsorib orj ul a xtv.u ti: or Jr- 'lo ’.UoiIj “ 6f r ^o:\oD ovb but* 

■ 71 ■ ■ Jj . .. . .■ *.i '■ ; " • 1 

i'i. ' . Jox ff.l . ; do -x: • x : ‘' • ' fi '- '■ ■ ■ ' ■ 



v'ijya. .. " 

i£.yy anovilrzoo 

. 

■ ■ £ 

- 

, 

; chiG 





*. ■ 14 




. . 


tz ‘10 V ' 

w 

.r. 










■; (-•); 

X 

11 ol i 

'00' X: 

■ nol-h: 

/.I 



' 

• fiO; . 


O' 



•V X jf L *. 

‘ ify 

111 oo 

i: 

>A; -,4 ( 

XJ.j 


■: 


j: *!." 










0 

.. 

vO■ 


oo:: r j- 

•J-0 

'=■ 0 




£i 




( ••:X) 


V ' . 

ilOGCl o 

# 

■l. • •: _ 

o d »o 

XG 1 

A , 


r 

:c 



* ' 



rb b 


O' Xj; ; LX 

, ■■ 

0 0 ■ 


•■onofi 


ii'* 

ciJ: s 

.. 







• 


; ' £>0 




f [it . 


f \.D0u 


);, o; r’ 


' 

o::i: 

: 

: ii rv‘l 



. 

1 - »■'' 

- \ 

ii 


i f o'.' 

o o 

1 

■ 


yrr y)' 

hull./ 


/ . ..yto 






ji/J 





"■ rd-d_X 

t . tz 

i'. t: o;:i o : 

. 

r; i.GiO'rc 


/ '.C 1 : 

0 0 








< ;d 0 




c " r.o.o ' 


• 

10 : 

0 i Vi 






' 

boo:.’' >6* 


fO 

' 


. 

JCA 




o id j J" 





‘io :o 

.A.Lu xi 


: xkt 

1.0 



. 





• 



: 

:»fXo 

I ‘XOli 

Gild* 




; J; : i '■)' 

XX ■ ‘ X . ■ X j . Xf. ,- ) 

-X .XXX. ; j.r; :c, .! tot : : XX :-■■■■.Xox X:'" ':.o one At ,7Xyn0o/,rcx) uiilo-U ■■■ 

txXt to XX.,; :V XX . ;r , ,x x r.XX.x 0 ' o a..- ;ot - TX-I XXX; vl 




i ool / TO tot 7 : ip f»Ti'f.LTiTOXr 

) 1 or.) :: 



olio'. 1 ■ y ■ 1 j \ d 

XloJiXOX 


... X X ,t ■ ,X..XX;rr d'ye j -\'L v- :r vl: JXXA: 

- . ; , > ■; ■ .. ■, ..; . .v : o • n . . J \ •X : J ‘ 1 • ■ 1 -r 'O 


Ti\. ■ !. 


28 


(d) Effects of Cortisone on the Organism. 

Cortisone given to young rats suppressed their growth and 
development (111), and in both sexes caused marked atrophy of the 
adrenal and thymus glands (166). Similar atrophy was noted in the 
spleen and lymph nodes (123)(167), which suggested that the hormone 
might have a depressant effect on certain types of lymphatic tumors 
(168) • Subsequently it was found that adrenalectomized rats showed 
an augmented susceptability to n transplanted lymphatic leukemia” 
indicating that the adrenal secretions might have an inhibitory effect 
upon the development of this disease (169). Heilman and Kendall (168) 
later demonstrated that transplants of a highly malignant mouse tumor, 
diagnosed as lymphosarcoma, failed to grow if the recipient mouse re¬ 
ceived cortisone. Pronounced regression of these tumors, even though 
well developed, occurred with the administration of the hormone. 

Cortisone and the other ll-oxysteroids have the capacity of 
Increasing muscle strength, endurance and efficiency in adrenalectomized 
animals (X70)(X7X)(172), but these effects have not been observed in 
animals with intact adrenal glands. Physiological resistance to stress 
and shock is greatly enhanced in adrenalectomized animals when cortisone 
is administered. The substance has been reported to be highly effect¬ 
ive in protecting such animals against low temperatures (165). 

A striking sense of well being is exhibited by most patients 
early in the period of cortisone administration (52) (147), although the 
degree of mental stimulation varies somewhat with the size of the daily 
dose given (173). Usually there is definite improvement in the mental 
attitude of patients receiving the hormone, but some initially depressed 



. i • .( ■ . •' " ' ' ' 

. Cf 

i >4id* Q %'kiC ' '.’ ' ' 

T: ■: "> " '• ■ * v ■ - ■ ; ’■ 

s ■ 1 • ■' ' ■ ' 

s^orc. & o.U ul 777.7 '" : .o 7.7- . ' ' 'b—O ■ ' •' 

b9-'Oi.7; ; J\ bn.:7 • 7 . ■ • o or viis.i:: .i ' • 

H 7.77.77:7 - 7 : 77 - 7.77“'7 {i c.O 7lo '' ■ 


'07 


.. \S.: 1 ) o' oi- v- j- 

hir- I 'in ‘ v b i 

•- «1. 77 v .o '.’O': 777777} 

45 . ' 

■ ■' 5 


' ' : ' ' 

(Gb.r) ..iJoih/Frl on o . OV.:.; ^;7 .f.7; ^'07i-,7,v7) nl 777 

,-u;, • •.’> 7 717:. : •'* 7 ■ ■: 

! 

--0‘i cKoiioo: d'.rr".7; J oe‘7 .'j ".7 no o holl.nl . ■ ro o ■7 ' " ,.' ’ • :' -7 ; ) 

...... j '7 70.: c j i"7 V7 ,77t)/7r7 7 77!7.r7 ' "7,1 • ■; ■:■'£■ 77: 7 ’'77 77,/'. 7. . 0,707 0 ■> Of) Ojv'1 ,7) 

.0 ..7 ' - * " 

• le 77.70 ■: a V 7- : ... -;7.'-7.: 7 777: :, 7,/l 7:7 ’• 77.'7 J 7'7C> 1) 

iluoio 77 L 7 . 7 ... 77 j 7 J:l. '7 03.177' ’,,7. j 777 3007 7 7.73! • ' 7 . on v r/' : .:' :.0 7 ' f3 .'7 73717 7' 


ill . 

■) 7 

on 7 0 77 7(1 ' 

:t07 

OVO 0: 


■■ - 7d' d'H- 

7 

(71 HIV 

1)|C 

v r,L 1 p ( .r,i 7 


; 1 0717 7 

od' 

7:;7:7d-7j7;,'7 

. *, * > 

: u.i 


, . 7. 

00-0" 

tfee 


1) 7 : 7 1:v: 

' ’ 

77 7 d ;j 

. . ■ 

/••/.it: fii •, 1 r;{ 


7X170. 

.. ■ 

[77> . six. ' be' 0.1 


'7v 7. : .7. .i’jU; 

77 , a 

. 

7 : 



;:ii7ij v 


,..1 7 07 

77 Hi.,,-.'/' 

7! 77' * 7.007X17 

. 

; ''71 ,« 

1 '7.77 

d7;xi:.a;:fe 

' 


• 

v7 : U) ;-7 


C.T70u 

kfCJ. J' ;/ 

■ 


777 70 


d‘C‘"7 f -'.I 

■ 7 Vl. 

■::d':coi 

d.7. 

d',,ori x<S h* 


;X"03 

7.': 7d:1..7 

7777 77 






'7 )i; 

uoiLf 


■■a \ 

/ 

:•[oi; ■ 


■ : t ■■ 

XOO 



' 

r-r. 10 

V.L r 47) 


' 77 7 ; 7i; 

*> f 7-j 

i. 7 

777'! 0 

• 7 .7/ ’ 7 no 

1:1 7 


7oi77 

) 

77,ob 

' '-7; 

a r. 

7- i';l. l.r ;;.. 

"7 77' 

■71 7 

d -771.1 ’l7; j 

77 .7777 


, ( 

.VI) 

’ 

on oh 



'.IJ.liij: ... 

. (.7! 

J ;.J; 


i 77 i.nov 

i.OO'0'X fid:07’;: 

I-‘5S 

'77 : L 1 

iJJ-7 




29. 


and pessimistic, may become frankly euphoric* Cortisone tends to mask 
pain, and death may remain unsuspected and unheralded by the usual im¬ 
pending painful symptoms (174)• 

Other effects noted include decreased libido in the male (147) 
and a return of febrile i ndividuals to the afebrile state (175)* Appe¬ 
tites usually improve, and with the increased food consumption there re¬ 
sults a corresponding gain in weight (52)(147). 

(e) Effects of Cortisone Reflected in Laboratory Tests. 

Elevated erythrocyte sedimentation rates are reported to be 
significantly decreased within a few days after cortisone administra¬ 
tion is started (52) (173)* Improvement has been noted in the erythrocyte 
count And the hemoglobin levels (173), particularly when anemia is pre¬ 
sent on commencing therapy with the hormone (52). Small but significant 
increases in the total number of circulating leukocytes have been noted 
during the protracted administration of cortisone, hit no significant 
changes in the number of lymphocytes or eosinophils occurred during or 
after long tern administration of the hormone (147). A lysis of fixed 
lymphatic tissue, a transient decrease in circulating lymphocytes and a 
marked decrease in circulating eosinophils from the blood have been 
noted during short period administration of the hormone (152). 

Ho significant changes in the electrocardiogram pattern of 
patients treated with Cortisone have been noted (173). Acceleration of 
the alpha waves of the electroencephalogram have been observed (173)• 

High doses of cortisone may produce a metabolic alkalosis due to in¬ 
creased urinary excretion of potassium and chloride. In such cases 
electrocardiographic changes characteristic of hypopotassenda may appear. 





on* 


I :s.nu ( :.:o X rJ 


1. 7o ; b?:d‘0 XIaJM 


idTii’f"': 


■[ • 


/ 1 . ■ 

\ • . • 


o. 1- r ’ L >0 ; 0 ' ; ; ! 

7 ; t i J *S ' j ‘ r ' - j - : 


j' 




‘ 


{ r> ,v 


l '; f ‘i 


jo:--'17 :7i c ifJ;d too lo 


1 


. )■. 


r;-f 


. \ : • 0 ‘1 J • ‘ J ■; ■ ) ■ ■ 7t 5 l ' ■ ' : £ 

: ' ■ ' ' sri ■ i- « ' ' 

-- *r ;;j .• r; • ;f . 7 . ' ' •• - V. ■' J ; V: 1; - C)i " : 

. 1 ■; rv t ~ ’•' r 1 ■ ' " 1 r 

: j.ft it 3© I : . . d C» : tel H-! ' ; : 1 ' 1 " 5 ' ' v 

IV ' , ' - 


*i*i ’ ' ' ' ; 1 4 1 '■ : 

'.to :V it 7 ro.X -77 o 


* 


exK 


> 

tv 


!■% ;f/ : - u • ’ : ' ’ • ' ; 

VH'7 '(.I' X' i.' 7 ' -'7v, o V- • ■ ’• .•' • 

: 7 . 7 " I . X,ii .! • • ; i ! ; - ' l- 


• ■■■ .,j j- /; 10 fold' ni ooori oX:> co 

; :■ ■: j; . ( V ) .. -X. r: r vv ' r:o j'i • ‘ •• 

, V 'c : r :: -. ,.f • / '-x. C. r •;!' •' '.o: C/ d'/' .d f i.-i'J lO x-vvr .vi 1 

■ ■ ' ' d . 7 ■ ■ ' ' ' ■ n ■ ■ ■ ■ •' "■ " 

, -)hl f > 1 ; ’ ■ • t ' ' " ' ' " - '• 


' ~;V 


vri VCh oov/i ‘do nxd'o 


■ . 





30. 


The T wave may be lowered and the ST segment and junction depressed. 
Concomitant with these electrocardiographic changes, lowered serum 
chloride and increased CO 2 combining power of the blood are found 

(U7). 

In certain instances where the basal metabolic rat© was raised 
(due to causes other than hyperthyroidism), it became normal following 
cortisone administration (147). 

(f) Other Hormonal Effects of Cortisone. 

Objective signs of hyperadrenalism have occurred in some 
cases where cortisone has been given for extended periods and in large 
doses. Rounding of the facial contour (moon-like facies) is one of the 
earliest signs of cortisone excess, and may or may not be associated 
with some fuzzy hair growth (147) (176). Disturbances of the menstrual 
cycle usually in the form of amenorrhea or irregular menses may occur 
with prolonged administration (147)• Transient edema, usually pretibial, 
has occurred, but disappears on reduction of the dose or following the 
use of saline diuretics (52)(176). Manifestations of a mild Cushing 9 s 
syndrome characterized by acne, hirsutism, rounded facial contour, 
amenorrhea, stria of the skin and mental depression may appear, but 
disappear on cessation of cortisone (147). Pre-existing diabetes may 
be intensified, thus necessitating an increased daily insulin require¬ 
ment (173)* 





-air. .'-r.: V ■ 'V,t -.rc.r. ' v ' iJ 

: ' vjr^oiV : t ! ; 

i . <y- • y -o ''AL-LAAcDal-O aO J VaAAL';AAA ALIA -Li 10 


r I : 




a- on 


i 


■ : o o rt: u ' ■ 

. r ( ,y n yy. y; to all 0 €>o 0JJJA') 

. i -■' - ■' 


: ' ti ' 


•! 


t V--J 




;i. noL ,".r V - 


•d rci.i ’ ■ \ 




A’ 

' 



j'0 1 



' 


A> 

bw: ‘~o 

eild' 






• *T'J 

rcv noo 



. A AJ 'AC 

- 


, 



■ 


V.;V* A’ 


or: 

5 

0X». CL 

r 




■ 


AT 

■ 

‘ 'i o . 

- • 


* a 

"A)A 

; 

TAG 

Ay v :L 

A. i. 

: AA'A ' A ‘ 0: 

fit.A 



o 


■■ 



■: o;'4i 

OA, aO 

It.. 



■A. Liufzss 

elo'H) 

j • 


,r iq L 

■AiL: , 

. £.■ .:V ' ■' L‘ "! 

‘ 


• ^ • 

j jk.M-.-'I 

■ - A ih. 

LiliB i 

i'tC'.A/rq dtiw 




I ’ :q 

: • AT- . v'. 



• y.5&‘' r 

no 

A AO 

( V 

■SWi 

, A' AC« 3 cl 

, i 


. 


1© : l:l; 



. 

>VJ.) (::: : 


?,0.AT w‘ 


01 .■ 1 ' 

‘.to ectf 



, ' 1 \f.K - J. /’* ■ •" 1 




• 1 


, ! 0 

Vs 


x OjA 

. . 

C'diTA.i 





;• A if;: i , ‘ 

\t rv.->,T 

J>kt 


‘ 


iflj' 

.A A A 

\ h 

■lOfBiuA 


■ 


■ ( fl * ’ 1 ■ 

* (-lVX) 



31. 


IV. The Nature of the Adrenal Hormones. 

(a) Introduction. 

In discussing the nature of the hormones produced by the ad¬ 
renal cortex, certain mechanisms of hormone production are assumed. 

Of prime importance are those hormones produced by the pituitary, which 
act on "target” organs, causing them to produce characteristic hormones 
which in turn act on the peripheral tissues. Such pituitary hormones 
are called trophins, and in particular those which act on the adrenal 
cortex are called adrenocorticotrophins. 

The exact nature of the hormones secreted by the adrenal cor¬ 
tex still remains obscure. Present estimates of the number and char¬ 
acter of the steroids produced by the gland are based on indirect evi¬ 
dence, such as the types of steroid isolated from the gland after death, 
and comparisons between metabolic changes induced by the adrenoerotieo- 
trophic hormone and those produced by the crystalline cortical prepara¬ 
tions at present available. 

(b) Theories Regarding the Nature of the Secretion 

A number ©f theories have been postulated to explain the exist¬ 
ence of so large a number of steroid compounds, and the multiplicity of 
metabolic patterns which an organism may exhibit under different environ¬ 
mental conditions. 

(1) The Multisteroid Concept. 

In the early phases of adrenocortical investigation, Selyefsi)^??) 
postulated the existance of four distinct pituitary trophins which pro¬ 
duced four separate types of cortical hormones. According to this view 
the adrenal cortex is stimulated by a "glucocorticotrophin" to secrete 




: .. ) 

■ X y . • . XX- . ■ y r: x ' x;n •.. ■' ' x: ’ : * ■ ■ : fl 

, . ./ ;• : V ;x... '.x". ... ) ” ■••X /. X . .> . . X -x 

v . .. q ■ : x -xxx , . x ' y • ..:.' xx ' XX 

x.xxx. J xX; . xX Vxi-x. ,XX JO 'X •' 6 n HO 

• •. ■ • ( v x x H \ • yo x :x' I ro.:: \: 

yyxx. *d xxX «J jj&itfTsr xi be yx;iykyyyJ xxuxo 41*05 

. -s. 

x:yy.yx -X.,-... ;x • ■■ ; xx,.x xjfxxxxx: axi-j ‘io 1 x t< uxT 

■ ■ \ l: i ... ; »xx .x- J; x + 

■ v y., y.‘. \ y r 7 . : ;.. ; 

■ i ■ ... 

■ . ' : ti£'i X . 

;■ .. ; , -ryy ■" xxxxox. xxy’ xx xxxcy' x;\ ilyexf 

. 

.)• Z.'L> X.OX-, xi Xxlx'l Xft y j.I.L XX XX ‘\S &&'■',££ (••»)' 

.: 

'V, ., -.y-" v . ..; ;.x/ : ■ lo "y ; y '•X 

'■ '. -X . X. •' : i ».!.r ;x X..^, : .x,' -xyjvXx yx.Lo 

.•'5Ci ; </:XoJiiK OuT. { .1) 

y.iir y x,;v -r'X rsl 

.. Bi 

■ ' 

■ :: '-’y , ! ■■■■. : : ■■■• . • ., y - x- L xxxty^ : x. xx xX 


32. 


steroids influencing carbohydrate metabolism ( w glucocorticoids M )> 
by a "ndneralocorticotrophin 11 to secrete desoxycorticosterone or 
DOCA-like steroids ( M mineralocorticoids M ); by a M Xipocorticotrophin n 
to secrete steroids which induce deposition of fat in the liver 
("lipocorticoids”) 5 and finally by a ,, testocorticotrophin ,! to secrete 
androgens ( M testocorticoids n ). He suggests that the components of 
adrenal cortical secretion may vary independently according to the re¬ 
quirements of the organism, but such secretion remains yet to b© 
proven. 

(2) ”N 8i and Hormone Concept. 

Albright et al (123)(178)(179)(ISO) in interpreting results 
obtained from mouse experiments have suggested that the adrenal cortex 
secretes a or n sugar” hormone (Cortisone-like compound also desig¬ 
nated as 11 , 11 -oxysteroid), which is under the influence of a pituitary 
adrenocorticotrophin, and an W N ,! hormone having the anabolic properties 
of an androgen, which is under the influence of the pituitary luteiniz¬ 
ing hormone. 

Urinary 17-k e to steroids (which are structurally similar to 
adrenal androgens and have an oxygen on C17) have been r egarded by Al¬ 
bright (123)(178) as metabolic end products of adrenal androgens and, 
therefore, are an index of adrenal W N W hormone secretion. Urinary 
"corticoids" (steroids having one or more characteristics of the corti¬ 
cal hormones) are regarded by Albright as an index of f, S w hormone pro¬ 
duction (178). 

The lack of parallelism of these two indices, both in normal 
men exposed to stress and in the endocrinopathies, are regarded as evi¬ 
dence in support of the dual nature of the adrenocortical secretion. 


■ :V-o•'/ G.; mH . a o T •’ - • d - 

■ f£< '( i j* ■ * ' ' . u n nl ■ ■ ‘ oool ■ i '■ J 

j ' ' . ' 

■■■ v . ! at 

— : ' ■ , : , ■. jll Ji•' • w i :i ) 

M.o aJv[onoo • — o'' .3 v ■- * (3 ~... c c; gggojwo' j gig£;gg. j.I '< 

~e r i t'ii3 Ou \g:g' • g ,; g. r- : V7 g ; ...g '\X0 lgoGO ''-/G ... 3: ‘XU 

;>J Cvt ;hj^ /••'. go.Ugg.: ro . lou . •.•/; • G.iox:'GO ■ iU xo 

. :i.yVC‘ ‘.C[ 

,) ■ noinoh n -y- 1 u, {<•;) 

J i grtt/sr j . £ti ; ) j - $ 

j:bo'£qq Log ... : •• . , .• U ...>: gog- .. . , v.ii 1 go co g-g . ooV J.);>iii:od*:;io 

0 ro . ■ ) ", C ; • " ■ . ' 

■ 

; ? : . .. ' -■r"xx ■ :t: :J i ■ r; t -3 ..c^O'OO.o:/, c 

; [i £j d i \ l . ' u 11 f " . : . . . ' rxs -1 q 

. 

iT ' 1 . J ' ■ 1 

- 1 A : ..) 0\c : •: :. : .' uv.:sri {L. - !. • 7; .o a ; ;.v ..' go; zg.. 1 c'u'i • . EO'i zz; 

■ ■ ' wbotq £> mol . ' [ . ) d ! d 

G'.: G I.:-’’j x -'v : 'b; t/ :• ; , 'O, /■: '...d 

o. e i / '■ -j i . ). ' 

gx ■ " V' ",.J ...33 jii. ."g-ILa v-i holy'., 3*x.3 ( 33 . 3 -... •;:g3 0 

■ . . V } 3 .. .' , . 

• • 3.;. O J - ; . ‘ V,J- 3 3 3 30 VC.ij.oSl 3 . ']:o '3)3l 

■ .3, < .j f> Q(/X C r ' 

• ■ ' . -J - a- J •' o ..• ■ ;. >onuh 


33 


The methyl testosterone-induced depression of XY-ketosteroid excretion 
in the castrate is interpreted by Eeifenstein and Albright (180) to 
mean that the exogenous androgen inhibits the release of pituitary lu¬ 
teinizing hormone (L. H.), which is the gonadotrophin presumed to stimu¬ 
late the adrenal cortex to secrete androgens. Further, the contrasting 
pattern of metabolic dysfunction and urinary excretion of steroids in 
Cushing T s syndrome and the adrenogenital syndrome (123) exemplify hyper¬ 
secretion of n S w and M N W hormones respectively. Albright presumes that 
each of these pathologic states is an exaggeration of one of the dual 
functions of the normal gland. 

In the mouse there can be little doubt that a special X zone 
of the adrenal cortex secretes androgens under the influence of a gonado¬ 
trophin. However, there has been no convincing experimental evidence 
brought forth to demonstrate that luteinizing hormone (L. E.) acts di¬ 
rectly on the adrenal cortex of species other than the mouse. In addi¬ 
tion a compensatory increase in the secretion of ”N M hormone does not 
prevent the development of euniehoid symptoms observed following castra¬ 
tion of the human male (195)* The importance of the pituitary regula¬ 
tion of the androgen secretion of the adrenal cortex is at present un¬ 
known. 

(3) The Autonomy Concept. 

In the rat it has been noted that following hypophysectomy the 
zona fasciculate and zona reticularis of the adrenal cortex atrophy rapid¬ 
ly (181), and no longer stain his to chemically for ketosteroids, whereas 
the zona glomerulosa shows a compensatory hypertrophy. Also in the rat 
it has been shown that the zona fascieulata produces steroids affecting 


ou ; 0 c;l) iX Xo: X', rXoX m XX X:. 'X • X. X •• r.rd ;*o o d ni: 

r X ; / h h : ■ ' O i ' a *4 ■ ' : 

... / J- o ’■ , , v ■ : f :. ■ ' ' 'i ■ ■ -■ ■■■"■if • J ■ ' 1 

J 

n.: : Xo oX • m n ■ XJ X X • ’ fo XX •: X ^'XXo:- 

■ ■: c • ; . , ' i - • bcm ■ f - y * ' ' 0 

, • X. ■ • . [ M ' ■ ' : ■ t ' ' 

X ur) id : f [?q ‘l ) • '/ n 3 ®> ai t d d a x ©I rid m rid i o c 

. ■ ; X; . oXX Xo o■TiXXnrT.rj'l 

snos X IXooqo B chvX 'XocX oJX-X: -r >o •• XX ooo ' XX ni 

—OX rio"' b Xo oo me; XX. X o X ; • ' 'X •- ; X o -:X-,:oo J. oo *£ o o/.X Xo 

oor* rvs JXX c: ■ ;q: ’ • ■ ♦ ■ 

■ . X 

.. 

Xcri rjr o.j one: .t o . !f '. n Xo f i ...X ’"Sjc: ■ ■ X ro* ov, xn.o X.- xtsoJ*. stuiociaoo o ;y. 

- i , . t ■ •, X' x o 'X ' ■ X . 

X . ■ d 

-Ciss cz'Tc J- :oo .. 00o.cX.o slid 10 n. .0'fXr: . lid* Xo no.?X 

. 

X ■ o;d •; 1X x ; 

0 X ; , ; ; j • X.ol X ' j o-.: ■ ' • r. :X 1 X; ' : '.X :rl 

• • ,X -: yy. o-.y;; • o :r:cc, J -X; ; ;X' Xo oXo :X:::XX\v; onyo- Xrxo oXo.’j-oXo ;X 0.0,:.: 

.o'..-;. -X • : . . ' J - • •' ' - ’ • -' ’ . X ) \ 

. 

X : . ;rXo‘i Lifoiioo^X >si i d 1 :un Qii ■ 




34. 

sodium and water metabolism (182) • These observations together with 
the fact that the hypophysectomized rat in contrast to the adrenal- 
ectomized rat can survive without salt therpay prompted Swann (182), 
Greep and Deane (181)(183)(184) to conclude that in the rat the zona 
gomerulosa (outer zone) autonomously elaborates a hormone which regu¬ 
lates electrolyte metabolism, whereas the zona fasciculate, which is 
the zone producing sugar end protein hormones, is subject to pituitary 
control. Supporting evidence for this concept was presented when Ingle 
et al (185) and Bergner and Deane (186) observed that ACTE had little 
effect upon electrolyte metabolism in the rat, in that sodium retention 
was not observed. They also noted that hypophysectomized rats did not 
lose vital amounts of sodium and chlorine (187) as does the adrenal- 
ectomized animal, and suggested -feat the secretion of active sodium re¬ 
taining steroids by the adrenal cortex was independent of ACTE pro¬ 
duction by the pituitary. 

On the other hand in man ACTE has been found to cause marked 
salt retention (188) • This may have been due to the type of ACTE used, 
for Mason et al (189) using Li f s homogenous material got no retention of 
sodium and chlorine in a study on a normal woman. Further, this con¬ 
cept fails to explain why panhypopituitarism in animals or patients im¬ 
pairs their abiliiy to adjust to situations of reduced or excessive 
electrolyte intake. 

Sayers (190) uses the following explanation to embrace more 
adequately the experimental facts. In the absence of the pituitary and 
provided dietary conditions are optimal, the adrenal cortex secretes a 
small unfluctuating quantity of cortical hormone which is sufficient to 


ids--r r fi'noj OJIVjI ff/Ofio 0 V d 

. *. d d ; . ■ v. : "0 0 o vr ■- 

.. ’ ou/dddo id 

-X- ' 0 vo)3 'id J oi d :d 

TtOO u: J/3T h 

- - do rrd'J '/;/ /■ ^oi o ; 'X d' "'/id 

.; . O' 

, { I'd.) '.1 £ ; T , •„!■. '-do : oo: , 

V. O ./X ;• d V3 

:j; • -j Xdvr ovdo/";i -0 d /x 

ipXoo 

fine: .'dr d" v; tjid -j. 

; ; .« )i . ■ 

co idd ; i) (Cod') i-L'dl; aaoi 

rr: V 

~-Fs;y .-t us.hiv o<n or X *, 

r-d'.'/x-oiol?) vo : 

vifo ! .o'v:[■ ;>d.ir > 'ii/'O " .odio ) / 

" v: ,; c/ ; 

■3d: doLi'.f , ffioo ' oof: 

Bno;:? '/ dd a oo 

>rlir - fffp.i'lt ■■ ' 'd .j;;r d oi/-.d' ,v 

,f. w,&nl 

:■ 'd ' ' 'XX Oo d o id do: d 

, ‘TOli 00' 

: ‘ i;: •: / ■: 03 OS.tVM 0 ;OVO,' 

or j' / : c uit 

s df.fi .rod:'' ood/io ; .• •• o o 

■ 

di ■'•■ v'd; o o' u)'. do/ ' ■ ill d- ■ o. ■ / d ■ 

, )■*■." o 

oiu'J'il ■ ■ o.- li’L'Jd. f o ,.d 

oo: oXo (d>81) 

0il V:>di O' . O' :d /’o.-dl if, ( 

• r ) do do 

l io.:d'f d */. ,• odor: i f of d 


01., j'J OOf -.X :',d'\0i-O‘XX0-'.>X;> CIO 

■ 

J'O/X -d_d> •,./ ■:>: o.d.-:;( d ; .: 

V. I -. • j :[ Oid,t 

JO./: . ;i *. Vd/ild . V VO o d- 

.. dr Vi 

~l;OXO‘I.b 3 : X'io* 00OO 5 ' 


/■> • Jjjidoo "dv '. / Vi To; ' ; •.... 

n l ' 

-0*1: J. d ")■ : Ydd'OO 'to rod 


. 

: >■. rod'os 

-o*oo dF/OA i:> coo.: 

,Uil , V: . d 

■ ' 1 . " 

J ,/i.IiivX 



. d. X ,j d . 

. ; :■ j -• . 

J92t^X *.f.£ i.'.'O/.'O OX //O'-d: .0: 

iOCd .3 S.d :fOk 

■r o . of coo.od '".oX'o c.', i ;fO 


, . dd ) d d:0 >' ' . J V; ...X . 

■: , »'v 

* 

: > J- yt d' £ 03 


lo fiod !' :• j ’:<>i J'O • d . /•: / >o- >. T ' J . ode;; ' (ddo[) Is df noosi1 • *Xol 

— rtc ‘ ol fX'-SOdi , ;i 0';;;. O :/. U.O d'o/d.: '• «.!: f '■ rulhon 


1 : J ’ i :!..j < 10 v '/.//: d • of ■ ’ d; of v/uso ovd./ p.s.yL.-ZV od -"dfodi: Jr;so 

•v • ; 3 ■■■::»;; :■ oo ; v, ... ■j /o;ivr 1 ; o-t J'oxd‘,oi £lid r of■ fl ■ soI:oq; 

. :. o; d . ■ dv. 

'.‘O'.' 9 ff. (J 0. O'.-J" ;■ j w;.jf olloi 4>.dd‘ aofJJ.tr {0°S .) 

1 vd'/d ,7 w . ; ; l-. : V.;Jo •: I.oOf'/o • ;0/ Of - d 000/ 03 

• • 0:0 ::.d"f>o d '/ovr... : odd cod d/do t./;c o OfsoddX '000 ■f.rfNi o o vdd/cfrr 

do f d .d:•-: . .od ; ; fuo.' .o". oj.dJooo d.o vjj sit'jn ■ wil&™.n$0JV'l f i r f if'/na 



35. 


maintain electrolyte balance in panhypopituitarism with its associated 
low metabolic activity. However, when the regulatory mechanisms are 
taxed by dietary inadequacies or excesses, the adrenal cortex is in¬ 
capable of meeting the situation with an increased rate of secretion 
of the cortical hormone. 

(4) The Unitarian Concept. 

This point of view suggested by Sayers (191) regards the se¬ 
cretion of the adrenal cortex to be of fixed composition and under the 
control of a single trophin (ACTE). The rate of secretion is thought to 
vary with the needs of the peripheral tissue, which determine the blood 
levels of the cortical hormone under any circumstances. In stress, it 
is suggested that the blood level of the cortical hormone is diminished 
through an increased peripheral tissue utilization of that substance. 
Further it is postulated that the pituitary responds to the reduced 
titre by discharging ACTH at an accelerated rate, which in turn results 
in an increased production of the cortical hormone. More revolutionary 
perhaps than the pituitary-adrenal relationship described is the sug¬ 
gestion that perhaps a single steroid can account for all the metabolic 
activities of the gland. 

At present this suggestion is open to question and a final de¬ 
cision awaits the accumulation of more experimental evidence. There are, 
however, many workers who believe that there are at least two major hor¬ 
mones produced by the adrenal cortex, the 11, 17-oxysteroids and the des- 
oxyeorticosteroids, feich can account for the diabetogenic, as well as the 
sodium retaining properties of ACTH. On the other hand, it has been 
recently demonstrated by Forsham et al (126) that cortisone (a carbohy- 



1 *• 


-5 $#1 Iw.bv. K^l'X'Hv ilJJO -0 .OV'd- 

~iC j ":-:. o r . •: - 


rrco 


nr. id M:o* 3 £i 




e^Oii-r 




• ; i , -v.t'y: j.C..LoJ -J • OoJ. 

)'.U: ■ ".V ''■."l'-' - I V’ .0 : -Ox 

it I t Jtf 1 ' ' ■ f»i 

p 


. daooood fied 




‘ : W>‘V. : \d 0deorr>'0 -00 io rOXO-C O.U:a 

mj aolui © : t ' ■ " 

' ' *( ■■ . C - ' ' ^ ' ' 

hooLd fis: i- ©rti. x--x v-o -- r • r ■ .dvoei:. : ... do y or,:r r.-r 


; , •:■ . . . ' : v 

, d x i cb pj ■ c Did" I 1 ' lo : ) 1 ' 

. ; -.d"; ' , d . d . . .* ‘ 

*•- add cd r. mx> . o e : : ; ;-v; :: *./,i ded 'de rd.dao,. -:l &s. 

, . , id* ui r DE&XsO is ■ ' ■■ , ■ 

yff X\t:oM . ;'v ! r. ■ " •' ■7 l ':T0D u:' X 10 rU/j-Xar •U ( ) r :JO'S OO'lr.JfL.. 0-.0 O .. 

a , : . ■ toic - t t '•:■ ! 

. • 0 , . h _ 1 ' - ' 

J.0 : ddrlvid or 


-o.b laUi ■' ;toi:j:;or.r j id o h .croid on \m odai dnarenq d'A 

' .*.v.' X ■ • ' • ’ ; ’ 1 

.v:o\ •... •, ■; d J- ov-iii.sd or-• '.'o:d(;Y "do--:! ^csvovo/I 

r '..’vt .i o- - ," d , . : -.,X ,:.:sd-.::oo loi-ro: ore -o' ?.'>'jvocrt.v « ©hoist 

o<.;d ...i . ■; 3 . o‘. : > • a• I-.eoO ic/.-: d-'o-j ,-o ■- a::.o do sic ? ybioT:oJ*oooii*.»oo;*q-co 

•;; j - ... u}. •: v .W) ■ r tc o doirocot: ; nr, i \do-r .do - 

_ o - . ) 3 ...:", J .d (d 'J') 13 j - ; ; 3 ; ; ; .Ordi d: »j." do: aCf^T. O d 0 0 ^ 


36. 

drate regulating hormone) can induce a small but significant sodium re¬ 
tention in patients with Addison’s disease. This would seem to suggest 
that <sae steroid could account for the results obtained when the gland 
is stimulated with ACTE, but it is difficult to concede that the func¬ 
tion of the adrenal is controlled by one trophin, because the salt re¬ 
tention produced by cortisone is significantly less than that produced 
by ACTH. 

Although it is possible that the regulation of the many meta¬ 
bolic functions under adrenal control is effected by a single hormone, 
it is perhaps more likely in view of the special attributes of the dif¬ 
ferent groups of steroids that more than one type of hormone is secreted 
by the adrenal cortex under normal circumstances, all arising from a 
common source (Compound F). It also appears probable that some unknown 
steroids of high biological activity may exist, since the effect of 
potent adrenal cortical extracts cannot be accounted &r entirely on the 
basis of their known steroid content. 

In opposition to the Unitarian concept, most clinical investi¬ 
gators believe that the cortex also produces an adrogenic hormone. How¬ 
ever, the data presented to explain this view may be as easily explained 
on a basis of metabolic degradation (195). Administration of cortisone 
has been shown to result in an elevated excretion of 17-ketosteroicls in 
patients with Addison’s disease (126), and in addition produced mild 
hirsuitism in females with intact adrenals (127). This evidence, coupled 
with the fact that 17-ketosteroid s having an oxygen on Cll have been 
isolated from the urine (192) (193)* would seem to suggest that the an¬ 
drogens may arise from the degradation of the cortical hormone. 



- y 

-91 rjir.tbo3 baoa;ib.’.nob. ; 

boo; bb voo .0 oojjboo 0 -0 {:? ; : 1 • f. " n.::b oib; ,.rr oboob) 

bo- 'G;o:: c t not .?3 0 • loro " ■ 

8 1 , . ) ■ 1 j : A 1 t 1 : J j f b 

/ 1 ;IOiI.;r <1 b. At ob 

j- ' bb.O-'O 0 oOO oo..b . • 0:00.0 blor. 0 .bi'-' J' ’ OGD b Oibt 


-Offjr'l: ob' .j L’ , i! o • J" '■ L: .:i.o ob ' borb ,.T.. b\ . ■ r ''O' ■ O'o ■ b . ob 


-f'‘I :'I • ob' O OOfo.ob 

nor; 0 ; ' ,,..b .goo b o"g 0 ’ i ' > ■ :.o ‘ o'v io noli 

' •-.>■:) o-ooo 3"Mi'- 0 '.b 

o'0:'j of : Jo 'Oi GO O' : O0; 0( r hoOUbo'xd 

- '/aoo: : o.J ...0 0 . . .0 

•j.rr' •; to \i " 0 d? 1 . 0 ; -;i CO: :I =. X/C /o' 1A 

. ori I 1 ’ o;b 

■ d' ) ‘ . /■ ' 1 I ' 

--btb.b : ilJ ‘ID Gobio bbobb • 

/ £ ; 00 :0, 0 '10 00 07 GO \0LOiOO 0 0 0 O . ojf JO! 

y j-r‘io-■-) si eitc -;:\coib bo 

O' ';' . -no o oio o’l..'. dooio 3 £o lo 

noobl orb : 'oj:o Jbb " 

, ■ o •: / , i:.io J. ; > -o-o : :><zs: : ■' ■ 1 .' obo o or ,;i 

n -on: (no go (j.'-: .j- vlb 0 £ b ' 

'.ooi- 0'1 rj '..fiOoto.-O'.’) o'-o.';. : '• o rcO 

"to 01 :J 

. . . . v v ; • ' ' r \ .booooo.b; 1 1 A ob oo :;bo. o.ooj.o 

oxll no o;!. ob bo 0 6: > 

•- . o' ' : 3 ( 

.j "O r. " oooi.oA-. ' •' bob b::o "obood" 

■ ‘ ■ r ' . ' 0 > 0 

. J : 0 /•. :• O 10 obbo' .oo : ; " r O' ok il''o- ro ol 

. itoi \:or' g oto. o‘ ; b ‘ 

oo- o -io "/or cob - -.zM&doo o obt bob' ov. .b..o? £ goo: bvo 

: ' vJ.l JO 8 

' ' :■/ Ob' O'b bo0 ■ , i: .ob ob; -bo' e K'G) 

oao'o": loco J.o ro bb ;v bo.b 

b, X) Xioob; - ; '' 0 . 0 --bo.o :b,0;o 'b.' JobooJ' /to 

•r : : : i ys ’■ - 0 .- x - 

G.-bo • : ■ bob no 0.0 an c:l: cbb/o . t»d* na'o.bo’ :i a>b ;igx1 

XJiI )OOUuC J b 

o;' .. ■ o ■ . 1 ' x xi : 

- 

. ' bob; oJboi-'obo; Jo;: J ..bob'./ o-.bo. obi o.l i -x,.' J '.a •••' 'a 

i£v. cv-d Lbb tii no 

; •• ; • vnoovo: iao/o-J ob o’"bor bo bl oj.lv'- ;b io; 

■ 0 b b .. b J- , ,0 

b ; a.- ; . bo— , (bbA)(bP t) ea.bio t•<b iooo'X ,.o b, : Jb',:; o 


-■ ■ ■ ' . -1 - ; • j ..1 o> . - > . .,b . ~ o •-.) :J:• io v ui orb;;-:,// :b 



37. 

On the other hand the high androgen levels seen in the 
adrenogenital syndrome cannot be explained in this manner. The andro¬ 
gens here may be the result of a neoplasm, or arise from an abnormal 
secretory activity of the adrenal gland. Another possibility could be 
that the mechanisms normally concerned with the degradation of the cor¬ 
tical hormone have been altered to produce androgenic substances at an 
abnormally high rate. 

Because of the confused state of the literature concerning this 
problem and the lack of convincing evidence in favor of any one concept, 
it has been decided by the author for the sake of simplicity to regard 
the adrenal cortex as the origin of three types of hormones - the "S” 
and the hormones of Albright 1 s (123)(178) classification, and the 
w Na f * hormones (mineralocorticoids) postulated by Selye (51)(177). 

¥. Measurement ©f Adrenal Cortical Activity. 

Increased or decreased activity of the adrenal cortex is not 
readily measured in a direct manner* Instead many indirect methods are 
utilizied to assess cortical acitivity. Most important are those changes 
>hich are noted in (a) the adrenal cortex, (b) the organism and (c) the 
urinary excretion of steroids. 

(a) Changes in the Adrenal Cortex. 

(1) Gross Changes. 

Increased cortical activity due to ACTH administration has 
been shown to be reflected in weight increases of the adrenal, propor¬ 
tional to the dose used (49)(50). Further indications of adrenal 
hyperactivity are seen in color changes of the gland itself from yellow 


'. 

irii.';' ni •OL. V :I 1 "/- 4 i - •' ' i'h.L.; ' • ' HOll ‘XcU'lJ'O o: -^0 

C ■ 1 

,. ■ . ■ - £ ■ : ' : II 

' '■■■• .O' 

‘ ... ' 

£| ‘ d\>, >•; •; •; ',t V •-* 00 O ' O~ .>!• O - 0 If .’O'" 0 <t Ij.O 0 iV.Ul • '••■;. '• O fold - 

. o' ;0 O LI V I xnowln 

o .'. .... > ;.c ' c ■ ■ ■ 

o tc ' tov ■ tv tom v c 

/.O' v. T < C'X : -L E ' 

. oo -- .ooi'-ooioL Lo .-,o Lo .'"Tc.. :o,/. o . •: oooc :-‘j* ■> ; ' Ld' 

' y . 7 . . . . ! 

I) -1?) I ' ' 


. . r ' o . V 

oo/: oo oo I loxbo lo /vLLj o t oo >oo ora 

«> 

4* • i r • 

. 

(o) ■.. • ta o. (of) t to sno'ib ’ ) .nl fott n £foJ 

to J.J-: • lo :■.! • •;; xtt::s 

, ,:--d 00 J 0.100 L A: j 00 OOOiOj o) 

. . ■ ;o J ; ■ , J ) 

: ol ooo.t o-.to ’ ,L J; , ILL.)••• oo ojj .7 vyLL/Uo) : I.cvjicKo^ Loooooool 

'O' . ■ . , - o. d i l ; 

' ' t \ ' JfFOi 

i .. . . ! ■■ 1 1 ' o 







38. 


to brown due to the depletion of lipids (194) and in the appearance 
of hemorrhagic areas on the surface of the gland, 

(2) HistochemicaX Changes. 

Sayers (195) has noted in a recent review of the subject 
that there is a remarkable parallelism between the density of lipid 
stained with Sudan or Scharlach E stains and the total concentration of 
cholesterol in the adrenals. In general, lipid depletion denotes hyper¬ 
activity, and lipid accumulation hypoactivity of the adrenal cortex (194)• 
(3) Chemical Changes, 

(at) Adrenal Cholesterol, 

Chemical constituents of the gland tissue also vary with 
changes in secretory activity of the cortex. The cholesterol content 
of the gland, as measured by the Sperry-Schoenheimer method (196), is 
depleted by ACTE administration and Hi is change is synchronous with 
metabolic changes which are characteristic of adrenocortical hyper¬ 
activity (194). It has been reported too in hypophysectomized rats 
that the adrenal cholesterol is inert and fixed at a concentration which 
is higher than normal (195) • This data, together with the fact that 
cholesterol is closely related chemically to the adrenal steroids, 
would suggest that cholesterol is the precursor of the cortical hormone 
or hormones. This supposition has been further reinforced by the recent 
observation of Hechter et al (197) that the adrenal gland when perfused 
with cholesterol is able to introduce an oxygen at the eleventh carbon. 

Stress (198) and ACTE (199) have been shown to deplete the con¬ 
tent of cholesterol of the adrenal gland by fifty percent in three hours, 
and cholesterol determinations have been used as a supplement to gland 
weight in estimating adrenocortical activity. 




39 


(b) Adrenal Ascorbic Acid* 

Adrenal ascorbic acid has similarly been demonstrated to de¬ 
crease with increased adrenocortical activity (199)• As with cholester¬ 
ol, the absence of the pituitary causes the concentration of adrenal 
ascorbic acid to remain unchanged in response to stress (198) • Although 
the exact functions of ascorbic acid remain obscure, there is a paral¬ 
lelism between the concentrations of cholesterol and ascorbic acid in 
the adrenals (195)• However, Sayers (195) points out that levels of 
adrenal ascorbic acid mast be employed with caution as indices of adrenal 
cortical function, for in acute stress in animals with nutritional de¬ 
fects or in chronic experiments involving malnutrition, other factors 
than the rate of secretory activity of the adrenal cortex may play a 
part in deteuaining the ascorbic acid level in the gland. For in¬ 
stance, impaired synthesis of the vitamin rather than increased cortical 
activity may lower the level of adrenal ascorbic acid in malnourished 
animals subjected to stress. 

(b) Changes in the Organism. 

(1) Lymphocytes* 

It has been observed by Dougherty and White (200) that circu¬ 
lating lymphocytes are under the regulatory control ©f the adrenal 
cortex. This observation has provided an index of adrenal cortical 
function, ^hich is particularly valuable in that measurements can be 
made using living animals. A lymphocytopenia is initiated by the dis¬ 
charge of ACTS from the pituitary (201) and is mediated by those ster¬ 
oids having an oxygen on oasfcon eleven (200)(201)(188). Neither stress 
nor ACTH will produce a lymphocytopenia in the adrenal-.©ctorn!zed animal 
(200)(201), or in the patient with Addison*s disease (188). Therefore, 


, ' ' ■ 1 p ' ) 


-3.5 


v i- 


\ J .O' .3 : X '£•; ’ ' A 


5 13 * ■;:);• O.O £ r'\l lOVO/' 0 0 300 3 03' OOO;.;. 'O' 'jo : .003''X' 5 : -'3.5 30 3:')OOB5 o 00.5 r 

.j r f oo,;-.L.\ .('a) 3 30 0 / • o5 . • •: rJ. . xr-;.: 0,5 or.; ; .5.'. r. o *3 Aoo 30 5(0 3 ;.' 

. r V • ;.■ 3 . r : j ■ , ■ X O'! 5.3 3..;. \X:o' 0 o.'',O 30 " OlO.fJ'O W‘ I uD f >XG OXiJ 

it ■ biz • i ■ ■ ■ ' ''' ■ 

‘io ?.[ -/ 'X 5 o.X •.'■-■.j ' 3 ./ .. i : , - 5 ' ■ - Y : : * ■ - - : ■ • } 1 

*i5 ■ X. . • joI b t p< X 3 s>3 

-03 Jo.mC'X X 5l5j.r.:'i .003 : : • r •• o" 3"'; ■ ... ■ 1 “'.Gi . ;fO.-u oo.'o-. ... . • .j 

:.r.:c5o.-o> : 5..'o 0 ■ :.ooo: v. X. '5 r o'ior -3 o-:- 3 . rr.;.o ro: or; ■ •£ 

... Y - j' , ;;;0j 00 ; '• . ; 33 X( OO'OOOO: qocOOOOOO; 30 3 Vo Oil../ HOi.u 

~ru:~'.:o'’J q.-oX oo..t 00 : XovoX . Xo : . 5 333, : .33:;o/ 2': :q" 

.r.-o V'oo 5c. ; 'i,o. v o Xo o X ■. ■X...o;;.c7 oooy Xo :5ao or or ;: • '5: *•: 1 rroooj:: 
53ii3;j:oojo.olru:j o.:X r o> ; v,o. o , ; I ..:trvJ..u 5o Jo-vol utf xtooI yooi v/XvX ooa 

, 70 ... 3:131; 

*.:: . X -i 3. • ‘ 0 .. s 5' ! ? 1 o j' oiO’rfX (ci) 

. ■ . o q . : J 

. .jo:; ; ; jo,5 {(.)«./..:} 5 - -o 1 :: ol . ; 3 •. 'j • 5 ,v /or: a- o-.' ■■■.yx.>xi 51 

/. 3 3 ..o.: ' .'■ 05J JO •' 3 3:.: ,;. 0 ' '3 • r.j 'V :■',r':30’, j'VOC'ii'j: r^.f. jiiijoX 


•3 IV 

'); i 'r;o 3 -3 :'3j: : X.XX ;J < f. ; 3S:X.SV 30>.o oliol;v O.i .XOO , f£Oj:5o£fX/l 

. ■ . ' ' . 

-- 0 :. J oo.o- j x 3 .X 'X. ■ X : (XO '.) 'X ."-.rX'/rvo _ orid HT'Xii io ov'tooo 

3.', 0,0 X': "X , (; '• ,'X , ' oX: ( ..XX'X t /'" ; ;ro‘o w • :o ao -oi.'/v ,o ablo 

13 ; • ; X' 3 : '..O' o..'. 3.o ; 3.3;.ojo/o,iXo'~ ; X- 0 OOOfXo'rq J'.i.l3' XXXA 

: • ■ 


40. 


failure to induce lymphocytopenia with ACTH may be taken as an indica¬ 
tion of adrenocortical deficiency (188). It has been postulated by 
many workers that the lymphocytosis occuring in adrenalectomized ani¬ 
mals (68)(200)(201), and in the patient with Addison's disease (202), 
is due to the low blood titre of the adrenocortical hormone. Converse¬ 
ly the lymphocytopenia seen in Cushing’s syndrome (202) is probably the 
result of an elevated titre of the cortical hormone. 

It should be pointed out that circulating lymphocytes can be 
employed as an index of adrenocortical function only with certain reser¬ 
vations, for a number of factors other than adrenal cortical, activity 
determine the number of lymphocytes circulating in the blood at any 
given moment. Among these are included a splenic discharge of lympho¬ 
cytes (203), and lympholytie agents such as x-irradiation (204) and 
urethane (205) > which may be a part of the therapy of the individual on 
whom lymphocyte determinations were being made. 

(2) Eosinophils. 

Probably the most useful index of adrenocortical function is 
based on the observation of Hills et al (206) that the number o f circu¬ 
lating eosinophils is determined by the activity ©f the adrenal cortex. 
There is an eosinopenia following ACTH administration (207), which is 
less variable than the lymphocytopenia previously mentioned (188). 

Many workers have shown that stresses such as labor (208), eclampsia 

(208) , surgery (208), epinephrine injection (209)(210), insulin injection 

(209) and electroshock (211), produce an eosinopenia in man. Absence 

of an eosinopenia following ACTH administration is indicative of adreno¬ 
cortical insufficiency (212). Epinephrine induces an eosinopenia 


-.nolhul nr • noon' o' von .XXX. X.X; ' J. .00 r 0 J 70:.:' I: r "o' oonXaX on ooXo X: 

d. r roXo'r , ." . : . > : '• ’ o X o-- < no-: ' . '£ d.o 

-lii : / GO .. .• or:; ■ OrO , r. X.j ; • V ' ;jrJ ■;.> 0 : CO rOO : : 

- : • ; ; . 0 . ldj. ' d d , Y2) ( . . 5 

- v- 0 . oogo .0 irooXroGoo; •c o e; id' Xc. vt&ld 3 odd rvl td‘ -o o': :• r 

Gili v rd ”.3 r o'i:: d (o'.:’; ■ : no; . • Xol ..0.0 1 o".oo ;C ru e-o&x:e\dr : j:r<\ r . 00X vl 

o r o' * !- .. .. ' .0 - O'd j : > J 7 dd . " : V.c X.L r f v . - 

9 ::f noo asd•oooro: X- 0X.0 :.d;Oo.Xo, o odd' dm, n o 0X0 'dd'oom "I 

-•xor; o.f oXXmo rod.,: ; r ooooo'd /rod X". ord:r too, ‘to O or*. 00 .'O', do,' door 
v-jjcv 00.r X 7 J Ld-o' ror..' ■:Jo; do 7 c *.r .0 t -5 0/1 . oio.ldv 

r • d • b 00 f t d • t I Xi • ' d 

-c •' 0' Xo . ;y: o : .'r, r ' ■: . 0. . . d ".. ,d r ./•; n: 

m . £ . ' ■ o ■ . . ??ct ) ■ 3 5. ... "'X o t ■ - ; ' 3 \ 8 

•' ' XvX iffl ro '. ■ d* ■ oid c (0 ) r . 

• » O'"' ■ ' 1:; :iv 1 J 0 o o: o ter ; )o. I : 0 j o.;o 

. 0 ; oji 0.0X000' ('■} 

ai: ncljonn’l X :al;j-o^o::,orr:oo Xo .ro.o.* ,d.'‘rro; Xr;oo£ roX v.'J v i'cori 
■■’ 70 ) 0 V. o o: ;.rj;x o: o d _ . X; do. or . X •' ',.'.0 or00 v ...- goX no .o.r'or.f 
X "0 rr 00/; . . .0 "X. r,: i-..o.Xo\. 0 ... . r X’.Xi o dori ; oXr S 

y: ' ror ; ;o'X.; :!, ; orr ;'.o>r .X ;.o. do o..', r.XX':X o T rood 00 go go o.:r,.XT 

• (‘ '• ; 00 J‘ o' ... "/ ■■ _ do ■/;-o*'o 7 " ■; • . .J' ; ... Xo..:v 00C 

i--'-o : :oo o , 00 O,'or o • o 'go or r; 00X' j ,XX r or,.. ..v ;i oorX.roo '"odd 

[ ' ' . ) x ■ 

* ; : ■ x ■ '.X j.o;:/» .or ::r)r;i/r.: t (rXX) , n dr r; od r; dr .or' (X-,o) 

: x.onx ., d -.' X - .1 ' r 

' ■ ' ' ' ■ d ■ ■ '' X d - .' X ' .0 " do: odd; V.d r. r; o/O O) 


41. 


through release of ACTH by the pituitary (213), which in turn stimulates 
the adrenal cortex to increase the production of adrenal steroids re¬ 
lated to 17-hydroxy-corticosterone (206)(210)• The increased production 
of these steroids leads to a rapid fall in the level of circulating 
eosinophils (206), which is greatest about four hours after the injection. 
In the absence of adequate anterior pituitary or adrenocortical function, 
this change will not occur upon administration of adrenalin. While the 
eosinophil test described by Thom et al (212)(214) is perhaps the most 
practical measure of adrenocortical activity in man, it should be inter¬ 
preted with caution, as factors other than the secretion of the adrenal 
cortex may influence the level of circulating eosinophils. An eosino- 
penia can occur in infectious diseases, even in patients with Addison 9 s 
disease ( 215 ), and it has been reported that large doses of epinephrine 
can induce an eosinopenia even in the absence of the adrenal cortex (195) • 
(c) Urinary Steroids. 

Assays of steroids appearing in the urine, which have one or 
more characteristics of the cortical hormones (corticoids), are performed 
on crude urinary extracts. Corticoids having similar biological proper¬ 
ties, which are determined by bioassay are called biocorticoids, and those 
which are determined by a chemical means are referred to as chemocorti- 
coids. 

(1) Urinary Biocorticoids. 

The injection of ethylene dichloride extracts of urine into 
adrenalectomized animals increases deposition of glycogen in the liver 
(216)(217), prolongs life (216), increases survival time after exposure 
to cold (216)(218), improves work performance ( 219 ) and reduces suscepti- 


podolmoid'o sr-usl rd 


\-x n\ oXV r ;o • >n. v f ••• 07 .crc nJ- 

-viT o ioooin o'• ri c.-:. • X 7< •" oni 

u Oil ■ /HOT P ‘‘'"i ^ } O'O/O £ ■ : 077.’ J‘ 0 .Yl <7J • 0 .'ll 

'Tjrco;.’o .b: "/•■,: 7 Y ' ; : ■ X CP'O'Oo. • nr-. •! : • '• • 'o' •:!' '.to 

} ' ■ ' ■ j . ■■ r ; X > ‘ ' I i • 

*,o 1 . jri 1 • - s 

I/O L.I.: " ' jr 7 

o b * ■ ' :c b cl lid ■ ' • " 

• - J d - . ' ■ ■ ‘ • ' ■ , . - 

l.'Hioob;* _'io / V ' : 7/' J-;. o ( .• ..Jv: jot ; 

- • ■: ‘'o / : : ' : •'» 

'' 1 , ' YY. ..J.' : ' "/ ' , ! V :-l • ■ ' o' : 'Yo: . P'O 7': 7 7 "; 

P * ' ' . • ■ 

{ ; ■ : ' t ! 1 ' • 1 o ' > 1 ) X i ■ 

. ■ J J ■ Y/U (o) 


'.7 :• ■: V : 7 '-.'. '7 ,7 

‘id:’US b/6 f'LL oi 1 7 .’> p j 

’.tb a 7 :. o p ,7 


7 7 , \ - .77 7 7 

77 .. 0 ) aoofoii .C.-oi'cf'.co.o 10 . 7 ; lo 

777' .1 J' ! -770 : o' 7) 77*17, 

7 r’o PM'oo: 

77'.; I/: 77.77 o.i’c.? ; 7 : ■.. 

'r 7'J ■ 0 'o ; . • " 

/ '7 

■ O'o no 

J' b r i: 7 opj 7 r oo-r , 

£ 1.00 • 7, 7 , ■ >1 D 7 ‘ ' 

: :■ j *.b . 3XP - toll 

fw p'' id' 

:■} f: J '-o 

■ ■ . i .0 J 7 ; • ; . 

: v .') t ■ 

: ’ xioiiit-r 




, 


. 7 '.7 ' Y 7 --X , ' ■ ■ ' ■ : ) 

cct' -7 r f."'77' 'ip :::)o y. o' Y 'oIYolY o o JYn'Yo lo r/olu P7. Piii 

■ 1c n . 1: ■■ ) jjj ; ■ j ■: ■ . I ’ - \ ■ ' v., ; . p -7 H 3 

7 ' ■■■-.’■ : v /■ 7 -7 : ■ ■■ ;-i. .77 , ^ . '. ' . '. '.) 

7. J -7 77,7 { 7 ) 0 0 7 ;,77 7 r 7 -)C zl'IO’-f P-777. 77 l-J; t \£SS){vZXj bloO ci 



42. 


bility to water intoxication (220). These responses are characteristic 
of the cortical hormones, and their occurrence following injection of 
urine extracts has led to the belief that the biologically active sub¬ 
stances in the crude extracts are cortical steroids. 

The properties of ”cold protection” (218) and liver glycogen 
deposition (217)(221)(222) have been made the basis of quantitative de¬ 
terminations of urinary biocorticoids. Close correlations between such 
determinations of biocorticoid excretion and the activity of the adrenal 
cortex as judged by clinical criteria has shown biocorticoid excretion 
to be a relatively good index of adrenocortical activity. The methods 
of assay are time consuming however, and in many centers have been re¬ 
placed by urinary chemocorticoid determinations. 

(2) Urinary Chemocorticoids. 

The assay techniques in use at present utilize the solubility 
as well as the chemical characteristics of the cortical steroids. Urine 
is extracted with a suitable solvent, such as ether or chloroform, or a 
mixture of these two reagents, and the extract is washed with aqueous 
alkali to remove acids and phenols. Chemocorticoid analysis may be 
made on the resulting neutral extract (223), or after further fractiona¬ 
tion between benzene and water (224)* which separates 17-hydroxy-corti- 
costerone and cortisone-like substances from the less water soluble com¬ 
pounds such as desoxycorticosterone. Further fractionation can be 
carried out into ketonic and non-ketonic fractions using Girard 1 s re¬ 
agent T (224) • Several chemical reactions may be employed on one or 
more of these fractions. 


viv-' Jo v: -J.:o : •' ' -'-o 

J.o nolSov {„ v.rO ro.F..u-‘ 

— cFj io " v;I i>> • :■ 0Sc ■■ 


..IT M v- : v j f J.In 


fOQO 


- 


:r r . { -..y^, v ,, . (>■; j ,} - . V ■ / ■' :: ‘ ’ CM ■' •’ 

- •) ‘>0 ' ' ' ■ ' ' ^ ; ‘ ‘'-‘' V ) • ^ ) ' ' ' '•) ' 

•v ."- i d f no I : 


ictt . 


t I x) J : 


lo 


beer' ", 


-8 *X fiofltf. 8 V>.;i! 


.i/evc».- prrSr.xm.WQ 


, | ' O 


■ 


v;iOP, xij; ' ' ' ' ' " ' 

:> ... . • :C< • ■.< '' : 

. • ■ lo .: • .olr.' ;:oJ..:b v : r o 


nr/v'O/r rd'.’. . '.■.i. d '• dro oriJ 


•1 ■; •: I ■' , J. !, : ,0 . " ' " '’■ '' ' r . . 1 V".' •••’ * v ’ 

: r ?'r 

: : ; : ‘ : ' :j \" ^ h,i; """" 
... ' ; .-. • •: .•!:.>* . ) :: 

.?•:<;■■■ i'; W.:;}.■: J ■ '■ 'f'- S ’O!’) 


... 


fft) ; V'‘ ;<■.> .t 





...o 




43. 


(a) Phosphomolybdic acid is reduced by steroids containing 
a primary or secondary alpha ketol group, an alpha, beta unsaturated 3~ 
ketone group, or both these groups (225)• 

(b) Copper is reduced by steroids having an alpha ketol 


group. 

(c) Formaldehyde is generated by the reaction of steroids 
having an alpha ketol or glycol side chain, with periodic acid. 

A method using this reaction was first described by Lowen- 
stein ( 226 ), who treated a urine concentrate and periodic acid mixture 
directly with chromogenic acid. Daughaday et al (227(228) improved this 
method by distilling off the formaldehyde using micro-distillation 
apparatus, and developing color in the distillate with the addition of 
the chromogenic acid. 

The above reactions, it should be noted, are not specific for 
cortical steroids, and do not separate completely the non-active from the 
active steroids. Blood (223) and other organic substances normally pre¬ 
sent in tissue may react to produce falsely elevated results. However, 
the methods outlined for the determination of urinary chemocortieoids 
lend themselves to routine laboratory use, as they are relatively simple 
and less time consuming than the methods of biocortieoid assay. 

(3) Urinary 17-Ketosteroids. 

The 17-ketosteroids comprise a group of steroid compounds 
which, as the name indicates, have in common a ketone group at position 
seventeen of the steroid nucleus (cf. estrone Fig. 1). Because ©f the 
presence of the 17-keto-group, they are characterised by a color re¬ 
action with m-di-nitrobenzen® in an alkaline solution (Zimmerman re- 


; , ' ; to p,f.: ' j - ; bt c ' l X :> zb , F - F 

: ■ ' i . , v.. I..'. , ■ i 

. ' " e ■ ■: .v . t ■: o , ■'' •* :v d ' 

J'.Cvtc:- vijbl,; • .y.dv'/v voy v'rviy ; vv : v u v- voO V ; ) 

. 

' 

. ‘ hr t ■ : * & 

J vo ft ji >-vs v;; > .tv tv: w. wiF ov: v: :v.“:v.j vvvv.r.r vo:J': v: A 

. )2o i oXbcJfc x >. d f*n v o cv.«i 5 ■ - t 1 3 

'J . ; V ( \ / ■ ' . ' F ... V ’ '■ V v ! . ? ’ '• ' ' 'i ■ • ’ VV , ■’ •' ' FV'V ' > 

■ t ’ d 

. j fs.U 1 j I 0 - • 5 ' : ' 

, • .* ' ' or \ v 

•io‘.L oiit-voy i V;f ..-v : , • v sj.Uk h;> v , -ir .* to v/■*■: * votfo viv.’ 

u o j ■ oJ 31 g c :■ " iqs d f o ; ? sMo* d?5 IboI ' sc G> 

- . ■ 'X/j do I) -. . 

. . .■ . . . sr/slo e j‘ . ■ *x ifGfj'dd* 

. • F.vvF . •: -oj • .,■ q; • V.- vv xd vvi : 1 • vdvF alf iw ;vFciFrvr.i exvt 

i r ■ - , ,r : ■ . . d twrX ) I 

► '.j: , V V '..-V/V"; r.*) '.V. VV wxl j ;1X£ 

V:,V::j-VO,; . VJ: (f) 

• ■ • ■ ' ■' ■■ -1' ■ . ■■■ . ’’ - .< ■ :: -'-./i. o-J . - q 

V ; vj. - i' •• -vi vv : v :< , ■ vdvvj.i v.v ^rr.-wi ovv; r; • 

.••.I ’ V ; :;. r ; vFvv .;j : ;. : J 'to :.v-v,y.;r. v . 8 

'• L . v:oJV-> > b. jv:; \ v; ;« \crld ‘to ooaose'ltj' 

• ■ ■ ii • • I jrdcus 



44* 

action). This reaction is the basis for a number of relatively simple 
and acurate methods at present available for the analysis of urinary 
17-ketosteroids (229)(230)(231). 

In normal subjects under normal environmental conditions, 
adrenal cortical activity is responsible for two-thirds of the 17-keto- 
steroid excretion of the male, and for the total 17-ke to steroid excre¬ 
tion of the female. In the male the testis produces the remainder of 
the 17-ketosteroids. Variations in the amount excreted are in some 
measure reflections of variations in the amounts of steroids produced 
by these two glands (232). 

There is some confusion as to the exact relationship between 
the corticoids and 17-ketosteroids. Forbes @t al ( 233 ), and Venning and 
Browne (234) have utilized 17-ketosteroid excretion as an index of the 
androgenic activity of the cortex. The reduction of 17-ketosteroids with 
stress is taken to mean by them that the androgenic activity of the gland 
has been reduced and that the cortical hormone has gained precedence to 
meet the emergency. Sayers (195) on the other hand regards 17-ketoster¬ 
oids to be degradation end products of the cortical hormone itself. He 
cites as evidence the parallel increase in 17-ketosteroids, chemocorti¬ 
coids and biocorticoids after ACTS administration (188)(189)(235)> and the 
increase in 17-ketosteroids (127)(147) following cortisone administration. 
Further Mason (192) has recently isolated urinary 17-ketosteroids with 
an oxygen atom on the eleventh carbon, which is a characteristic feature 
of the structure of the cortical steroids. It is probably true, however, 
that the activity of the adrenal cortex influences the rate of secretion 
of 17-ketosteroids, but a number of variables such as sex (231), nutrition 


v (j'Lilflt £* 

Y 'lo r,J.ro. doi; : v; •x'L •. .!"■:[ ■ I J : < ^ • d ''.'..or- >' 


;.j ,;n;"> j. HOi O.'GT * V*.;''* .■ 'tncfl ‘XO Of'l/ OXOO‘ : ' .! X OX 1/ 


o4" . ■ ■.. - 2< 8 ■■ L Id- \t$ 

- 

■ '= - ■ 'OO 



; ■ a • , , r 

o '-O ':;/ 'T" ■■ ■.’ 


•■or; 

AO *1 C:bi:l. j 0 •' 

j- i,; ;i- 0 '.cn .'.o [j. 

„■ 

' 

6j;tO’3 nx O'A.'. j.-Of.: . 

. ' ' . 

c 'f J" 


hi o ■<: t ■ >1 *s. 3 -i ; 

olid' tC. ancid'ii'i'X’V ?.o 


,• -t.u • 

■■ •' J t 



n .. it'.-l •, cod' •: 

• O / X y;..:" 


: 

}■■■:. i •' f 1 1 .: x V - -• ■ . (v' ;.i ■ : . - x ox>: • "i 

■ , hr?. i ■ ■ ' 

x o ■ ... - •: • ■ x .. - o/..: . : J o . . ...• lv’ ' x ' • ■t ■ 

:. • f ....... , d Ic v. o':-:. ■: •- o x ; X .. cd" o. . v ‘ do 

■ 

cj" no ■ . • ■ . 

' . • 

•' v-‘. ; . v . .J. . ..‘•.O'.’. '-..o' ^ v ! ; ■ d'XO 

17• ' . v': '; / ■ \' . . j ‘ v ■ Xo.I:f' ‘ J'i ’ OX'jA ‘IvJ ' •. . ■ - ..‘ I).' J‘ '' Ax A.:'>.,0 «.oJ:00 

. acd£ •.*•:; 1 r h .&•*. o no :\Av - .,o: ci'/cA. (?^.£) (VAX) o J:-..o. XocX ■■i'-YJl rJ: exoio'xon 1 

■ ■ ■' ' ~V'i’ Jo£< . : : t. . ; ( : ‘ !’ % 

o' ; f, j v - ;J- . ■ . j ^ :o ;f:; 

.. ; ■ • /. .i ; . ... X; ;; J- ; \ 

- ’j.o f:J ,■■:■{,i:i\: .! :: j-\vo J. j i- /v.; j y-i • ? j- j. ;::u 

: ‘ ^ ' V.- . ^ ' -v - ;x ;;; hid .. o' ■ := r io 


45 . 

(236) and liver disease (23) may serve to mask or completely obscure the 
effect of adrenocortical activity. 

VI. Regulation of the Rate of Secretion of the Adrenocortical Hormone 
(a) Pituitary Regulation of Adrenal Cortical Activity. 

Accumulated evidence indicates that the major regulator of 
adrenal cortical function is the anterior pituitary gland, and that this 
regulation is achieved through the secretion of adrenocorticotrophic 
hormone (ACTH). The production of AGTH has definitely been shown to be 
an essential link in the series of events, intiated by stress, which 
activates the adrenal cortex. 

(1) Hypophysectomy. 

Hypophysectomy in the rat results in adrenal cortical atrophy, 
which can be prevented or corrected by daily homeo-transplants of anterior 
pituitary substance (47). Stress, which normally increases the si^e, 
and decreases the concentration of cholesterol and ascorbic acid of the 
adrenal cortex, fails to influence the gland in the absence of the pi¬ 
tuitary ( 237 ), although in the hypophysectomi z ed animal the adrenal con¬ 
tinues to secrete minute amounts of the cortical hormone at a steady 
rate (195). 

(2) Administration of the Adrenocorticotrophic Hormone (AGUE ). 

The adrenocorticotrophic hormone (hereinafter called ACTH) 
has been isolated as a homogeneous protein from sheep (49) and hog pi- • 
tuitary tissue (50). The hormone so derived is a complex protein sub¬ 
stance with a molecular weight of nearly 20,000, and an isoelectric point 
of approximately 4.7 (49) and capable of stimulating the adrenal cortex 


XXX.X 


Slid r '■ o -x d :.’I . '<>o : '•' <■ ■’ 


- ■ ; ; • ) j ?J t ■ vli . s 


e.ooxio-I Xjo J:d'*.\oo on. -i oA ■ xt 1 ■- /?:.x xx; x.. : - A •’ " 

tv.WO ' : - ■ 


' ; • 



.x 

IfX 

* ? 

" >-Tf 

xCx 

•A-.X:.XXXV' 


. 

: x x:::.x 



S. . Dibs 

' 0.1x1. 

a r.* 

. ' ■ 


XXX 

) •- ■: 

■ 

A'-X./A'^' A.V', *'■ 


' j,;X.XX A 

XT :. 


• ; XX :.AX 



fix 

09 


\:- r - ■ 


) nmi HTOA. 

'to 

v: c lx x: ■ xx • 

$ 



iloi: 

l£v 


■ ‘ 

in 


fox l:i- 

:i xx;,x 

lo 




; x ' 3 










. 



X V/1x0X5 


, X. • X :■ : ; XX. x'i (a) 

. ;i r :• •. /. cxx " . . x ■ ox a; _ • *j • 

XO.XJX'trio J.o n j r 'r rV'y j- r >'f (^' lx ; xo x xx.' ;r x xa ox x .v. x ex,.: ojxtx 

> '• jrnilru ' ■. ■ ' ■ * 

f X C A ' :' ' ’ ' ' ■ ‘ ■ ' C ■’ 

or v lx dot *x:l■ ■ x ni . ox ; ■ xx earx-fol x xt xll 1 f : x c ? j-xxxxixx 
m . ■ ■■ \ . i ) i ttl i ■- - ■ ■ 

"••X •; j.: y j--;» q ft Of X' OX : XxId'X.CO Oil"; It) X J'XfOX v : XXaI A-;’ AAA . L''f X Xfuixl 

. (?'U) :xxxx 

a ■ x, ,; ■, /. ini ' .. 

(IIj'l x l/xo lVv\: a a.) xxxx xuxi xlx'xoil oxIxxxxuxaax: xil? 

■ -1 oi ... . 1 q ■ ■ ' f . ■ b . tood 

. 

C' . A.XAX \lxxi •. ■ : ,X XXX lo .-x: ; . „ 'AA.A.-'X'-XAa. ' C ; a; 



46 . 


of a hypophysectomized rat. Recently evidence has been presented 
(238), which suggested that the biological activity of the molecule 
may reside in a polypeptide fraction of the parent protein, which has 
been isolated by Li (239)• 

No substance, other than ACTH, has been observed to have a 
similar trophic action on the adrenal cortex. In particular no gonado¬ 
trophin has been shown to stimulate the adrenal cortex in the absence 
of the pituitary, except in the special case of the mouse, where a gona¬ 
dotrophin (luteinizing hormone) apparently acts directly upon the !, X n 
z one (240). Injections ©f highly purified ACTH, however, will restore 
the hypophysectomized animal to a state indistinguishable from hormal 
(191), and in. man ACTH produces all the metabolic changes which have 
been attributed to the adrenal cortex. 

The major physiological effects of ACTH are dependent on stimu¬ 
lation of the adrenal cortices to produce steroid hormones, the actions 
of which have been previously described. Administration of ACTH to ani¬ 
mals and humans with intact adrenal glands results in increased secre¬ 
tion of glucocorticoids, some of which are closely allied to cortisone, 
and to a lesser degree in increased secretion of other cortical steroids 
such as those which influence electrolyte metabolism, and those which 
have an androgenic function. 

In general the administration of ACTH to man (147) (152) (188) 
(189)(241) and animals (158)(187)(201)(242)(243)(244)(245) produces the 
following results: it affects carbohydrate and protein metabolism in¬ 
ducing hyperglycemia, glycosuria and a negative nitrogen balance (147) 
(188)(242)( 246 ); it alters electrolyte metabolism, producing increased 


boin.T o:q ncod' i t ootvtvo '::ttioob-H" . O Oo;,. to, joo'v n 7:o 

7 - ' j ’ ' - ( 

. 

v7 oo-l 'totc n ot7 

> O / \d O j ocv ; :t Off 0 T <. 7'i 7 '•' - : TJ -3\i.: V c cJi Ok 

. . 

.- ; A ' • - • ' •' ■’ 

■ 77 ’n /‘".V- TO;, \ 7 ;. T T. ( 7 "T;.OT.fi %<.: >'-TT TT :.■ j • - .0 '/T'CT 

■ ; /' : ' Jrvr % t 0 "Oil . 

: • . i ■ # xjt 11 . . : r ru 7/ ... - ' < t J s ■ • ' ' ' 7 

■ ■ o LL 3 l 

. •: • . . ;.<• . 1 ■: 6 . f 


'.rdo no jnohnoc’So on It’jo ’70 tiooO'io X..tt;,.(T ottot oo’ t .± 

- ■ ■ ■ , : 

7 V : 

-oioc": jo '.so. 1 io il. rri: ./c o it 3.7 X tciiTc 7't, 0: i olio- o ?. *.t.:X Jivts 71 or: 

' i • *Xi> do id . 1 ■ . it j , 7 >drid toooi ■ I 

130Xih 00 o fc 1 ■ 7 ■ EO ? TO I ’ J. 3. < 7 CL I 

7o77 ‘ ■ . . ' t 7 o.., ..... tv \ ' t ' 01# : ' 77) to 

* .' v' . :.. i ■ ,t.7‘ : . :. : v '... 


(77.r) (7X7) (7.71) n ■ ’c770 ■. O.o nol i; r iO. tluXt : : 7 Xtitio;; raX 

■ (5 . . i ; . 

: clod # ' n : ' Xi t l ' 

(VO-7) ott! -. I <•: t - 77. - v vXio /t r * ■ rt.-- . • -.7 o.-t ;." y-::v-x : >' '7riiocrb’ 

7 • . •' . ' 6 31 7 : dj ) ( .... 7. ' 


47 


excretion of potassium and decreased excretion of sodium (147) (IBS) 
and occasionally sodiumphoresis (188); it inhibits growth in young 
animals ( 243 ) and produces thymic atrophy; it promotes hematologic 
changes which include falls in total eosinophil end lymphocyte counts 
(188)(206), an increase in circulating neutrophils and atrophy of the 
lymph nodes (201); it causes a prompt and pronounced increase in corti¬ 
costeroid and 17-ketosteroid excretion (189)(235)(246), and enhances the 
excretion of uric acid. Androgenic effects such as acne and hirsuitism 
may also follow ACTH administration (147)(188)(189)• 

Adrenal cortical hypertrophy usually follows the administra¬ 
tion of ACTH to animals (247), and the cholesterol and ascorbic acid 
contents of the adrenal gland are quickly reduced (194)(199)(248)(249)• 

A single dose of ACTH may within three thours result in a 50$ decrease 
in the gland®s cholesterol concentration, and it is during this period 
of cholesterol depletion that evidences of increased cortical hormone 
activity are observed. This observation suggested, but does not prove, 
that cholesterol may be utilized in the formation of the steroid hor¬ 
mones (250). The relationship between ascorbic acid and the cortical 
steroids is not yet established, but the adrenal gland®s sensitive re¬ 
sponse to ACTH with respect to this substance is now used as a means of 
bio-assaying the potency of ACTH. 

(b) Regulation of Pituitary Adrenocorticotrophic Activity. 

At present the exact nature ©f the mechanisms which determine 
the rate of discharge of the adrenocorticotrophic h ormone by the anterior 
pituitary are not yet certainly known. There are, however, several 
mechanisms which may be determining factors regulating the production of 
ACTH. 


/ 


(■-;ol) (V.,\'"} YYf ’y c>Y ' YO "Y JVy;yyyyyj '.v-• : ,A " ,; ‘0 CTOXtV* --'X0X9 

■'Y.'yY, ,Y . /■ ‘ '■ ) YY ; ' Y ■ f r ' 

■ [;■<■: . : if..' o ■: ' • 1 y ' *- ■ "■■■ 

P.-ji'JSOO ' Y ' )c>:\ ’ YY b-Y'O't YY Y-YL y: yyyy yy • ' Y-; YOi'iY) 

orf.j ‘ :o y■ Y • o y y‘.' ■: ; 'v'-. / ■ : i- 1 "‘"yy: f.c»• t (O.L) 

Y'~'>Y yjyy ’ :y Y". ■ .'/ ’( • Ito QJYY*£Od‘YCO 

. .;. r : 0* ? Y Y ; ' . Y'Y- Y ‘ Y Y '■ 

) ' ■ ' ' ■ iO ; ' ■ 

\yy. ,yy ortj yy'cyY'VY “ I yy y; : ■n"'V- yy YY '. '"-'Y " .’"Yt \ 

hlo ?» n/." y';vi >: ■ yy yy ot :Y - , 1 "• \) "• yyy . y'Y., ' ' ycX j 

..( \ ) y,; ' ! i:){ ' PJ) . ■ '■ r. -• : bn ?1 m ■ ■ ' • 

a s • > b 1 ; • IS ■, ■ . 

: !t ‘ ; ■■ • - :y" " ' ' , "• '■ ■ T ■ 

Of cor i'.rox. Jy-:y' J'YOO 'y- : : Yj ‘ ' ■. :: yohy 

, '/.. -V'" Y . 'Y '• 0 ' 

-y::yy'. bx-Y y:Y : P '/ y'y.'.y' • r .'.^y.LyP'y y yo. .lobn .Iyy.yJ' 

i 

Y • Y Y ' '■ • Y-.- - ■ . ■; ' ;• • S' ■ 

■ ■. : : ■ ■ h d to \ . • y 

.YCj'r/YTO.Y i i ■ ’ T Y : Y XY YI b l ‘Y Y»‘J‘ YYS-YCp 1? fiO S’f yLy’- O,;( ') 

■ ; ' t Y . ' ' : . ff< 

‘ t. • y y d’ ff Y- - V' *y \ r--;,-■-•■■■■ : rrv-yj.r: \'y ‘y :> y-y y'yyy ^ ‘.to ■■■d'Y/'i Lo 

■ ; . -o' ’ ' ■' ;P . •• t“I ' J ■ ' r to t 0 * 1:0 ■ y ■.' ’ • : I 

tY‘ )T ' /Y • :Y ; ... Y ; r r ’ fLYY'l. d !) 6 ' .!.Y YYYY.YYY -Y 


48. 

(l) Peripheral Humoral Mechanism. 

The concept of a peripheral humoral mechanism of pituitary 
regulation considers the acitivy fef the adrenal cortex to be dictated 
by the requirements of the tissue cells of the organism for the corti¬ 
cal hormones (see Fig. 2). That such seems to be the case is suggested 
by the work of Taylor and co-workers (251), who have been able to demon¬ 
strate ACTH in the blood of untreated patients with adrenocortical in¬ 
sufficiency, but not in the blood of norms.! subjects. 

Much evidence has accumulated t o support the conclusion that 
the titre of cortical hormones in the body fluids, which is determined 
by the requirements of the tissue, regulates the rate of discharge of 
ACTH from the pituitary. Atrophy of the adrenal cortex has been shown 
to result from the chronic administration of .the adrenal steroids (167) 
(252), while adrenal hypertrophy, which normally follows application of 
a variety of non-specific stressing agents such as exercise (237)(253), 
thyroxin ( 254 ) and electroshock (255), has been shown to be inhibited 
by the administration ©f DOCA. Farther Ingle (237) has shorn that cor¬ 
tical extract also will prevent the adrenal hypertrophy which normally 
follows muscular exercise. The prompt release of ACT1£ which normally 
occurs upon exposure to cold, heat, histamine or epinephrine (210), 
can be blocked by pretreatment with the cortical hormone ( 256 ). Deple¬ 
tion of ascorbic acid, which also normally follows exposure to cold 
(257) or administration of epinephrine ( 258 ), and the lympholytic action 
of epinephrine ( 259 ), can be prevented by the administration of adrenal 
cortical extract. These many observations suggest that the majority of 
non-specific stresses stimulate the adrenal cortex to activity by in- 




V ) 






xo xd xxsoi.;idl l -vxl ; .xxx;: • 'mo oxx 

■; ■ j 3 oo ; • ' c ox,. ; 

. rr ,| ;rf o .■# r lo o,r.iy:> oyo Ox ’■"doxo 


x-o) 


fi v 




0 luj^i 0; hoi >0; OC 



-oor lo'x'Mro cl -'oxo'or xo ■ oooxoxx • x-v; 

fteroLodolob ri: lolrix . vlo-oM. 

' \ ■ • 

. 

(Vua) ridoxolo Iootoooo * ol. 'xo nolo roll ;.L:•..>;• 5.f/'c/c xx ocx j •'" • ' r G 1 
10 -- ' ■ r 0 ' ■ - " ■' ' ' ' 

■:) o - ilaUX. 7 : '.1X ■ O ’Xj 5 f-i >>0' '-fJOH ‘itO .« 

■ ■o ...•; .d ol <(■■'■■■: A I'oo-V'.'-r !■' 11 0 'lo:Aoorl 

-'105 dxol a Oil-: x! (11xotlorrl ♦ AID-1 'V x Aoolo 11ono orid” \d 
ylLXrocori-i.ohlj \*d ooAoo/oo .Jloioxln non An:oX,. o;n nil/ onl • 5sr:d‘':o looxc 

: ; ' , ,, 1 ■ :, ' ; ; - ■ : x: A • 4 0 '■ 'A ' ' ' ' ”< ' -i ■ -'l 


■ ' . • * if ’ j'Oj . X ^X>x O' x ; £ 5.0 S7J5 0 

" 

' ' ■ o'' “ i>V . I i ' > r 

>3 5 ■ X"Aol 0 :■ A vAA A;.o* .(AM } :'v Llndroxolx 'A, :i'o;x vs;'-,-AxAin 50 - (V?;*;) 
/xV.:, Mr) K ’ M v !' ;.i. A MM\ • 7 A '' A Aon ‘r- ;-o! non AH'] nolo Anoloo lo 

:..:. 1 A A I : ,ry oo •: o x’ : "v. *'o. . :M' ' .5 : x :.. l x . ' M •; 

r.t v'l ■ .'j I - / 5 .fi oJ' ;: 1.x ?o mxm :j?l,xXc?;r'.L/x^ xxxxn'td'x oxii:55Cf5-non 


49. 

creasing the requirements of the tissue cells for the cortical hormone, 
which is thereby utilized at a more rapid rate. The elevated titre of 
cortical hormones produced by administration of adrenal cortical extract 
or cortical steroids appears to inhibit pituitary adrenocorticotrophic 
activity, and the resultant adrenal cortical secretory activity, which 
usually occurs to meet the increased demands for the hormone induced by 
stressful conditions. 

It has been reported that with an increasing intensity of stress, 
the amount of cortical steroid required to suppress pituitary adreno¬ 
cortical acitivfey becomes correspondingly greater (191)( 256 ). This also 
may be explained if it is assumed that the rate of discharge of ACTH 
from the pituitary fluctuates in accordance with the varying requirements 
of the tissues for the cortical hormone. One may think of the pituitary 
adrenocortical system as maintaining the tissues in a state of well being 
with regard to the cortical hormones (eucortieism) under optimal or stress¬ 
ful conditions, just as the pituitary-thyroid system maintains the tissue 
in a state of well being with regard fe thyroxine. 

In hypophysectomized animals the trophic action of administered 
ACTH on the adrenals, as measured by the increased weight of the gland 
(16?)(252) and ascorbic acid depletion ( 256 ), is not influenced by adrenal 
cortical extract administration. This data has been assumed by Sayers 
(195) to show that the cortical hormone acts to inhibit the release of 
ACTH from the pituitary rather than to interfere with the action of the 
trophin itself on the adrenal cortex. 

The operation of the peripheral humoral mechanism as outlined 
fey Sayers (195) suggests that under ideal environmental conditions the 



, -J o'- iw'0 9 : .... >D CO CO . ..'O' ■ - .•d" -.0 CJ 09' " 90 OlJ .CCXiOCV .'O'T D 

d ■ , t , ■ o .. ; ' 

dv crt •-■> o.dJOOO - ■■ "d.;- do '• -i- : ‘ >'■ v. : , ■ ' Ho 9 O'- O."'b bv.v>.:<;0 

. 

d:b,b ,. 79 d.'ldo o:):-o oo oo>o d-co d oo. o. o.or brv ocovid'.:! ■ 

_ - ' ■ c. .6 ■ " ' "■■ 

. ■ ' . *;j L ■: " '3'iv a 

? "'’ 3 .vot c do X' d dod 1 - ’■ d-o 1 .dodo,;; \ ' 0 . ■" i. 

-ocodd 3 :\t Oi-'O'i.a od o. o.ocoo to^olo cocoo.:; •• :o ■; ;L./oiiLo orb 

• 0 ,?j: *, -ufiT . (3c. ;) (Jd?I) dd'dI: • ;.r-"(oo 'o-. .b A o , iooXvJ'ooa 

tb i ■: 

O'v rood:;/ coo ^nio;o,.'V o,;j bd: soovr oOD,: ni: 'v croyd o.\o o to. do ? odd .• xrxi 
; ■ doddc , ' 'o '/■' .. .Oddo-c- ■wb •• t ob dec 

•cnxob XJ.mr do 'o; o: : ": o..t a abb: o[d dob,.bb boo * ozuhry. I':vo xdoo*) o ao‘I&3 

~r;:o;h 90 1. 9. .Ld'-O 9: ..I Ob ( ■ '9. c / 9 o i •) . ff b 9 ■ ■ or) bd 09 999 'OOv,;: JiiJlW 

O . t : ' i - ' 

: btyi-'o vhmz Jo noI:da 3 o' v o'.-o- colt 'oo:::o loooooo-o.;c.r^dO'Oo' : x /I ol 

;'oc od' "to •:] O' J:o:: t> , - .■‘.O.-OO V :•■' ' t* 0-' 'V : j , ": O'. - ' o"v'd'■ ••• i’O iiT0.\- 

t ' V ■ OO: OO-^JlloJ do?'' ' V {' <■ ■) ' Id d O dt'OO : ; Ooc.H ( •-!' •) (Vc>X} 

; "o ; t/o'C'j.i ; '• '.:oc od'o.o . 00 - 1 ! •■" .■ Jodojo:...^ v-d :o lood-'t'-cD 

1 

;■ dd do noddo; ; *. rid dt i.. -o'dico-dod cd oc cod' -xcovdoi -<«'£ J-'j-.i i. cold oooxdl HTDA 

idyieo t ; C : > 

■» o ' .oo.oo r-j-M iocobooito 0:1 i 'cooir.; itroo'l do'-o: obd %q co.:.'do^ioqc> odT 

o. ' • ' ■ , i*no u otxv 1 >. d . 




PERIPHERAL-HUMORAL CONCEPT 




Figure 2. 

The Peripheral-Humoral Concept 


CENTRAL-NEURAL CONCEPT 

AND 

CENTRAL-NEUROHUMORAL CONCEPT 

STRESS 

I 

AFFERENT NERVOUS PATHWAY 

I 


HYPOTHALAMUS 


* EPINEPHRINE? 

NEURAL AND / OR 
NEUROHUMORAL PATHWAY ? 


EPINEPHRINE? 


ANTERIOR HYPOPHYSIS 


ADRENAL CORTEX 


PERIPHERAL TISSUE 


Figure 3, 

The Central-Neural and Central- 
Neurohumoral Concepts. 













50. 


pituitary adrenocortical system is relatively quiescent. The peri¬ 
pheral tissue cells under these conditions require relatively small 
amounts of the cortical hormone and the concentration of the latter 
in the venous blood is maintained at a level -which holds the anterior 
pituitary in check (see Fig. 2. Note the boxed arrow indicating 
inhibition of the pituitary). Minimum amounts of ACTE are e&borated 
by the anterior pituitary and minimal amounts of the cortical hormones 
are secreted by the adrenal cortex. 

In contrast the pituitary adrenocortical system is very active 
under conditions of stress (195)(216)(233)(237)(253)(256). The rate of 
utilization of the cortical hormone by the tissue cells is increased 
( 191 ) ( 256 ), and hence the quantity in the venous blood is temporarily 
reduced. The pituitary responds to the reduced titre of cortical 
steroids (Fg. 2) by discharging ACTH at an accelerated rate. Increased 
secretory activity of the adrenal cortex follows, by means of which the 
increased needs of the peripheral tissue for the cortical hormone are 
met. Sayers (195) further postulates that such increased activity of 
the pituitary adrenocortical system continues until the stress is re¬ 
moved, or until adaptation occurs, at which time the requirements of 
the peripheral tissue for cortical hormones is diminished. 

The possibility exists that the cortical hormone may act 
directly on the pituitary or indirectly through some metabolite (see 
Fig. 2) which varies in concentration as a result of an exeess or a 
deficiency of the hormone. Sayers and Sayers ( 256 ) Have suggested as 
a working hypothesis that the action of the cortical hormones is a 
direct one, because both Cortisone and DOGA inhibit pituitary adreno- 



. 0 ? 

. . . . Y0 • Y.Y ■ ' v 

LZxsei vix/v.’::,--j: ■. s.uwt •ujo.i.j ins-;, vxv-Jf/r Irtisxiq 

-i:3v7J-p,I c-iiJ- “,.C aoti- e:i$ V ; ■, ::x/o a l-oicf-roo ©itt lo atauoxx* 

v/ *l©dxt . j ■ . : ’ 5s ' £ oj ■' 

^nlvt 70 jYGY' • X.J JH.’ Y.:"'ut jjY ‘ JJJ } '.'O’ 

. I) •:!' ; "c • J i 

gonQi-zcori j>,oxj-*xoo •••< Y-aAYis .y.y;Xjlj . jy ^ y: "Jj:<■Y o.hY -Tr^7, 3:ldr 7?J 

. 

rjviwO -.'.ov j j. ■/•;.■. / •,....•" - -.’7 ;i r .. y a y jt ■: xv. 

, , ) ; , , . 

^os^iohj: aXJ-Y.o oy-yy. / oxL) /” ©aw-oX - : *.o.r j^oo •: XX Xo n . ■ dir 

.. 

5?, 1 • > 

i ■ ' ' . ' ' . 

©• 1 X 3 onoxirioY jvj.Lyyy^ ,, "c‘i ■. YYi.it X* : *'*:-'**i jy Xo yy-yy Yyyy yyxjj: 

). . - i ■ . 

--sy •;! ::: YriY'; o.uX IAyjj :; :.-xr 7 JJ yy ; r ■■ ■; y ; : .1.77.:. jo ;y ."X iYrjl c; yyX 

. 1 *3 , ' 

. •:•!. i. fo-■- .> 1 Yr ■ i j ? . .• ■ ■. : • ■ 

JO' YJ YJQJYIOX X yX.YIOO JlU JyuIX 7'• ;£J.J \y JYYYiYYoq o.jT 

; J l . ■ , . JTH . ' I > 

3 Y .: i ' \ 1 ■■: 7 ■ ■. : ' . J 

’• • •. v } jyx-'jv ; ryr 7 ’.j ... j 'i:o 'Yjru->i:o.f.loi.) 

■ 51 £ ■ id ■ • aol dd ■ . t t 

-oj *!••.■: '-: r z JjY-rJ'i-, XX Y .'j ■.v/x.;.; ; j - .ono 



51. 


corticotrophic activity in stress despite their quantitatively dif¬ 
ferent metabolic actions (210)(237)(253)(254)(257)(258)(259). 

Many apparently anomalous reports on the effect of DOGA ad¬ 
ministration on carbohydrate metabolism may be explained on the basis 
of this working hypothesis, DOGA when administered for long periods 
has been shown to impair the ability of the rat to mobilize glucose when 
the animal is subjected to a variety of non-specific types of stress 
(253)* DOGA also has been reported to increase the glucose tolerance 
of alloxan diabetic dogs and rabbits, and of normal and diabetic patients 
(260), and has been shown to inhibit the hyperglycemic action of epi¬ 
nephrine (26l). Cheng and Sayers (262) have demonstrated that chronic 
DOGA administration induces a state of insulin hypersensitivity, and 
Woodbury and co-workers (255) have shown that the elevation in plasma 
sodium and the reduction in central nervous system excitability, 
which accompany treatment with DOGA, may be restored to normal by the 
simultaneous administration of ACTE or adrenal cortical extract (ACE)• 

This data suggests that DOCA induces a metabolic derangement 
characteristic of a deficiency of the M S i! hormones. Part ©f the action 
may result from the suppression of pituitary adrenocorticotrophic 
activity, and thereby the secretory activity of the adrenal cortex, 
which results in a hormone imbalance characterized by an excess of the 
administered hormone (DOGA), and a deficiency of the endogenously se¬ 
creted hormones which influence carbohydrate metabolism. However, the 
possibility that DOCA and the 11, 17-oxy-steroids (^S 15 hormones) compete 
for loci in effector cells must also be considered. Indeed evidence 
favoring this concept has been recently presented by Woodbury et al (255) 


r :-\ 

* ■ 


" i v ■ ' ■ ui ' 

* i c! 

IttXl Jo u'ooTl : ■. ■ :■ ctocooT onolono/ro •otto.r nj ‘ ;nt : 

• r'j . ■ . ■ . 

Odoiov: iTox o "f / Jot o : i . :' ■' -0 . no; >' o;t ;; ntnoovc ni It 'io 

n-ul: on O' • '.JJ.JJoo! ^ ■'/ t n nt J,. on "Of. r - ont icon'' ■ t /ro ; :.:o f root 

. ‘5 ' j itlio * . . )9 1 Cl i ■ 

0 r: J ,0 o :■ ' > J ■ ; . o '• : n J -■* ' . ■ ' ' >. J : .'I . J; , 

stnoitnq olto.-f :1b on : Jo non lo Jr ? no Mono Jo • tooo oftodnoJ /xoooll ; Jo 
- 1 1 > J ■ nc Wo \ o h a o J" ri . . r dldliiul d ■ a t (OdSi) 

oJokoc.Jo coo.lt Jet no ;:j ; o .) ; o J ’ I ' ;o o; ■ • o: ' J . oo 


‘ 


v j [q 1 1 tio' f o i I '■ j < > [. : v ■ 1 ) !*fov-oo tas f' dc 

- ..' 1 

■ t mo t c .' ) • t : I . o , ...'I , d . ■ oltiw 

• ■' > - I r J.J.: o . ; ■ ■ : on ‘J. J? of :t ■ , 000 ;.ooJJont■: 

tno.no;jq os;) oflofnt0: • 0 o.> too; ;Vi 'o toft ,t : 0 n ; :• J o 

roite . d : o . ffoi ■' ' ■ oldoil'i .' ' *rlo 

■0 ‘it Koi J o ' 

r. : OO'OO .1 :0 0 : 00 * 'J, . J ’ 7 .‘ Jo : J .‘.O o ,0 :0 0 ; "OOO..: t J'XO t xvtotois 

■O. 10 o/i-O■■ :> a.- i r.> • • o ooo 0J0J..0.' oioc o .0 ro. ott:root J:o : o:o 

••00 eoloo 0:!.v. 0000 -j "to O):: .J.' J: / o too , i-V>Ou) enoooroo: 'o o Joot,.T; 

• - - - ' ■■ % ■ ' . ■ I ' :0 , ■ ton! J - 

• - 1 ' ' o J: ? XX U d ■ J d . ; / £ : 0,0 » o 

» : 


Jet '•) JJ: to i/rcltoot. v I J. ,Ji r I 


O) "C Ufjtxi tcroonoo oiitt 0-O.OTCVOC 



52. 

(263) s who reported that cortisone and ACE lowered the previously ele¬ 
vated electro-seizure thresholds in adrenalectorn!zed, DOCA implanted 
animals and suggested that this was due to the competitive action of 
cortisone and ACE against DOCA for strategic loci in target cells. 

The peripheral humoral mechanism of regulatory control, con¬ 
trary to Selye (51), who postulates hypercorticism as the cause of the 
pathology of stress, implies that a normal pituitary-adrenocortical 
system does not allow an organism to be subjected to a plethora of the 
cortical hormone. Just as a normal pancreas regulates the blood sugar 
level within a narrow but definite range, sd the pituitary adrenocorti- 
ca 1 system probably maintains w eueorticism M , not at a fixed level but 
at a narrow range of cortical hormone concentrations in the blood. This 
mechanism is apparently not the only mechanism governing ACTE production 
by the pituitary for both a central-neural, or neuro-humoral mechanism, 
and a sympatho-adrenal mechanism seem si so to be intimately related to 
its control. 

(2) Central-Neural, or Central Nuero-Humoral Mechanism. 

The rapidity with -which ACTE is released in response to stress 
suggests the possibility that a nural or neuro-humeral factor is involved 
in its release. Cheng and co-workers ( 264 ) have demonstrated that 
section of the pituitary stock in rats does not prevent the discharge 
of ACTE which usually occurs following injections of histamine, and they 
concluded that the response to stress is not dependent upon intact neural 
connections between the hypothalamus and the anterior pituitary. Sec¬ 
tion of the inftmdibulum has been reported to have no effect upon the 
release of ACTE induced by chronic exposure to cold (265) . Furthermore 


; 'C. V \ r '', ; !' O: X hi '10 'O.'- ' ) ! .."i 0 id'OQO O .. X -» 1 "-0 ' ' 0.0 ’ r (". ' ) 

ni ■ ’ 

xo v'ox-j or. ovx ]'i:/ otqo r.o-i exi’o o • . r oooo c 

..X •• ! r • • r ; . : I ■ X ■ . ■= X « ' r ■ ' r,:.o' : 

-noo ' : hr.:'- ~ o -s’. ' . ' • 


axi ■ lc aau o .. U n s ai' id * -■ d : I c 


o id 


ooctan s- ' umc i-.dtoifr 3 1 : : 


@j# 1< Oi I 5 ( d ■ . I . t ci ' ■ ■ 


•or; n 'OO rxoO'T 


“W rr-, L ' o- j I ,7 1. ■ Of. o' . ’ 'Or: ■ . ' Xo . >■ : '< ' ' X. " Of) 

o ‘ h X . • ■ d 3| . ' 

,-tol loval .Sdoii.o d; • doxi <roe;- oxe” o.nl xr' •.: \ X : 

X .' : ' ' 

: ic | ©nq i T )A. 1 . ' ; ■ > ■. ; \ . ... ...... ; 

od- h d* • 'lad ... 'J ' - mzicmk ' * - : . ■ 

. ' v r-tr-.o od'X 

.itoxrr •'do* X. I a- o> oX I vtto 0 o . •/* r. i;--l rid r D ( i; -) 

' . ; - .‘; r :; < ” .’OA dpi ‘ 

xvr rr::: J o V',. X-v., . ror;r. re - o " r ' " d ' -X • o: 'j ./•; :y\sr' 

. - . ' 

. -. ' . von -.. " • . rdi; i. 

~v?a ';;-..1 •, Xo I;:;o/d’ 0 ;- ; 7 oX ‘rx. ; :'.>oo 'X:;'.Tr r rb X d" rAO.'. 10 

. d d x od 930 ' ■ t 

' Id ) :..r ‘X ■. d ■ f.'J n ; ( j 0 

■; ,;c ; jr dooVX;:-'evd od drt-roran noovf o.,-r r j;Jr. r .;joi..rrx/:>. J. r; d Xo fiord 
. drier; re? •- •; r. ‘\.c ■ e ..r£ee; 


53 


in response to acute stress, ACTE is discharged from pituitary trans¬ 
plants in the anterior chamber of the eye or the spleen (266). Although 
the degree of ascorbic acid depletion following stress is less in the 
"transplanted” animals than in intact animals, such data indicates that 
the integrity of neural or neuro-vascular links between the anterior 
pituitary and the hypothalamus are not essential for the discharge of 
ACTE. 

Recently Hume (267) reported that although disruption of 
neural and vascular connections between the hypothalamus and the pituitary 
in dogs fails to interfere with the function of the pituitary adreno¬ 
cortical system as measured by the eosinophil test (212), certain speci¬ 
fic anterior hypothalamic lesions completely prevent any fall in eosino¬ 
phils following administration of large doses of epinephrine subcutan¬ 
eously. fie suggests that the hypothalamus releases a neuro-humor 
(see Fig. 3) when activated by stress, for the injection of an acetone 
extract of the anterior hypothalamus of cattle into animals bearing hypo¬ 
thalamic lesions, resulted in a prompt eosinopenia following the use of 
epinephrine (26?) as a stressing agent. 

The central neural and central neuro-humoral mechanisms are 
essentially similar in that they both attempt to account for ACTE pro¬ 
duction without regard b the tissue needs for the cortical hormone. 
Assuming these mechanisms to be the only ones controlling pituitary ad- 
renocorticotrophic activity , the central nervous system in stress would 
be activated in some way, perhaps through afferent nervous pathways or 
the direct action of epinephrine on the hypothalamus or the pituitary, 
or both, and resulting in stimulation of the adrenal cortex. These 


-Olfoor;'- - 

70 ;:\t J: ;;.7j7 v .ocro”'. 7 > ; y 7 . 1 ; 

!:o7: or ;:717)7, ,0 ‘o 

nj ed'iioo; 

0 ,;; -■noo : ?,o‘T 

rx 

t. '. 

. (7 777) ; o: r • ■ • :o ■ -Q 

o'.;V :or\t "to ‘i : .'o;7 

:•;> ■ MO'O'J--' : 

' 

• r 


. : h-K : ' ■ l a ' ' 

Vv* o' ' OovH . ' 0 : . '7 0 0 ' J 7 ; 0 '. i:’. :,; 0 •/ : •• r ' 

■ ? ■ id ■ ■ , : 

. jw ■') f\ 

i-j uc7.ooo:o:.o7o xoooi.o; :/O',r ; :r>goo: rs r-rc.r;-. o-7 

■ X 

.o r ; 7 : v 7c o. o o-oiv : 7. o7;.' •I ?, o7 ro. 

■ -i 0 ■ :hs >0 , l. ;) d - . ■ p, d ■ j* N ■ 

£ ' ' ' , ■■ 0 . i . J . > ' . ' | 

0 o:ooo o .olo 1 ' 3.0 ; ■ oy-o ; .:. ‘ ■ Id or;? o7 ocio .0 0 0 oco7 •oCioc; 

o. 7. . - ' . " ) 0 '•:; 

c-qv£{ r 00 00 .3 o.L .;o,n.n cJ*'ii: o_7.7.7oo 7o • 0 0 ,7o 7 ; o• .. 0,0 lo &n r oKj::o 3 

7o 00 ;; , .34';. ■ 7 : 0/0 o,'.i cl O OC!.;; o, ’ 1 ro- 3 /': . o77, o- ,oO...'oo7 -‘o' .;o. r " 7 u 

,7 7 ‘ 7 - O ' "■ ■. ( : ' •: 00 o. Oui: :0 

C 01.0 XinofaTrt-oxrji::!^ l.B'id'rtsa r>rm X.?f :00 .roo7/;o>:) . o.: 

■ o ■ » . . , ■ [i ■ ■ _ > .:o-: 

.o-aoo-orol 7 ' 0 -J"uo.> oooo-oq o.ooo.i7 70.17 :; :o;: 7000 .faoi-Jhi r.vzd'JosJb 

: v . 0 .:' 0,7-.. . / . , 7- ; / ; ;o,vo o .0 ■ ov foo - .. ,7 , 773v7/o ■ o. 07 ,7o"7 .:; o ocor 

. ■ ' . 

• 7 ; ■ - ; -Oo 7 70 . oo7ox yo ■' .77 r/o tml. olco: 7.,o ‘10 . r. I Jo 7'iJ. ; 

■ .' : o' .0 . ■' o', ;■ 



54. 

mechanisms differ only in that the Central-Neural Concept (see Fig.3) 
regards the infundibular neural connections between the hypothalamus 
and the pituitary as being the important link between these structures. 
Evidence recently presented (267) seems to indicate that the hypo- 
thalamus has a secretory function, and that a neuro-humor here elaborated 
acts on the pituitary causing it to produce ACTH. That epinephrine 
may act to stimulate these central structures suggests that perhaps the 
sympatho-adrenal system is essential to pituitary adrenoeorticotrophic 
regulation. 

(3) The Hole of the Sympatho-Adrenal System. 

The close anatomical approximation of the adrenal medulla 
and the cortex together with the fact that they both play important 
roles in homeostasis (195) has led to much experimentation regarding a 
possible relationship between the sympatho-adrenal and pituitary-adreno¬ 
cortical systems* 

In 1908 Babes and Jonescu (268) observed that conditions of 
stress and multiple injections of epinephrine into rabbits produced a 
depletion of the supra-renal lipids accompanied by adrenal hypertrophy. 
Yogt (269) later concluded hat epinephrine had a direct stimulatory 
action upon the adrenal cortex, for she was able to detect cortical hor¬ 
mones in adrenal venous blood of cats and dogs following the adminis¬ 
tration of epinephrine * Her experiments, however, did not rule out the 
possibility that the epinephrine had acted through the pituitary and had 
stimulated the release of ACTH therefrom. 

For a time evidence favoring Yogt 9 s direct action thesis was 
forthcoming. Epinephrine was shown to produce a lymphocytopenia in the 


■ m 

yy x ■■ /•' f j '' V.7Y/: ; ■: ■■ ■ o./‘i •, ;■ T 

'■ ir ' ■ qml ' * * *' ‘ i 

Y ■ Cvi- or- • 777/.7, 'X YO. : JY; 1 ;/ 

[.-A'' yy ,. ■" yyy- .\ , ./ ./y y U: ■ ,rr/.d-/ ty- oxy;/ a ; us u.-.r; ,v r // 

. ’ 

. i 7. .. . i ' ■ 

0.TilerO "U- -..-yj-r-y: • •; . v/ ■■ j .LYi'Y /y y- 7 ; /.; OB-Dfid <_x r ;7 

. ' :• v. 

. I cE xu 77-obl 7 r rr , v. J‘ AC /bd OlfT (?.) 

all/MSM IyshkixV. ?£o yy.yy ■ .f.oolxod yu/ y do stf,? 

. / i Id ' . ' ’ 

■ Z : '■ ( 

-■O/YY/XY.“YX: YO -i, Yi.Y ■ : 7/ ’j ; •. '■■; • v; ./7 ■<"OY &:■' du Y|f J .r -O.j/.i 7 Y HOC? 

. •: yJ' j ;; j.. -3 /,7 7/ 

lo uc-Y/J:..; «o d/db vyyy. y;> r-ifO/nnct. : /y, .y\yy .iC-I nl 

■B .boOixf.io^q r-utMdVr oyy : : -■:L£'Yik;,yi:dY*o to /uxodYh)./ [/fu /• ha crsoTChs 

* • .cob vx »' ;bi ■ - x i . 

voyJ :iy J.; J-',)-',.'...' y h'Mi Yr.rii yy;.. • d"xi oivoj'/j yy//- - xy j y.l (' t>&) j ;cV 

'£0.i7 Y'-d'YOO YO/'d'Y/ J' ' yI • 7 i 7 .7 :7 TOY t s ■ :'J’'7/7 Y-'. ,‘7. 7/. ../Y aOO'U XiO.fJ'OB 

' ■ ' 

'-'Y Y.YY 7: 7 ' . , YY'Y/yJY; YY 7, l , ’■ 7 .YY; iV- ./ 1 Y', i ■;.. {. 7 ytS 

■■ ' •• d V. li . 7‘ d % 

‘ ■ 7 . 7 j.. ' ) ■ JJJ -j;J‘Y 

i"i YiY: 77 ,-c ■ O;:/; ■,:Y/.y./' > o '/.. 777/ Y 'Y r/'i 

1 ' ■ : ' od rod , ■ 


55 


hypophysectomized rat (270) and an eosinopenia in the hypophysectomized 
mouse (271). On the other hand only ACTE, and not epinephrine, was 
shown to stimulate the production of chemocorticoids by the isolated 
perfused adrenal gland (272)• 

Sayers (195) suggests the following pssible mechanisms for 
the action of epinephrine in inducing the discharge of ACTE from the 
anterior pituitary: I* epinephrine may act centrally on effector cells 
in the adenohypophysis or through the hypothalamus which in turn would 
activate the anterior pituitary; II • epinephrine may act like other non¬ 
specific agents and stresses to increase tissue utilization of the cor¬ 
tical hormone with a consequent lowering of the venous titre of the 
hormone (Fig. 2 & 4)I III* epinephrine may be the denominator common 
to all types of stress and the specific agent which promotes utilization 
of the cortical hormone by the tissues (Fig. 4) > IV. epiphrine may act 
by any one of the various possible combinations of these three (see 
Fig. 5)* 

In a recent review of the subject Sayers (195) points out that 
if epinephrine acts centrally (cf. Fig. 3) to bring about discharge of 
AGTB without regard to the rate of utilization ©f cortical hormone by 
the tissues, or to the titre of the hormone in venous blood, it follows 
that epinephrine should be therapeutically beneficial. If on the other 
hand epinephrine acts by increasing cortical hormone utilization by the 
tissues (fig. 2), then it would be expected to be of slight benefit at 
most for the tissue instead of being flooded with an excess of cortical 
hormone will receive only quantities of hormone appropriate to the in¬ 
creased needs induced by epinephrine. Further he suggests that the 


c ; . . :lf ; 1 ;xusqo low i ''' . j • - ' 

* IT ■ ■ • . 

■ ' . . ' ' ' 

. ; “ .:■> ■ - :,Tx::«i 

ru: .'"..‘I X Xj XX :>■ : X/ : " i. • .X.XJxT ‘XX.VX YX ;': X: r x. X' ■' V' 

inc'.-j; :.r?l.V J 'V; ‘ • :,;xd' xy.Tx'• r:;i: V. • "x *'-• x '• Olio 

.... . n . x ‘ - . i . - - - . I ' 

. r : . ' . x . . . fO* l ■ ' 

-no :r -o xxx,- ' r;' : x ' V ?> . . ; ;. . : - cjj ' x f 'o sv.J.cJ-o ; 

■ . ) • f# " j . X " SJ & 5 -JS EO ’ ■ ' - ' X ' ' 3 > 

0 5 1 ' ' ' Ui i Y . J ’■ • 

HOX . O ' X. vV /. ' ■ ■ ... - :V’ i '• V: • . . 

■ ' ■ X ' 

i 

oas) X.. ;v V' -.rxJ: v x.x'cx : .xj.x . . \ ' •/ ' . x :r. xT! 

• * •’ 

& ; x j ■ cxo? ( ■ t : ' x 

. . . % 

■ . : o ... si x ■ f® t i rr ; 

r',. O.'lIoV: J'X - x:::,.! X ; ;xx:.x X' J :XXX’XXX. ;.. O: T ■, O'XX/i.j XXO . .7.: J' x.x.Jj 

hi . .. ft : . ' ,t; : 

•i'XJ i :.V...j-;x: x- , v w X. v. j,j ■.-(:) YVnJ. YX[ . X X..; , ‘ Y: XY, :• Of lid 

■ : ■ ■ '■ X GW rl i : : :>x , {.. . t -. ■ 

■' : x.- x vx.a.xxx ■ ., ,.J.... '', xx.x: J ’in 'w'-woC ew.ro.ooo ... V xo?; :.vx: 

-x: ' xxxl, • X ■ X)' ..i,;--xj;x:-.;X/. ■ • v. h O a.xjxjY j-.rixi.rp y'.x^x t-YY.s 0 00 x'.Llx 0 OWMGll 

. /jfj'iic 






SYMPATHO-ADRENAL RELATIONSHIP 


HYPOTHALAMUS 


NEUROHUMORAL PATHWAY ? 


ANTERIOR HYPOPHYSIS 


EPINEPHRINE 

I 



Figure 4 

Sympatho-Adrenal Relationship 


STRESS 

1 


HIGHER BRAIN CENTRES 


I 

NEURAL PATHWAYS 







PITUITARY-ADRENAL RELATIONSHIPS 


Figure 5. 

Pituitary-Adrenal Relationships 




























56. 

elevation of the titre of the cortical hormone in arterial blood neces¬ 
sary to meet the increased tissue requirements, may be expected to have 
some influence upon the diseased tissues. Interestingly enough Thorn 
and co-workers ( 152 ) reported a slight but definite improvement in 
rheumatoid arthritis following epinephrine administration, although the 
effect was significantly less than that obtained with ACTH. In explain¬ 
ing this result Thorn and associates state that n Xn contrast to the 
uninhibited stimulation of the adrenal cortex that follows the repeated 
administration of ACTH, epinephrine administration has the disadvantage 
of losing much of its effectiveness as an adrenal cortical stimulator, 
since endogenous ACTH production is inhibited by a rising titre of ad¬ 
renal cortical steroids.” 

Several workers (191)(253) have shown that in the intact 
animal, reduction in adrenal ascorbic acid and the lymphocytopenia 
action (259) produced by epinephrine can be prevented by prior admin¬ 
istration of the cortical steroids. Further neither dibenamine, an agent 
which blocks the excitatory effects of both sympathin and epinephrine 
(273) y nor tetramethyjlammonium bromide, an autonoiaic ganglionic blocking 
agent (274) influences the reduction of adrenal ascorbic acid, which 
takes place in the rate in response to acute stress. These observa¬ 
tions suggest that epinephrine acts like other non-specific stresses 
by increasing tissue utilization of the cortical hormone, and that it 
has no direct action upon the pituitary. 

However Long (257) (253) regards epinephrine as an unusual type 
of non-specific stressing agent. He suggests that epinephrine is the 
major factor in the activation of the adrenocorticotrophic secretion 


■Cr' 


P'f id 1 r : 1 -■ J ' . ( ' ' ■ > 11 ■ 


ovxil od .xxxoxcxx/ cx r \ x . , ' x 

•..j ,jx.‘,; c.c;xx.*:x ■jXBBX'Xon.I: xvid' tfeoLi od •;*' 'i 

nvcru ji'XJiorio r i': x r .x:J-;? 'vx x;x 

r „ '.iO : • 'XX Xid : f i X XXIi ix.ifx: BI X I 

£L. xr'W voxcrd ■ i 

I , ■ x pxr ■ ; ' at* tCM-Ot : h l ’ 

'X j i'^jro X : f J X ' 'x.x ' > 

■>, ;• _,x ;;X- .r {-X X) ' X'X' X'.'. XC ’ P XX.- X 1 '" X‘X "> Xj. X ixJX 'X' . 

-X:0 •i'XXO XU ■ .'MTOd Li'-f. ' xx x 

•jXx ,f \{ ■ irxjXd XX X X. V/' XJ X . SXX XX: XXvI 

odd od d«.*‘:dno.‘> rd :i 

: : -XX XX d"XL -CX X.; XX X xXX vliJX X J' IX 

c rd xxolld' x •. r 

.'xxxiftx ■ Xc: ,xx.xi" ‘...xv xx? bwdicTli- 

■ XiXBuIi BVb.XalX CXll XX O', i1- ' 

t HT c • 

xxoxxdxxxixlx; Ixolx ;:e o J. rxr'x 

;r : ' ' ; ■ : V X.Xi . XX ‘ X fiO JX ■' /;/ f S ' ■ 0 .d ‘.U) 

■ 

. : Mi ■ x i< i f i ■ : ] HT i 5 ■ . , : ■ 0 X : 

■ j f* o . 

X0Bit 1:1 ; ill HS J • - X.: !' r ;'C 

xx :.v.-;.n ('"cx\IiM; x/x id'-xv j-xxiv 

o J;n9COv , '''.Toxx '. L •' ; ix - x 

j?nx xixxixxix '■ j! .'Xx x, (,-x r:x: ex jx‘.jxx.n"r ? X■■ xxu;x?> 

•-/X. X) I solv..;- X r ^ Of XVI 'Vi Vi.; 

LB0 d. -'d - ■/ ; ;) . fo 

d'H ■ ff ■; ? Oft.1 '' .1 i * tv i; ; 

„ 

...... T J ; 0 f, ■ • X t- 

rxod xo xibx'X'x ' : ;xoX''-di j'.;B c.xd ai-loolcf riojxxi 


..nx:doiix oxxoidxifxxi :dxx:xxd.xr-’ ft? ,rxi lx cxx rxxXiofu ;d x'x ;xxxdx: von (xVL 


■ f< x dT . ■ 

i n 

■ Lx 

x . : X ' . ' f-I .■ d . d -x . ' " •: - I'd 

u.k X.-’-Xx Xn.B ¥ '}f!Of' fl :COri IxOj. 

.j xc;x nd xo rix-x, ; ixjxxxld ; x.L :x^ xxxd x;x 

, - - • ’ . r ixl Cm.;. si < ’ .X) ■ , ) ■ . Oft ,t 

e jx lx; jt \ssnz ; n*:i :-- f <: v: i,nJ 

r x:■■ i V., *: ■■ ; :) : ;x.. J x-.i vv-io 


■ : ' X . . . J ' .... . I ■' ' . ■ ' i ‘ '■ '■ ‘.d - ' \ - ' 

o X;xxxQaxvxjx. xxx lo fKiduinxidox o;x; fix vodonx 'Xoxxt. 


57. 

from the anterior lobe of the pituitary, but that it is further regu¬ 
lated by the blood level of the cortical hormones. 

It has been pointed out that epinephrine may be the common 
denominator to all types of stress. Evidence on this point is meagre 
and in conflicting. The completely sympathectomized dog is hypersen¬ 
sitive to insulin, but resists cold, heat and anoxia almost as well as 
do intact control animals (275). This would suggest that acceleration 
of adrenocortical activity in response to acute stress is not dependent 
upon the activity of the sympatho-adrenal system. However, it appears 
that epinephrine is not essential for the aeion of the adrenocortical 
hormone on the tissues, for the addition of epinephrine to an infusion 
of ACE did not improve muscular work performance of adrenalectomized 
rats over that of similar animals given ACE alone (276). Although the 
sympatho-adrenal system apparently is not essential for the response 
of muscle cells to cortical extracts, the integrity of the pituitary 
adrenocortical system appears to have considerable influence upon the 
responses of certain specific effector cells to epinephrine. For example, 
the pressor response to sympathetic stimulation is diminished by adrenal¬ 
ectomy and restored to normal by cortical steroid replacement therapy 
(277). It would seem in the light of present investigation that the 
sympatho-adrenal system actively drives organs and organ systems to in¬ 
creased functional activity in emergenices, whereas the pituitary-adreno¬ 
cortical system plays but a passive role by making cortical hormones 
available in quantities appropriate for the varying needs of the organ 
ism. In more simple terns, the sympatho-adrenal system appears to 
initiate, whereas the pituitary-adrenocortical sytem appears to support 


cellular activities. 







1:1 I X H 0 ' 

.. 

■•I 


:I 

'.:o 

lol 


.. . 

7 

all 

f c* cM 



. • u t 

Olf S.'y. 


ZOO Ol'll 

:tc- 

lev 


CC.0 

,T , v - 

I 


if ; u O'. 

' mv.’i.ftiO id - 

ed ; ■ . * MM 

oI\;o d 


■ 

•d'jri 


0 0 £• ■ • 

Go,. 

7 II 




''■■■'-X) 

■jx aI I 

f.iioq : '.II OB 00 

oooMr/I 


. 

1c 

. 


■ ' 

od 

‘ 

iofjrs.0 

-HE: 1.3 


l : :i c v :>e 

.',t rxr; 








7^ 

0 o 

1 .In-, 

as.. II 

pw as j. 

v, oil's ;,v :ur* • v. 


1 Iv.' O ' ,1 



* 



c 


v ■ J- r •; 

nclis 

7 ole CD.:; 

. I;0,1 i-o ; ; 

luov a 


I . (M 1 ’ 




loo 

I nc 0 

J 

■ 7 X : 

nl oh 

cratoM. r: 

qob Ic.x 

nl '..I.: OXK'O 

i» 07 0 


. 0 0 :: .7: 






CO 

: * 

> '■ j, ;. 

r^SOq 

I’ U '-X a 

. 

' 

’•••7 I .7 : 



.iO 





nooa; 


■ OOOI'i 

zhn ,®i!I 1o no ho. 



"1 i. 

7*. 






.‘.’..jO 

7.0.0.7 

. £iolT,;: 

. J t 3 

O-O : £i j 



F).G r. ; J 






.70 


xi- n..u : 

: . ' l I ■ 

00 77) ; 3.0 00 X Or 








Ion 

X 


’Mo *to 

Qiisr il 

ononlIX 

, 





r .xO 

I £/ t 



, 

a aroq; < ; • ‘i a no *s ol I :M : ‘ • '• ■ • 

• 







at‘ c ti 





v 

oil Id ^.xjiopjn 


■ 

7 •>. “..I 








7 i 00 

Oho 

noci; omv xxilt'Vl ol I 

‘0 000)0 1 


v. ■ I ol 



’ *.! 0 I 

’ • 



XOBCOKSXIO 


I 

nM;.dqonj:o o oJ' o 


07 

• Ha 








, ■ - ■■ 

. VO 70 it 

Mil MI 'X vM nclo 

rJn It:.: 

! 


o - 0 •• •' 






:;; 

"C X v - : 

vM I'd 


.Mol 

Mo. 0 o -..L 


or; 0 

I Of 

xoi 

a. 


; ■ ; 

: X'd'ov 

0<; X/ 

■ 0 'I i'K Xj.BOlJ'0. •V;. .' X =' 

a ‘ ' 


■ mm mi •• 

. ■ xt 






- 

{ r'vo;} 

: 


O ff 0 . 3*10 b£l?» a/IV 

• 

\ j: 

7 ) 7 

Itj 



: ...r, •. 

,7 ’. 


•coo) 


cnx'xbs- 


I:, x:,I: :-:o 7.7M 

... x > i 


v o:xi9 ril: 


'Ivlv 

:.) ■ 4 

: - >110 

7,717 .. 


0 rO,:-.i .0 

«. fj 

:CiOO- 0 :i;;{ I 

'soliotoo :x;;II.3o.: 

V* 


evoM: ■ a<£ 


IxicT 


‘a >: 

0 O '!;! V 


Xbo 



' ' i j ) • ns .. v - : ■ ■ < ■ - • ■ 

' ; ’ ; , ■ ' ■' . • * ; . .( . .' o 1 ' F 

I : . I ■ ■ ■ . c)i 

, ; 



53 


VII. Some Physiological Changes Occuring in Stress. 

Since Selye (51) first presented his concept of the General 
Adaptation Syndrome much work has been done to determine the relation¬ 
ship of the adrenal cortex to stress. That tfuch a relationship exists 
is strikingly revealed when one compares the metabolic effects of stress 
with the effects of cortisone and ACTH administration previously des¬ 
cribed. 

(a) Increased Utilisation of the Cortical Hormone. 

Hyperactivity of the adrenal cortex comparable with that ob¬ 
served following ACTH administration and an increased rate of utilization 
of the cortical hormone is necessary for the mobilization of energy for 
cellular work, because it has been shown that the adrenal cortex is 
hypoactive in myxedema (278) and hyperactive in hyperthyroidism (279) 
( 254 ) (278), in which state all cellular activity is markedly accelerated. 
These facts would suggest that the increased rate of cortical hormone 
utilization parallels the increased cellular activity oecuring during 
stress. Such a parallel relationship also would account for the in¬ 
ability of cells in adrenal insufficiency to perform functions which re¬ 
quire a relatively great expenditure of energy (280)(281). 

(b) Metabolic Changes. 

(1) Carbohydrate, Protein and Fat Metabolism. 

Trauma in man irrespective of its locus is followed commonly 
by glycosuria and a reduced tolerance to glucose (282). Anoxia has 
been shown to reduce the glucose tolerance of the dog (283) and to ele¬ 
vate the urinary nitrogen (284). Intact animals (285)(286) and patients 
with normal function of the pituitary-adrenocortical system character- 


• c 


. o.O •: : . ; onro A: •>'tut; ;y: - 'i 

-noXA .:,L: % oo,v oii-'.::-r?X ).«.) 'I‘O;. 3 on A.oo- ■■■■-:•' ■ 'A no-.v 

: / . . ' A X • ■■ ' ' 

: : *?d ' ' ' rx -■ • ' ■ ■ ■ • v ' ' 






. ■■ ; V ; , A o 1 , A /‘"A A 'i'Of.-I ( ' ■ 

-cfo $ ■ - - 

f TO i: J' -0 K i X J. ci' a 'io oX’T X.v- o A: > nc.A) voX, A:nA \ AA ; A A v ao 

-.to'; vv;o- ";to ir; A’ 5 :A.', ooV. aoa aA-a ;.;A: v/-;. j. A.aAA •: 

i j c j \ 0 :: ■ ■ ■ • ' ■ ' - • 


(vV c 0 -A: oy Aa'a x,; 


b/(AYS:) : ■' 00 - a A rv.X 


■onocfvn 


, ■ \ j . v. J 


x Jayxaaax) 


' ' ■ 

<txV t j 10 v' ' r . » 

* 

' . X •. , ■- u: -A - 1 

/. (IoX) (Co •:) ■•;'/ . a lo oyyGAAi:y :;3 A-.y; vL o'J Lsz £> i^c.lirp 

. A . 11 ■: : ) 

.... : ■,:! .: ■ 'A.. , -v A.- A. c -:H 0 A } 


•\;.CsrOi r.c'.: bx <: XX. A r,j. a a a: \XA 10 vXlyy_ 0 ...or.-A o. v.- ni ,u oAt 
. . } ;,.;0 ' 

-do cat Am (AAA) ;;o., o/.iA Xo . a. a:-. a A c-ocalA;! oj A oooiAy cA isaiA nowd 

A, ' i - . ' A .-.A A ' ■ 'A V 

OX !:AA":V' ; ., .'O.v-'O'O.'.'l.lA; : 'A; rrc,.IJ •; (V ;A: A.:.o;'"o!I oXAn 






59 . 

istically show an increased rate of excretion of nitrogen after trauma. 

On the other hand following adrenalectomy* trauma (285) (286) in the rat, 
or anoxia in the dog fails to elevate the urinary nitrogen. Fat is mo¬ 
bilized and stored in the liver of the mouse following exposure to stresses 
such as cold and strenuous exercise (287). Experiments of this nature 
have been interpreted to mean that the adrenal cortex is largely respon¬ 
sible for the diabetic-like state and the catabolism of protoplasm which 
accompanies stress in the form of injury, since the cortical hormone 
characteristically acts to inhibit glucose utilization (151)(158)(160), 
increase protein catabolism and urinary nitrogen excretion ( 154 ) ( 155 )# 
and to increase the storage of fat (287). 

Recent experimental data would seem to indicate, however, that 
the adrenal cortex plays a supportive role rather than a causal role in 
the phenomena cited above. The hyperglycemic reaction fails to occur in 
the absence of the adrenals, but a dose of AGE, which does not elevate the 
blood sugar of non-traumatized normal rats, restores the hyperglycemia 
of trauma in adrenaleetomised animals (288). Similarly it has been demon¬ 
strated that amounts of AGE, which did not cause an increase in urinary 
nitrogen excretion in an untraumatized normal rat,, make it possible for 
adrenaleetomized animals to excrete nitrogen at a rate comparable with 
that of intact rats in response to equal degrees of trauma (286). 

(2) Electrolyte Metabolism. 

A number of stresses such as hemorrhagic shock, muscle crush, 
surgery and intestinal obstruction produce a characteristic feature of 
adrenocortical insufficiency, in that there is an accumulation of potas¬ 
sium in the extracellular fluids, and an increased urinary excretion of 


. ■ '■ ■: o : 'V .oo-",.7 .■ J .k, ■ - . r ' • o. 'd'-.i 

■ 

. . ■ * . . ' ... .I'..'', ‘ 

vo i/"'o. -.o : 77 ir -,- r-d' v.; I ., *,I d..d'H ; ; s ' 

• - . • ; ' ' -v .. ,■ . - 7 ' ■ - - 

-:V:', r m - j .> /'r",^ -oaoi o - ■ ; >■ ;"::>ho o-.o' r ovod 

•i'd.V' .uIO ■■■■’.J.djO-J'O* O'; 0 ' 7,11 •• : ■'$ '0 O; . ,t ' HIP, 07'O^'7 '*7'd.* --o ’ ' : do e. ;.V.f «"d oXdxs 

(H-oms, n I,7.oi odd oorro ,^"HOdO- 7:.e ooo't *r>:- 'od r;c ■oo<*a o .doOjocro;)^ 
■ , '’ . • O’ d ' 7/ : :: • . • '.dd; . . 7.\ ' d ‘ " " 

: . I :■ } l ■ 

, d" t " • ' - 

: t'*. o : d v ro...' • d o. 4 "vO d.,.- 7 'n1 v£: 

! . ov. :o - rod 7, d o r 07 7 - 0 :/ oov oo o to do on oo^odo odd 

1 t ■ ' m « Lb 

o" ' dr/d.., o ' O'. ; 7: - ■ . d ■ d < : ' ' ,o.'d ":•/ od - -oV 

r 7 . Jr. ' .V i .7 . , ’ .. 7- ■ 0: /0-. - 0. ■ . ' ' 7o 

7 7 d 0 O'. .. '.,-0 77 .. : d .7 J : . 0'7 ‘ ■ V+?. 

7.Cd .7 7, ■ '77 ' 7 , ./ ' ' 0.; ,-7':0 .u t . 7 '7 4 77 ' :> '7. '.O'.-dO:'' 

• • ' • V . • b 5. 

= ( ■ ■’ ' ' ‘l 77 : 77 ■ ' 7';0'.: .7 ■ - .7. ' • ).uto> ' : i: ' ' fit 

, : . V 7 i&x.r.oTL&ov# ( '} 

?!: ' ■ t< 

-i.d 7-7; ■. ; '-O o- j :,.7. : 77do ,7' 0\70 ..COO’ ilOXO 7»i.0vta7.;0 .07 r;, ;.J7 7 ., J ' - 7 ;7I0 7000'O.UB 

'7.d■■ . .. . ' 1: ;■>: oo , . 0 , 0 .. ' 7 ' r 70 7.70 7 ! 7 . -rim 

■ ■ 7 : ' :V . * ?, .'o'- . , ; 7.. o. 


6o. 

that element ( 195 )• The accelerated excretion of potassium is thought 
to be mediated by the adrenal cortex for cortisone characteristically 
results in an increased urinary excretion of potassium and chlorides 
(52)(147). 

It is very difficult to establish whether the adrenal cortex 
plays a causal or supporting role in the production of the electrolyte 
metabolic changes observed in stress* as there are numerous other fac¬ 
tors which influence electrolyte metabolism. 

For example, it previously has been pointed out that DOCA 
administration results in sodium retention (134) • Recently, however, 
it has been shown that the elevation of plasma sodium produced by DOCA 
in rats can be prevented by the simultaneous administration of ACTH or 
ACE (255) • This coupled with the fact that cortisone (an W S M hormone) 
has been reported to induce sodium retention in an Addisonian patient 
(126) has prompted ¥oodbury et al (255) to conclude that the w S n hor¬ 
mone can normalize plasma sodium regardless of the direction from nor¬ 
mal, whereas DOCA acts always to produce sodium retention. Such ob¬ 
servations serve to mask the precise role of the adrenal cortex in the 
production of the electrolyte changes observed in stress. 

The marked similarity of the metabolic effects of stress and 
those produced by the administration of cortisone suggests that the 
adrenal cortex determines the response of the organism to stress. It 
follows that resistance to stress, although a complex phenomenon, may 
be also intimately associated with adrenal cortical function. 



. 


,0 r, x •• J ; J.: ox ’ o. ; T * (";• 'i ) J' "0 xxx; d v x 

£ •• . j . £ . 

..OX Id'L'i D '.£,0a J'-: DO IxiOOjl. 3 iTCf xJ ©tf <Xl 


io i v id i*i*r • ' 

.(v' o( v -: 

:.J-‘ too . . ..- x r , x...i . xd •' c j ,‘' .• ;• :x*v < i dr I 


xi.d do... : 

. viv rU t-Scyx oxxxx'';o' a,ffi *:ro X.-xumsi is e^b.Co; 

■••Oil •: r-J ■■■.;• Sr.. . 

. . ; • , : xxx ; / .xxvo: : xX ; v .0 xlo oiicx: xd x 

f i 

x/J0 ... .J '■ o d 

.' . . ,xx,. xi \J -11 , jl xto :x -ob 

* x •; C . , O . 

. . / x.< ; i. J ojtxOoo n:i .. box ' x xx ,'b xrj- ini;, in 

'dJUu ■ 00 .0*10 f.'J X , 

> . . . . ■ ■ : . 

*fo li'i'DA ao nold'^Otdo'1: 

' xxxxlixxx ox x •</ i b. d x.-vov. b axo xdxvx :-i 


. 


i 

d'' ' . :b . /•. J oj bt •. ox: xxod 'll 

x : ox....' dxxb 

: • ■ O' ' ' •■. j , O'. v : >C < > . v : t. ' ■ . ’: • 

• -".'o r :. mc*.f'2 .0/ bioxxi . ; 

i'd' >. , ■loco •; j.. r:oo ;orr6n 

■ . 

x ■....o;.ii'CMq od xv'r. i..; : 'xto-a AD'OCi r:xono/rw t Jo-ox 

x;x • xt‘ 1 . .* •• , 

1 . oIc‘i ox J / o:..; 1 v. «:.j V'^vf! xac'id'.ov-oxo 


"i' 1 ; : '• . r .tj x - .x x.'x ; Jxxx x 1 dx.x'x,xx 

ftrts • 'Ic- xdoxVx x.xJX'-i<rx.f,:; oxij - dio; x.I ,. ? ic^z/nX otiT 




: ; • od: .; ; . 

/ '■ /'X.i J'xX.j 'X i 


iu OX/iOOSO'l Oil J X-:>ili;v; r rod'Oi:) ..odox .0 .Laf£i>^'Ui3 

. \;' i:'< 

.. •. " : '.X . • .y i - OX.-X ro-LLc-’x 

* 

xjid^ov . xv..- , i.o ; ixdi : j.'. r.:..oeX#;> ©<J 


61 . 


VIII. Resistance to Stress. 

(a) Definition. 

The term resistance to stress is defined by Sayers (195) as 
that capacity of the organism to maintain constancy of the internal en¬ 
vironment, and normality of body functions during exposure to stress. 

The degree of resistance to stress may be measured in a number of ways, 
including mortality, maintenance of normal concentrations of metabolites 
in the body fluids, and the maintenance of body functions. 

It has been firmly established that resistance to stress after 
adrenalectomy is markedly decreased and that the adrenalseternized animal 
is extremely sensitive to a great variety of agents and environmental 
changes (69)(70)(71)(72)(73). This fact suggests that resistance is a 
function of the adrenal cortex and particularly that lowered resistance 
may be due to a hypocorticism produced by stress. 

(b) Mechanisms Producing Hypocorticism. 

Several mechanisms which may produce hypocorticism have been 
suggested, among which ares 

(1) An Inadequate Pituitary-Adrenocortical System. 

If the adrenocortical system was incapable of producing hor¬ 
mones in sufficient quantities to meet the increased demands of the 
tissue during stress, it should follow that steroid therapy would in¬ 
crease tile resistance of the intact animal to stress. However, adminis¬ 
tration of neither DOGA or AGS increases the survival rate of intact 
mice (289), or rats (290) from scalds, or infection with B. Tularense 
(291). Although Kottke et al (292) have shown that Kendall’s extract 
will increase the resistance of intact mice to hypoxia, the general im- 



n 

. 

&Ut 

rad 

• ' 

*d 

i o 


-r;xn.a 


. ! 


r^a u) 

i . ■, 1 ' ■ ‘ 


."ir 


r *£0 <r-.y T, ' ■; j 0 ;; ./■ j ' "V ; * 0/ : :\; f O' ' \'j' ‘ 1 f. . ''O'’ 0: .0 0 i X,' 


o X or 

' ' 

r' 

} ■ 


ox n ic 

00 ■ ■ ted 

ii.n 


• • 

! d • 

alhn 

Dili: 


. ■ tdo i 


. r r. 

OCi 

do v oo rtV; 

j. > £ J 

a, ; 

dm 



vfiOU 


V ' 

.. 

c<7 s?m;j ?.s. 


' ■ 


J • • eld 

■ 



O-JK 


: 



j 

r'd'D*oI.of : or •, 



d- 


--GO'-: VO 

vllbiv 1 


::.r.j V; 

!oc.'dooX 

. ’.o 

T 

rraisrrro* 

1:V.o; " ' 





d 

e 

£>•/ 



vo.oraa'. 


’ 

■ oo;r u 

a jo 00 doou 



.0 ? 

1 d o oj. ... r ; 

;r.fT , (:;T 


■*' / 

(r 

0 (ov) 



.000 


bo* woJ loo 




or ':.vd-,v 


r> ■ : 


o/5 arid 

do no 

J \i 0 




„ l 


' I'iTU 


;o?:.q aoXo 

id- 

■j;oO 

CKpdjd' r-d ovd 

• S 

vr"’'.;:: 






•i.d'lC 

iOOqvll ; v: 

> 

r, < 


1 0 

odd 


evori 

f® ■ '; d d 0‘ > " 

r ' 



j) Vo: r; v: 

j. ;i 

srio 

00:. 


* "• 1 . 









' 



' 


• r ! ' - 



. rv 



r- •' 

c- 1 i ,Vi 

■ a 

' 

-- X 

d 

3U; 

.vdvvndi 

nA {.L 

\ 

) 



■ :<:*■ D do 6?XJ 

• 

.00 

• 1 

0 - / J :od V 

' ■ ,r odv; 




5 ofdd 

d- T 



do do 

aorrorM) boos 


' 

■ 

S'.'fid o VOID 

v a ddl 


.o 

d.i 

rrexoidJd 

t 

SO 

ffoio 


'o’ '.J--*- '• d ori on.rjVd: Ado/oX d. vd • oofoold 

’V «- ' d . 1. : ;i : d ' <. ooood " : or d o ; ‘ o 



d do : d'OM: .1 ■/d.V’o.o.: f!.r-.d oo, 

/ 

10 \ 

os.: d.X.XI orojd'djor: die, r?o. 

' d.F0i:d 


d’ , " . • j ’ ‘ 

. -x. -do 

m:o*x 

0" . >•: ■ y . ; ' ; £ j 

o o joni 


1 . - . : 

•ii (old' 

:) Xo 

, ■ : . . ' 

im) 


ae:?, aril cl cjdJ. n Jo:.< Xvl lo eoiMd^Xe,?-')’’! arid XI iw 


62 . 

pression one gains from a recent review by Swingle and Remington (293) 
is that cortical steroid therapy is of no benefit in improving the 
resistance in the intact animal. 

(2) Exhaustion of the Adrenal Cortex. 

Various bacterial toxins produce hyperemia, hemorrhage and 
necrosis of the adrenal cortex of the rabbit (294) and the guinea pig 
(295) • Sayers (195) postulates that such tains may impair the cells 
of the adrenal cortex and that a relative state of insufficiency of the 
cortical hormone may be so induced, but he eoatems the use of the des¬ 
criptive term "exhaustion 81 . He states that the conclusion that a gland 
exhausted of its precursors is impaired in its secretory activity, is 
not justified in the light of present knowledge regarding the relation 
of the concentration of certain constituents to glandular secretory 
activity. 

(3) Exhaustion of the Pituitary. 

The possibility that a deficiency of the secretory activity 
of the adrenal cortex may arise as a result of deficient production of 
ACTE must also be considered. Because ACTE is a protein, a deficiency 
of amino acids may limit the production of the hormone. In this regard 
it has been demonstrated that the rate of excretion of biocorticoids 
by debiliated individuals subjected to an acute traumatic event in¬ 
creases slightly or not at all (234)? which suggests that the adrenal 
cortex is less active in mal-nourished than in normal subjects in stress¬ 
ful situations. Sayers (195) however, reports that despite the pro¬ 
longed discharge of ACTE in scald cases, the pituitary content of ACTE 
is depleted not more than 50 percent of normal. This observation 


' (JO 


. 

sold ■' 1.11 \ii:: 

feni o-'rqiTrciiae.;'" , 

. 

sii&o iiL • ■ 
o : to 

-3 eh 1, O' ‘10 Oil i 

- ' 5 ' . 

■:-i • ,/ ■ ■ 

noidxIon oiit inii 
Yxcdi 1:013 \iiiir 

'lilvidoi no: 

« i >J ■ ' J 

yon ' • , 

. 

3 'i jooJLJ IX'lioid Jr 
oiJ - 

■ in d:m •• d j i 
Odjl; fi.x xd-o,i 
-one oacr adilid. 
i? ! i 'll 1 

icil ,y,:.'-v'iu : 


'll 



niLi/d 

: XX .0 ! 1 . * 

’ i ‘ o' - fic "• 




• k ' " 

' 

. 1'". X 1) 111 GO 1".Lj 





■ 

Lixirro ly, 

i't^C "id! nL no:O'"'3.1 

o: i. 



* 

.... 

xx.oA -■ ii i 

ii 


r-p’f f-c 

- 

r 


' 

rsiyolooif rwod’t iV 







diox ' id' d’o siici 

i.-»n 

' , 



/ 

lojii.ilioi 

' 

■;] 








■ v i;x 

o ' r: oil . 

1 

*oilj ifv •TOi;!i t ,COi l J. • VjJ* 




.iiii 

ni- y'-i i 

. i i.' 

i • ■ ' ;i' ! • i. .'■ ; v.: 

‘ no 

11001 

* 

‘ 

: I'l'ii' - 

i 


; 


x Lion: 

;.:.,l:r03 .11 


■ i. i i ivin; j :i 

■to« 

• : 


d ■ >j- 


' 

r3 • ld'.oiu.i mo noo wid' 







# 

d'O '0 




. • 

,!i:X arid- X. 

! n ' i i: i' L (• ) i 


■ 


. 

iO XL 'M 3 

"il i.L: 

il .;;yv ^ c f? 


id Lx, 

j Jo 

d'lo :v 

•. 3.3 0 

■ 

: ; ' oo i 3 ffy.tG v ci'Li' 

10 


■ nl 


nr n.>a 

. 

ICO 9 Ci 03 i O' 'll I/ 



L 1 : i 

loLLo-noon 

q x ' 

1 r/wi oi.li • ojax.ii 

■to 




.. .■ 

•j Ml Lyd‘'.: 

i- . 


. : 

, tu 

0 3 fl# 

o.l uod’os 

' 

b 

;■; 




■ .110 

..LI ". 1 '- j i-.i 

; i'o viij L .Li. o 3 o o .irf.o 

• 


/II; id’ 

Hi": IIU'CII-I 13 ill. '■ 

viJ'-i", 1 r,.[ :L: :i,;r 

TC& 



■£ 0 < 

ir:..-v:v.;*on 

. 

1 


i.L: ; 

. 

‘•>3 -0 bXaoa nJ: LXO .. 

xo iiii'iiii .■ .o:).i: 

'TO I 

:.aT 

. 

nron L 

■ o ..iirxonxi 

i Ox ii.iiL' 

/loir Lon .dJ'i.L-o o 



63. 

strongly suggests that the rate of discharge of ACTE is never the limit¬ 
ing factor in the ability of the pituitary-adrenocortical system of the 
normal organism to meet the production requirements of an emergency. 

It has been inferred from this data (195) that the survival 
of an organism with intact adrenals from an exposure to a stress, 
which severely taxes its resistive capacity, is not limited by the 
failure of the adrenal cortex to fulfill the tissue needs for the cor¬ 
tical hormone. Apparently the answer to the problem is not concerned 
primarily with the supply of the cortical hormone, but rather with the 
action of the hormone. 

IX. The Mode of Action of the Cortical Hormone in Increasing Resistance 

t© Stress. 

The markedly increased sensitivity to stress occasioned in the 
adrenalectomized animal (69)(70)(71)(72)(73) has caused considerable 
speculation as to the mechanism by means of which the adrenal cortex 
confers resistance. Several possible mechanisms have been suggested 
by various workers in the field. 

(a) The Detoxification Theory. 

Arising from the detoxification theory of Brown Sequard (296) 
is the belief that the resistance of the animal to stress is related to 
the action of the cortical hormones in detoxifying noxious agents re¬ 
leased from injured or metabolically deranged tissues. Histamine has 
been indicated as the endogenous toxic agent, and the adrenalectomized 
animal has been shown to have less than normal ability to inactivate 
histamine, which ability can be restored to normal with BOCA or AC! 



n £.. 

Gi# 

cfc-' Wca • 

x HT 



■ Ip o'J'-t 

G,b" ,f 

ii 


' 



■ 

' 

n: 



■ 

' ^ - 

o - 

'■ i 

■ oi id' 

1 »! \ 




« 0 


• • 


■ : HR" 

oo ' 

' j 0 : ' C: * L , 

r riJ d' :• 


oi M 

ij ;v.. 



•CO/C 

I ■v.I- 

■gr- \j 

- 


<■ v 

od >:*fo oiiil - 

luOlilt bop 


ri‘ f 

. ■ • 

;! n 





■ : J 



- 


■ B‘ h 

io vd 


' 

r:, ' c 


n ■ 





- ■ 

'<4- 

. . 

, v . be ~e 


■ - - ' 

8 •• 

■ 

Cl,,T; 

■.—c 



■‘LOO ‘ 

xl;r 

. 

o -<.; 


• 

bob od' x l 

J'^OG d 



. •. . . 4> 




r wr 

\ODOOO d'O;' : 

\ 


o !;■ o-j* T. 



m: v 


. 

’ ::oii 


io 1 d 

j 

j ■. 


■ ■ “ 

j 'jjti 

, f 


k..q : bb 



i ' 

' 

■ ■ | 




' 


■ -' ' . - ' . : ■ ' ' ■ ■ . . ■ O. O' 

C-J 

si.iu cii yooobocooo accc;/-: "vj;j\.ur;o*-> bor ,cooool . T 

- ' ; F ( ) . . ■ . ) ’ ■ - 

■ l i ' ■ ' ' ' hsooi 

b ; ■ v ■■■'■• ■ 1 ■ : . ■ c V ■ • ■■■>.’ -V ;' ; 

. • " j.- .to ." ' -V o, ' 

. .-d? .li f j --1 ,-.o (-) 

' ■ ■ ' c ' ' 

Co •") ’ •'£ C:j:. rv-'V’ •• \ v- ' :■ o: co , ' + : f.o : ..S.r 

. i Hsjohtot ' ■ • : • ; ' : 


) 

. 

c l 

'0 1 

l ■ ■ ■ 

■ft d O'COy I 

oj-doj: v. 

ob.n ' c v bo 

■ . d.0. 

OiJ-OflOSObaO 

oiid- r-jo bodcoDj 

' 

■ '/.• J 

■ ; 

-L/^roion riru'id' : B.o 

-■x GV*;d c *& 

Ifii'OdB f’OOO Of 

. ' 

0 -:o 

A '\yti - 

••'o-' od' A coco: 

od /; ,0 cd' 

' ■■ ■ • ^ ;C r CC , 

o' c.d 


64 . 


therapy (297). Also both blood (298) and tissue (299) histamine 
levels have been reported to be elevated following adrenalectomy 
presumably because histamine is inactivated less readily in the 
adrenalectomized animal than in the intact animal (297) • 

(b) Cardiovascular Theory, 

Swingle and Remington (293) have reviewed the evidence re¬ 
garding the influence of the cortical hormone upon the cardiovascular 
system and concluded that although alterations in the vascular dynamics 
contribvie significantly to the collapse of the adrenocortical insufficient 
animal, they are not the major cause of the increased susceptability of 
the adrenalectomized animal to various stresses, 

(c) Antibody Mobilization Theory. 

According to White and Dougherty (300) the lymphocytes con¬ 
tain a portion of the globulin fraction of serum, the rate ©f release 
of which is under the control of ACTE and the adrenal cortex. They 
have presented evidence that an adrenal cortical regulation of anti¬ 
bodies offers an explanation for the elevated antibody titre which 
occurs in response to a large number of non-specific stresses (301). 
Contrary to this concept, other workers have found that adrenalectomized 
rabbits produce antibodies in excess of the amount produced by intact 
animals (302), and animals treated with ACTH did not produce increased 
amounts of gamma globulin (303)• The action of the adrenal cortex in 
increasing the resistance of the organism to infections and toxins is 
apparently dependent in small measure at most upon the release of anti¬ 
bodies from lymphocytes (195), 



' - ' - .. 

vr,c..J* 0 ':.-I•' '■■{.!' >'0.l.WJ. ; :.'9o .V :£$■ &u od' hod v:x,cri uj-ox ov-oh ::olovo)Ih . 

-oh,:' : I.. o,v' h ,.,e j ■ / *iX. r , o' hh ■ :X‘ oo h T A ‘I 

. r ■ o s : s. j r r .I; ■■ o .h " o-<h.•• •• 'oh- ■ J of. o. •'* 

7 *' I,:>0 ' •TC ' ' O'. : (: ) 

;>o ” • ••'' O • '. y' ' O'. 7 ■ [ ; ' . 0 .L -xi — 

0 ;jh -V.:J • O' '0 ■ L" "• r '.fv)u J. oo*.J' • C- ; o' 7.0 ■ OO i; ..ox -V ' ff- 'O'. V 

noxiiouno) o' o '-•'•/ : o''' oo / v ■ oi.' hoiooho. f oi*. - j.' ' o ; ■ o o'o ;,i 

,t• lo. foxll XT.;oil ho-o .I •.oot.oh • .00 ho xvo' '■ :) . h ; J ro-.o; 0,0 ...‘ 0 ;.eo . 00 0 . ooloxo) 

7o thJhh 1 .oh 0 OOO ; ..o; i-,h .t '• 0 OOj '. OiOh •' CO •: r i' ' / " 7 . v . 

!'ol‘ . 

ooriT ■ ooi : v.i.i...: 'o'oci'hhnA. {■>; 

~noo no>J' o- ool :... j v ■' v hr . } rjou ,.r - hho,- oi )<:.. ! ■' ■ C’O 0.7 

'UxxJuo : • j ' f ; 7 r '' » u ' ■!. oh sj-;k:S& ro-J rtoii'ioq ' ai :?7 

■ Ooif L o' • . ' -• ■:/ 0. O - - 1 -. 

■ : ■ 5 I J. ..V . }j •' ■ • ■ 

iin.oTioo'" o- ,. j •v.v.lo rc.j oioo ; ..ro ’.V::o "ooioxxl 

, {r ' c ) ;o .-:0 oJo ^ i-oo-a r o- b-r:- ■. *. .0 >; f oo. ill o:o.-o 

. . ; O a; J' 0 = : 7i.; !. . i iO'-'f 00 O 0 -O'.'-O " J ./ ,00 ,, j';;x, OOQO ...X. cJ' X.'J'O LO.ij 

i ‘ ; ; ' 

boOOrOXOoi 'OOjrorv 0 vV J ■. jj'O',; Ooj..: O.t oi’.. ‘ .,05 OIUJ , (70^ ) 00/v ,.70:1 

oj: oo ■. .r;: •: '■ ,7' ' :o/ '■ •, o-o’ . i, • } o' o: o.o, ;\.v- 'U: \i n o'er v , 

oi ■o';.oo.c.''.i ;o.o". o> ‘o • j oo rioi'ie'oio oild oo oort..d ol ioo •..7' oioo'f'voxom: 

-.oj'io lo oovoo ho j.; ■' o". o' o • ohoeio oh j oc'V.vi-;oh v : 7,.:.y,:o o.o 

, ( O ) 0 O.:";. 0 - ' OO o' ■" i. 


65. 


(d) Ubiquity Theory. 

Gordon and Katsh (304) have recently reported that the adrenal 
cortex exerts an influence upon the phagocytic capacity of the reticulo¬ 
endothelial system. Sayers (195) suggests that this may be the mech¬ 
anism by means of which the adrenal cortex increases resistance. Far¬ 
ther he predicts that all paths of investigation into this particular 
phase of adrenal physiology will ultimately converge upon the conclusion 
that it is the ubiquitous role of the cortical hormone in the function 
of the body which holds the key to the increased resistance to every 
kind of stress. He states w that it is not unlikely that the varied 
actions which have been assigned to the adrenal cortex are manifesta¬ 
tions of a single fundamental role ©f the hormone in an enz&tie process 
common to all cells.” 

X. Adapts.tion to Stress. 

(a) Definitions. 

Adaptation may be defined as that state of the organism 
characterized by increased resistance to stress, wherein previous con¬ 
tinued or intermittent exposure to stress has induced changes which en¬ 
able the organism more efficiently to counteract potential or actual 
alterations during subsequent exposure to stress. Selye (51) defines 
the sum of all these non-specific systemic changes brought about by long 
continued exposure to stress as the General Adaptation Syndrome. Speci¬ 
fic or non-crossed adaptation is adaptation acquired through repeated 
exposure to the same agent, whereas non-specific or crossed adapta¬ 
tion is adaptation to a particular stress acquired through exposure to 
a different stress. The development of antibodies to bacteria, and the 




. 

i .j ;m\j r. Jxco . \J ,';x o x£ v (LGy :i,.-.r£ : , i■ rrnoMo!) 

... ... ' •: : .. 'V- ; 

; , ■ } • ■ ’ ■ 

* Oim-iu ^.‘4.?, ••.‘loo.l v-uf-ioo W'llxiw 'to fxxcnx; 

1 x •; " ,x •> ■■ r •• ■■ ; ' .x 1 ’ : '■ X ; • ' ' '' • ' ic> ; 

a cljvavS i ■ •" ..J' - -:. J.'■ xjx,' .G :■*; x.x.l X' x r : *. X 

.•> : s: ■ v \ xX * X yx xXx X;x ' c x.< 'tf • J' '' 'io 

.XL. r. :v :..X y r: ’ i ■' ’ j X :i . J X ■ L . : '' : - > ‘ 

'. • . . • . : ■ / : • f OY i oi ■ ' 

:V:xdc*Iv oJ.oSiUY-J 11 ■ xJ : n. c l ■■ t :c ci-n-v,:Xi I y XX lo XXOict 

. ?J. £:.x> .Li c Ovt rroira oQ. 

. . ‘ •' "• V . C 

. X ( .) 

icunccio v.'x; Lo ; Jc/.j , t v: X:,x.‘ \x b od ex ' n : : <x oxxL> : \ 

'''--:rxyrUx/xic; r;L •ici'c , 'exx'X'. o-t ■' :.; .xx£J ooa.rv toju x; ■ bcxxxt.:dc>x“i,x.fji0 
•••:: > c; Lx <r\: : .i.ccx;: : ■...■:•* J‘:‘o,i ' • c; o C-. ..>\ $ J7i :"...iil :o hps:ru\t 

' . : c • : ; c '; i \:-v : ; ‘ ; c. '::o •• ci - 

(.iy • '.y'..- c.x-o J :.cx •. ■ : ! -xroi i" 

x 

'•-i.CKX'X' > Oi /O'.’* ‘i\ \ 1 fiU..i.v. '-.i y-.i . ■ . r: • .J ' x : \:x ■ :'.xxy : LxxaxJ'xoo 

■> . ■; ; *. ■ - . ' • ■ • )■;. ^.'Xxx/xj-mtoc: 'co x.-:1 

. . v : : ■ , • ■: . ?, . r L' ( ■ -ex: :■ *) 

L ■■ ■;:-,x'' ; xX • *;x■ l^cxLhi.xq > ,x aoix! J' .Xj:‘ ./ noi.t 

' , ; c X. / X £ C : ! -j ' : ) ■ 

■ 


66 . 


increase in the number of circulating red blood cells in response t> 
continued exposure to low barometric pressures, are striking examples 
of adaptation. 

(b) The General Adaptation Syndrome. 

Selye (51) has described a pattern of alterations which may 
occur upon the exposure of an animal to stress under the term "General 
Adaptation Sydnrome". There are three stages recognized as belonging 
to this syndrome: the alarm reaction, the stage of resistance, and the 
stage of exhaustion. The alarm reaction is defined by Selye (51) as the 
sum of all non-specific systemic phenomena elicited by sudden exposure 
to stimuli to which the organism is neither quantitatively or qualita¬ 
tively adapted* Generally speaking the signs of the alarm reaction are 
those of shock, and include hypothermia, hypotension, tachycardia, hemo- 
coneentration, increased capillary permeability, and nervous depression. 
If it is mild, however, there may be no shock in the ordinary sense of 
the word, and slight hyperglycemia, tachycardia and leucoeytosis may be 
the <nly detectable symptoms. There is a continuous series of transi¬ 
tional steps between the definitely physiological adaptive processes to 
the stress of every day life, and the most severe alarm reactions which 
may cause death. Such severe reactions are characterized by extreme 
tissue catabolism with pancreatic, thymic and lymphatic tissue involution 
a lymphopenia and polymorphonuclear leucoeytosis; and erosion of the 
gastrointestinal tract. According to Selye ( 51 ) the blood sugar may be 
elevated initially, after which it falls. The blood Non-protein Nitrogen 
and serum potassium are elevated and the concentration of blood chlorides 


. 

d r.vv:c :'<s hSX.oo ;.ooXJ p jxc.t^Iiro’tro "io ’Oitt nl 9$fli*iorii 

•■ ' ; ■. , .. , ■ ol'ti i $d- v . ■• 

.:-<i -v-■; r l) : AA ; 

■ ::ioA..A; n A At A- : ; , :■' ; > .'i-iioo ru “! ( *. • • : : • > 

Jj^'x 9 i'it>D n i: i 'X::cr - *o\i'o o c.'C)' i -i-'i > £i?-i ‘to j.r..-.or■ no : ;.r oo 

■ ; . '' ■’ ♦ 1 ; ' • '• 
/ •. ‘ , )Q l ■>& '■ ' - 5 ' 

: ■ ) i&zmsi 

' ‘x' f •;o ?r \ • v/;; l-AA'-' ' . ' i ■ • x :vA‘ • Ao v IA ■ ! •'' : 

" T oil..LpiAP ’.EC V." .-V.',A -:>y -oil' ; - A:.. o\ij; ‘ j 

■ ■ r.r; • -A ) '■ 'i " :S . .. V o " •. • ’ ■ n ' • ■ ’■ .. 

-o. r o.A-Vxx’D-; o ':r , u'-J A. 'ox .• >• • x r ■ " ■ *- ■ > )Ow: A.. 

HI, ’ • 

10 r; ,r . <:i vo •. o: xio : : •• ■ noi: • o i ■ ' ' * ■ . •■•Aii - A A\A A: .A 

ad xoo: lo: ;oA-- I ..o,; .ox/loo ; on ■ L.iot 1 " *x ?" p' Ail,,.::. - o ■ J.vro ; ' At 

- ;,j A ; "■ t; iro ' ■ : « " t. J ' 

O'T : vAi ; :: A ip ! ‘ : ■■ J'ooAA.o. 0 :: ,o A- ; -, ) J 

iAoA;.; i , ;.'iiA:A'0 A a? . .-.A ; :i ; ,.a:.A: ; / i ) “; v. '.v'> : A : i n,/ 

. ■■ ■ ■ . . . ' 
fEOXCTiLl'cv i: . -,A. , f - " A" • o. - A; : A; \;',A A -.ror tA 4 'A • mlXoux? '0 ouooiu 

nt .. ' ■ :■ : J ' . 

:■ • . 'i ' i ■■ • ( A . ■ , . A' ' - ?" A ■; ;A‘ A :,~*j ■ ■ 

' • oci A 

atiLlToJ.j.::; AooJA; Aio o lari.?. .0 ;a 3 - ■ -v.-• A. or- trir no 



67 


is decreased. Opposed to this so-called "shock phase” is the defen¬ 
sive potion of the alarm reaction called the ”counter shock phase” 
during which there is adrenal cortical enlargement, a progressive in¬ 
crease in corticotrophins and corticoids, and resistance rises to or 
above normal. It is important to note iaat during the ”shock phase” 
the adaptation to the alarming agent (specific resistance) is acquired 
at the expense of resistance to other (non-specific) stresses. During 
the "counter shock phase” non-specific resistance is increased, but 
this crossed resistance (non-specific resistance) is never as great as 
the specific resistance to the particular agent with which the alarm 
reaction was produced. 

The second stage of the General Adaptation Syndrome is called 
by the author the stage of resistance and is defined as the sum of non¬ 
specific systemic reactions to prolonged exposure to stimuli to which the 
organism has acquired adaptation. During this period the organism has 
an increased resistance, especially to the stress to which the organism 
was exposed. Most of the morphological and biochemical changes of the 
alarm reaction disappear, and in som© cases the deviation from the nor¬ 
mal is reversed. 

Selye (51) denotes the third and final stage of the General 
Adaptation Syndrome as the stage of exhaustion, which is the sum of all 
non-specific systemic reactions developing as a result of prolonged ex¬ 
posure to stimuli to which adaptation had been developed, but could no 
longer be maintained. During this stage adaptation wears out, the lesions 
of the alarm reaction re-appear, and farther resistance becomes impossible. 


- Yd 




’■ 0.0 Y : * Y ■;£iq 

Yooxi 



YYY.w.; 

"■o’ ;Y oY Ye 

. 

■ 


r t 


1 i * ' . f 

, n 

YY 

h® 

■ 

y ooc o n\r;Y 

,.c> lit Ye 

, .: Y . - 

€ V ‘ 3 

.fix 

V 

o • CV •; . . ' 


six 

'i r Y 

30 ‘ : 

i.on ; ;yi *. •- 

’ 

;: '°YXlw j. 

nlTjob 

1 ■. 

oi 

"Y." oonoY' ;Y , .• 




YooiYoco 

• ■ ■ y Y. 



«'0Q‘IO 

ri 


Y :Y;YY ? 0/ / . 

Ytjj . 


• 

: 

oi oj • 

YY yY 'OX .; 



ovoci 

' 

po i 

• ■ ■ ■ 1 ; • 

■ 

r*j-' 

■'■CfS 

) i'Y po ■ 

j 


■jixipnYi 

0 orti 


•Y.o-: - 'O' : YY Y 




o 

o;)x ot-; Y e 


tt q . 

• YY Y 

vYi 


!' 





-non w o : 


■' 1 - r ; b 

ft 

R3 ic 


?■. YO'Y ;i. (•••: 

;.t ij oj'; 



0.1 

$-nop) ooo 


boy yoxo 

:,YvY 

irx£ 


orii or)l,|,. -Jl , 




■ 

• • i Y cY -j 

:.'Y Yx.vo 

'-.Y'-YYx- 

£5 OIao 


* • r:\)' r" • w n- J j ■) 


YY.Y >0 \Y :y YY .Y Yo ■ Y:- .>: r oo •• oYY 

1 ■. " : i ■) si ■ : i ic i . i ' 

6' ’YD.aYr e:Y YYtYY" Y: ■; Yxrp • Y .Y : ■ • D ' : ?vi 

' rii"' o : YYoYe • YY :"Y. . ; f v ' i.• : 7.V y>v ■•-•Yv; :v:r 

no£:'tTpoo oYl‘ . \ r o Y ; y/y Mix > i Y.kxtr*' . o ■ •' )•■)£' r iO:Y n.s 

Y Y; Yv ’ \ • ‘: Y .yy f ' < - « - ?v y ’ 

\ --‘iX/i o;YY into: yc i:J Y.t x :-YY yyy -o rycy Y Yy;o , i . y ioo: YY y g..YYj ; y .yyj>, 

. 1 ’ Y 

YYvyyneD 3> J Yc y w yYy J ‘,-Y.Y Yx.:y Yx.LYY ciJS n.y;byyyb (iY:} vyYjY 
£ * Yc ; : r - ■ : Y ; : j-: Y ’ , y YY Y:. Yc op :Y- obi ■: \ sn cni rrcii ic.«M 

-yy by ff.t; b',-;r; Yc- YY;n c ", • pyyr oil. v@|) y.ocYYyyyy 1 : oxycxYovy oi?d:ooe;'n-/for; 
on .bJjjco to:' , Y-rtY''v h fxox £>.'-■/.F no Ydytox Y,y iPi'Yy cY ijjjyiYy cY cmxaoq 

- - • ■ ■ . . - > ■ o .. ' Y ■ - -' y . t . • Y *, * ■ ;• ; 

: -b'Y.Y:;';0' Y: 'on.c o. Y non Y :;YtoY en - ^xo^C'CY-st. noiSs&o'i t:?i •:!tsfut Yo' 





63. 

(c) The Clinical Importance of the General Adptation Syndrome. 

The clinical importance of the General Adptation Syndrome has 
only recently become evident. It was noted that exposure to non¬ 
specific damaging agents (e.g. cold) would produce hypertension and 
nephrosclerosis in animals sensitized by unilateral nephrectomy and a 
high sodium intake (319)* Pituitary extracts and DOCA have also been 
shown to be active in eliciting such responses, the changes not infre¬ 
quently being accompanied by widespread periarteritis nodosa with myo¬ 
cardial lesions and arthritis similar to that seen in patients with 
rheumatic fever. These experimental observations are all compa.tible 
with the view n that during the General Adaptation Syndrome certain 
hormones of the anterior pituitary and the adrenal cortex are produced 
in excessive amounts in order to increase resistance.” This increased 
production of such hormones is thought by Selye (51) to result in an 
endogenous hormone intoxication, which causes the appearance of renal, 
cardiovascular and joint diseases. On this basis Selye developed the 
concept that the most common maladies of man are ^diseases of adapta¬ 
tion”, resulting from abnormal adaptive reactions to stress. Among the 
diseases which Selye considers to have a relation to the General Adapta¬ 
tion Syndrome are nephrosclerosis, hypertension, nephritis, rheumatic 
fever, rheumatoid arthritis, periarteritis nodosa, eclampsia, gastro¬ 
intestinal ulcers, the appendicitis not uncommonly associated with a 
variety of contagious diseases, and the acute tonsilitis which may 
follow burns or other non-specific injuries. 


.oLc rrbfi'b; fi-Ld I : b bo r. xx.xrb ex x.j ;I X I nil 0 X".' (o) 

’LL obxfibmL ricbb -J-- 1- ". *. J' ■ X- orb bo oo.aoL'xo;L JLo.L-ii o oi'T 

, •; ; T r 1 ' ,' ’ J' £ ■!! O. j . ' ' i ' ' . " 0 "i b X ■ 0 r : X 1 

.: ■ u. c .. ( j ‘ ... ;J i ■ 

) .Of' ••, V < J-p :■■!>[' Ofi b "V- O' :SbVS VO ’)' Ulf X J I. V Lfi ’ fib Lxrfi lOfiCfiLfifiX fi 

;■ ■ ■ ■ f v V j . L ' ' j \;*t bL b . i. fix' i j ' X ': > 

ob ’ j'f../: " ■ x, xi , ,•..xx. fi' a boa : ;-fib.bb.oLf o : ox’ b> • cJ' fifi'cLo 
- , ' , t > c r \1 ’ .1 br Li r I ■. ■ r : >c l *, c . b. L ■ ,Id r ;; 

. ■ J J IS l i c;*. ' b ' i:bi ■ : ■ ' x ici ■' ■ 

: j' J. [■;:?> b v : b ' b: ' a :: ; ; - bf . / '. :: * J' a ; r bo 

■ j J- 1 ~ ,c ' ■ : . fiL < . 


boor.r'X:/!'; 

: ' 


,L o 

1 

' 


xfj 

■ ■ : d ! 

xuti:;? ao 

L a drr 

■* 

t lo 

a n 

01 

fjer.xxmpr: 

' ! 

!■ .. 

0 • t 

T;.J' 

d 

: oo 

: mi oS 

‘lo : .’To n 

J: & dor 

'.■a ) 

£ V. 

090 

. :o ni 

: : 

■•Las: 

. 

a,)' ( 

.[ :; 

) 

. ■ 


tr[ f/ox.ii 

' 

• ( 


lo nr 

j j 3 

:: x '; 


;o qoa 

r 

[ ' 


j 

■y' ora 

;.;j 0 

rioi 

id 'a Leo 

• 


. ' Bi 

a if 

Xi:c.ijfi9 

.. [X h k 

c X©'V 

•L 

t ' ; b 

3 ■ 




nO * ; o ■ 

j j 


r -* ■ ; 

dXx.ro o 

■ :"W0 

i. o 

/.. 

s ..xo ,a 


50 ii 

L‘ s 

e 

■ a ■ x 

X: 

: JLifloj 1 ; 

noi: i • 

d ‘ (,)J:T 

&di 

j rC 

d'< 

oorroo 

>JIS ' ft Jl 

. 


id j £ 



id 

' ‘; 

xv::J I 

iuinciiJ o 

rc 



i 

La id 

‘Svr-hX I.: 

[ • i 

c 

' 

nc 

idfOl; 

; a r. 

av,xd Ou 

■: hi n 

d •; 

id J.i- 

d 

■ > 

' 


fi’bb x X'X- „ :b rico • . ri ox t " xl ,: :o*.rfilo o' rb - ,<r \i\.: o: ct. fi-L an ' J 

' 

; , x vix : r [..q j , j t V . ; xv i 

j'o.’. : ' - x: ,t r..\-'ro! >ivy.-s ■ <:.V; , cx“;r IvxXix J'XX 

; \i X;r ; . 1 ; f,;i . . ' ; i •, • '. r J : 

'i dSo ruse! - • 




69. 


XI. Does Stress Produce Pathological Changes? 

In view of the hyperactivity of the adrenal cortex and in¬ 
creased corticoid production, which is known to occur during stress, 
there is a possibility that there may be pathological changes which re¬ 
sult from stress other than the direct action of the mechanical forces 
involved. However, the evidence concerning this point is extremely 
controversial. Selye investigating the toxicity of the adrenal hormones 
has marshalled much material to support his thesis that chronic endo¬ 
genous intoxication with the cortical hormone is the primary cause of 
the “Diseases of Adaptation”. 

(a) Toxicity of DOGA. 

Experimentally Selye and co-workers (51)(305)(306)(307) have 
produced pathological changes in the heart, blood vessels, kidney, 
brain and joints following the adminstration of DOGA to rats sensitized 
by unilateral nephrectomy and a high salt intake. Cardiac lesions 
similar to those of rheumatic endocarditis, periarteritis nodosa, poly¬ 
arthritis and nephrosclerosis have been observed in rats so treated. 

In the chicken (305) DOGA with a normal sodium intake has been observed 
to induce edema and nephrosclerosis. 

Sayers (195) points out that it is difficult to reproduce 
pathological changes in animals by DOGA administration. Indeed some 
workers (308) have been unable to reproduce Selye ® s work and have re¬ 
ported -feat prolonged daily administration of DOGA did not induce patho¬ 
logical changes in the heart of the rat. Harrison (309) attributes 
ihe lesions described by Selye to infection alone or in combination with 
cold, for he found that rats with pneumonia exposed to cold develop 


- ' Y’ .YY A • ■ . " ' "■ ' * 

d*/:t■-.> i’. m j:o v..' :in,v yy-y' oyy ‘.':o■ (,rj.v nl 

i’iol ■ • 

I. o^YrcnY y - yoy ' ■ nrijo.,,: i.h rr^ixi 'loudY' 5 "yyyyy yyyy. 

::: • Y jY "> : Y ;• ' ' ' ' : - • * ' ‘ 

, . Che®. oxycyiIo j-i.b ; . d J yoo/h .Uit'n.t 'H yy> n. jVJJ 'YYYYYi. y "b 

J.L v'.1. . ; vy • ; yc ; 

* • •) ' Y :.r, vc ( ) 

Ov:id (VC A) (dOt) • y yy ' "/ ■' ‘Y - ^ • yy' y~- .. u‘) Y/ f >o ; y :* yc VI 

, ■ i ' t r y y ' ' y ■ - ■ - ' y~ 

' ■ | j 0 j ■ ' tl ' 

3 io V ,' X y : i ’0 . : •YI y ; . ■ y - v leer irioo • 1 ■ i Kim :C 

•~vIqy f yycCoy 'y'y’y' .yy: . y „y y •: yy -y'y y ' y- y ' Y YY oJ' y. Y.< J 

. r -Y J-Y ';.■}■ (Y: YY "• ' ff • : V ,y 1 ' ‘ ■< y • : . y YY; . YY-' 

'fivy-cYCvd'o Yosef ■C Y'Y..y-y I. vy:-' - *, "/VY"'. [■)(, \) .ft yyLyj y;.y Y.I 

. ' ; v Y v Y ; ,1 • • . :v. £ j ■ ; .' C "s' 

. 

r.'.oY i>ooY.i;T . no Id "•••;; AOyu tJ i.I. civXuy r-J 3 /j/ju'do Z'^i.-oio li'r^q 

C . ■ ■ " Y ' • ' ■ ' : . m ■ - 

..y:y;y ; Y. r; ■ Y : A :y.yy ■ y : Y : •. ■ . ;y ,y J.y: ■ -Y -■ 

-■■I Om-My 'yycyiyyX » y.^y y.y.J- *xo Yi >:Y y . yy: :r .r: : o Ayo1;;o y 

' LYO 

VOb ■ ' JWJ ’ 



70. 


cardie lesions whether treated with DOGA or not. The impression is 
gained that DOC A must apt in combination with as yet unknown factors 
in the production of pathological lesions in experimental animals. 

(b) Toxicity of ACE and the 11-17-Oxysteroids. 

Neither ACE nor the 11, 17-oxysteroids have been shown to 
produce pathological changes similar to those induced by DOGA. Corti¬ 
sone has been reported to induce moderate hypertension in intact 
nephritic rats and striking hypertension in adrenaleeternized nephritic 
rate (310). In Cushing 1 3 syhdrome, which according to Albright (123) 
is caused by the excessive production of the 11, 17-©xyst®roids or 
M S n hormones, there is a high incidence of nephritis and arterioscler¬ 
osis in adults (311) and of kidney damage in children (312), but 
Aschoff nodules, periarteritis nodosa and rheumatoid arthritis appar¬ 
ently do not occur in this syndrome. Selye is aware of these findings 
and has accordingly ( 313 ) ascribed the cause of the M d±seases of adapta¬ 
tion” to an excessive or abnormal production of the salt active corti- 
coids in response to non-specific damage. 

(c) Toxicity of AGXH and Anterior Pituitary Extracts, 

Nephrosclerosis and cardiac lesions have been produced in 
intact animals by the administration of lyophylised extract of anterior 
pituitary tissue in conjunction with a high protein diet (314)• These 
experiments were confirmed by Ingle (315) > who reached the tentative 
conclusion that the adrenal cortex is a supportive, but not causative 
factor in the development of nephrosclerosis, cardiac and joint lesions. 

The pituitary powder used by Hall (314) was extremely toxic 
and in view of this it is interesting to note that Simpson and co- 



X croiooX oi oceo 


A 


■ rxirer-’i ,; i eXI .Ion ’ o Alin! Xllr m.X'o ol rr.oX 

crioX? -A a rorPnir; I.;-o; rXXo no il ;* > - -■ 1 X id: O'ox; cr oxo: •' A>. 0 £I o'orlvt x?.-)iu.:vq 

. : . X ; ! J f£X. ! : • FX r I.' : 0 X ' ■ d -. X' ' ' •’ -• - r •< ‘X . ••• : X n*. 












. . 

cc.c 

(o’) 

CX»‘ 

a -Oiio rot 

y.[ -vox ' 

ore I ":..5 5 

o-vi: 

t r - : 

,: "‘ 1 i fij 

00 


.. 

• 


-IXocD 

.; x x: 

c; " 05 v:X o J. 


I ooX 



r ; 0 .: 'O 

I.noX ole 


'oon'ivQir 


d\o . 1 .. 

r OO.:. ,;.:r 



; r .■ • 




1 ,f ft 


:-5 oil erjoa 

s ' b 

x. 

ood'ooJ. ox " 

’ -. nc 

' ■ 

x 

;ri ralvi 


Xo ;>ij6 el 

ot o 

.XXX . : 

X ' ) 

Oil. .I.XI 


500 0-5 0.‘. 

X.: X 


nfvo 

l 


X, ojO fll 

.; 

J.X.) r X •••:;: 

*10 

oLIo‘1-7 I 

■ 

. - 0 10 xO 

ru. Id 

oho < 

-4 O 

V' 


0 0 


' 

--colon 


iiao n id I/ix 

.X ■ ■ X " 

one! I 

roil 

J..X Xi 



1 O'COjId' t 

7 FIC 

. 'r;: : ' X ! 


i->x 

, 

; X: 0 O 





HO 

■ (ix-i xi 

£ 

" 

XI 

15 o X ' X 

t'l ■ t)h 

-••• ?■• 


•c ■" e 

i - 


•T/.: 

Xt if I 


■' .XoXooA 

aj d b 

:X'i c-o.ofI 

'10 0 •io.rro 

X. 

. 

•c. oXf 

: 



l 

Ion 

ob XIno 

j . A ’ 

’iO 000X50 

X.X' O y 


v.j X 

r 

: o r, 



.) X-yX'^oo 

‘COO i : 

. 


03 * /' d o i XI 1 olio c - £o vs . $ " i # 

e XX, ;• • I o o.d o 



» 5; .’ 

5lX: d lr vr 

civ •■■rn • , . Xo 5 d XoXrr.X X. ) 

ij'i: bcoji! 

Icrcq ifoaa . v i\* 

ik i ; X 


••., 1.0 .« ■•X ;oii 

'Il.Xl 'XlI: . ’Z(j 

j.o 'id ■ ■ 

''X' '■ 

; 

. X ;X,r X loolil 


/ \ r . : ■ , .... . 

J 

: - X. i;X . • .. I.X; roll o X 

sod at s if & ail 

' ;... it ' o,; ; 

•Xa^I ei I Xexo ■. i 

. x XX0.) 5- 1 4 I ;• f , .- 

XXtO'CO e*T£©vT c: 

XioXo ,:o 

;r :0 Ib.r. XX ? •.>v..' I‘- 

-jv: •* ei: iv-Xyoo J'ofo*' 

0.0 5 00 .X Il'ilvt 

: x iocXor-co 

■ .o'. -one; o X. 

'X XO Xi 

niqolyv&fo ciid' 

ill XoIo.oX 

X or; I;. 

X* -i-X 'O '. 005 .X;F",Jj 0. . .!••••; • 

OirlX: ‘liq cjoX 


h‘-iX 

• !«... i oI " ;X I ; .of IrX cl. 

' •; 

.' ‘. : 



71. 


workers (316) failed to detect any changes in the size or histology 
of the kidney of rats given a purified preparation of ACTH for both 
short and long periods of time. No Aschoff nodules, periarteritis nodosa, 
or increase in heart size were observed in mice treated in a similar 
manner for as long as 33 weeks (317). 

Sayers (195) agrees with Selye (51)(56) that during stress 
the adrenal cortex is hyperactive, and that the production of the corti¬ 
cal hormones is greater than under optimal conditions. This according 
to Sayers (195)? however, does not mean that the production is excessive 
enough to permit intoxication, but rather it means that the production 
of the cortical hormone has been accelerated to meet the increased needs 
of the tissue. Sayers states ”that Selye fails to distinguish between 
cortical hormone production by the adrenal cortex, and the status of the 
tissues of the organism in regard to the cortical hormone requirement”. 

He points out that it is possible for the tissues to be in a state of 
eucorticism, hypercorticism, or hypocorticism with a hyperactive gland 
depending upon the requirement of the tissue cells for the hor&one. 
Further he doubts that there is sufficient inertia in the pituitary- 
adrenocortical system to permit hypo or hypercorticism to persist for 
more than an hour, and that on the whole a state of eucorticism exists. 

(d) Deficiency of 11, 17-0xysteroids Induced by DOCA. 

According to Cheng and Sayers (262) DOCA treatment leads to 
a state of hormone imbalance characterized by an excess of DOCA and a 
deficiency of the 11, 17-oxysteroids (”S W hormones). This state of 
hormone imbalance must also be considered as a possible basis for the 
pathology seen in the cardiovascular system. The pathology so induced 



V 



V , f. 

' I J. •' 

: o> id 


• 





;) rev roY 


i .J’CU 


r?"3, 

'lo; 

nri,3 

■. 3s ) 

:v belli 



' 




• 


' 



v. . Tko 

1 V, rO-y Oifi 

♦ 

% ■ a 

.*nun c 

■ _pf o X 

brie d*T<;>£ x? 


-..v. t-. ' 

• 




vvr V 

V . : 

He trror 

y v‘y: j 



■ ■ ■ *.■'' > i .i ' vO 








. 



'■ffJOX 

0:3 0 



& 5 3 


■ - j 



){£:■} < 




r) :roc 

% ' ■ 



co rrld 


no,' j' 1 ,; 

xjdc 


■: 

d ; > i V „ 



d-o: 


V: ’OdV OXlt 


■ . 




l-j l ■; 

-XV, Jr,: 



. 


roicroxl 1.30 

ivi 

• 





J- 

nwai 

tna a> c- 

t 

re • ,s j 1 


: 3 t . 

rtc 

xXoubc 

-XC; 






■io ? Hi. j V 

: 1 1 ye d 



c. d iv ; uono 


•V ■ a j 

s ;> • vo 


«© 


j id d x [ooo/: 

n: * o-J or. 

VC: Oi'XO/jJ 

4 ioii lv 

• ■ 

:c o .rod ' lo 

ff£ 

S ‘. C:.Ki 


' 


od o 



■ H . ;• 

d v-v 

* 


' 

vj' 

3:0 cured 

■ v t 

oiid h 


* 

* ioo i- avror 

3d y r nc 

i jy,y’ onc.*r:Yof! 

i Isoldofoo 

■ 

■; * 


7 QllQKfl Oil 


drier = 

oxy od j 

■ - ■ 

. 7 . - f 



■ , . 


-!• -V 



|j 

J : 


iy o ol - 

V..C j: ' v g 

- ' * -y r 

d; 3d 

o'.(70 

txoq oa 

3'f 

• 

■ 





OVQOOV Y, 

if -:r , ! 

■ 

o'.ro : 

t • 

.i v J 7oo : r' 


. 


• rid o 

ol 


i 

'•V 0 . J' ' 

j .0 tfitiA i: 

■ ' 

: i 

(lO'S 

vaibneoeo 


.y r\t : 

;vi l 

0 &Sm 

£ 

£>U'‘x 

i i d :; 

h).i yy 


-id 3 Vk 1 r; J'O j :) 

.3 ’fv rld'o xv'ii 


i 

■ 

c '■ r.. 

; j 0 

j;j-v 0 

nvoyl 

’7.0 OC' 0 


C’d 


l 

‘looo or, 

'■ 

■vJ. V; (•': 

yd Or 

vd-yooi* 


O Vj 

■j 0 B - 

>iOfi'w: r 

V 

■rid Lno 


fry 

mid oroi-t 






> 0 

' 

Jy-r jvr 

.■ • (;u\;\r 


lie Vi 

('■>) 

od rVr 


[.V'V .y ■■ :;.V 


AdvXT 

( O') 

vyv-^3: 

. nr ;-]no 

£iO 

YTjy Tv. 

. 


i? 

bri k 


lo o -V 

vo : 


Y .j" 00 •' 

1 - • 

i. y;v; oon 

: J 

cneexr 

or! 1 

v: od' dy r, 


lo 

■ X 

: 

- \ 

v v. 

• 


nsd Yg :c 

.. 


lo Y 

' 


•' ::i ; ' ' '■ ■ : -'. 0 * v rdv'u ;> O'J iY:l crgr. free ..d'cVi ■ irrr‘.y;.d 

■ rx oXoHd 



72 


may be the result of a lowered resistance due to the deficiency of the 
n S" hormone. In confirm!ty with this hypothesis Woodbury et al (318) 
have shown that the administration of ACTH inhibits the development of 
pathological changes induced by DOCA alone. 

(e) Production of the Diseases of Adptation. 

Selye (319) produced hypertension and nephrosclerosis in rats 
sensitized by unilateral nephrectomy and a high sodium diet by subject¬ 
ing them to cold, formalin and vigorous exercise. However, he reported 
finding no Aschoff nodules, periarteritis nodosa or arthritic changes. 
It would appear from these studies that cold, formalin and exercise 
alone or in combination with a high salt intake do not reproduce the 
changes induced by DOGA. Selye has not as yet presented convincing 
evidence that chronic exposure of animals to stress uncomplicated by 
DOCA administration induces pathological changes characteristic of the 
collagen diseases. 

XIX. Therapy of Collagen Diseases with Cortisone and ACTH. 

The recent successful use of cortisone and ACTH in the treat¬ 
ment of the collagen diseases has not as yet been properly explained. 
The findings are not compatible with the thesis that the collagen dis¬ 
eases are induced by hyperactivity of the adrenal cortex preferentially 
or otherwise. A number of theories have been postulated to explain the 
therapeutic action of ACTH and cortisone. Among those which have 
appeared as the following: 

(a) Interference with the release of, or the toxic action of, 
anaphylacogenic substances resulting from the antigen antibody reaction 
( 320 ), 


. 

Jb 'od l : . ■' J 

i. c 1 ' - . ■ ; r! 

J.o •: i;.i o.' J 1...: rlVOA lo v"J o..J h:hJ rv-Toilz t-v-vl 

J .. 

. • • / 'h:> , •: o' . v Jo: r (&) 

oJ'o‘i r.j. :J'::Xo.OvJ u. c-o.oO'oo: hi; ■ nol . 0 cro:oxo g*t~ (vI’O o'jloJ- 

' ' i ; 1 i' i . 

.0 • :o ,0 .V: r. . J . •: 0 :y • .. ■■ ■ J. 0 - ' . ' : , ".'J' 

. :■ ■ ■ ■ ' ■. : ■ ' 0 ■; ' ! 0 , . o'' 

■ ; XO - ... 

. ■ ‘ ■ " ■ -'o ■ . : ■ i % # I , • j ,‘ 

' • •■ > if':c 0 betray, *:s J ■; 0' : ' o.?;o ./G:,i o;o •..■ 0 ' • .'oi. o. J- 

'JO! b $norS;j:rc:>r.y ' " '• rJ. 'J .0 'lc • .r.o. oo oco- :. 0 ; J .• oJ' ■ o;o: O.oy : 

Or j 0 0 ..’ 'O j-j ;J. • ; L .:0-j . J •: •:<: 0 0; ... o"r:J ,•••■ J 0;r.-'\' J; \i 

... 

.... 

.. J ' ’ ‘ ' O' O' j ' ., 

• i o' .0 ■ ■; •; 0 • - .' : J.; o ; 0 ....... ... -. lv . J . •. ;J 

■ - 8 ■■ ' o s l ■ i 0 o ■ slifj o iqsucc o ■ .. . ■% 

■ : ■ 1 ' ‘ C0 ■ :* :l ‘ ' i . 'S ■ 0 V 0 ... ■ .... ., ‘ ■ ' . ■.. :. . : ■ 

' .0 : ' i .» 

- o . .o ;■ >i .A o ,. .:r oo o..l. O’. . * j- .. 

; . •' ■ ■ c : 

-.'■ o J ; • r ' oo.JO .‘Jo oo J o? -J . 0 , v , ( •) 

. 


. 


73 


(b) Alterations of cell permeability through hyaluronidase (321), 

(c) Suppression of mesenchymal tissue, and in particular the in¬ 
hibition of the development of granulation tissue (322 ), 

(d) Maintenance of eucorticism in a deficient connective tissue 
characteristic of the collagen diseases, 'which connective tissue may be 
abnormally insensitive to the cortical hormone (195)* In this concept 
the deficiency is not in the adrenal or the pituitary, but in the periph¬ 
eral tissue itself, and restoration of eucorticism may be accomplished 
only at the price of hypercorticlsm in the cells with normal sensitivity 
to the cortical hormone. 

However, much more work is required to determine if any of 
these hypotheses actually account for the therapeutic effects of corti¬ 
sone and ACTH in the treatment of the collagen diseases® 

C» Introduction to the Problem, 

Throughout the literature pertaining to the adrenal cortex and 
the cortical hormones many controversies are noted, all of which will 
require extensive clinical investigation for final clarification. Data 
obtained from animal studies are not enough upon which to make con¬ 
clusions with respect to man, for species differences are always a pro¬ 
blem complicating the interpretation of such results. Ultimately the 
knowledge obtained from animal research must be confirmed by clinical 
investigation, 

With this in mind, and to provide further data which may aid 
in the solution of the complex problem pattern surrounding the adrenal 
cortex, a series of clinical projects were undertaken with the co-opera¬ 
tion of selected patients. The precise nature of the studies was de- 



J.Svo l.o (X} 


* 

- i 0 •'I'" . : d ;■ • ' > ‘: .o . - ■■ 

oio'/ o7o,.oo:.:o.v"7:.o.: ' r r'.i v t X'/ .v/X).•:/o o X .noX') ‘o. : iXX o'* 

♦ , ' ' ; ' J ■: . : v x ;; 

■' ' - f ' - - ' ( ) 

■ ■ ' v fooanoo iloi w&i ■ ■ £< ' •- . . 

■ doioo/ioo nil X nl . i r ' } ;;. t r • =. .i •: ' /■ •: •• . • ,f ;vXX iorosarX v.'.X *, ion os 

-rlrxioq o', d'.rjn. . -X X- : XX no X/oo •... : ;1X : .X r .o'XV o j..j 

■' " ■ ' ■ 5 ‘ > X n X. ■ . x ■ ■ ,11 ©j ' j 

V.X ' v ! I • n o: . ; /• . • £ .. ■■ ■ ■ 1 ■ - 

* ‘ X , j 

io \t- 3 . ij.: enuni:- no-.- oX .. 1 'X n> o ,;£ : r ‘-oo • 0 : 0:0 iO/oso ,‘ievo- -cXi 

• ■ : ■ . r j’O ' . . . I,-j • ■ - ■ . • • o ' ; 

• '■ • . O'- o. X *i'.c X 7 0;,X o: :X‘7\ o .;( fx.j "> 


f 


Xo:; ;.«.J-v:od XnnonXo .v:X t =J yiinx Jo- 

t ' &0i 

X.L * O'O 0 ./XO'/ o/O 7 7 . 'O'- j_ 

•0:0"' 07100;. 00 fXoXX ’ .O';'".!' ll l i: 0 0 
-0O o no.owX.o 701.0 o :)/ o. . X.3 ; 

. 

Xaoio'xxo *{o .booo"i.XJoo r on X/xutx d on 



r- r ■ ; 

Of: J 

■Xjooi m. 

' 



' 7 

r ■ ' ' 0 ' , 

)i>. 

zononvxu 

' 

X".7O0 

ox *./ 

* J 

• X,iv 

7 Vi ox X. 

' 7; 

' . 0 -V •* 

.7 7 -X 07 

‘ - ■ o 

JO'! ■ 

O' 

■j 7,;; •' 

- X mi an 


"h ms. 

fJ'do. 

■)C , * i 

■ X . • 

o& 

q s o 


nmjd 

0 LOO 

n Xd 

• • i 

ill 

:0. X ;jxf 0'0‘ 

7 ; J. 7/ 

: i( / ■ i 

.7. x.-r 


J X: • 

loo 

■ . hi ' ’ ■ 


o.;>oX 

• 





1 

;XJ .7 

. •' 



r.o.:'. 

drl 0 X 7 . 

■' o" :.J ‘ o X ./v;, od' nr. 

.doJ- :.X olnX.fvXX 


X irtai :X. •» 

' 


' " > : ■: 

? X . j -t o 70 :x X.o rtcXXijXoa 

: X | 

or.-' oc ■•-00 

Old' 

. XX • : 

lx a .' o: v J •: 

x '";Xo X ■ 0 Xc 1 Xdv, 1 

. : ■ X * '7 c o 

• o v, 

; ol-o. 

rbij'X'j - 

LlX J.0 t-LLvioUf tvoXooiq' Bif; 

• • X : : -X 7 0 . 77 7.' _■ ; 

.70 fO.Oo 



74. 

termined by the availability of ACTH and cortisone, the laboratory and 
hospital facilities at our disposal, and the clinical material which was 
in the hospital during the time allotted for this work. We were indeed 
fortunate in being able to study patients with Cushing® s syndrome. 
Adrenogenital syndrome. Allergic Urticaria and Epilepsy. 

D. Methods. 

(I) Hospitalization. 

All subjects were hospitalized on a metabolic ward permitting 
close supervision of diet, fluid intake, activity and the collection 
of the necessary specimens. They were ambulatory and moderately active 
in the ward. 

(II) Diet. 

During the experimental period the proportions of fat, carbo¬ 
hydrate and protein in the diets were as uniform as possible. Caloric 
intakes were adjusted to meet the needs of the individual patient. Mrs. 
C. and Miss G. W. received 1900 calories daily, except for days one to 
three -when they received 2200 calories; Mrs. J. W. also received 1900 
calories daily; Mr. fi. G. received 1700 calories except for days one to 
three when he received 1500 calories per day; and Mr. M. A. received 
2000 calories per day. The dietary intake of sodium, potassium, chlorine 
and nitrogen was calculated daily using standard tables (323)(324). 

(Ill) Fluid Intake. 

Fluid intake was not accurately measured except in the case 
of Mr. M. A. During the initial course of investigation and the first 
nine days of the second investigation period, water was permitted ad 




■v • ;£( ' y •• US V . > : dX£ o HT \ l . , . i 'SI v *. r'd ; mxtta 

: . iv J X .'Xly.- • S. XX Xy." t S./y y j; ■> vj/O X ' V- J'/.t I jXX " Oil 

j ' i.'i ■ ' . . " ■' ■' X '> X J--j ; 5 ; XX : C ' l ■■ : / //.•. 

S : ' X. ; .:.:X ; ::X y XX j c d . r - ; : J.. ■ X. ,n y-:?;cX> 

.... ‘ n . I 

. X ' X ,■ • ( ■) . 

"fX XXX, . 7 :: :-lX: X X r ‘ ■ \ -m y ;X'y 'X " ' 

AolXoel ■ ji. !)xi3 • ' , ' , '• i n X . tm > oJ 

i Y ’ V j : : . Of ... " X ' '• 4 . «i ' ; 

. ' 

H-*ocfa$o .XXi lo axxoi^'fooo'xq erfr -bolT.-q l.sdTfeml'XQqxe o/fct • aru.<i 
C . ■ . X. ■ J 0 J 

• ;y r il S'.ioXX r- J yX vX,j.X: y X y. y 'XX Xyr/ y X .y Xy .yry: :\rX \. ; : £ 

: -i-o >' X -t. y : , , . : u .*■ o: . \ X. ■ v’ ■ ■. . . ..y . ;.j: y .0 

. 

: ■ ‘. ‘ J . ■- ' ;1 . yy ' • • ■ . . . . . j; .y y 

■ v/'-.yo ; r, -v ;■ :. X r -j yy yOy . y •/ : yv : ^ v i' 

n ■ . 1 ’ " J siIT . 

• . - v y y f- ;. I. 1 ' . - ry • y y..' .* ■ ■ . 

. '.' ... x) 

. .o i ,,’ r.y J'. y 0 \X -X £:£!:•:):, ;£on ay; : vib?Snl' Mx?!'? 

... 

" o •'. "• •; ' '.i yy i t -oX:i .v< : ’.J j .1’J’ < . V'iX o z Xl : ■ -r-niti 




75 


libitum and thereafter was restricted to 700 c.c. a day. The pre¬ 
formed water of the food and the water of oxidation obtained from 
standard tables (324) ( 325 ) were also considered in the calculation of 
the total fluid intake in this case. 

IV. Collection of Specimens. 

(a) Urine. 

Urine collections, without preservative, were made for 24 hour 
periods, and daily creatinine determinations were done as a check 
against incomplete collections. After the collections were completed, 
the volume and specific gravity were recorded and they were stored at 
ice-box temperature until a three day pool# had been amassed, when suit¬ 
able aliquots were taken for analysis. Samples of each three day urine 
pool and all unused serum specimens were frozen for future checks. All 
glass containers used were washed without soap in tap water, and then 
in distilled water to prevent contamination of the specimens. 

(b) Blood. 

Fasting blood for the detem ination of circulating eosino¬ 
phils, serum sodium, potassium and chlorides, and COg combining power 
was drawn on the second day of each three day pool. In the case of 
Mrs. G. and Miss C. ¥. additional blood was also drawn at this time for 
total protein and fasting blood sugar determinations. Serum studies 
were not done in the case of Mrs. J. ¥. Blood for the determination of 
potassium and sodium was drawn without an anti-coagulant into syringes 
washed without soap and rinsed in distilled water, and then in sodium 
free water. It was allowed to clot in tubes treated in a similar manner, 
immediately after which the serum was separated by centriguation. Blood 
# In some instances two or four day pools were used. 




--./.a .»i£T 

O f lc 

'ic t ; )A • r 


; - - . ■ . 

j :.o do ■■‘■J e ;), 1 doo -..'Of/ -iJ '. o o, Jo..; befool 

■ \V • ’) " ' 1 ! xx "- 

. . • VI 




b ■ . vJ vzoBvii ’ - 

.... -- ■ : ; .? -; : ,• : :■ ■■ ■ •. •• ■ 

O' 1. vJ ■ J- - ' > ■ > ' 

' ■ . \r ■ * •• c Y - i • 

r; K ,y. ■ ■ . ' , ’ : OOX X ' X A ■' 

.. ,j .. * i . 

--j---.'* * ■’ ~o : '>•• ’ ’ • ' 

c-j ;-!•••, , o": j ", •' ooo ; Xf.'c: .d/d-* oor.'OOO . ‘To r •' •': 1 00-;; .o-o.< .oo) 

V,- . ,r ; dr >0 d i'OO’CO .V • O i • c o - O V. 

* road [ ) 

.••••.. ... : '0 \ < r . ■;.) fV OOV dOC-id T.I? dt ' j J. 

■)'. : : ■ " ; ' ' • : , ' '' • .. : ' . - •' r ' r • - ; ; ' '-i , . ' -- 

, : ' ■ 

o r '• . . • 

0; ; ;‘Xvi n : :-xi:r .o; d-ju’.c I xiod 

' j j ■: . • . ■ '■ 

ivjlujC -;i n jr..J* di-.i , r:.. V L*o Uiiaid nl Ijs'xrii'v ijiig q.^oe; vU/oridlv .bojcfeaw 

, nc?i.c ^ ■ ■ ■ : ■ c . doli ■ 

']:i sm-vr' slcoc; v.n& xrjfcd *io ov/vt ''v:;:d x/u: oftos nl % 



76 


for the hematological studies was preserved in balanced oxalate, Whit8 
blood counts, differential counts, hemoglobin determinations and hemato¬ 
crit studies were done by routine methods. Eosinophil counts were per¬ 
formed using the method described by Randolf (326) (327) • 

V. Blood Pressure and Weight Determinations, 

Blood pressure determinations were carried out on all patients 
three times daily by the same observer and using the same sphygmomano¬ 
meter, Each patient was weighed once daily on the same scales with an 
empty bladder, and just before the noon meal. The stool was not retained 
for examination.# 

VI. Chemical Methods. 

The following chemical methods were employed: 

Brine creatinine was determined by the method of Folin 
as modified by Bosnes and Tans sky (328), and urinary nitrogen by the 
miero-Kjeldahl method (329), Brinary and serum chlorides were determined 
by the Harvey modification (330) of the Volhard-Arnold method (331), and 
the method of Sehales and Sehales (332) respectively. Plasma 002 combin¬ 
ing power was determined by the method of Van Slyke and Cullen (333) > 
and total plasma proteins by the Biuret method (334), Fasting Blood 
sugar determinations were performed using a modified micro-Shaffer-Hart- 
mann method (335), Duplicate sodium and potassium determinations were 
performed on both urine and serum specimens using Bedoaan and Barclay 
flame photometers (336)(337) (see Appendix 1). 

The determination of urinary formaldehydogenic steroids; i.e. 
n Cortin t? , (see Appendix 2), was performed by the method of Baughaday, 
Jaffe and Williams (227) as modified by Venning. Partitioning between 

# Except in the case of Mr. M. A. 


. O? 

• -C j ; J r .. : • . ■ ' • • , ; %j ■ " d. S-- .. ; 1 . • . > i.:JC ' C - 

• • • : v ' ' . ; ' • . ■ . , • : ‘ f • •: •• - "... ■ J:brj'j ' . ‘ : 

* 

* 

•: . ' . ) q bot 


.rid i . ? . 




f 



4 

■ ‘ ■'■'i. I.-.:: 

1 '■ -'■■■ ’ ■' 

. 



. 

, ; ■ : ' :» .C' 

; >• J/j "■ ■ ■ ... rn ■ •' U r .:j i .... V 

/ ■ 

. 

. .. ■ ‘ >' ; . ■ ' U 

rrfs. v : 0 X/. n-vV ■ Xo.; 5 •. •: i \ ^rX. Xft.tX., ruft; *Tiv/n<. 

‘ • ’ r b.‘ 

IxJX.cw.o.rf tr-.V: X^?, #■ :vt ; ©*w sr-o \J&aJtrri&dpti.' 

. ; , ' 1 f.-r:■ . M 

■ ' ■ • • \' ■ ! • . . 

« 

■ ' :r '' •• ' ' • ■ ;' ■ ' '-o :;;X ■ ." . ..: •: j'.v 

• ' ■ -v .; • , . . . : ' ■/-:■.' ; , X X; ... X ! 

* ‘ ' ' ' ■ • >■ (X :) yyi:.:. • . ,■ ," \ X 

>X .' c :■ • ;i o; : : ni . ' 




77 


benzene and water for separation of the desoxysteroids and the 11-oxy- 
steroids was retained because it also assists in preventing artifacts, 
which may be introduced from contaminants in the redistilled chloroform. 
No back extraction was performed on the 0.2 N, and 0.1 N. sodium hydrox¬ 
ide washes, which were used to remove most of the pigments and other 
non-cortieoid material present in the chloroform extract. Normal values 
by this method generally range from 0.5 - 1.5 mgms. per day under basal 
conditions. 

Measurements of 17-ketosteroids were made using the method of 
Holtorff and Koch (229)* Ketonic separations were not performed, and 
only partial correction for non-ketonic ehromagens was attempted using 
a potassium hydroxide blank. 

711. Statistical Methods. 

Statistical treatment of the data was performed using the 
methods described by ¥alker (333). 

E. Case Reports and Results, 

I. Cushing 1 s Syndrome Treated with Cortisone. 

(a) Introduction. 

According to Albright (123) Cushing’s Syndrome is a form of 
hyperadrenocorticism which may result from a pituitary basophil adenoma 
(Cushing’s Disease), or from some hyperplastic or neoplastic dondition 
of the adrenal cortex itself. In many respects the disorder is the 
direct opposite of another syndrome associated with hyperactive adrenal 
cortex, namely the adrenogenital syndrome. The former condition is 
characterized by a cessation of growth before epiphyseal closure and a 


- ^ 7 ' 7 .'. J y. ; . , [ 7 ' 7 0 ;-;r 

,77-y ; -ytd • v "" : 7 ", ■ o '. £ ■ 77 ' > r : ' ■■■' dxoyijy 

- .. 7 .777.7 .7., 7‘ o o ■■ ’' r 7 ■ . y' 7 7 

- ::c '..' ': . .7 ■ . ' 7 ! ' ' . : 1 • '■ ■ ' ; ' 

‘X . V' 7 .err • vr, ■ : '• .or rrlrrr , : [ m 7 

y o'.i■■■.y .yxojcdl 7 : . V .o :7.7' .7: 7 ' ■ . rr r--‘rr-ri--.r : 7:o-i.*.v -A.o-ror 

, 7 

. i -77 ' 


d' ; 

fi 

i 

7 i i; ; 

rrrr pjit o* 



77 7.,.: 7 ; 

> 

bar .7 


I * ■ 0i. 



■ or 


. 

• 

n.7:7:j- h 

■ . 

..77.0 r , , v 

Oil 

• 

, • 7 

vA^cioc 

t<:7. ; :• *;:•;! 0 

I ,7u‘X v;; y,.' to 


..7 ■ ’ : 7 ; .7 7 

f [> *’ rnrrr 7 y. 7.,. .•■ 7 • .... 7' y . J ■ • • >.:! 7 7 • 7 ;• ■ 7;' •;! ' 

. ■ } \< 7 ' ; * 7 o :■ / ", •(.> .7 : 

■ 

» ’ : 

o -■ 7 - ;,7 , 1 : -, 7 ,;- 7 ( 7 . 7 .; ; J ; - :-y 77 , o 7 t ‘ ‘‘,ooo i 

! v ; t V 7'"j f. -77. 5 ;;iO‘!.'7'. ■77 i\;' y0;; t 77.7 . ) [,'J ' ,j*T( 0)0 f ‘7') 

f '7 7".;: :’j .. . -7 { ■ o '7; > J7 rrc':. ‘o r '- : > ,i 1 r • ■ J. . ; f':) 

' ■ ’ - - ;J • 7 7 r.; 7.; • : *; r.l , • 77j';, 77 ,v ;.oo I m- •. :7 ‘to 

• ; ;• -x . . ; 7 ; y ■ ■' :7 k rj ; (7 \coi77vr , 7;o . .7: :o ■•■ ■)■•:> .*-.;..7 

ro 7; • ... . ■„ \ , 77 '. J .oo -.'7, ; 7 o “/f , ", ; i 

* ' ■ 7 7. i ' ■ ! r r x: '7 7 ' 1 ;r 0 ;f 77 .' b ... -'7' ' . '7.0 


78. 


decrease in strength, muscle mass and skin thickness, whereas the 
latter disorder is characterized by a tendency towards masculinity, 
rapid growth before epiphyseal closure, and increased strength, muscle 
mass and thickness of skin. 

From the endocrine point of view Albright (123) attributes 
the manifestations of Cushing* s syndrome to an excessive production of 
the "S n hormones (11, 17-oxysteroids) by the adrenal cortex. That such 
is the case has been substantiated by Mason et al (339 )* who isolated 
17-hydroxycortieosterone (an n S f? hormone not normally found in urine) 
from the urine of a patient having Cushing’s syndrome. In addition it 
is well known that in subjects with normal adrenal glands, high dosage 
schedules of cortisone (also an ”8” hormone) and ACTH maintained for a 
long time will produce the characteristic features of Cushing’s syn¬ 
drome , which will disappear on cessation of therapy (147)(188). 

The clinical features (153)(340) which usually appear in this 
syndrome are; a mild diabetes which is resistant to insulin; a pro¬ 
nounced muscular weakness with a low creatinine excretion indicating a 
descreased muscle mass; and osteoporosis, which is most frequently ob¬ 
served in the spine and often associated with nephrolithiasis. There 
is a peculiar obesity of the face (”moon face”), neck and trunk, whereas 
the extremities are thin and may' even be wasted. The thin atrophic skin 
covering the thighs and the abdomen is easily bruised and is often 
marked with wide purplish striations. Mild hirsuitism without other 
evidences of masculinity, amenorrhea, impotence and diminished libido 
may also be observed. A mild -erythrocytesis and hypertension may occur, 
but the urinary excretion of cortin-like substances (11-oxysteroids) 
always is increased significantly. 


• r 


.AY 

XT;' XxTT'. • . I "Ax' :• : : i.f:- TiX'; I -0 X ?. • 

• tiro : ; : ■. ' i TO. x : • i '' ) ' i ' 

AxlOTJX , Axxx-xo-i , V. TX f ;o. ; ' ■ ' 1 x 'id A - t '< -A X >1 

. ' H r : A >!- ' un 

SWCTJJC'J i‘ACi"h-3 (AAl) A AX X’A.X Txlx lo'-.'j-nxo--: SxA.VXTXT) X ' ToYf 

o‘ )X3 a ' n ' ~ ' t i ' 

‘ij.fj: r-,. t; • ? . • ■ r - « A*. -xx ,■ ; x ' t j. ■ x t i x : ' ' M .A 

i hoJ&Moni oif ■! , \ ) ' ■ T'; '{jl AxA i.A xxj T iAx,; fix: xu ■’: ■ i x x) *xij xt 

(•.>xx.bffjjol 'xxx x'.xxf J*o ? rr.rc ..,1 '' <r •) xt x-A" to A’x 0 ; x xx'v -Y 
■ i nolJA ■.' 1 • x. .. x x■/ •. ' . . x * / o. ■ x ’ .i t • ■ . ' ■ 

-■v v.iob ^xAnx.- • • ■ . x • > Aitx' sc ox£ x.x; -A rx Atx/ si: 

4 XEOl j'flX ' ' • ' £ ■ 

■ ; ' ■ i - 

• - , ■ : ‘ . '.x 

3 Xiid" XX • : • ' : ■ ; XX ' . : •' \, 1) " X ■ A 'xAojxT) XX’ - 

-OTA X. ;il ; :':;ixi'. C ■; O'.'.X-j XX xx AfXXriT TXXX Lxlr X: ,':' x :.xx xnr-’X-xrrx 

5 is c x.b J rj( 91. : ■ ‘ . &.h 1 om 

-/O ‘: r I; X '.o : . / , X:. ';0-.xrxi xt ■ .x ; : ;v ■'xox/Ji.' )XXXXXD3 -)X 

- X-;Xi... . ' ‘ X.X/X: XX.X; X..-: ■■ X ' :x„X.- JH'*. X, !.J: : X. , f'X 3CV T /X :1 


x; - i x ; . . , x 

: 

our' 1 } / A ■:<: vss.s 

.vx o * T. 

‘ 

' 

TTlX 0 !': ;■ , ■ • X X - 

.s / - : x:- r<x,:.x: : x\x 

Xr.ix 

Aix-sivA-: xr.it 

ffxi'lo C, 

i LiflfJ X ■ : 

x a xo'xix xA.t xrx xl 

: 

■ A ■ 


i.x J: v; ,Lxlx.r.;r;rxLx 

» <10- X X..X '.-X . ... ‘ X x. 

0XJ.;; 

x • ■ .-x"'.xxa 


x ■ i' Ixxxx.u XT?, tx x/xxi; , •.xirxxx-jrtx ixi;o.,-x ‘lo xxx.rxx;v:> 

X~x ,X • . fit i xx .xxxx\x. , : xxx,^/ x;.;vx,T ;.X; <:.IJ A , XT'/v,xrJo •••.>:' oxx :,X: 

t..\t 'jJ- r-r.x..Lx} x-. OT •’ xAf;:- -■ 'ir x ■x xx:tr -x x.Lx; ,xJ j-j/J 

. . ! x J: ■ bxx • x:x : ; : t 'X,', y /I , 


79. 


Patients with Cushing’s syndrome have been reported to re¬ 
spond in a normal manner to ACTE administration (341) (342), although 
ACTH is known to increase ,, S M hormone production by the adrenal cortex. 
The manner in which such patients respond to cortisone has not been 
thoroughly studied, and as opportunities do not often arise to conduct 
metabolic studies on patients having the disease, we were fortunate to 
be able to determine the metabolic effects of cortisone in this instance. 
The results obtained proved interesting, particularly when compared with 
those from a similar study done at the same time on a patient with the 
adrenogenital syndrome. 

(b) Case History # 96690 . 

The patient, Mrs. C., a 38 year old female, apparently was 
well until four years prior to admission, at which time she noticed that 
her eyes had suddenly become ’’bloodshot and puffed up w . She was treated 
at this time for an infection and possible allergy. A series of allergy 
tests revealed no specific ailergin, but physical examination revealed 
an elevated blood pressure and she was accordingly placed on a salt 
free diet. Her eye symptoms remained unchanged and she developed pains 
in the back of the neck and weakness, for which she was hospitalized with 
no improvement, Tw t o years prior to the present admission a diagnosis 
of hyperadrenocorticism was made by Dr. D. R. Wilson, and testosterone 
proprionate 10 mgm. per day was prescribed. light months prior to ad¬ 
mission she commenced to menstruate and has maintained normal frequency, 
although the flow is scanty. Four months later the patient was seen by 
Dr. J. S. L. Browne of Montreal, who raised her testosterone dosage to 
20 mgms. per day. Since beginning testosterone therapy she has noted an 


" 

c-j Jo ->■ - I x r ;;i ojxgo om: x f :.c/0 rix.ro x-xn: Vs 

xx. r!x. x . 'x>J v x\ ■ ; • = '•*; ■' x?o \ x...•-rc.r:-■ - r \ xx;x: •. r * .oxxx 

r-t i v"t ; xi . X > ' X : . , O ■ -X..o: 

■ 

' 

7-C 3.'.,/ .7. , x ■ ■ - ' • " o' • •••• [ 

Vi&rw S' it r r • o * ••/ ■ >o «- r\ :T 

s.-tJ' i'oS/T &SVU.&.SX.; x no • : *. ■ • o J i jxxx/-: o; - 




' , X 

. X' 0 < b X'T 0 . O' J ' '• • , / : ■ :• ' • ;• x i‘. Ox : 

X 0 • • r X r u ■ . . ■ ; ■ •/:• • ■ ■ ! • ; _ J 

'voxj-ollx 'io ;; x . ;j - i x x box nc.'.b Vxb ' • xcb. .'.t. vi • 

joIsovx'i: n: •.in ; ; xx.bo;;X' n.n , x e x.bx xb:'.:;I ox or; boov 'X xHo j 

. 

■ ■ 

. ’ ■ ■ ' . ■ • ■ bxji , x fj t ' . ' 


'■ ■ ■'< ■ ' ■ ' x- V . ehtO s' 


* ‘ ■' ; - X-: ‘ - x. ’ x 

■ ■ > 1 . i' ; X oxx-.-;xx ,X‘ cy r ■ 

.";xxrx. r ;. xx*i:: xx, : -x jxx -j ■; . x-;r. .xxx r. r xx v xo'x: c,/ oxxx' v xo.o o-x o; • •;:: . 


s j 1 

OJ- XO; VXOO o r: x .> J cJx.: X:.;!' 

■O-' - • , : ■ V 


. ; 

J -> ‘ - • • x , X ■ .V f.i: -;,x .XO -/V . I 


xor v .y|pjoOu Oe.t 


: 


:i ://or:Jxi.o ■ 

o . T, ,‘X'I 

. 


. 






Figure 6. 

Cushing 1 s Syndrome #96690. Photo¬ 
graph showing slight puffiness sug- 
gestive of moon face. 







80. 


increase in her strength, some diminution in the tendency to bruise, and 
states that her face is "less round than before" • Three months prior to 
this investigation testosterone proprionate was discontinued. 

On physical examination the patient weighed 60 kgms. Moderate 
hirsuitism was apparent on the forearms, legs and thighs, and was sli$it 
on the chin and cheeks. Some puffiness of the face was noted, which 
was suggestive of the characteristic "moon face" (Fig. 6) and her skin 
was thin and reddish and bruised easily. Her blood pressure on admis¬ 
sion was 140/95- There was no enlargement of the heart to percussion, 
and no murmurs were heard. Ophthalmoscopic examination revealed no 
hemorrhages or exudates and there was questionable A. ¥. nicking. De¬ 
creased motor power was noted in both quadriceps, and the right grip was 
weaker than the left. All reflexes were normal. 

Routine urinalysis and her hemogram were within normal limits. 

An intravenous pyelogrsm showed the kidneys to be normal in size, shape 
and position, and the right kidney was noted to have a bifid pelvis. A 
lateral x-ray of the lumbar vertebra showed slight osteoarthritis lipping, 
but no osteporosis. No chest x-ray was done, and perirenal insufflation 
was not attempted in this or any other ©f the reported cases, as we have 
had no experience in the procedure. A coi'tin determination on admission 
was 1.6 mgm. per 24 hours. 

(c) Procedure. 

Prior to instituting therapy a six day control period was 
carried out. Cortisone, 200 mgm. q.d., was administered intramuscularly 
for the next six days, following which it was discontinued and the patient 
was observed for a period of twelve days. Following her discharge the 



iVr • <. ' o> ? : A ■ • . ;■ o'. oo:.! dor o'.'O.tl of'cc f “fori rri' • ■ :• : *iDrxi. 

. . ‘, • ■ i- 1 : • ■ ' v -' J 

Oo J O'’ f'■ : V O'V.,; Ool O'0:A'<'A10: '0"' J" - ”> O.Oyq H'C 

0,0 . ' ' A ' O' - 0 

* ' -■:* • ■ ' 

- 1 ' . 

, ' 

co, o *. / ■ oo ‘ ' .• , 1 o o o: n . • 

. , . . . 

' 


Ismo i ■ ■ ■ j • ■ . ■ - 


oo: o.A ; ,.o,:l.o 

• J 

f O-d '.j iOl.l Oil 



L f[A 

. t'f . 

ilollo; ■■ . 



. 0 


id: oo Ll oo Ao 


1 

;■! 9;V 90.0 i 

• i:f. 1 *>o vovi--x I-rio 

. 

•oit •iono.l.lURnJ: 


} lo:;;j ,9 909 99V/ ' OVo1 


. 


. 

">o oovl' 

'■ • 9 'Jo T Mil ; 

OV'Jvl 90 >? 

All nl u.ol.o ooM loot 


no' : i 

jO'Cll ' 01,; : 0 

i l 

f : . 

' 1 : 00 0. 99'1: ' 009 CO 

£)■,;: u;[ 





■•■■■■ ■.... - >.j: 

9 VA 


- 

. • " (o j 


too X ' ■ ■ '0 o . , . , < d o 

, • ' , o ' : , ' ,,, o; u> :i o )dd' of 

> o < 1 i . o ! 




81. 


patient visited the Mayo Foundation -where an adrenal tumor was 
removed. 

(d) Results. 

(I) The Effects of Cortisone on Electrolyte Metabolism 
(See Figs. 7 and 8). 

a. Sodium Balance. 

During the first three days of the control period the 
patient was in sodium balance, while during the remainder of the con¬ 
trol there was a slight retention of the element. Cortisone, 200 mgm. 
daily, resulted in a slight diuresis of sodium during the first three 
day period, which was followed by a slightly positive balance. On 
cessation of treatment there was a diuresis of sodium after which 
balance was restored. 

Serum sodium values showed some elevation during the adminis¬ 
tration of cortisone, but these values remained within normal limits. 

b. Chloride Balance. 

The urinary chloride balance closely followed the sodium 
balance. Cortisone produced a slightly negative balance followed by a 
retention of chloride. A negative balance similar to that observed with 
sodium, occurred after treatment was discontinued, but the diruesis was 
more sustained and balance was not established until nine days following 
cessation of cortisone. 

Serum chloride values showed no significant changes throughout 

the study. 

c. Potassium Balance. 

Following the establishment of potassium balance during 
the control, cortisone was observed initially to induce a negative urinary 




a m - ■ ; i 

a - . o .«.! r/ • :'c .1 •• •• rixxt ■ >v-■ J..*. -,±v hnottoc; 

. 

oohhn hi (>•) 

1 

■ • ' '■■■; L ft ' : • ' ' . 

. ’ , 

. . ' 

(a ' ' 1 ’’ 

■ 1.o n * r>. a ' o ot ha ?s.‘i •’.•It ” ‘hoot 

or't lx -rao , r V"- • 

. ’ : ■ -ft d • ’ ; 1 c i ; v ■ J' 1 • :>it y 

, 

. t 01; :: d. / . 0 foohi . : • tv: O J "O ■ .. . ■ '!;'•[ GO*."' 

' 

- 

. : 0'[ ■! , i -- ■>/ 

'• •) ■ / . ■ . ■ o'.■ , : ... • '• 

■ 

, ■■■.■;-to ': a 1 : G . oh t’f . t 1.0 . tot t 0 01 GO 

d • ' . 

-a ' o'. I> 5 dJ ~ ■ noJ 

■ . X/i&OQ 

, i ' I ' ' ' 1 

.. ■ a i. v ■<-.■'{ ox'. •/ oaooh .: o ' .too: '\yb‘:.oo to oo.lih.orh 

, j'j h .» r o ■ 

" - ; : :it : K.■ ,o L ; •■.‘l v;!i 


: a f t >v.cIIq1 go a gi.. • - 

. 

j it.hr r > or-::: olo t r. h h -• 

: o" : " V,v o; 1 . •' .'V. o.h l .0 . ■ rtf; t fo 

; a.o;f eht doxa „ 

> oot.hh ror 1 to a'.o* hoarh ■. '.oxt rotto . : xooro>oo r n:,'i:ooa 

■ t i ro • t■ . i! a ...iJ 

'■ u -;1 ■ • ; o'. . ' 1 O' ;jonto;’Ofo; ; 

• * 

tyod;. iKrtiti R9;:>aarf-:> ihxaa. 

' t..' 0 ; GO t-orciu': 0. J.fJ. -V oV‘7 Gl(fc r'Ji'O ’/I 


■‘O'XOV ■]'» 0) O'Of i 0! 

mszttti ov .’.t ojoo b youbjttJi 

. 

1 t;; " tooi'ai :;iidstao oj;It " o. r oo.Cot 

: ' o ;o ■ ■■ : ' ■ "... : ' ■;! .... o., o ■■■■. 


















Figure 7 


Figure 8 


Metabolic data on Mrs* B. C. #96690 with Cushing 1 s Syndrome, 
to show the effect of therapy with Cortisone* 

Metabolic data in this and later figures are arranged accord™ 
ing to the scheme of Albright (125) • There is a horizontal base 
line, intake is charted on a reverse scale downwards from the base 
line, the urinary excretion is then measured from the intake line 
upward towards the base line. If the output exceeds the intake the 
final level will be below the base line. Thus, a positive balance 
will be indicated by a clear area above the base line; a negative 
balance by a shaded area above the base line. 





























































82 . 


potassium balance accompanied by a lowered serum potassium level. Dur¬ 
ing the last period on cortisone the serum potassium again returned to 
pre-treatment levels, at which time there was an urinary retention of 
the ion, which persisted throughout the post-cortisone control period. 

(2) The Effect of Cortisone on Weight and Nitrogen Metabolism 

(Fig. 8). 

The administration of cortisone resulted in a negative nitro¬ 
gen balance of increasing magnitude. Following therapy there was a con¬ 
tinued loss of 4 grams of nitrogen per day accompanied by a correspond¬ 
ing loss of weight. 

(3) The Effect of Cortisone on Cortin, 17-Ketosteroids and Eo¬ 

sinophils. (Fig. 9)* 

Urinary cortin and 17-ketosteroid outputs were increased dur¬ 
ing cortisone administration. The cortin level rose from pre-treatment 
levels of 2 mgm. per 24 hours to 5*5 mgm. per 24 hours, and twelve days 
after therapy was still 2.5 mgm. per 24 hours. The 17-ketosteroid out¬ 
put rose from a control level of 15 mgm. per 24 hours to approximately 
25 mgm. per 24 hours, and following therapy gradually returned to pre¬ 
treatment levels. 

The eosinophil count showed a prompt fall when cortisone was 
begun and remained depressed following therapy. 

(4) Other Effects of Cortisone in Cushing’s Syndrom®. 

(See Appendix III Table I) 

A sustained blood pressure elevation (Fig. 7) was noted follow¬ 
ing cortisone administration. From pre-treatment levels of 130/80, the 
blood pressure rose to levels of 170/100 and continued to be elevated 
after termination of the experiment. 


S’I.'j 


c 


: ■ - ■ ; 


,r ; rox ; ' 


, " ■: V:. ; J V. J it 


'.'■"'(TO) 


' 


roo '.o n 


>1. TOO i ■' v'C 0 .1:5'' "" 


m hir: :i:,Xu'rv; 


0. ’ ,* ' » ■ i!■ 


if m 




■ ( . ) 


UJs) 


jn.i .j". 


L£ 


:.CPIC0 


no 




(.v' 'rrn'V ■< : . 


iO'1‘ 


; i ■:c r . ■ -or^ :' nnoo I.nno'dv;o 


T 


un 




V ! ■ 

\y . 1 J ■'.r '■ J ■■ ' ■ : i nX X; * ■ 

...in :>J iX'i »X'• l.'VX 10 TiJ ■■ V ■ J, oJ' 0.'O‘C V'WnSi) 


x: c J 


- 


1 I;j ■ ’ 









RG 96690 
GUSHING'S 





Figure 9- 

Metabolic data on Mrs. R. C. #96690 with Cushing*s 
Syndrome showing the effects of Cortisone on Urinary 17- 
Ketosteroid excretion and circulating eosinophils. 























83 


There were no significant changes observed in urine volume 
and specific gravity measurements. Fasting blood sugar levels remained 
within the normal range, but rose from a mean pre-treatment level of 79 
mgm.$ to an average of 96 mgm.% during therapy* A marked leucocytosis, 
in the absence of any demonstrable infection, was observed during 
cortisone therapy, the white blood count rising from a mean pre-treat¬ 
ment level of 5900 to 10,180 cells per cu* mm. Very slight elevations 
in urinary creatinine excretion were noted accompanied by a slight in¬ 
crease in total serum proteins. 

(e) Discussion. 

Plasma electrolyte disturbances occuring in Cushing’s syndrome 
have been described (343) (344) * Among those which have been noted are 
low serum potassium and serum chloride levels accompanied by elevated 
serum sodium levels, and on elevated COg combining power. Urinary loss 
of potassium may be so great as to induce a hypopotassemic alkalosis 
(344) • On the other hand Power and Kepler (344) have reported that the 
electrolyte picture found in Gushing’s syndrome is most often essen¬ 
tially normal. The present case showed no marked abnormality of the 
serum electrolyte pattern, and the urinary excretion of electrolytes 
was within normal limits throughout the control, although the patient 
had not been taking methyl testosterone for three months previously. 
Further the mean eortin value for the control period was only slightly 
above the established normal range for the methods of assay used in this 
center. These facts suggest that the patient was in remission at the 
time of this study. 



* Ff’ 

xxxrlov enxxx xi: ixr/xivvfo -x* v r x, o • '-;•■ A AA • r; v ! t ' x/x; 1 ■ ■ — 

7-; ' A.' , : : 'X '--V '• i xX - 

■>V io IctsI A i-•■•;:■:} •.•• ‘.t■ ■ i : x : j* xxox Ax : ,■■■ \;x or Axxxox eXo or .A A.’X/ 
„:xr ( -;od-voooxjy.L x x : A A rxniA ‘'Axor A ’ ‘A: xx vy ,-v ■ oj- x 

xx A*mij xxv 1 x r • xx xxv ■ ' ;x o o ■' ! 'i’. * : xA 

--J :-£q n x-x : mu’fi x.AxA; ■ Aoxtfcx.' JAoolM xAxlA,.- o:Aj * vx <Th.. A xnoxxj^oo 

xxx A A v. .Ax AMxA A. y -V . • *, ^ ; x.AAx x A‘AA, . ! A '• A:; 1 I. v A Ax,;; 

-~xx AA: ;y; ;x-y x xycxx) ■ A Jvj; xxxx xoAjxxOXx x A A A xxx A' ‘xAxx xx 

«, . ' " r-.r , , ■- x . A X . V \ 

. xA 0 " ,A : ,; 

.‘;A x ’ y : X .A ■ ■ -: ■ x 

ox : j>-ye ; ix- { ■:■ y 1 A-;' X" : ' • ■ x\ . ; ■";A '/". . ! b x ; ' v x 

b-AxvolD x " bxixixxxcooo xf v x xAjxx A x -xx o :x ■ : A x•• • x i ur:-. y xrol 
r-;Ro.r. vxxxxM; xtyxy: xxAx : • - o -'0 1 o x x/ h X'X xx ’ vr.-J ;x xjj"xx 

x.-' :o. . -X.I ■■ oxnoxx oc.'w ^ a:.i o f xx J*xr/i r.\ r..cf a vix ; i: ■ I ' A -x Mo 

’■ j* ;1 x-'.if i 

■ ; dx;o; xAn : • 'A rf’oJ 

c.A.A A:o xaa" x; ixoxv,'; !f ’■ . ' xxA:- xxx.o ."xxi x x: r; .' .A : ox: xA. - A:' 

^Ovj^xCo'vJ'OxIO Aj XvAA •• X'J :■ x • XX A.x.: Sil A OX ; .XyXxi x.; eu ^XoXX.XX.’A, wm)3 

■' ■■ . I ' ■ ' i 1 Ax-A • .. .C ■ ,t . . fjc*aid rcM I ' E ■ : : ; . 

. Oi i - 1 : 9 x A.A- •■'■.'■! X -A : . .< ’ 1 la ' 

■ v.Aj'xrx/x vAio R;W box-io.. lo‘:xh?.6o ■ j'A' xoA. xxxAox oiAxco •f.r-uxA xixi' “:u rLAox/x 
F; J: Au' iXi. A'..",;/ X XX;/- Ao 3 A(,:■:■ Atof: : , . AA '■;£< At 0,0■A A;. S.ryiyny boxA; AJAf 0JBX 0.:^' : VO'Ax 
: ■■ : : ■ ■„ r,' or :■ :■ A ; x ■ . Ax A <- - . 

; .• ; xr Ax.) or..C# 


T':x;Ax 



84 


In most respects the patient responded in a normal manner to 
the administration of cortisone. However, sodium dirue sis, rather than 
retention, was observed during the first period of therapy. This is 
not surprising for presumably the secretion of the other adrenal hormones 
was not impaired in this patient. It has been stated (345) that in the 
presence of other adrenal hormones sodium diuresis can occur, and that 
cortisone only shows a consislant sodium retaining effect in Addison*s 
disease in the absence of DOGA therapy. Presumably the ability of this 
patient to produce her own DOGA accounts for the paradoxical effects” 
noted. 

The diuresis of potassium observed during cortisone therapy 
was not unlike that reported in a similar case treated with ACTH (342), 
or in normal patients treated with cortisone (127)(147)• Accompanying 
the loss of potassium, which occurred only during therapy, was an in¬ 
crease in the urinary output of nitrogen which persisted some time 
after cessation of therapy, and resulted in considerable weight loss. 

Such a phenomenon has been observed in a patient with Gushing’s syn¬ 
drome treated with ACTH (346), but the reason for the apparent lack of 
parallelism between the potassium excretion and the nitrogen loss is 
not at present known. Interestingly enough during the period of most 
marked negative potassium balance the serum potassium level dropped to 
2.8 meq./l. and no apparent clinical effect was observed. 

The increase in the urinary output 11-oxysteroidg (cortin) 
following cortisone administration to normal patients has been des¬ 
cribed by many workers (52) (127) (14?). The elevated excretion of 
urinary corticoids observed was normal, in this respect and is probably 



. 

. . ; ci.ei - 1 ■ - 

i ■■ J e ' . :c; ?U. 

’ 

, 

. B 1 l x ' 

' i rtruj >sv Bcfd" " ? e. 


Avxxvx exxA x > .. >-o AXxx-'e xAX A xxx o voA /i.i Ax 'xe Jen 


■rUt rri AnAA (AA'A ' A d 

• ; , '■' r . ;: ox A X' A J c •; 

dxrl.t ban xir.rooo ■•••'> ed: 

’ A ;non xxxxx:oi.i J’ x.fex on 'i- nJ'o *lo ooxdbvxix 

n J cccx ' A A n X->Ax 

' " ■ ■ M h i , k ) 8V01 . i site 

• - : 

r . ,j X ■ ; A. ; 


,.; x ‘ ,J u/j;.)- o ■ ■ ; •: 't v: 1 . ex. ' cd* An : v - 


■ vc;,xx. 'A ixtextA'icx 

■ o 'vv/.A o; ej'oe A- A . xxA. X dxIT 

( A-') :AA ' fi : .• 

■:J m.'. i?,:.hr±Q a nA: AdJvx.o-' jvsXii d:AJ; Aar Ao ; n ' 

■ ' :< 1 

-ffoe ’ A*tod a Ax : nodxxn A x. ; rr,..TJxx X^/rrco" nrA o:o 

- i . 

HC B > k ■ A '■ n . 1 . 3 • v. - 

enAA otxoz JxA xA-x-■ 

■ AxA •; n.A.ceiAAr; 'A.- XxoAx :>i- n'.. nee-XD 

. xA J A A . ' •. • o 

; ■. :• ,.A • A.L. r r;vv:: An ,v '' o noAA.v; xd:) •.'•-jJA-; 

■ : ! A ■ A 

A : , : A A- •/ : v s.' • :: , . A. riOiivi e': - A e i J;' • A 

'I ■ : ‘ > ■ ) ■ ■ 

: . - , ( "A J A .. . .J ' - :A ■ ' :A •.i-r;.-, A 


z \ ■ } ijI d Ji 9 rdx til;;JA 


J’"ox " O XV-VS 

■ «■ 

oi ibae- oxo b val. / •• : 

.:.,.A.v ..v ■:J’ dOvXsjA••> i ixul xA.x; oxxA-o- -x ■:'xAfx:n 

. ■ x- 

;; :> ' A A . - ■■ •: ■ : . ' .. 

( uA:.XGOi •v..A;v A*: 


• •ddA -vo ■ x: o-An .* 

' •. r ■ oA re; AA'/xJ";.A i. X' ^ A A- ; - / vA'.:o.i.loA 

x<> aoAJvrxo :o :x:,A 

0 /--: j' ; " , (VAx) (VA;X) A : AA VXlv. x,: . X 'A A V:.;o:d 

YAAeofoTT e i • ; f ’ J > 

I . \ 1 • ) ■ iXo ? 


85. 

due to the addition of exogenous "S” hormone to the endogenous pro¬ 
duction of that hormone by the patient. Cortisone administration 
usually results in a prompt fall in 17-ketosteroids (52)(147), however, 
elevated values were observed in this case and were probably due to 
measurement of some of the metabolites of cortisone in the determina¬ 
tion of the 17-ketosteroids. 

The pronounced drop in eosinophils was characteristic (147), 
and indicated that adequate dosage of the hormone was being adminis¬ 
tered. 

(f) Summary and Conclusions. 

A case of Cushing* s syndrome (in remission) which responded 
in a normal manner to cortisone administration is described. There 
was an increase in the urinary output of ll-oxy steroids (cortin), with 
increased excretion of urinary potassium and nitrogen. Urinary sodium 
and chloride excretion was elevated initially, following which there was 
a retention of these elements. This **paradoxical effect*’ and an eleva¬ 
tion of 17-ketosteroids, not usually observed, are discussed. 

II. The Adrenogenital Syndrome Treated with Cortisone and AGTH. 

(a) Introduction. 

The adrenogenital syndrom^,like Cushing’s syndrome, is a form 
of hypercorticism usually associated with adrenal hyperplasia (347), or 
with adrenal neoplasm. It may occur at any time of life and in either 
sex, but is throught to occur more commonly in females (348). The 
characteristic feature of the condition is a tendency towards mascu¬ 
linity (349). However, the clinical picture of the syndrome depends 



. ■; 

• 'IV ^XiOiT0 ;;0 ' :.0 t 

•• •: ‘ n ■ o. •: ■ ' • QfiJ' cd' * ;.o> 

: ■ JOiO/A \ , '• ... . ' ' 

. . : ■: J' -. / Wo ■ :( l.o 

.■ ■/.■V'jyi , {■'::■.! j {:."■) ■; ■ 

V~ ! . i.';J - ! 'i iu.v, ■ ! xx v_\l. •//?■!i. r 

: oj f 5 1 ). i ’ ;.r.d u-'.fv; ■ > 

■. -o < ‘ ' T " lo JT V ‘ \ V . V 'V X:? 

- ;.j ojld nl • (s •:.■ • 

j .l.o-i r - v " r .‘ ■.’• o rbion. 

V r J .. •,' J Ac iiC lit 

, (V,U) • 

. ; ;,o' : .n . >$of uoi '■ orJT 


r • . . io • v ; • j -..*f >^vb i >oJ‘ jo 1>mix nan 

4 

oO 

lx.nrn -'• 1 ’ ■ 

f 


; v. :.T • ‘ . ' - ■ (.,■> o ' ■ ' ,ri v •: o ' nl 

■(. ■:>; o-j \ d c - c d O'jrd: n • 


oi:.LWo : • 

j d ■ ■ . . 

."Vi ;w L’i~ >... j .. t v.. t. • .■ » 

.' J ■ ■ 

... ,r : ■ i f ) 

■O.V ' ■ ‘ M xj : v 1.0 { '!. .' J :.. J . '■ P, 

,h ■ 

o \, r .L ! • . : c; " -. J ,:c J :. : -\i Wo ; k: 1 d 


. 

.. i * . ' '■ ? . TI 




jr/'ol : .* ,nrro- r 'i f> * ••••• X y 'p. , ! . dr * < .on ortT 

; IG p,;t;i>T in'. ; ooJ o ,;a s ' Loj.rejjj a ®Inl S"iQ‘yioq-yfi lo 


' 


■. . v: . r 

m 

■'?. v .c.-.' ■ o : l.n., y 

■ idol: nx/j i'W ':,o nWool. old ■d.-fo,oioA.0 

vJxi o’oh oj'X-'i. ! td' 1 'a 

■ ■ - :• J. .. i ■ . ■ 1 v '1. .. . A' } r d';: 





36. 


upon the sex and the age of the individual at the time of onset of 
the disorder (350). 

Congenital hyperplasia of the androgenic zone of the adrenals, 
commencing in utero, results in macrogenitisomia praecox in males, and 
pseudohermaphroditism in females. In the case of the former, puberty 
is premature (35I), but essentially normal in other respects. In fe¬ 
males, however, defects in the orderly development of the urogenital 
tract occur. The clitoris is considerably enlarged and resembles a 
male phallus with hypospadias. Infantile female generative organs are 
present and, although no external vaginal opening is visible, a rudimen¬ 
tary vagina opens into the urethra. The way in which these abnormali¬ 
ties are induced by the over development of the Wolffian duct system and 
the suppression of the development of the Mullerian ducts, has been des¬ 
cribed by Young (352), who also points out that these unusual findings 
are associated with masculine habitus, hair and psychic outlook. 

Maleness is superimposed upon genetic females, and accentuated 
in genetic males when the condition develops in childhood prior to pu¬ 
berty. Precocious puberty occurs, and in the male accelerated isosexual 
development produces increased genital growth (homologous pubertas praecox). 
In the female precocious heterosexual development results in a clinical 
picture (heterologous pubertas praecox) which includes hirsuitism, en¬ 
largement of the clitoris, a male escutcheon, acne, a male body configura¬ 
tion with prominent musculature, and a change in the character of the voice 
due to enlargement of the larynx and a thickening of the vocal chords 
(34$). As the condition progresses in both sexes, there is rapid growth 
of the long bones, following which premature closure of the epiphyses 


'j.o bo r> : ivr ’■ • ri -Iv\: ':if: l. ;ij Vo- o; ;■*, c 3 e. nocr 

. V } ' ' • ' >■ :X 0 ■ 

• ■ '■.■ ■ ■ ■ • ' • - ' u ' - 

♦ .I'vl-J". ’•£■.! ‘ ' ■ ' ' ' : o "j,o * .,j : ? •; lu (ii • ' fy rod 

\ 1 " i .. ‘ ' y <v o/on ob.occui 

*■:! . ; : . {/"’ ) - J : ■: ■- •• 

I .o v U rootro; r .. .7- ’ -xJ' ; / - : « bob .[ •, ■ 

■ r X. boo : ‘ ' ' , •• no • r. :)■ 

': i » ’ ' >,£./ ■ ft ■ I •. 

o .oXuIeiv j ' ,nv .i. ; 0;; r ;-:o jJ - t >: ■!. :eo 


; ■ -xX^rxoir<j & n q orb ; ;o r ; % ■ 


. 

ib rvlril 3x1 

•coo Hex .-v x^x.ed* 





■ 1 • eeid 

-3 B-h fi'Oob 3.-3.' ..Rj-OO'i 

: '.: r -■. :o..b' 

‘ir.. J-^r oxooJ , 'v 

r R ! '-J 1c 

i 73 ‘too t.r. e.dd' 

vyi.'x ; ’. r ■ ■■ 



i 

• '0I vd bo bo.;.; 

. 



V-‘: • o'bbo 

' X •. J --'C. 3 ' • • ‘X 

• /X3 »ael'xxn'.;. 

') ' jrVRV' JT 

OrjT •:■;■>; •. • j 

3. 7(3 '; J 

r: .1-3: 

' 

:aoaf.:-o 


fieri-' 

x •/ - o/d'orfevj til 

- r r..;-->3c:ob- vt: Ie» o.>. ■■ 

: 

■ 

1 7 "to 0 it; ■ 3 .• !f 

■ ^ ■ - 


• 0 £>.:'"-Vi"'. -3-0gjxo^olo, ;cu co::, I k-en;oooo.‘ asoxrbc/j-o bnonqolev-xb 

.;J : p ■"/o' o*■ jj rj ..?o:n-o ,bo .ok.o ol.oTnx n<:j nl 

™n - 1 ■ : . ■ ' c i ' (.,'<00 ■ 3 . : • • TO'.' ©TfiJitoj 

■ " bo .,■ > ' -J. ' . . o' ' • j.’ : 0 - ; -J. 

( ’ -i'!'- "i: ;j ;> - ■ • r 0 . 0 • ■,;/ :indTff* f lrx/rc ib'.nr 

C .'ocv oob lo :\nJ -■.■obo.' id- ;• • ' >;;t b:. .: -o xo■’■xolx: ■ c;t oj/o 

' '-ibr TOCJb ' \1 {■-!■■• jb.; ■ ft j ; -. n jo r 'j O rlj xO 





Figure 10, 

Adrenogenital Syndrome # 96696 . Photograph 
showing facial hirsutism. 





87 


occurs, resulting in persons of short stature principally due to a 
shortness of the limbs. 

In the adult male the adrenogenital syndrome is difficult to 

recognize and is often missed, but when it occurs in post-pubertal females 

masculinity is again apparent. A previously normal female develops 

$ 

hirsuitism, amenorrhea, an enlarged clitoris, flat atrophic breats, in¬ 
creased musculature and other evidences of maleness such as a male escut¬ 
cheon, habitus and a coarse voice (349)® Not infrequently there is di¬ 
minished libido and a change of sexual interests from a heterologous to 
a homologous one (343)• 

It is thought that this type of hyperadrenocorticism, in con¬ 
trast to the Cushing®s type (123), is due to an excessive secretion of 
adrenal androgens (^N® 1 hormones), which is reflected by a markedly 
elevated urinary excretion of 17-ketosteroids (123)(343)• In most cases 
there are no carbohydrate or electrolyte disturbances. (353), although 
some cases have been demonstrated to have electrolyte disorders causing 
symptoms similar to those of Addison 8 s Disease (354 )» which have resulted 
in death ( 351 )• 

The urinary output of 17-ketosteroids is presumably (123) an 
index of the production of the adrenal androgens which are responsible 
fot the virilism seen in patients with the adrenogenital syndrome. As 
cortisone has been reported to reduce the urinary output of 17-ketoster¬ 
oids (52) (147) (355) > it was of interest to study the effect of this drug 
in a patient with this syndrome. 












Figure 11 . Figure 12 . 

Adrenogenital Syndrome #96696. Photographs showing 
male musculature and body build of the patient. Note the 
small breasts and short extremities. 







88 


(b) The Effects of Cortisone on a Patient with the Adrenogenital 

Syndrome. 

(l) Case History # 96696 . 

The patient, Miss C. W., a female of 18 years of age, apparent¬ 
ly developed normally until the age of nine years at which time it was 
observed that she was taller than other children her age and that there 
was increased growth of hair on her arms, legs and face. Acne and in¬ 
creased strength were also noticed at this time. Growth ceased at the 
age of eleven, and breast development and menstruation have never taken 
place. During the past year bilateral temporal recession of the hair 
line was observed. Aside fm>m the above noted deviations she has en¬ 
joyed normal health, and to date is well adjusted to her condition. 

On physical examination she was 131*0 cms. in height and 
weighed 47 kgs. Moderate acne and facial hirsuitism (Fig. 10) requir¬ 
ing that she shave every two days was apparent. Although there was a 
well developed widow’ 3 peak (Fig. 16), normal amounts of head hair were 
present. Her larynx was enlarged and her voice was low in pitch. Hyper¬ 
trichosis, particularly of the abdomen, extremities, shoulders and about 
the nipples, and a male escutcheon were observed. Her body build and 
musculature were that of an athletic male (Figs. 11 & 12). Bib breasts 
were small and undeveloped, and her extremities were short due to early 
epiphyseal fusion. Pelvic examination revealed an enlarged clitoris and 
a small vagina and uterus. The ovaries were not palpable and no masses 
were noted elsewhere in the pelvis. Her blood pressure was within normal 
limits. No other unusual findings were noted. 

Routine urinalysis and her hemogram were within the normal 
range. A lateral x-ray of the skull showed a normal sella and a chest 


.o 


' p,iT (n) 


« ! 


d 


vj. 


o ■- j" ui •> 


•J. i.Vi 


, GU' 


eoo i to o o'? o,oo- t . :■/ J..’ - '-Oo' ! ' oo r o ; o-o oo-- : ... : o* •' - r ' ; 'o''t ' o^oo.'-s'ld 
notlod- , i./'v r ; v n. f -vxjii -o... : .o . o•.£' o: o" r =■■:■' f j revolt to 030 

... ' • ’ ;' ’ 


;'. ' l ■ O' " : *U ■ O / "T : . d 


, -‘0 { . '. -v ( ., 




too *oo ■. - oo.~ ' cr o ' f, "o tvo,o loto J-m 

. :.. ‘ o •. :v.x . J ■ : ........ o':) .o : ;,/ . oro ' v . > 


. f:O r V‘?Ui O'llB UfSt; 


crin 


. 

rblf/QUX - O' oo 1 : ooo , ootTOo<! t? tow ‘to • \ oo. :.t oiot*t;oq- . o joioilox'id' 
Ov' 'v .... . ■ voo : c - • or to J' o o t: ’ ■ oot , o ■ Lo o ( o .& 

; ( ■ £ XJ. . 'o', .. , .. 0 J / ■ ’ -0 , j ' o j- *1 OOJ«■ 

,£ ■ oj o; ;vo.:: ■.o' V o ooo ooo,; .'ofO , .o' o , •'■j’:- v ■ 0 / o : .Lio.oa ooetr 

y-xih 

. oioooo.ioo .tor: .. 0 oooovv ..so' .. root ,or him onoou-v toons o 

, ■ / O' ! , ■ ■ •. ri . i.iv : . ' : o: , ;• . £ . hi ■ 0 f.i - 


* 


oruol 'JjoH 


: oijx :.o .,j "to .. o oit r ou. 4 






DAYS 


Figure 13. 

Metabolic data on Miss C. ¥. #96690 
with Adrenogenital Syndrome to show the 
effects of methyl testosterone and cortisone. 

































89. 

x-ray was normal. An intravenous pyelogram showed depression of the 
left kidney to a position lower than normal. A 17-ketosteroid determina¬ 
tion performed on admission was 97 mgm. per twenty-four hours. 

(2) Procedure. 

following a six day control period methyl testosterone 
(40 mgm. per day) was administered for nine days, after which the 
patient received no therapy for three days. At the conclusion of this 
period, ocrtisone (100 mgm. per day) was administered for three, three day 
periods. The patient was observed for a further interval of six days 
before her discharge. Subsequent to leaving hospital, weekly determina¬ 
tions of 17-ketostsroids were performed for two months. Six months 
later in an attempt to induce menstruation and breast development a 
course of oral cortisone (25 mgm. b.i.d.) was begun. Her progress was 
followed by 17-ketosteroid determinations, which were performed over an 
interval of two months duration. 

(3) Results. 

a. The Effects of Methyl Testosterone and Cortisone on Electrolyte 
Metabolism (Fig. 13). 

(i) Sodium Balance. 

Methyl testosterone had no apprediable effect on the 
urinary sodium balance. However, during the first two periods on cortisone 
there was a slightly negative balance for the first three days following 
which a slightly positive balance was observed. This,was then folbwed i?y 
a pronounced diuresis of sodium, which persisted te a lesser degree for 
six days after cessation of therapy. The serum sodium values showed no 
significant alterations throughout the entire period of investigation. 


. ■ . ’ ’ ■ 

onr.o ;od" j c ' Vot; V;. ' -■ 

r-i'j T '/ J ' . . ■ l" o.c:V. .o r ;j ■ ; 

' 

■' , TO* * 

a ■ i l -■ \ 

: c''u : . 

. 

1 . « « ’ * . ■ 

II v T : VO h'^f'TX I’iTq .Cl 1 )'; J")‘' » rHOoJ'liV.OTH : ' ■ v ' 

- 


oJ-vlo i ..r:’o... X:.; ho ono^J:/":oO oo- -.ro • r -. .; -' i’.v. Vo •■ooo'j 

. 

. 

L: ' " vOOltB 

o; ,;.o' v ■. v. ooT-ij d'BTltt oo'.j To'i ■ orvJ'.v.' ■ov 'V o o.fi 1 

# 

- • o . 0.1 •: '> • .• . ‘ -m. ..' o ; . r r r*j..L r'V. ' c 

Of: V;ov0 •,';; :;,,J;.Lv 7 ojjVV'O ' otoo . o'.V • ■.:? 

lo J ■■ O 


, i‘ ; ? ■ 7, “'.- ' 

o o.t v-o'-ItV cKv-il 
:" . o. or.'' O’, .'J 

■ 

V o .\ir\f 

.. * a*) 

' 

; oaxd'Too , .boi *feq 

,5 

' 

' 

V -0. . C VtO O r;Hi 0 

o-VI vcf Jy-vfoSl cl 
; f O' V : V j •: ■ 

, r 

X 'o V: . ; 

.. '■ ' j -clooa 

. 

‘I. .1 o do : V 

ov. r . oo-j.THorroTq s\ 
:*do ‘ioj-T,; :r^h x.la 
\VJ. :• J a. • ^ 








Figure 14 * 

Metabolic data on Miss C. W. #96696 with 
Adrenogenital Syndrome showing the effects of 
Methyl Testosterone and Cortisone. 





































90. 


(ii) Chloride Balance* 

The urinary chloride balance closely followed the sodium 
balance in both magnitude and direction, except that there was a slightly 
negative balance of the element during the administration of methyl tes¬ 
tosterone. Cortisone at first increased the urinary excretion of chlor¬ 
ides, after which there was a slight retention of chlorides for three 
days. During the first period on cortisone a marked diuresis of chlor¬ 
ides occurred, which continued until therapy was discontinued. The serum 
chloride values were observed to be slightly lower during the administra¬ 
tion of cortisone, although the values remained within the normal limits. 

(iii) Potassium Balance. 

There was a slight retention of potassium during treat¬ 
ment with methyl testosterone and also during the first two periods of 
cortisone administration. This was followed by a slight diuresis of 
the element during the third period of cortisone therapy. Serum po¬ 
tassium levels showed no significant deviation from the normal through¬ 
out the study. 

b. The Effects of Methyl Testosterone and Cortisone on Urinary 
Nitrogen and Weight (Fig. 14) • 

During testosterone therapy a slightly positive urinary 
hitrogen balance was observed, but there was no corresponding weight gain. 
Cortisone administration, however, produced a marked diuresis of nitro¬ 
gen accompanied by a pronounced loss of weight. Following cessation of 
therapy, there was a gradual diminution in the urinary output of nitro¬ 
gen, although the patient remained in negative nitrogen balance until 
conclusion of the study. 




. • : ■ • .i‘w ’ 

r< x k.?< ■ ■ - ’ 

.; - , t ' ■ ' I ' < ' : ' ' J 

: --- - -'- - • '' 

* 

. . ■ . . ybtH ■ ' r. - , - i , « ' ii 


fi !'■: 


. •. ... ; ■■. j.v ■ • r • ' < ‘ :*x o n 3; ~ 

■ ' { • b v ' i 1 ‘ f 9 l in. 0 

; J W ,7 jrr>rVj i.0 lo :ic 

. ' ■>. ‘ : 

' 

■ o-..:- . 7 : - ott ■ j,- ,/ jichr/r &-:va 


.. 

snt > . ' . bk ^ - 

Lt/tom r -:*■' -J-/.:-' J - • • -V- rr L-*/:.!* rui'-.t-xd’ 

. 


. 

v j l < ' i { 

, v- '.v: ./r : , v :. mk; ■; 7 J :--.vv ‘ 7 0‘iJ'lxi 

r ■ • i ‘t < > >'iov \ o < • v : r / - onesJ j\. oJ 

• . •, h(oLlo% . : ■ it "■ >n o* ! 

... 0 \ ' - f Vco : c/.'-o i.:' - . r nx :■ -r: . .• 

ft . " v V/-'f:/ •• " i : ,v -'' i ? ■ ' 

. j 







AORENO-GENITAL ! 


METHYLTESTOSTERONE 
40 MG/24 HR. 


MG/24 HR. 





Figure 15. 

Adrenogenital Syndrome C. W. # 96696 . 

The effect of Methyl Testosterone and 
Cortisone on the urinary output of 17-ketosteroids 
and cortin, and on circulating eosinophil levels. 








































91 


c* The Effects of:Methyl Testosterone and Cortisone on the 

Urinary Excretion of 11-Oxysteroids (Cortin), 17-Ketosteroids 
and Circulating Eosinophil Levels (Fig. 15)* 

Cortin values were slightly lower during treatment with methyl 
testosterone, although they remained within the normal range. On corti¬ 
sone therapy, however, there was a rise in the cortin level from a pre¬ 
treatment mean of 1.02 mgm. per twenty-four hours to 2.44 mgm. per 
twenty-four hours. The urinary cortin output returned to pre-treatment 
levels following cessation of therapy. 

Methyl testosterone had relatively little effect on the urinary 
output of 17-ketosteroids. On the other hand cortisone therapy produced 
a dramatic decline in 17-ke to steroid output, from a mean pre-treatment 
level of 77.1 mgm. per twenty-four hours to a normal level of 11.9 mgm. 
per twenty-four hours at the termination of the experiment. Weekly de¬ 
terminations carried out following the conclusion of the study revealed 
that the 17-ketosteroids did not return to their pre-treatment level for 
sixty days. 

The eosinophil count showed no changes during testosterone 
therapy, but a prompt fall was observed following cortisone administra¬ 
tion. The level of circulating eosinophils remained depressed until ter¬ 
mination of the study. 

Menstruation and breast development, unlike that reported by- 
Wilkins et al (353), did not occur following a second course of oral 
cortisone therapy of two months duration. Minimal dosage, however, 
again resulted in a pronounced decrease in urinary output of 17-keto¬ 
steroids from 69*5 mgm. per twnety-four hours to 17.3 mgm. per twenty- 


0 


...... 

Vv'-'A odvd.-Yd , (.7 toj "H dc •!...■ j 7X7 0. JJ 'lu HC .U '•' " iyifd-7 J 

.. T : ■ -c-.c-: r )j 1 :o„•. 

- ■„ .i . rj i ' 1 r.J. . ■ - "* ’ K - 

;•!, ,-yp.HY\ 7 rr.l-H : . •' ■ ' - • r : .y 

- : D'll 31 ' .*£ ' l I : ' ®J*C 

*j;< q A,Y*:'; < .j' rv; ; .‘ y . ' . '-'0 a.y I J\t. r -V d ‘y r id 

.J ,t • n ■ V .' - 

„ 'j;o : o y^nr-cXCo! < 2 1 V J. 

i i'U. 

0 « 

j . ; ■ ' t tmllOi 

. • ' . . • 

- v.) -vfv;3;/r :: J :i\, ■■.J.io''d ,r y 

■ ; • Y, ' " • 

•jot. I:..v,: I d'l-u.J y/yy--. \ •. '..A • t Xu >■ j; aLiov.. XicX A-Vi -'A 

. 

L'no'icckao^r^J- ynJ-y.y u; yy ■. 33 vcv. . :> ro/co X hk : pnJ i*,o^ d.iiT 

>1 ■ i> v ! Ic • < a t '■ 

. ;r'< u " ■ . 'j..-.'. ■ : ' '07 .7 .V .'J 

. 

byj'ic .. . d iyr :/i j:.*-■"?;'■ , r r ‘ ■; .. o.i -yv : , . b -771 ■ 

1 . 7:0 ‘lc 7 7.7:77 :7:JOV :7 'i . ,f: ' I'.J.'.lsl O'J.iOOO 701 , 3 r j d,; j '' .'..id 

> 

.'7..L ",;o dj. j;;o .L v ,:. r j :.r - 3 ,/jM.on.o .beon. i ::vi 3 r:d oo,'yi ; 

.... - y , 










Figure 17. 

Adrenogenital Syndrome Miss C. ¥. # 96696 . 
Photographs shoving appearance of acne before and 
after Cortisone therapy. 







92. 


four hours, which rose to a level of 106.4 mgm. P®** twenty-four hours 
two weeks after cessation of therapy. 

d. Other Effects of Methyl Testosterone and Cortisone (Appendix 

III, Table 2). 

Therapy with methyl testosterone and cortisone produced no 
appreciable Alterations in the carbon dioxide combining power of the 
plasma, total serum proteins, or blood pressure (Fig. 13). However, 
there was a slight rise in the fasting blood sugar level, which rose from 
a pre-treatment mean of 82 mgm.$ to 91 mgm.$ during cortisone therapy. 
Similarly cortisone administration produced a leukocytosis and slightly 
elevated hematocrit values, which were accompanied by a drop in blood 
hemoglobin from a pre-treatment mean level of 15*4 gms. to 14*7 gms. 

Urine specific gravity and creatinine determinations were slightly 
elevated during cortisone therapy, while the urine volume was slightly 
decreased. 

A marked improvement of the patient’s acne was noted during 
cortisone therapy (Figs. 16 & 17). However, w.th the gradual rise in the 
17-ketosteroids after cessation of therapy the acne returned, although 
three months after discharge the severity of the condition was not as 
marked as before. 

(4$ Discussion. 

Cortisone administered to the untreated Addisonian patient 
consistently produces salt retention (345 )9 but when used in the pre¬ 
sence of other cortical hormones sodium diuresis may occur. The nega¬ 
tive sodium and chloride balances (Fig. 13) observed during cortisone 
therapy may be explained on this basis, since the patient exhibited no 


/ r . ■; ■ . ; . ‘>c ' ■ ' : ' ' ' 

. -j- ‘..c ■ XX. •- ' 

:,y 



. X : X X 

on o£|o-:ijJ''-c:o .onn mks 

cr j ;■(■ & ZO& J.\ X : :X X ■ VC ;i ; '■ •••' 

orl-X lo o- ; XX 

: • : X' ' ' X 

. v . , ( :i . 

:.x., .!' i ‘T.o »JMil X ' i ■ :: X tfou V.c 

r iy/1 occx floXX:: ’ •: x jj '. ' r : oS.\- 

XiiXX.xrXX oXX XX. oyX ..*■ 

• 

.V ( • ■ ’. ' • . X r.i X • ' 

• v.LGTi; •j:.. r .x .o'£.; aXocu .oc.: ; . r r X /;• Xoojj 


.bool’i! ill co~::o x; ec-x x/vx. xrxox 

■ *1 . f ; :oi ■ v ed"‘i v ■>/ 1 ;v It* 

iV. 

' ■ J ■ j \ X >i ll 

\;XX. 1 ■, \ .'yr.XX ill; 1 . • 


v. r .ill r.X Sijvr o; Xy;; yyX 

XX ... , , v; X' ; ■ ■ ■ X ' ' J >">/ j • 


. r ' ■ > ' ■ . ■ " ■ ■ : 

- .'.X xo ore:;. A . 

©xlu :X: ;i b . r ■orXr XXX /XvVv'; 


X >ic i X ■' f . ooirx/X ■/ yo • ' X ’ 

X,, rroiX ■.'■ XX: XoV';:X’Xr.X,';X--?X 

;•< •• X'Ofi nolo'j OuC‘J Xc vd 

,X;r. v:i.-j.:X X' ,t ;x:Jnox r X 


- : ' ' ) 

X :: X: X - * ■: • X ;■:c X • ’;A i:> 1 ■ ■■-iX • u.r 

v. =XX C-X ;X;-tvXX :X:i.X,.X i ■ J..X -foO 

- : .. j - X •>;>■'; ■ i " l: . ■ r „ YX-. 

. ^ • 1 1 ' ■ ■ 0 

• 

: : X . ' -:o •, i ' ■ 

t o'.: y -■ nei- v' texe-roe m: y'.lo X. :> 

- 

on o’ • ,X . X> v v.’<... \_XX 

. ■ X.) or: '.X. •- ' ; ; X •. . »;■: 1 • : ".. ■■ - v.‘ 

a hell- 'XX'.cv: X: .XX ©prii;-; 

., . X -; x i •’ Xi Id’ ' «■ > i j . X 'X r" r.- '■.. i' 





93 


Addisonian symtoms or evidence of extreme sodium loss during the con¬ 
trol interval. Presumably her endogenous production of DQCA-like hor¬ 
mones was sufficient to cause diuresis of sodium and chlorides when 
cortisone was administered. 

The diuresis of potassium and nitrogen (Fig. 14) observed dur¬ 
ing cortisone therapy in this case has been observed by other workers.dur¬ 
ing therapy with methyl testosterone. However, potassium retention was 
greater than the retention of nitrogen observed. The opposite was the 
case during cortisone administration, as the nitrogen excretion was 
considerably greater than the small loss of potassium observed at the 
same time. The reason for this lack of parallelism is not completely 
understood, but in the case of the latter phenomenon is probably a re¬ 
flection of the anti-anabolic effect of the ”S” hormones on ingested 
rather than endogenous protein. Catabolism of endogenous protein re¬ 
sults in release of the intracellular potassium and its loss in the 
•urine is accompanied by a diuresis of nitrogen. On the other hand no 
potassium is released as a result of conversion of amino acids into car¬ 
bohydrate, but the de-amination of these substances also results in an 
increased urinary nitrogen excretion. The observed findings are congru¬ 
ous with this hypothesis. 

The apparently anomalous production of a weight gain coincident 
with a severe diuresis of nitrogen (Fig. 14) may be explained when it is 
noted that there was slight retention of water during the cortisone period 
(Appendix III, Table 2 ), On cessation of therapy the retained water was 
lost rapidly resulting in the weight loss which occurred during the pro¬ 
gressive diminution of nitrogen loss. 


■ 


-o '~i j ■ ie ‘ ' ooob , ub o • ' Ofo‘ebc. Mb • e0i.r".- ■ o ' o\. o b - ;j - ;; •-• ,i: - 1 

~%od .1 . - : t<) i )I & i i . . X • ■ ’ ■ 

rU'ih: 300x3cob !'o .a r• i,. : Jo.eo 1> •- • - ; : - 

. •‘■ ; ‘ ' T'' 

> £)SV ’,cf< . ■ c i £Ji iawwlh 

.. . ■ ' ts . ' 

no l&i J ' ' ' a .... - ' v ©H . ■ ' ■ - J 

Of." j 3 to cdbo c- 1 o or.o.’ , o-v -.;oo ' ob o'b f o it v v.:.;o. c-v :o on. 

8T0 field'- - i'..oo. 1 '.oo"!:..o - oo' ; ... x r: ‘ - 'o:b .*r ' ~ J "’ Tf '3 00 ...o..o..; o.;o. o 

9 li.J u i OOVXOBOO I. /•..- d'CO IO \ . 0 .- • 3 - 

\InJ- -.r.rroo boo :..I: looijbb.x o:- .q be ; o. .1 o,o o c 

o . i ' 

■ ■ . ■ ; ■ G ' ■ - 

ooo/: o: '.o i ' ■ • d' 0 . o • •' <• L '0 • ' :u: : ' /i 

f- ; .'■ ;b '.O. r . b '-O ' bb • :v>'3'Ovl ■ b -OO o3 ' OJ 0... 0-', 

. ' 

-''f/'-o 0.1 iii obiobo o/oob '10 nclfrisvnoo ‘jo IIrae'X. b r;s .bo8.ox J.ox uis;s- 
c^o f cr Iji-'0:9/ ObJb; roo- .:0;./r ooobb- io boob ixboo-o o e.u, box:; o-fo.. :n©n 
.0*'E (o: . j iC ■ r ' : 


‘O'- o' 3;j.uj:- r ud*X8fiOO 

. 


„ ■.. . C" - 

:■ nor.lor! oo oi * dof eloo o do ro: .id':> 0 'eijoi-x cno xoLl o. ;_.o 




; eroo..:,-;-To:/' 3 : ,o , _,;:.oo j ;0 o.-doo Mo :x ./dood'., 1 :: d'.o ' o.o . it j -Ad ixoroo 

... . ■ ■ * (St 0 .i - 

.-.f ■-/o; k-x* '//o oo .'lOX/iv poo.'.. /.I'fio-xo'v/' o.iX' i-x: ' ;.iAi :ol.:'3co'; Yo.Oxoox; jr c>J 

1 

. , c fi r ' '.: ,o.:r:.3 x .. 1 . v ' 3 v ‘ ■ 


94. 


The most striking feature in this case was the prompt and 
prolonged decrease in 17-ketosteroid excretion (Fig, 15) which was 
accompanied by a marked improvement in the patient 1 s acne (Figs. 16 & 

17). Apparently methyl testosterone does not produce the same adrenal 
response in the adrenogenital syndrom© as it does in Cushing* s syndrome 
(123) • In the latter it usually depresses the 17-ke to steroids and also 
the excretion of corticoids. In the former it failed to depress the 
excretion of 17-ketosteroids and has only a slight depressant effect on 
the corticoid excretion. 

The eosinophil response observed in this case was characteris¬ 
tic and was similar to observations made by other workers (152). In¬ 
creased fasting blood sugar (147)(173) and serum, protein ( 52 )(147) have 
been observed to occur following cortisone therapy. 

From this data it is concluded that these results are probably 
due to an indirect effect on an abnormal gland mediated through control 
of the anterior pituitary and regulation of ACTH production. 

(5) Summaiy. 

The effects of methyl testosterone and cortisone in a ease of 
adrenogenital syndrome oecuring in a pre-pubertal female are described. 

Methyl testosterone resulted in a slight decrease in the urinary 
output of corticoids, a slightly negative chloride balance and a greater 
retention of potassium than of nitrogen. 

Cortisone produced increased urinary corticoid excretion and 
a prompt and prolonged decrease in 17-ketosteroid output, which was accom¬ 
panied by clinical improvement in the patient*s acne. A fall in circula¬ 
ting eosinophils and a greater diuresis of nitrogen than potassium occurred 


•,< 3 u fiii 


• 1 < \ o J • . v; L ./ *c .. ".1 ; J' 


{ - . : > • ■ ■ ’ n - 


v 0.: . • T o : 0;ib " ' ' . o . ' o'o v. 00 : 

y : ■; ■. ? •: ■■ ODO.& 

bobi ■ r /.. , • v. :toj: o o ■ :oo • .■ b v ■ ■ 

■ . 


■ ' . oh . ; ■ re . ' =?/a ' v 


; d rid . . - 

« 

'Ob i . i . ‘ ■ 

■:r:;r .'...o rrcJ:d 'tj :a odd' 

CIO dosll.v ;o -.■*£ ob Jobo.l.o:: ' vXoo o ,b ■ 

r .7 :■ j" 

. f'U, 

-GX‘X0.7-‘:yr";Jt; oo o.o odd b. r :» / • "'O ov; r v ' 

'A on f : o 

-■ill . { ;•. b ■ ' cc : . .: o '• . ;: 

■ *r sXl i;i ha ; old* 

ov-id (bbl) (be) ui: J'to . jjtoo dno (-'.’VI) (Y*.f.) t ■ o 

. :,co i. ; .<■ ; V'c "a -:o 

• 

o,i rfo :'nod 

-■rS.drkv::^ oto 'obiiur: o: >j ..•/ b obb ■ obo, L--jrco-> _ :i • > 

i :>> ' i. :.■/ . ' ■ r''! 

td'0oo d-\. Id . * ■ ■ id« 

‘ ■ . ' $ Go 


. ..< V .> r do ; ■: ' i r do ■. j b ‘ J J: ; ioo O": ■ --i 

. . (,•';) 

■ ! n ' ( ' : 


. 'i i •. ;• d -J : ■> i. /■.-/•.c ; ; ■: i ': .-v o 

</T .-;i; J’ \a '‘1 r'> 


od h-.il 

■ J ! 1. . ) V 'J ■ ' '.A'.'. 

, . I: 


J "J i ; b 1 

oio /rob j-yzo :bbco~ ooxe o ;i od ojj boa/oocoob b. -or o'l ■ o/icooboob 


svr j I ■ - ' : A ' : ■: j c u :■ . I b 

bo; 1 - -i./'i , • ,'o:; o-orrcroq -> 

■Jj/O'.:> d,:'! dd' ri h 


...t ■) v-o-: t v.'.J' a- ;;.o'u;irr d.c ■d:'■ • i :■ 

:: Oil '.o:"G'i.o:oo ;;.n ’b‘ 






Figure 18* 

Adrenogenital Syndrome R. C. #99205• 
Photograph showing male body build and muscu¬ 
lature « 







95. 


following cortisone therapy. An attempt is made to explain the latter 
effect, and the diuresis of sodium and chlorides observed is discussed. 

It is concluded that the adrenal gland is abnormal in the 
adrenogenital syndrome, and that the observed responses are due to an 
indirect action of cortisone on such glands mediated by the anterior 
pituitary. 

(c) The Effects of ACTE in the Adrenogenital Syndrome. 

(1) Introduction. 

It was concluded from the data obtained in the previous in¬ 
vestigation that the depression of 17-ketosteroid excretion was due to 
an indirect effect of cortisone on an abnormal gland. To test this 
hypothesis and to gain more information concerning the mechanism respon¬ 
sible for the depression of the 17-ke to steroid output, it was of interest 
to determine the effects of ACTE in a patient with the adrenogenital 
syndrome. 

(2) CassHistory #99205. 

The patient, Mr. R. G., age 8, was a pseudohermaphrodite bom 
witk congenital hypospadias for which considerable plastic surgery had 
been done to carry the urethra forward to the tip of the glans. Rapid 
growth, abnormal presence of abundant pubic hair and precocious mental 
development caused the parents concern, and at the age of seven a 
laparotomy was performed. It was thought at this time that a mass could 
be felt in the region of the adrenals. Although otherwise healthy, the 
patient was unaware of the reason for his hospitalization and investigation. 

On physical examination the patient weighed 36 kgms. and was 
noted to have the body build and musculature of a male (Fig. 18). The 





i'l OS 


■ 


;.) &fK 







. 






»'“ " ‘ • ' • ' O 


o no o 


■V 




IX ' CKO 




'[ 0 


■ ' 




I :- [J s ' - 




' 


" -V 9 ) :):l !' 'f ' I 




■ 




0 ii !' ons, 







;)jii vxr’iV o'' os.o'O-)!. J. r •:" t: o iio'yjioc■. ?o.;qovj : ! IQ^hiir-'irtoo rtf'.'j 
. . . r... :)i rl •'•o' ’ • rj l’r' ; ocr oejcO ci000 r 

r ...... .... | - , / ; 0 0 r ' / r ■ \ " I) O'"' ' r ' ' ' ' r * . X ' ' ' 

•’ - v-x • ■.; J " : L > , ;vxooooo otro o.r v .o?d - ;rr:: : -r; j' r i::;i'i:"oX.0. r/, S 





-3.. 


. 


".[( 











• ■ . j._ -.O'/ 


‘X O.J I J- 10 ox 


r ■ "i: r 


O' 


10 


9 L-zoi 


;r{' rrO 




‘ip 




j.. r -. 


©v.a d 3) ■ 










Figure 19• Adrenogenital Syndrome R. C. 
#99205. Photograph showing male phallds and 
female distribution of pubic hair. 



Figure 20. Metabolic data on R. G. #99205, 
with Adrenogenital Syndrome to show the effects of 
Methyl Testosterone and ACTS. 



































96. 

larynx was enlarged and his voice was deep, not unlike that of a fifteen 
year old boy. Axillary hair was present in fair quantity, and the 
pubic hair was female in distribution (Fig. 19). Pelvic examination re¬ 
vealed an enlarged phallus which bore evidence of considerable plastic 
surgery. The urethra opened on the under side near the glans. The 
scrotum was empty and the testes were not palpated. No masses were noted 
in the pelvis or abdomen. The blood pressure was within normal limits, 
and no other unusual findings were noted. 

Routine urinalysis and the hemogram were normal. No intra¬ 
venous pyelogram was done, and a chest' x-ray revealed no abnormality. 
However, x-rays of the wrist, knee and ankle showed a bone age of about 
fifteen years. Psychometric studies revealed that the patient was of 
bright normal intelligence. On admission the 17-ketosteroids 42.5 

mgm. per twenty-four hours. 

(3) Procedure. 

Methyl testosterone (40 mgm. per day) was administered for six 
days, following an initial control period of the same length of time. 
After an interval of six days without any therapy, ACTH (25 mgm. b.i.d.) 
was given for two, three day periods, and on cessation of therapy the 
patient was observed for an additional six days. 

(4) Results. 

a. The Effects of ACTH and Methyl Testosterone on Electrolyte 
Metabolism. 

(i) Sodium, Balance (Fig. 20). 

No change in the sodium balance was noted following the 
administration of methyl testosterone, and a very slight negative balance 



oooj! y.%. o 10 ■ > v.l [ ' ' Sj3,3 ■yo r ; o'ooii 0.133 iiioY io :'' ‘ ;, o. 'oo: orrqi 




f- io n 

or ' . 

1 ' 




• 7 

'• T 

‘ 



• tOOO OtOOOO 

£ ' • 

. 


) r -v 

‘ 








ii : . oO, ■ i :oj i< c ;.-. ■; : 

' 





0 



■ ■ 


« 









- 


- r :o 

O'.-:/: 

' ■ OiOl 33. ;■ j.- 

;j o'.: 

. 







• : jj.o 

•; o 


; ..i . . .. '.oo 




iq •■( 



o 

c bii ‘IO Oo 



l 







■ 





on 

hu3 


. > 

£ »i •;[(. 

il : ‘ JOVr r i v : 






’ 





. r' : 


o. —/' o • 




- ■ '• 




:o;j- 

'i-jrv 


(.> '• i .• :r • o 








■ ',0 J’,:.-:: 



0 


. 

BC| Bit 

j O J O' 




oioo 


. 





. ' ... W . 


■ ! J'J.— ; '.1. '. 




. r 




T f ; 









• 


• .'foi-. firry 


• 











. 

.:) 



■ 

no 1 : jJT' J' ; ;i 


3 3'./ (^30 • 


. r 

■■ Cl) 

JJO'O 


■ v ;• i .oil n 





. 

. 

ii.es • orii io 

30 


tC.LJ 

"0 ll 


f. j i 

. : 



. ' . . ! 

) HTJ 

3 » jo rvi 





"i ■- 




yij oqyrooi' 

lo ao.iu 33000 cto 


, 

00c 0130 

v:;-j. 


. C ’ ■ ■ " 


■ 

px ~ 




. .O'vlb ' 


5 :i ' ■ 

. 

V V 3 1 , ’ 

■r •: 

: J 

o oq 










. 





oi^Xo c i^DoI:j 

ao .'.j 

;yu j'oo tfvoT 



Lo; ■ 1 


' 












. 

J. o .i ■ .«j../ i i 






















. (0 

. 

00.3.f ‘ 

io,;. 

. 3.00 ooi ( i ) 





, ’ :■■■•■:*■ r r o ■ ■ oo < ‘ •" - J ; ■ 

o-v-.ol ;:J cYLjoovof ii ii. ■ ytoyo : -T‘ . .: uro i odr oiroJ oo jo o; : ' j‘ 



97. 

was observed during ACTH administration. The serum sodium levels re¬ 
mained within normal limits throughout the investigation, except for the 
very low normal level which accompanied the slight diuresis of sodium 
during ACTH therapy. 

(ii) Chloride Balance (Fig. 2C). 

There was a slightly negative chloride balance observed 
during the intial control period. Methyl testosterone produced a very 
slight retention of chlorides during the first period, and a slightly 
negative balance in the second period of therapy, which persisted through¬ 
out the second control interval. ACTH produced a more marked negative 
balance than had been observed during the proceeding control period, 
and following the cessation of therapy the diuresis of chlorides per¬ 
sisted for three days. No changes of significance were observed in. the 
serum chloride levels. 

(iii) Potassium Balance (Fig. 20). 

Methyl testosterone administration caused a fairly marked 
retention of potassium in this patient, which persisted to a slight ex¬ 
tent throughout the second control period. There was a slight retention 
of the element during ACTH administration, which was less marked during 
the six days f o 111 wing the cessation of therapy. Serum potassium values 
remained remarkably constant throughout the study at a mean value of 4*76 
meq./l. (S.D.i 0.48) 

b. The Effects of ACTH and Methyl Testosterone on Weight and Ni¬ 
trogen Balance (Fig. 21). 

There was no weight gain (Appendix III, Table 3) con¬ 
comitant with the retention of nitrogen, which resulted during methyl 


,'0 




t* • 




J/JOO IK? 


5llo 


: - r .’■/ J. .!. unon VOl '\” [•; 

. ■ 7 r / . J J.. ' \ rL. 

oo ; -I iCi .IvoiiiD (il) 


•’) ■> i./..,./ 


vT/a/io eon •. 


00 o': o 
- : , 


Oil.' V 0 J UvT 1 C 91 t J ; ,a_L' 

c .11» *'lo no.*;! rc J' J/d; . 


lo UOI'IOO 


j.i.t 


i.l j. 1.0 •• J* j 


■ J / 


j :oo .it o ?, 'i 
:;ci >i i ri. "iij o on 


: c< 


o r>- 


> Il» . ) 


>on ' i 5 lo "" n uiD <>11 . T7 o»* 


j ;/' ' 1 n s.J /si 




j. :; , a . •. i • ; 

> ; ■.I.. /T J- oJ- ; j 


jl'JL CV -Ui CT 


; //or 


c; . o : 7. ‘ f o 


1 i i , . > c: * ■ ■ i >■ o 




:. l ’j 


b/ofn 


: , t < j T ‘ 


:;> .id ml cl.. 


to :.v 


. 


lit 




: j./ j: }•*’ no 


Ou • 7 .i. ■- / 10 - : .7/ ' xl.i-'J i i.lO cio ■> X ■ 

. 


tt> ( cl i IT , 


’C HI 0 .j 


oc / ■ : 


: JJ.O\ 


.10 ric.j.o 0:1 *c ; i:J : . 


o i /. j oo 





















R C 99205 
ADRENOGENITAL 
SYNDROME 


M. T 

40 MG.Q.D. 


ACTH 

25 MG. 

B.l. D. 






3 6 9 12 15 18 21 24 27 30 

DAYS 


Figure 21. Metabolic data on R. C. #99205 
Adrenogenital Syndrome to show effect of Methyl Testos¬ 
terone and ACTH. 


R C. 9 9 2 0 5 

adrenogenital 

SYNDROME 

M. TEST. 
40 MG. Q.Q 


ACTH 

25 MG. B.I.D. 

CELLS / CU. MM. 




400. 

20 0. 

N. \ 

f \ 



0 . 

EOSINOPHIL COUNT 


MGM. /2 
1.50. 
1.2 5 
1.00 
.75 


.50 


- -xSZZ ZZZZZ^^ZZZzzzi 



Figure 22. Adrenogenital Syndrome R. C. #99205. 
Chart showing effects of Methyl Testosterone on the urinary 
output of 17-ketosteroid and cortin, and on the circulating 
eosinophil level. 





























































98 


testosterone therapy. ACTH administration produced no change in the 
nitrogen balance, which had gradually returned to normal during the 
second control period. 

c. The Effects of Methyl Testosterone and ACTH on the Urinary Ex¬ 

cretion of Corticoids and 17-Ketosteroids and the Circulating 
Eosinophils (Fig. 22). 

The urinary excretion of 17-ketosteroids was slightly de¬ 
pressed following the administration of testosterone, and showed only a 
small rise during the last three days of ACTE therapy. The cortin output, 
however, declined progressively during the control and was most markedly 
depressed during the last three days on testosterone. On cessation of 
therapy the depression of urinary corticoid excretion pernsted and showed 
but a slight rise during the last period of ACTH administration. 

There was no pronounced drop in the eosinophil level through¬ 
out the investigation. 

d. Other Effects of Methyl Testosterone and ACTH (Appendix III, 

Table 3 ). 

No marked changes were observed in urine volume, specific 
gravity or creatinine excretion, but there was a slight rise in blood 
pressure from a pre-treatment mean of 101/69 to 112/75 during ACTE ad¬ 
ministration. No clinical changes were observed. 

(5) Discussion. 

Throughout the study the patient co-operated well in collect¬ 
ing the specimens. However, it was noted that the volume of the last 
specimen of the fifth urine pool (115 c.c.) was much lower than those 
previously recorded (530 c.c.). A urine creatinine wasCperformed end 





'£i ■- 

,III -d 

5acJ' : ' 

d ; 


. e 

•; ) r ■ id .■Ti; ' - . 

x.-rri.;,n tv :■ :r : 5?-i v.Ll :>ii )>5'X ' > d ■ r '> • -- ■ ' 

' 

. . ' ' . ) 1 . 

: •: 3 : r: •;' : . c/y -V " d, a, di 

. 

! ’ ' ' '• 

,do - e • - dd ■■:v;d d >' r :;rr.‘ dn-i ( 

■ 

' ' r iK ‘ k I ■ ' : n > t 

i. HT ' - 

: y y ' d ' d d . v. d d;-. ■-.c \ o- • .■ ' : rd: 

. •" ■ : •• : v ■ • id re 

; *■■■■■. d - - ■ ■' " d • . 

. ( 

;' ; i, 

' • , dr . ' 

- ' : ' ' ■ • • 

d ■■■■■'; r ,f ' ■ ' dd, c : ' -'■/ r 

1 . d'd 

; ' v-c-oo -;q miS : : r jd djodJK/ddT 

' d t ' ' t . ■ ol * - 3 ' / 

I 

. « 

■ ! i: diddi'dio ' eerf A d . - L'tr) dd/rowr vJrroivr-xq 


99 


confirmed the suspicion that the collection was incomplete. Unfortun¬ 
ately prior to completion of this test the three day pool had been 
mixed preparatory to starting various biochemical procedures. On 
questioning, the patient revealed that he had had difficulty voiding so 
had not completely emptied his bladder. Fortunately the next twenty- 
four hour collection was found to have a much greater volume (910 c.c.) 
than normal, and when calculated the mean of the two collections (512 
c.c.) was approximately equal to the average daily output usually ob¬ 
served. On this basis it was decided to report the mean daily on cor- 
tin and 17-ketosteroid values for a six day interval, whereas electro¬ 
lyte studies were reported as the mean daily values for a two and a 
four day pool respectively. 

It was necessary to re-check several electrolyte determinations, 
as there was some suggestion that an error had been made. In each case 
where this was done (periods 1 and 3), frozen specimens were used 
(Appendix I), and the values obtained therefrom reported. As only one 
of the electrolyte figures was in doubt in each case, the remaining values 
served as checks on the accuracy of the repeated determinations. In both 
cases such checks were within the range of error for the methods used. 

Apparently methyl testosterone has no appreciable effect on 
electrolyte balance (Fig. 20) except in the case of potassium, which was 
retained along with nitrogen during testosterone therapy. This data sug¬ 
gests that the retained potassium was utilized for protein anabolism, 
because the potassium did not remain extracellular* as evidenced by the un¬ 
changed serum potassium level. That no concomitant weight gain occurred 
is unexplained. 


* o and-' . i' x;oo o'! 'tolnc "/X-~ t ■*. 

. :"v; - : .•/ ' • : -0:.■; ; r - -,y ' : .i ' ;*'V vi':OlO',o‘rC' 

- r : : ' o r i.. ; v'■ . I - • j. ' v-‘s do JJ ••••• yd ,yl y dd t; ; 

■■■■ <-■ •: rr : . ' • j" ’ ' : : :.>d - (. 0 O 1 ' "■ 

,o OJ J\1 > *ixi 

■> ■ ' . ' • • • . . : ' Si - 



-GO 


...... - f 







.1. 

•;r 


■ 



. ' . ■ 


■•-■100 

n. ■ 




’ 





V , -■ ' 

j 

■ " ' d' nf) 


; 














vd-V. 


1 rts. i 


• 












1 ?'i 

' 

■ 















• . ; ‘ 


^;>I) 



: ;r y 



- 

' ' 







* ■ • 






T) 

; 10 H 0 



'dr'’ 







>' ; u 


■ 










• , , r 



. (X. X 

.;.ool ; 


Of f".’- d 



-.'■so! h; 





* 






0 ryoMe 



% 

j: 



■ f 

' 




, O ■; ' 

: ;• ■> V 


&■: 

' 




.■'fvijoa 

.‘in l';-d 'lo; 

'0"0 

l ru 

■ 






> orr 



•V • 



; ion do . 


•v ; 


4 

x; " 

c.-i 



0:0 ■■ 


■ ' 0 



‘ 

’ ■ . 


00 do d 



> 

VK' 




■ 


' 

O 



X 

yhy 

'! J O.A. 










" ■ : 



i. t/O-'K" 

. 

r:) 


dyxUyiJ 




‘ •;' 

* 

■ 



c 

0 d. 

,j . :' J : XX > 






. :•’ f 




■ 







; • . ffii ' . 

• ) 

non$ 


0 07 't 


■-'•3 


■vit 






1 /Xdoo 

■/ r, abwi'i 

.tort hi 

y r.ir 

: : ' 




. 

, ■ i 




100 


The depression of 17-ketosteroids following testosterone was 
veiy slight when compared to the initial values observed during the con¬ 
trol, and may possibly be attributable to the daily fluctuations ob¬ 
served in such determinations (232). 

The apparent depression of corticoid excretion, which was ob¬ 
served following the use of methyl testosterone, is open to question. 

It is suggested that this depression was a continuation of the progressive 
decline which occurred during the control interval prior to the use of 
testosterone. Further studies are necessary to confirm this finding. 

The effects of ACTH observed suggest that the dosage employed 
(152)(356) was inadequate in this case. Circulating eosinophil levels, 
which are used to indicate the adequacy of dosage, failed to drop during 
ACTH therapy (Fig. 22), and the urinary corticoid excretion, although 
slightly increased abov# the pre-ACTE control level, never exceeded the 
maximal excretion observed during the initial control period. Similarly 
the urinary output of 17-ketosteroids (Fig. 22) during therapy with ACTH 
never exceeded the highest level observed during the first control period. 
This data suggests that the adrenals were never sufficiently stimulated 
to produce the rise in corticoid excretion, and the drop in eosinophils 
usually observed following ACTE administration (147) (188) (206) (327) • 

Although minimal, some electrolyte changes were observed in this 
case. Sodium diuresis (Fig. 20), although not exceeding that observed 
during the first control period, did occur and was paralleled by a nega¬ 
tive chloride balance. The cortin values obtained during ACTH therapy 
suggest that there was little !, S M hormone activity, however, apparently 
sufficient was available to produce a slight diuresis of sodium and 


t ■■ -r j '■ T h o'": ■:' ■ i.o rr ■■ T -o; —V [ : : r •“rcpb *m IT 

"too : V • ” ' Y.-ri :v .by ' V/ -by • r • •; - ;j -f-y r:y j ■ : -y.v 

—' •'<roborb .. b y.':> yb1 ...,t y l:T T ''Jr,.-: j ■ ' -; - -" .or t yy :r - .boob 

. (bbb) io.' vis v bob rb.ur: ri;' bov-ioa 
• * ' ! . ■ 

." !• r - - ■; . - . b ■; j; b riy •: obob o v - •; 

■ : b • •> • • v • .. • ' "• '■ L b -by •.! by 

id - ' b ' ■ ni - b ■ 


. ' • ; 

. C O ( ■: :■;[ . 

1 £ '• > r 1 

y-ub.: 


or-"J- •:y,t .-d* 

i 


>:!'o y'b". 'by. .b 


odf 


■ 



' 


(j 1 ,} ( ) 

• '('‘b; Ov ib.;. •' 

* . ' 



i u 

yrr doi/or 

u ■ ' ' ' • ■ 


'f -injB t ( 

• 


J bbTO". 

-;nv • 

, ' r r 'j royr r-o bT , 

• ■ 



' ,. .'. bo 

. ■. 

*! v . . 0 ... ■ i. J . . i' f - b 1 :. .j' ■ 

- 

b 

,fv.- 

- ' .[ojulzzr: 


• 

: - v ;cr -b'b' :• 

■ 


•y.b: :{& 


r b' y'/.r.■ v-r-v-: r - 

■ 


bo .bo' 

- •) ■: ■ -lovon 

' 

^ .'--I rvv: il 

-. ■ : j y y : ‘ 


' y 

1 

Tb r r i ;r y rr.c . .orb' 

. . ' ' - ) ' 

' j i co.l : ■ ■ 

o: ,r 


yoijoorq- cJ' 


- . 0 ( , tos ' Lari ■ IT X.. ' n 1 oil '' ;cf< x u s 

' ■ ' r 1 1 > • : v ,Ty;-'.I. : r :cr . X---. by.' - n yrbbb.l ■ 

i' orb : - ( ' . • ; ' r- ; , y o 

' ’ b • bb v.: ,-r v ■ boo y.r..yo bbb, ‘cbry;; .b/ yrbb y.bb yi/ or ■ 

' , - — ■■ ■ : . • 

■ ■ ' - . r 1 ' r' ' o • ■ :: : UT il .. s vi . ... J ' : . ■ • : 

' b ' ' . ■ : Y'j a?; 


101 


chloride when acting with endogenous DOGA (345)* Had there been no 
electrolyte regulating hormone produced by the cortex of the adrenals 
as in Addison*s disease, there would have been sodium retention (345), 
although such retention has been reported t> occur in normal individuals 
during ACTE therapy (147)(188)• 

The effects on potassium and nitrogen were unusual, but similar 
to those reported by Bartter et al (357) . Retention of potassium was 
observed instead of the diuresis which usually occurs (147) (188)(189) 
and no nitrogen loss was noted♦ Although these abnormal responses pro¬ 
bably were due to inadequate dosage, it is possible that the adrenal 
glands were abnormal and responded in an unusual way to minimal stimu¬ 
lation with AGTH. Indeed Bartter et al (357) have recently described 
abnormal responses to ACTE therapy in a case of adrenogenital syndrome. 
That no increase in the cortin output was observed suggested to these 
workers that ACTE in this syndrome had failed to stimulate the production 
of the n S M hormone. Eosinophil studies performed by them during ACTE 
therapy showed a slight but transitory drop following which the level 
returned to normal. Such a decrease would have been missed in the pre¬ 
sent study as the eosinophil counts were performed only on the second day 
of each three day period. Bartter*s study (357), however, differed sig¬ 
nificantly from this one in that he observed a rise in the already 
elevated 17-ketosteroid levels. Failure to observe this is perhaps the 
strongest evidence in favor of the thesis that the ACTH dosage was in¬ 
adequate. With this in mind it is hoped in the future to establish the 
minimal dosage level of ACTE which will produce definite evidence of 







. 






0 

! too:T meriu mil 

. 

v-'j AdOCii ujotio; 


Lid 


: [-j:.hr 

' 

• 

co : : 



id- : O”>o.r.f <v 

ono^rtoii 

•rrj ■ _ '/ • ' - 



.} 

rn d * 1 ' 


: • 



■ 



' 

i ’ 

lorci; 1 oi-oo ; 



cj v. >.J- 

.1.0 'A 




•jjja 








« 

)(Y 

.M) '.qo.rio.! 


w - Y 

r i ■ ■ 


: 

/v to 


'■ 




i: ■ Jo •; *io no id . 

. 

: ) 



; ; X ' ■ 


3 HU id •;)• 

{':.'.'-rl).(;Ki)(V.,U) 'r;. 

: > 'h 



’. 

’ - • jj 


. It 


irovHoad 0 

-OHq 

. . 


; ■.. I 



* 


r mol a 

■ 1 : 

• 0 : has, 

1 

113.5 Cold / 

I 

r o* 


' d, —' • 


' 

■ 0 : 

■ ■ql.-.i 

-IP-.M j r. 



. 'JJ < 

■ 


*101/3 • 


• • ' i •••• 0 


: : 

, )Q< / : 

)30 ;L.;Vi •• -r 


. 

,Y V'.) I 

0 j' 


' )0 

, 



. • 

;o J. Jj .'coc-orr »*i 

ro '5 

0 



•: j ' J 


A of Oo'.;n: 


■ £1 £ ' 

; •; [3 

of nod 


: 

r . 

.' c J ijo' 


s' 0 

. # LI 

■ 

: J Air 

IQXtOli xv 

1 :q 30/ ndoJjfjiij-d 

, < 

of 


0,3 3,0'’ 



rid- rO- 


OTO'lHOVr 

■ . 

j/uoiro noild 


I ': 

• ’ : ' ■) 

d • 3' ; 

.f.jrf 0 




: -:!■)■ . 0 


odd ';io.nio ' od 

( 

(...o’ 


•; oJ ' :t 



1 

bmwdx 

v" j; IJ' 



>5 • 

V.! 

Jl; 

\ ■: 

j • 


, 

dofro/doH 


- .1 . , V \ . 1 j'H ' 



y, 'u v-: 

■i ■(> O 'i'; ii.L f f\C< ..It , O' 


: It r -.. - : i . J r 

■/ oooodo OQ-. 

■. / ’ v . .; .- . >■. 

-• y.-'d 

; y.: 3 'vv;o,'j .iL’. i' 

t Hid j JJ Id 3; 

0 -iOV. 

- 


•:J cioo ot y.vjtif-l odt (d h ■■ori fl urdoi rJ: ■ trlt ntJJ' ,.'t mpoh 

'.to •- • norr-.o t. Urn /iol'ih-/ Ii»CU 


V ?I 9 ; V ‘ ; > ■, 



102 


adrenal stimulation, at which time this study will be repeated to deter¬ 
mine more definitely whether or not the adrenal cortex is normal in this 
syndrome. The possibility still exists that ACTH of a special type may 
result in a selective over production of the n N n hormone, which produces 
the symptoms characteristic of the adrenogenital syndrome. 

(6) Summary. 

A case of adrenogenital syndrome which responded in an ab¬ 
normal manner to ACTH administration is described. There was very slight 
increase in the urinary output of sodium and chloride, a retention of 
potassium, and no loss of nitrogen or weight. Urinary excretion of cortin 
and 17-ketosteroids w r as very slightly elevated, but the circulating eo¬ 
sinophil levels remained, unchanged. The probability that inadequate ACTH 
dosage produced the above results is discussed. 

Methyl testosterone administration in this case resulted in a 
retention of urinary nitrogen and potassium, and a slight diuresis of 
chlorides during the latter part of therapy. Urinary excretion of 17- 
ketosteroids and cortin were slightly decreased. The possibility that 
the diminished cortin excretion was not a result of testosterone therapy 
is discussed. 

(d) Comments on the Investigation of the Adrenogenital Syndrome. 

The data at present available suggests two possible mechanisms 
by means of which cortisone acts to depress the urinary excretion of 17- 
ketosteroias in the adrenogenital syndrome. 

1. Cortisone may by inhibiting ACTH production cause a de¬ 
crease in the production of adrenal androgens. 

2. Cortisone may act directly on the cells of the adrenal cor¬ 
tex, which are responsible for the excessive androgen production. 


•-yyhy c :■ l,<: jzo-s>'£ on: I,:: 

. ' ' gf • . £ ' ' 

■ ■ 1 f s. cl 

£ o; , j ■; -•* ‘I'-ycy orr~ 


■ . y ' I y: >" ;y ‘> '! - ‘ j ' / ’ ' y ' ' 1 ,' . -y-y - , 

l 


. 

!>•" 'f-. y-j- ‘io yyy; ' y • yy. y .Qinoiq .- o.y/ 

' ' ’ 

rr”’ h.‘; yo. y ■ 

■ 

'• \r ' „ 

■ . "yy •' :yJ “; j •; y. . • C->\ ed •x'yrfy;:: .’yiyrorr 

‘to ryyyy y • ‘ •, . : J . < 

. ■ 1 V ' r ■ y 0 oii JJ.J0 • . . / ■. IS v.'.v r;i; . \ ■ '<:•.> *rjf 

nlJ-ioo lo noldyvxo y> ss‘;>yi 

. "': ;o : J' ‘\ ■ cr, ■ .: * •; '/' ■ 

- 0 © ■ - >ii 

, • J y . r; •; • ;>,:oi^ y ■ y- ; -V' 

1 • j . > 

■ ' ' v ' ' : 

"-yy* . ■: * <vil;.ri -j y . " • .. J otofsbo'i" y ; o ixt 

.3 ill 000 J r: ; >‘I r.-i V) id' 


‘to oiyyv:.j.drl • , 

>: :• : ' u v" : . •; *• y 

-VI lo f re Lj ■ co >yy 

..: v. yc j-cvu? 'vj'y.yy.: yfi 'tje 1^01*50 

J'"5riv '$:■ 1 ' y'-.d 

• y , - ' • ■ 


t "V-, .;!■ ■./) : 7 1. > .j\ ■ , .r ■ : :■ •: •. v r v iJ' -‘v:: . yTTcy y ,.yy:r. : •• 


. :< y i . ' 

y " • ^ y'- y;ry yyyoO {■ ■)■ 


: ■";;-?XJ -.Qy'/y i:.y0 .'y. yy y.J- v. > • " 


oJ ■ ■ £ l ' 


- :• j 5 ; ; yy ,0 yoyyjj.yjo'i’ ■ . 

n r y ,s 

i.yy' y.i " - ' f . 


, , r _ ; «y : y ; ':.o c J .: ’ < y ' : .1 


jm : . : 



103. 


It has been suggested by Lewis et al (341) that the adrenal 
cortex is the primary site of the disordered function seen in the adreno¬ 
genital syndrome. Confirmatory evidence has been presented by Bartter 
et al (357), who have suggested that there is a diminished output of 
electrolyte regulating(?Na n ) and carbohydrate active (”S H ) hormones. It 
has been pointed out previously that the adrenal cortex responded ab¬ 
normally with respect to electrolyte excretion (351)(354)> and that ACTH 
administration failed to elevate the urinary excretion of corticoids in 
this and other studies (357)• This evidence has been used by Bartter 
(357) to formulate a working theory explaining the pathogenesis of the 
adrenogenital syndrome and the mechanism of action of cortisone in these 
cases. 

It is assumed that the n S M hormones are strong inhibitors of 
ACTE production, whereas the "TP* hormones have but a weak inhibitory 
effect. Data presented (vide supra) using methyl testosterone as the 
n N ,! hormone seems to confirm this assumption, as the depression of 17- 
ketosteroids is greater with cortisone (an W S M hormone) than with methyl 
testosterone* Bartter (357) postulates that the primary defect is dimin¬ 
ished !, S M hormone production by the adrenal cortex, which results in a 
release of the normal inhbition of the anterior pituitary. Increased 
ACTE production occurs, which in turn results in tie production of ex¬ 
cessive amounts of adrenal androgens hormones) • These produce the 

characteristic features of the condition, but fail to depress pituitary 
activity so the condition persists. 

Wilkins et al (353) suggest that the action of cortisone is 
through the pituitary resulting in a suppression of ACTH, and thereby 



. 


■ .. 

■ . ■ jj. n no.: K'*i9£rxoai ' ■ 

*r ,. 1 -j v ; 7 r;. *r : •; r ! ■ on . i ■ . ... 7' 

' 

I . xon or .o:o7 { {, 7 n } . n7 : o :, j '. *• 7 -o, rr io ; . ; '7' *?) ! ■ ■ Jr- 

... ; ■ tbaoCJZ i ' ■ . ' ' r 

1177) 7 J• •:• )• bn < (bc:C5'(JC'b ; :.) noli *.ry oo o7o,7; ■■ vi .'vk . .7/ 7 b: imoxr 

:ooi • i : '" 7 . . i ©14 talrrii 

*: j '. 

X.'. £| ' j ' ■ r ■ ' € . ’ ') 

j ni: one; ;ibn- > 7. n, 7n 0 r y o; : " i ' r o: 1 

. 

• to .yiod'lns.ilrl 7 .: •.J . :Vio : /:_j: ” 7' old J .• s no . ; ,i. 71 

V- J; ,1 , *. ... v: • ■ 0 . . ! oHi : . ' : . : .7' ' 1 ■ 7)A 

' ' - 
-V.c 7o nolBOvOu/o j . ;n7" n.;B0 • ~ lz..f rr.b ortoo n ororneb 11 11 

, . jh i - r 

7 ; ; -D 7i. : • . j . j n .' ' c r :. . ■ ■ •: 

--r ■■ 7 ;o no ior,> noon 0 :rti pJvjjb *■>*?: rrrnu no dnibv , •• 0 .. noli non: 7T77 

i i ' ■ - us 

. r ]• : 1 Vr •. ; .77 :;o,o 0 7 •, 0 " J v ' .' 0 ' 

: • \r,y 7v no.) ,!o.jvb.i • nib!' t 7J ,t^9'77 fJr: -b. bo 7 r i .' 

7 ■ 7 ,,7.77 7o ftoinr:ox; ■ 43 ' ac ,r7: J- ., , ' 7 . • ; '‘.i:.7' . . ±}U,n:\j 





104 * 


causing a diminution in the secretion of the pathologic adrenals. 

Evidence indicating a direct action of cortisone on the an¬ 
drogen producing cells is meager. However, atrophy of the zona reticu¬ 
laris by cortisone administration has been reported (358). This effect 
may be equally well attributed to an indirect action of cortisone via 
the pituitary. ¥ilkins et al (353) note that cortisone has been admin¬ 
istered to normal and hypophyseetomized rats treated with ACTH and 
state that in normal rats there was a reduction in the weight of the 
adrenals, while in the hypophyseetomized animals maintained with ACTH 
showed no adrenal atrophy. This data further confirms.the thesis that 
the action of cortisone is mediated through the anterior pituitary. 

(©) Conclusions® 

Sufficient evidence is not yet available to definitely state 
that cortisone reduces the elevated 17-ketosteroid output characteristic 
of the adrenogenital syndrome by suppressing of ACTH production by the 
pituitary. Although this mechanism is the most probable, more confirma¬ 
tory work is required to establish it as fact. 

III. The Effect of ACTH ©n Allergic Urticaria. 

(a) Introduction. 

Allergic urticaria is a condition of the skin characterized by 
the sudden appearance of an urticarial erruption accompanied by intense 
itching and/or burning (359)* The erruption usually consists of discrete 
or coalescent wheals of various sizes, which vary in color from white to 
pale red. Often the condition is transitory, the lesions disappearing 
a few hours after onset only to recur some time later in either the same 


' . V ' ' '■ ’ 1 : - ' V ' :: 7 7 ‘ * r '' ' ’ ‘ ■ 7 7 r ‘ " r . : '0 

- \ to ‘ b OO’tl 

•> V • •; . ' ■■, ■ . ' " "■ , ' ' v ■’ ' : r. vb 

■ ' . ' . • • •. :> 1 • • -t ' b b:"' : 1 \b 

: : T 9;V • :■ V • 7 _• •• ' ’ • ' ■ ' • • •• 0 ! ’ . ’ ’' 7 ' b v-".V " • ' " ' ; ’.H 

■ ' ’ ' 

bo.' "=T <’ b.v " ... ' :: ' ; - b r ■ > • -‘.mati ob •• v J";b 

9 ,i:l be d 7 r:bbrv\ orb v-'vbbvjbv-i; >5 r.jv r •xoiff ysvi: .oKuirroft ni cb-.bb Ovibcro 

■ b 7 ' b t . r : ;> ■ bo 

‘ 

v ' ' ' • '■ ■■ b ■ : . i b ' y s. • c .' cbe 77 ivo •■r:J 

? t ; -) 

' .. b o' .■ ' b b- •' ■ • ‘ ee ■■ - ■; ■ ' , V b ' ; ' 

’ 

:;>bb ; 9b' : ':.:e',-c'"' bob. /.o v ■ b ■j-.ycn ■ b ■’ ' [/-ou yv:.-i ebb bo 

■ ■ - b'b • ) " ib'O • ‘ ■■ bob , ; ' tv v 

' 


. '■ ■ - * 

. v U DJJibn-c,) t,l ( 0 

' ' ■ ■ X ' ■ ' ' ■ 

;■ ' ; : , :o,I V. J/ •• ■ b-b " ■ ‘ ■ b- be eoo .* O'v- o - b .HO bb.r;-: rj.bt 

• T ‘ 

bb v )>■■■.■ ■■■ -I.;. both- j:b b • v be: bl. ifl.; ■ b tlb'ooe.bee;; VG 

• : • - b : - t : b tv : ■ ' 7 I' b b ■ ■ •/ 

. : ■ :v v •' -.r -.b 1 iv cb b:. -V b ■ vo vr-b 9 




105 * 


or different areas of the body. Although ailergins are sometimes dem¬ 
onstrated as the cause of the disorder, the precise mechanism by -which 
it occurs is at present unknown. 

Hovrever, recent studies of allergic phenomena have indicated 
the possibility of a hormonal relationship, Selye (360) has shown that 
purified ACTH will inhibit the "anaphylactoid” reaction, which is pro¬ 
duced in rats by the parenteral injection of egg white. Control ani¬ 
mals receiving no ACTH showed a marked edema of the nose, tongue and 
paws. Studies by Long and Favour (36I) have indicated that ACTH will 
obliterate sensitivity reactions to tuberculin and the beta hemolytic 
streptococcus. More recently Nelson et al (362) have reported that the 
related substance, cortisone, inhibits anaphylaxis in the mouse. Simi¬ 
larly Dews and Code (363) have shown that cortisone decreased the 
severity and mortality of anaphylactic shock in adrenalectomized rats. 
Shwartzman et al (364) have reported that both ACTH and cortisone are 
able to suppress the phenomenon of local tissue reactivity in rabbits. 

The increased availability of highly purified and potent adreno- 
cortieotrophie hormone (ACTH) has established the fact that certain 
allergic syndromes respond favorably to its administration. Studies by 
Randolf and Hollins (365), Hose (366), Bordley et al (367) and other 
(368) have shown that bronchial asthma improves within a short time 
after treatment with ACTH is instituted. Carey et al (369) confirmed 
this observation when they demonstrated that stimulation of the adrenal 
gland by ACTH had a beneficial effect on the clinical manifestations of 
bronchial asthma. Samter (370) and Franklin (371) have indicated that 


' • ’ ' * V\D< j- .to ’ 1 ; 'EC 

■/* : "M r ." ' ■ v'. ' '■ ’ ’.to-*.: Mo .• r.j J rc 

. : 

; .-.j- -V.‘ ; r . ‘ 'Li ifTf;' • ’ ; M:.:, O t '.a- YOwoii 

■ ■ (r ; ■■ ' >‘i , .' .. ' , , ■■ ■ . 

“ Sx‘ ^'^0 .• • ■;;'/) Mo no ^.;■£* tid*r.c t)ooi:h 

M '• orf ‘■ ::J Mr. o' V; o ;-c uooa oMMM of? ;kj,v.M<o- •[ y. i 

■ • ’A 1 ” ■ :■ V • ‘ i\‘. ■ f ' / oJOV . 0 . ; : ' v i' 'o' . . ,.rv 

rud'v.rorT'fi 'j;o- roM: ; oM ;;>• a Jo : ,JJvo-,; ■: i .• J MMo 

' t } . o 

'-lo .0 o:’ xi: ;V' ■ M J 1 r c "- v Mir* J -J • 

■ on j- lr TW'to :b : o Joo'oo- Mrokr nvoxLv ^ v oJ v'-cO fcrctf 8 o ; 

. : 1 ' : : ■ • ' > .** ■' c■ ■ ■ 

■ i-\: ruo'iMJ ; o;J • -J- . ••• . ovx:r' ( .V ) .Hr. Jo. /ouoj-; oouo 

. ' ‘ ' ' r ' . ; fO. 

itsrhr', .trr.6v5ox 1 - ■■ ';S-X ' v o ‘-i■■ M •/ la ;• *r.pn-.t c-i'C 

■ i ' ‘ V 

' ' . ' ' ' ' ) , * V ' : ■ ' 

‘' 1 ' - ' O:.-' f O , , n.;I rf . ~.n 

■": :.MV ^ . v.i. 1 ■ Ic'Jjnorro'xd J' -jM sr.;C; : .r, ev.!Y: (oM£). 

j 

r . l i~ • X. '• • .*•' • hot n: j.xvvyx'r 0 

lc> .M’ v ! --MM: x i'.o x':iM no. -tosTl® IsioiMooeo'- x loio HTQx vcf orooC;; 

' 







106 


the improvement is proportional to the metabolic and hematological 
changes produced by the adrenal cortex, and is followed closely by 
an increase in the urinary output of 17-ketosteroidg and ll-oxysteroids, 
and a decrease in circulating eosinophils. Further it has been reported 
by Carety et al (372) that the urticaria seen commonly in many hyper¬ 
sensitivity reactions to chemicals disappeared rapidly and completely 
under ACTH therapy. He points out that the mechanism responsible for 
these beneficial effects are as yet unknown, and notes that although 
the urticaria is blocked out, the cutaneous wheal and flare response 
following the injection of histamine is not altered with ACTH therapy. 

Because few metabolic studies have been undertaken in this 
field and in order to obtain more information regarding the mechanism 
of the action of ACTH on allergic phenomena, it was of interest to 
stuty the effects of ACTH in a case of allergic urticaria. 

(b) Case History #99254* 

The patient, Mr. J. ¥., a female age 40, had n© previous 
allergic manifestations until four years prior to admission, at which 
time she experienced her first attack of allergic urticaria. The onset 
was sudden and was preceded by the ingestion of a seafood cocktail. At 
first hives broke out on her arms, legs and face about four times a week 
and were relieved by benadryl. The attacks became more frequent and 
severe and soon were relieved only by daily use of neo-antergan. Sine© 
using neo-antergan she has been completely relieved, but when she stops 
her medication her urticaria promptly returns. The urticarial attacks 
begin with an intense pruritis, followed by raised erythematous wheals 



" . -ivs 7 . ■.7/ 7 7 77. . 'crxjpl • ■ 7 

.. ■ 7 .. . ?“■' • •/ ■ ' ' /: Oifr '.77 ' \yv ! - ■ 

y I ' 7 ' •• ; i‘ ■ -■ ; - ' : ,0 : \ 

' ■ . • '• oj \ 3 - V ' ■ ■ i v ' 7 '.VC) ‘ ’V :..: 

: . ■ . : ■ , '.3.7 9 ■■ 7 : ? 7 V;vi 77 : 7 J. ; : ;77 

' ' ' 0 ■ 

.7 ■ .7 7 ; • 7 . .-70 • .0 = !>• 1 7..i' v 7 . 7' ; :i v.a';' 


. 77 . . 7 ...7 . o 0#,:.70 ''OiTOoIti' VS Jit". ii ^IV 1 ' 

7 .. 7 V 7 ■: 7o‘''7. ' ' J- .-V- J/o. '7 ■ ' 3.3 7 :: 77 ,7': 7 : 777 ! Soil • 77 'O.L 7> ) 

3 MJ 03 . 7 .-7 j- V ”... :;.17 3 ’ .i-37 v 737 v* l 3:. 7”-;-:7 

.. ' „'7 ; . -7' :7.77 ~ 7 7 ."" ' 701 ' ' • ‘O. 

• ' 

,■ 3 • 


. .70. 7.'' ' • i: -:J : -7- ■ .7 ,. . T . • rj-: -:c ssP 

7‘),‘37 'i' •. ,,7.7i3-J.|li)3 07 V ■ ." .o': '77 ;j / o7o7./'Jj7.7'7 loo 

. 

... . - . • '77 fa - yjd 

» ■ ! ! 


. • ' .7': • • 7. 7 , 77. •• .... ; ■ ' 1. '■ ■ IK .-.0-: ■ 7:7 oOOV .3 

. 

. 

7'7- 7 if.. * 3 i ,'3.77 7.7 -’.77' "7' 7.3.: "3:7 ' .7 77 77 7 733 







Figure 23. 



Figure 24. 


Figures 23 and 24 - Allergic Urticaria Jfrs. J. ¥. 
#99254* Photographs showing the effective control of 
urticaria with neo-antergan (Figure 23)? and the appear¬ 
ance of the urticaria with no therapy (Figure 24). 








107. 


which are sometimes clearly circumscribed and at other times Confluent. 

The patient noticed that she was symptom free during her last pregnancy, 
which occurred two years prior to admission, and that she remained so 
until two days post-partum. She had a complete series of skin tests, 
all of which were negative. 

Physical examination was essentially negative. She weighed 79*3 
kgms. and appeared much younger than her stated age. The blood pressure 
was 120/80, and the heart was not enlarged to percussion. There were no 
thrills or murmurs and the pulse was 80 per minute. The integument was 
normal as she was receiving neo-antergan. 

Her routine urinalysis and hemogram were within normal limits. 

(c) Procedure. 

Control observations were made for two, three day period while 
the patient was maintained on neo-antergan (100 mgm. per day), following 
which neo-antergan was discontinued for two days. Neo-antergan was then 
resumed for six days, five of which were unsuitable for biochemical de¬ 
terminations due to menstruation. After menstruation ACTE (25 mgm. q.8 h.) 
was administered for two, three day periods, and following one day of 
ACTH therapy neo-antergan was discontinued for the remainder of the in¬ 
vestigation. The patient was observed for an additional six days after 
treatment with ACTH. 

(d) Results. 

1. Clinical Observations. 

The patient was most comfortable while maintaining her daily 
intake of neo-antergan (Fig. 23). On cessation of this therapy she was 
bothered with urticaria. Erythematous itchy blotches appeared, accompanied 


.VOX ' 

f [co r. • r; ' , • •>; : vj v; • ' f pcr, • 

,-.;p ',/n • r ’ J p ' :• CJ " " Pi'"rl 0 " o : :l'- ' ' IPQP '-C' ' i 

r " "v ; ' .pc . hpi ' ?•I ' '■C ■' -t ''V'i.'l. 

. ■■■; ' - -'if . ■ 1 ! ri .i -j .O' • 1 o ;p . \P 

. •*. v j / • : •• ■ : io ' : ■ “ U/: • 

•-'V ' - ' - ■ ■ : ■; .• ' ' • ' • ' ': 

i-.-'ii: Vi' 'i" : DQC'-P C\d T . rr : • ■ ;’ r 'PPu' *: f pp . try P. 'O': c. '* if' . V.~'~ 

r r : ■ . ■ ' ; i ^ : 

' ■ T - ' . • ' ‘ ■- V ' •- ^ 

. r ■ ■ z; ;\p ' r ' ■ -' o -f iv-; : I J VVOfV 

, •; J 1 ■ ' 

• . ' V " ■ ■ ■ roi ' ' 7 ' • 

* r 'p.c u .r J -c- :v :o v / o 

f < . 1 r •. o'• ‘;>;c' )'. S'A 1 ' " ' ' ' ' -O- '■ ' ' -■ 

v- ; ' r.' i. r;, J, ' 1 -v." ”o " • '; ‘ ■ - : ‘ 

■ • “ ■ 

/ O'-'p -V •' i‘' f-" ' • ’’ • • ! ' ' P ’ ■ ■' '■ - • •• • ' ; ; ' ” •' 

t; : r • - v... ; • - v \ ■ ■: v-,. ' r ' ■ 

c- V' v. ■ • ' •; . IV i '■ ' f 

•: : • ' :• 

. (iv) 

. f ' . 

■ ■ ■ ■ r ]■[<£ \ ' . 

■ ' r r 

■ . . ' . 










Figure 25 . Allergic Urticaria, Mrs. J. W. # 99254 . 
Photograph showing the urticarial lesions on the back and 
shoulders. 










108. 


by confluent wheals (Fig. 24)and were evident twenty-four hours after 
neo-antergan was stopped. These lesions varied in location and followed 
a wave like pattern with some areas showing marked urticaria while others 
were recovering from a previous attack. Nausea was noted during this 
period and was most severe when the pruritis was at its height. On re¬ 
sumption of neo-antergan relief was soon attained and within eight hours 
no lesions could be seen. 

During the course of ACTH the patient was also bothered by 
pruritis, nausea and some edema. Once again the lesions were migratory 
and seemed to come and go in waves. Various parts were affected, but 
most commonly the extremities, back, shoulders (Fig. 25) and face showed 
the characteristic lesions. The first, third, seventh, ninth and eleventh 
days after beginning ACTH were the most bothersome. The remainder of the 
therapy period and ensuing control wsre spent in relative comfort. It can 
be seen that the effects of ACTH were not complete as the urticaria per¬ 
sisted, although it was less severe and frequent than in the period "off" 
neo-antergan. 

2. The Effects of Neo-Antergan and ACTH on Electrolyte Metabolism 
(Fig. 26). 
a. Sodium Balance. 

During the control the patient was in sodium balance, but on 
cessation of neo-antergan there was a marked diuresis of sodium which was 
followed by a slight retention when therapy was resumed. During ACTH 
therapy there was a slight retention of sodium, after which a rebound 
diuresis of three days duration occurred following cessation of therapy. 

A positive balance was established during the last period of observation. 


„ 

T - ' ; 1 ■ 'j;> - p' I:'-, : ! kv'i; ■ \ ■ o f • [ ' ' „ } o:.! ifo d jr.)/r. r .lrffy ^ > 

o'. "ip o prjj. .v ■■ pvj. oo:: dT . - . ;ro: ooo.p fi.v.-u dvro-nyr 

'' 'T f . . . O’ ’Ol j’ .! r r < .00 ,-P Pi: O' .,. . : o • Op. : POOP j ’ O'POCd'PU •-.;I : O' 

i : il ■ > - 4 • ' p fr « i v - r o“ii i £ svco *i $*rri«r 

■ esv 

OPPO d p-'PP rod. ' • 0:0 /. i • V • ,o p p * • 0.. . • • o-\ • p j A / • :p 

' ‘ ; . . f: 

lOPOP’lvOO opp ' Oo ' : f’.- ' i o. . ■ o' did; in cpo j ; p/p ■ pp •• 
p:. ' o o: , . . •. o: - p : p 1 t . ' do p ' p 

0 ■ ■ A OPO'O. • ' ' : . ■ • 0 V ' ■ ' 

-■doppvd *. : ■ , "0 ; " . J' OJ.O ' o p v;0 d 


J O'": ■ : • : " ' ■ "P. 0 . V . ' ; .. :• ; : .• dp", O'' 


mo jI 

. d-d 

■ ■ ,; ■■■-:, 

P . i; >p 

• 


po, ‘PO. i ;,j" 


odoro'P.; •''OP.' 

3i v '■ ' ' - . 


'p«o: p Or- oko J"o\ 


itf.'03 !Pd 

dor” 

■ 

' 

oo' :, : L■ ■ v o vo p o 

O;,0*l -0 OO? Of 0 iPri/O/'A 

' 

,d ::p; o 


(T ,' 

. 

. 

iftOoOOP'P popfi .0:0,: 0.000 POP; .O 0. PO Or; .OP ■. dj C '0 '• p. 9l.‘j - ./’'OPPO..'. ' 

* ■■ op o "r p ’to P .0 0 O: Pi) • o * io-o.; .pop Jpo- -ppp: V..c ok:- id opo/d 

pdo./od; . ppoo'O;' op - . & n jo pod Jo;: ,joo- cfrloi.rp :e v-rj .o^vo.LJ.'od. 

oo'• 0 ( • . d ?. n o i: go; 'J:c old J . ■ ■ ■ . ,p L p y id 

*'op ‘ . 0 " poo O',: 1 . dp'O'OPOPO'O p. op.:.' : ■v.o’j 0 : po 'do pop : o‘' oo 

• • " - • ' do -.j. ; r; POO,: .: OOP.' -■ P- o'" . P •, ’ "0 L- P./.i. A 












DAYS 


Figure 26. Metabolic data on Mrs. J. W. #99254 with 
Allergic Urticaria to show the effect of Neo-antergan and ACTH therapy. 



Figure 27. Allergic Urticaria, Mrs. J. W. #99254* Chart 
shoving the effect of neo-antergan and ACTH on urinary output of cor- 
tin and 17-ketosteroids, and eosinophil levels. 




































































































109 


b. Chloride Balance* 

The output of urinary chlorides followed closely that of 
sodium. A slight diuresis of chlorides occurred during the first con¬ 
trol period, following which a balance was established. A pronounced 
negative chlhride balance occurred when neo-antergan was stopped, and a 
retention of the element was observed when antihistamine therapy was re¬ 
sumed. ACTH therapy produced a slightly negative balance, which in¬ 
creased further after ACTH was discontinued. A slightly negative bal¬ 
ance was observed during the last control period. 

c. Potassium Balance. 

There was a positive potassium balance during the control 
which was followed by a prompt diuresis of the element after neo-antergan 
was discontinued. On resumption of therapy a retention of potassium was 
observed. Likewise ACTH produced slight potassium retention and after 
cessation of therapy a more markedly positive potassium balance was ob¬ 
served. Potassium balance was established during the last period of 
investigation. 

Serum electrolyte studies were not performed in this ease. 

3 * The Effect of Neo-Antergan on Weight and Nitrogen Balance (Fig. 26 ). 

There was no pronounced change in the nitrogen balance through¬ 
out the study. Equilibrium was reached after the first three days on 
neo-antergan, and there was a slight increase in urinary nitrogen during 
the first day following discontinuance of the drug. A slight retention 
of nitrogen was observed prior to resuming therapy at which time a more 
positive balance was established. There was a loss of urinary nitrogen 
for three days after ACTH was begun, following which a decreased urinary 



. 

X :.i.b 

1 f . 1 ;;X moio a o 1 

: ; ]y h,rtoll ;;; b‘ib.:bA ■; IG J r .i'bb .! aXC 

i iJ 

. ; ‘ibA " A ' 


vi/b., i. A . b:.b ; ■ b b ■ b_ b. " i A; x..'..b”,‘T. J/b-Jo r '../ 

.. . I-XxrqOo".i / j: * 1 i r.;0 i b ;.:I bAjbXOldO evibb:~}9f! 


•-••-V y.: vcrs^oiit of,ArbA 'A- 

■ \ joX'W /;"■ V'ibbbiu : V.,: "j fi-ij"*-;-10 bib:' Xc I'iOiXfiOtj'bbl 

- i it i io A;X; , • > o. i: iZ v. ,* v: .J 

. 

• ; ovAb ;;pb ' v i,bX J.j , \ 

. - ; 7, b - nX b b b ub • 

. 

■••b j b . • , :;b b 'b n;v; nor-) 

. 

boXbiob . bb'O ooriH-Ci i 

' 

- : ■ , ■ . e. 

j s .i bb : 1 ■ . c./ . . "b'i Ijkkh /.i - '.b iio l.Uu 

. , b 

. .:: b 

b.- ,i 11 noi br; nsj± 

‘ . ... ■; ;V b. : "o 

- o b vo : b j;j. ::; - . 

. V ' ' . j i 3 0 T 0 

io .I.-o.bwtJ An -J”. n.' *x 

• h 

■ . . 

. ■. ; b) ;; I XX ' >Gi • oX’ c 

. • bb. ■; ,j".; J ... X bJ'b:b.v!'i • 

X . ' • b , : 

' - , . :• • . b *.> b . X 

'.oli.vj S'i-J':. t-XXXtf • ■ 

.! • ■' ' : fO b ' ulni OU. . :-b . TJ':5 /'JT 

. 

. . . b.< 


/ '■ .i < . ■■■ :o A" / :.b .i i . JA . » b : b bJ b . fi .‘Ib, ;. b-O. .i 

... ■ ■. . ■: j 


' 

b nil £C J 1 .■ ’ l l 

■ ,t.v- •'O' '‘io ; Ub.b 

. b;,;bb.,i .!. ... , \ L. Ol' Ir*. , V ‘ ib’. b bb 

"xbb'-b'iJb.-j: JJO O-'L ‘100.6 a lioXxi&t b, 

■ oi. :b , i,b'-oi b-b: bb,:.., ■•..■.bj.- ’n oom: . j ’lo'J: 




no. 


nitrogen output occurred, which persisted until three days after the 
last ACTH injection. During the terminal period of observation a 
slightly positive nitrogen balance existed. 

Throughout the study there was no change in the patient*s 

weight. 

4* Hie Effects of Neo-Antergan on the Urinary Excretion of Cortin 
and 17-Setosteroids and Circulating Eosinophil Levels (Fig. 27) • 
Urinary excretion of cortin and 17-ketosteroids showed no 
appreciable change until ACTH was begun. Darihg this period there was 
a significant rise in the output of both corticoids and 17-ketosteroids, 
which was slightly depressed following termination of ACTH therapy. 

There was no marked change in the eosinophil level during or 
after neo-antergan. However, there was a marked drop in the circulating 
eosinophil level during treatment with ACTH. 

5. Other Effects of Neo Antergan and ACTH (Appendix III, Table 4 ) • 
There was a slight decrease in urine volume accompanied by an 
increased specific gravity following ACTH administration, but no changes 
in blood pressure were noted during the study. 

(e) Discussion. 

It is interesting to note that this case (vide supra) failed 
to respond as dramatically as did -foe cases cited by Carey et al (372). 
The possibility exists that ACTH was not given frequently enough or at 
dosage levels sufficient to produce a marked and definite effect. How¬ 
ever, on the basis of the cortin, X7-ketost@roid and eosinophil responses, 
it is assumed that adrenal cortical stimulation occurred. TuXpian (373) 
in studying the effect of ACTH on mycosis fungoides noted that although 


. 


f otti - 

'fe.n 

■ 

1 ?:o'Trr 

: • , 


' . 


UO 0 0 

■ ; h ; 

d'lfo 

■ i i 


: 



' • ' : 

f 



• n ’ f 


' 

:TjA d-« 

-j: 




» 

... . . 


■■■■ 

TiOtc 


' 

' 

; 

F: 1 .1‘ 

■ 

;'y- 

:/ ; < r: 






r;c '• 















: 















n!: j*roD 

id ncj , 1 ' 


' 




' : .1 ' 

0&0i 


. 



■' „ v'i 



. .' ■!/.'. Tii.. 1 ' 

i 


' 

- T. 

1 ' Jl--‘ 


, , 




■ 


j . 

• 5 ff.dt 




' 





I-- < 

: : o: ■ ■: 



• 



r : -i- 

i: e ;•/ r 


l 

u 








■ I d I/O - 

* • 

: 

■■■• j- 

. r . V"' ‘ 

• 

P> 


Lojii 

v< i r . . h . r . ’ • :■ ' \ r?:j\ ' ■//A ■/"; r 

f r.t • . ..■■■'■■ ■••• n ■ p i 

.... ' . . ... : • : {■: ;> ’. ■ ~ J- - r. ' ' ' " ' ' r . ;c n.tr.oo 

. (' ■■ . 1 . : V . •• • . - '>C; .-.dr A/"; . ; 

I ' A \ ' • . O' • r A'A : 

j ' ' i ■ J ■ ' 

. ; • : ■ \i ; nj ■■■■■■> Aodorf ;• >’rv.'.'/vc do old n:t 

. ••• ■ :./A v'! 

' 

. ( V ) 1 J‘ ' ' • J ■' : v/.s ■:'■■ ■ j if • r •■. Z CO 

c - . - ■ ■ ■ ' • ■ h'-l ■:<? v t j..; ;.o,r;.'.o-:i er:T 

i 

»o • « ■■ ■ r • ■ • ' ' ( '' ;r / ■ ‘ Vv: '. A v/I ' •; t- < -r- 

■ J : ‘ 'I t j : ■ ■ > do r .' .- •. ■ c , ■ v ■ 

J . t. ‘ - : • ' • v • * : vt-’t :■ • r.A bei ir.. yd d 

i{ ■' ■ ■ ' ■ d ■■■’• ■ '■ ■■/ o/A ■ ‘ oovi/; no AAA do AoeTi© r: ; u ^ ?•; : ni 



Ill 


the hormone failed to control the condition, it caused a decrease in 
pruritis. Although in this study ACTH failed to completely relieve the 
condition, it resulted in a reduction both in the intensity and frequency 
of the urticaria. 

The effects of ACTH on sodium and chloride balances are variable 
(147)(367)(374), although retention of these elements usually occurs 
following ACTH administration. This has been confirmed by Bartter (374), 
who also reported a retention of potassium and noted that following ACTH 
therapy a diuresis of all three electrolytes occurred. The results ob¬ 
tained in this study are somewhat incongruous with the reported obser¬ 
vations in that a retention of sodium and potassium occurred during ACTH 
administration, and following cessation of the hormone there was a diuresis 
of sodium and chloride but not potassium. Such findings are as yet un¬ 
explained. 

The parallel relationship observed to exist between sodium and 
chloride balances has been described (147)(367). 

The electrolyte responses observed following (a) the cessation 
of neo-antergan, and (b) the cessation of ACTH are remarkably similar in 
direction with the exception of the potassium response. A retention of 
this element occurred following ACTH therapy, whereas a marked diuresis was 
observed following digcontinuance of neo-antergan. The cause of this loss 
of potassium perhaps may be explained on the basis of an elevated serum 
potassium, which could result from cell damage due to the hypersensi¬ 
tivity reaction occuring at this time. Unfortunately no serum studies 
were performed and this confirmatory evidence is lacking. However, the 
fact that ACTH resulted in a clinical improvement when neo-antergan therapy 


.-ill 

: ■ ■ ' t rroi ■ . ; J mod ©rid 


l ' ’ '■"■■i- :( o ( • :..l bddbA , ; X - d. ' ■ .x A. or rid 


'V'V: 

dl J 

. e • "■ ,’d 'e: 

.d ; d 

1 1 iio" 

ncXl 

e fix bo 

lltFStt 


t&l 








• 

* 

l‘ r j: --Id >o 

X id-, 

1" ,V d 

> 

: ■ i 1 .. 

. -j >/f ■ r 

' 

•i • . do 


,-bT> 




. ■ 

■ I'M.: , 

L t;:: el 

Xo fell 'V.u 


d-d < 

i. V .) 

C X;)(Vdi) 


/ " ) ’• - ■ 

• I >: 

- 

j e •! - 


■ i.j dil: 1 

bx! 

! i-;y ■ 

-G-:H;Olloi 



ol.Xo I I'Ul; 

■ Dod'of; 

' 

go Xo' • 



leoc ■ 

-x .1 • ox h r 


1, rdl 

. 

" • G J • . ■ 

jO ' . ', 


.1 Hi X 


,' ; d 

‘ *r ’ '/'Sr . 


-•i: ddo 


/did. 

, xr ■ ■ 

Of'f:X O':-d, 

GOG 'VI. • 

"1 ' j! 'b. 

i ' d 

ni J i- ■ r: d. j 


• 

' I Id id 'dvG- 

, 

; ,d < ■<: ■ 

’ 

e .. j / 

' r X G 

1 ‘.j -,1 

: 


■ I i d G p\r : dr -'nd' 

irKdir/oiI 

1 

* 

rJeoIIol 


» : -v. Id 

■ t ! i . i 





. , 

1-ei^oq 1 o i 

:: d r J T of. 

id.foli: 

b Is: ■ 

. ; o-.’-; do 


. • e 1 


dee njjdoo-; red e ■. •: .1. . <. ■.!' ..■■•vr : A : ;:e I- . X: s loll vr. •/: orIT 

. , ] ( . , X j- . " v' ; . A vf elr-olio 

t:( A j .v :<; Xj.oX 1 v , o , :: r e dee-eil v : 13 CidT 
i 1 ■■ Id , i . ' X 1 d . ,, m : i ( , :: ,):,;-■■■ .n Xo 

X : * d d e .1 . •: e •• i . :.l 1 c ! i . ii id • ; : o J ed i: w eX J ) ed ■ 

•G : T ? e J dd •, ; j cJ d.C. i)( G' I Q JO: i . J 1. J 

dU, redf . g 1;: e ee: eod.1 . ce "J: . : ejecJdLoX dev-.: ■. e U > 

: - •. / X g ’ dd.:■ of; , e, d e ; d j. : ; el , gI id ' 1 k dU.• 

■xii ' 

V V;; ol Slid) r/'j 'V 1. j.j > 0 C r ;11 Ul.r-'; V Mil 0 id d. i 'J r l G-fllcx 

: Oil d d . ! „ ■ id I U .. ; ■ ') ' ■ XV 

. I d d ;i< d - ' ’ b co ■ ■ ■ . > ■ ■ . 

‘■•■'-'d- r ■, •• e-e d, J‘: c. i". : e J .L-ved^ildJ e * d, ddee .'.r Idl'd:, devd! lo 1 




112 


was omitted, suggests that the potassium retention may be a biochemical 
reflection of the dlinical response. Further the diuresis of sodium and 
chlorides, which occurred following cessation of neo-antergan (Fig. 26), 
was more marked than that which followed fee course of ACTS. The degree 
of difference roughly paralleled the difference in the clinical re¬ 
sponse observed with the two drugs. It was seen that neo-antergan was 
the more effective agent. 

A slight diuresis of nitrogen was accompanied by a loss of 
potassium following cessation of neo-antergan. However, this relation¬ 
ship was not observed following therapy with ACTH, The slightly nega¬ 
tive nitrogen balance which occurred in the face of potassium retention 
cannot be satisfactorily explained, but it is thought that the retained 
potassium was probably not utilized by tissue anabolic processes which 
would have incurred a concomitant retention of nitrogen. 

A drop in the level of circulating eosinophils has been shown 
by Randolf (327) to be a reliable indicator of the action of ACTS on the 
adrenal cortex. In the present study there was a drop in the eosinophil 
level along with an increase in cortin and 17-ketosteroid levels. Appar¬ 
ently the degree of adrenal cortical stimulation was not as marked as 
that produced during the patient® s last pregnancy, for her relief was not 
as marked as that obtained at that time. It is suggested feat higher ACTH 
dosage may have raised the cortin production sufficiently to produce a 
clinical remission similar to that previously observed during pregnancy. 

The pronounced depression of 17-ketosteroid and cortin levels immediately 
following ACTH was in contrast to the results reported by Forsham et al (375) 


. 


• ' A - • A- .' . :r I ‘ ' . . ; -A < -V " J, ; do L; 0 . 

to xtold 

A ■ ' ■•:<...• .. .O-A'i ■' . A: j ; . • 

! A .. A •. itf) • i v ’ 

■ • Ad .• ■ dr .. ’- - .. sjf : 1 • 

‘ r ,\i ' .’A j ; OOV.. V A - fMif.X 7>, 

. .!• . r; vlio r:ou :rv 1 1J- 

* 

Vv X' O J ‘ / v: . :■ '■ A...-- f " : ' ?0\> ‘ :/ .•! C.L A A. Air I' '■ v! "A CX; 

- \ :: A • ■: , , : •: v "/■ r.r .i ;::ro UX X . VO ;:i X' -.tor: \ : : 1:1:) 

•; ; r ' • • ' - ' ' Xfi 'OB O'.7)00 OB' 1 ,1 B B'7 ' bX‘ j r O O’ ' 11 fi B'V.'d' 

' • : : . ’ t : A tl - I to f. I ■ 

;.AAB ' P, ■■ ■ 00‘. ! o ? •' A". • AJ' V ‘ h...- .. AX 1 o. i" ' 'O'.fq 0 bo j bo B/on 

. 

ff T • . 'OB.A 0; • A • A BOBO d ‘jO i ■ /■ . d. : >X * < (V.O) A 

or. A fir. . A'd.l A -A■ : rod do *.fo-i ■ >r*'A: rdA XX or b 'o r < A (VAX) ■ X.u::A'aoK v;f 

\ ' . - ■ ■ A Vi ■ 

■ ,| r:.A boi'i-Tr;.-. do.fi vo .■J' f.i'i:; id:; .A- loofo.) l-r:ioO'A:>Alo ro-iroo) f.od vIAfro 
d o'. -- ; *t- A 1 ’ ' , d A--.;: .. J o: ' > '■ < " .* d 

A' . . ' . ■. : i A : ; ;.- ! l j- : .. A 1 . ■ • 

/; >* -c <. J ■■ .Od a-.A'/d o ■. r;- A;/;.: c‘ 0 '" 'o’ -o :, ; .r A'oJ , 7 \n o.;o::o b 

... - 

A J- i A: o.C- v A '■'■Av :0 - a \ ^ :. c •. ' od :• A-\ : i ‘A... -O' : : oA Ar ■ o>; rr o: rtorro oAA 1 

VZ) £h J i\ \:lu (<i - A.' A;.oAxck/o':c odd oi dois^drroo nl obo HTUA An-ruoIXol 




113 


(f) Summary, 

A case of allergic urticaria which responded moderately well 
to ACTH therapy is described. The clinical improvement observed was 
associated with increased urinary output of eorticoids and 17-ketosteroids 
and a drop in circulating eosinophils. A slight retention of urinary 
potassium and sodium, and a diuresis of chlorides also were observed. 

Comparison of potassium responses after cessation of ACTH 
and neo-antergan suggested the possibility that the clinical improvement 
was in some way associated with this element. Such a possibility is 
discussed. 

The similarity of action of ACTH and neo-antergan is reported. 

It is suggested that higher ACTH dosage would produce greater clinical 
improvement than that observed. 

This study, although not as dramatic in nature as others re¬ 
ported, served to emphasize the possibility that the basic mechanism of 
allergic disease may be closely related to the pituitary-adrenal system. 

IV. The Effects of Cortisone on Xodiopathic Epilepsy. 

(a) Introduction, 

Epilepsy has been defined as a symptomatic paroxysmal cerebral 
dysrhythmia, which is characterized clinically by a loss of consciousness, 
involuntary muscle movement and an amnesia for the event (376). The symp¬ 
toms of epilepsy are divided into three main groups: those characteriz¬ 
ing the grand mal (major attack), the petit mal (minor attack), and the 
epileptic equivalent (psychomotor epilepsy). 


. 


■ 


' 




:v J" 'i .t 





. 


; 1 '• ‘ . 1 ■ V rcr-, f r rv vc'> 






. ' 




-Cor n 



■ j ■. rt Uv k'V'Ck ::-V 



.-./•j :i . '■ / ’ : Jo' ' . / • ' : • , tloT 


'.to i:.., l:\ i' : - ’ [ ■ oj; :».’V- > i -.v. 

. :■/ • • ( . 

liiVickM;-;:) 7 ;; ?::~r :f .f : 3 i; ; t • iX-fi 'fi •*/ \;\ 



0)U r J.: x , {i'o tfjv, -vcxx ) lau'rj, :>'uf. 


■ v 





The grand mal attack is characterized by the sudden onset of 
convulsions, toich may be preceded by either a vague or a definite aura. 

In some individuals the onset is heralded by a headache or nervousness, 
whereas in others numbness or tingling in particular limbs or visual 
disturbances occur. The actual attack is sudden. The body becomes hyper¬ 
tonic and rigid and the jaws tightly clamped, the pupils become dilated 
and fixed, and the face congested. Following the tonic phase, which lasts 
twenty seconds, is the clonic phase during which the muscles relax and 
contract rapidly and there is usually loss of bowel and bladder control. 
Following the clonic phase the patient becomes exhausted and stuporous, 
after which consciousness returns and the patient complains of a severe 
headache, which may persist for hours or days. 

A petit mal is usually of only a few seconds duration during 
which the individual loses consciousness, but doesn*t fall. Following 
the attack the patient resumes activity where he left off as if nothing 
had happened and has no recollection of the episode. 

Epileptic equivalents ere characterized by the performance of 
purposeful acts, some of which may be violent and of which the individual 
is unaware, 

A great many well recognized conditions such as brain tumors, 
trauma, cerebral vascular accidents, congenital brain defects, toxemia, 
cerebral edema and asphyxia may produce epileptic symptoms. However, a 
number of cases are without demonstrable etiology. Treatment of such 
cases of idiopathic epilepsy is extremely difficult, and is impeded by a 
lack of knowledge concerning the physiology which produces spontaneous 
generalized convulsions. 


. 

'V; J * ,t\ . A ; .1 \A " J I ' l ’ ,"LY.V . U.A.' 


. o .': r : : .l 

■- ■ • •; ■> v ' .: ; o' 'i'.j • i .<.1. hv *< AoA; •-/re a 

■ ( V 

", . ■ ' A. V: * J- ■ 0,.A S. .* V -A ‘:SiK ■ f I 

A- ■ c 

C A -.-.AA • :A: ;AA y\‘ ..t -:o O'rnAi. ' BOK'Ado :>.? Av 


. 

', .A ■' 

AA i : ; . i ; vJh!;'A •. •?/o A ■ hi .. S:. AaoA'fnA 

.< Aj . . 

' A A 


..A ...• ... -i;: t bix'O^i "/ , i 

. . ■ 

AA" •; A/ o 'io ' :,. r . •/.; 1 1.- ' . ' ■ 1 1 ’ ;J: v, ,.’*o -vi^ac o 


j; J'-'-. . : J - ' AA ;v\ : : < -* r CC'.L • .,A AOT re:..' o'i 

;-V • ; ;> ' , ‘ ' • • n.-'. t i : ' . • 



, ■ ■ • ; r f . [ ■ . .. j ' ' . )-b V.’-- ■ 


rs •• ; .>nco :>• -v . no '.::o I.;-.::: A 

3ai-o.£i;oq . 

... J ! ....... . o ’ r J 


• .... .J-.£ . . ■■ • ■, , ; : ■ •. o A : . J J v.; :.o v A ■ : u A 

, 

10 : V 

■A •; • o- A. . . • ■" •. - j ■: ' At . oil,; 


A;.: A A. r' .A . AA A....' . . .j : ;■ A AAv : •> ' c •. i •" , ' i::‘l 'O :o 

• ' . A: 

, / A . ’ v:;.r .: . ; v. A.' : <■ .A ' A 


, -A ... , . 



, OiA ; O • : • A ; •••. r : ; I 0 





: A • . A : ol ■ c ‘ ; :o 


. :o . '...... 1; :1 

. i i 



115. 


It is known that epilepsy is an outward manifestation of pro¬ 
found electrical disturbances of the cerebral cortex, and that there is 
a difference, even in the asymptomatic state, in the electroencephalogram 
observed in grand mal, petit mal and the various psychomotor variants. 
These disturbances are thought to be due to a defect in cell membrane 
function or structure (377), but the exact mechanisms which produce the 
disturbed electrophysiochemical activity underlying the condition are at 
present unknown. Many phenomena have been directly associated with the 
production of epilpetic seizures. However, only recently attention has 
been directed towards endocrine relationships to idiopathic epilepsy. 

In 1931 McQuarrie and Peeler (378) introduced a test for idio¬ 
pathic epilepsy based on a susceptibility to seizures following a low 
salt diet and acute hydration. It was later reported that increased 
cellular hydration lowered the seizure threshold (379) in electroshock 
and drug induced convulsions, and that changes in extracellular fluid 
'volume when accompanied by changes in electrolyte concentration had no 
effect on such thresholds (379)(380). Later work suggested that the ex¬ 
tracellular sodium (381) and chloride concentrations were more closely 
related to seizure thresholds than several other factors studies (382). 
Cerebral excitability was reported to be related to an increased serum 
sodium level similar to that produced by DOGA administration (383). The 
implication that the susceptibility to convulsions is related to such 
phenomena (384)(385) suggested the possible therapeutic value (383) of a 
hormone such as DOCA, %ich causes sodium retention (111) (133) and helps 
to maintain the extracellular fluid volume. 


' fi : r ■ i: *i.; / .• v i ■' d-I 

■ J ; . n J. 

ii.-r ' i ■ . : •'!■! ■■ <: . • ;Vi'v 'j. fi.iVj e 

.. J r ■ 1 ■ - ' - f r ■ • i 

■v. i • . j <r , ("'7"; • 7 •; \ /:-■' 

• • r no.:.; * . r: ..J ■ n. r ..-r; v-t.fv/J'O i «he 7 . ;vd.;o € Tj 

.. 

. 

'-n/; 7: \c\ ’) ; j ■ • *>.; ;< 7 \ Vi) ■: r . ■ 1 i'7?I «:•! 

wol * nx-.;o ».-.c >7 ; •„ • : ‘..-.5 <.7 X 1 .i .tt rj c- Vo.U oj:^^ 

. 

;-bo/L:U.v: r d-o.v..i:: ;;1 ( / 7 .j .7 ■ *• I.. a . . j x:y.x\ r / .Lh;‘.r- ; ' t 7;j ' S.vv 

. hj .. .. )..*> ■./ . . • oc - 

O'T Iwi* nerd’. iv;J' roo, *c-o ■ J-7' - 1 - • . ,: • • ’ J ,■ ' .1 n*ja. ; .u^jSa/7 

. 

i '• .7 >. 1/7 .03 '.;7 r ILx> ■■■/ 

. ( ) 1 7 ■ < •' / ■ ; 

' 

... 7 . •, ; • ’. • i.: 

. , .: •; . .. ■ .■ . 7. f . i :1 

. -O ( )7 ■ :■ . • . } \ ; ; • : • • ■> 

. .. 




116 . 


The anticonvulsive effects of DOCA have been demonstrated re¬ 
peatedly in animals (381)(386)(387) since McQuarrie et al (377) reported 
that DOCA protected Wo patients with convulsive disorders against both 
the convulsive effects and alterations in electrolyte balance produced by 
pitressin. Aird (141) using sublingual DOCA in propylene glycol failed 
to confirm these results (377), but recently he reported considerable 
success following the use of DOCA tablets in epileptic patients (388). 

DOCA has been noted to increase the threshold to electroshock seizures 
in the rat (255)(399)* an effect which was surprisingly antagonized by 
ACE or ACTE (255)• In the cat DOCA afforded protection of limited dura¬ 
tion against convulsions induced by cocaine, but not electricity ( 14 - 1 ), 
and in the rat prevented both the convulsions and pulmonary edema after 
metrazol treatment (400). Such actions resembled those of DOCA, in pre¬ 
venting water intoxication symptoms ( 401 ) among which are violent con¬ 
vulsions. 

The relation of DOCA to seizure thresholds is further indicated 
by the fact that the alterations of the electroencephalogram are similar 
in water intoxication and in epilepsy, and certain phases of the former 
can be relieved by DOCA (402). While the beneficial effects of DOGA in 
epilepsy (377) (388) have been attributed to sodium and chloride reten¬ 
tion (377). Mo*recent investigations have suggested the possibility that 
the reduction of brain potassium (403) induced by DOCA may be responsible 
for the anti-epileptic phenomena. Evidence supporting this thesis has 
been presented by Cicardo (404), who demonstrated elevated serum potassium 
levels in the longitudinal sinus of dogs during a seizure. Micro incinera¬ 
tion techniques have shown that the loss of potassium during Seizures is 


. 


> / 


■ no.77; ; 






"j ’ ‘ 77" !. • jXJ'f'.O lIT 

■■ •}'. • ' 


' ' j ' 77, 



■)( 


0 } (tLPj -) x xTsiar. rd v.’. ^ 









• ■ ■ ■ • J' ; - ■>: - '7 ; ‘ ; 7 ;,1 





i 




r ' ;.!■■• .Lio 7 v’X :;IirV!7(.i . ' . :J ’ 

■ 

Lo O' 


7lv70*'7 

... .f r . 




7 1 > j ■ s. . » : ; : ) 




-.. u i\'y r "i 





7 } ' 7 ' ' JXi'i'^XOO 0«t 

• 





';c ■’ r Lo ':',n.b.’07io'^ 777 ■■ 777 

1 








' ' )()(! 

V‘ '7 


• 7. ' ' 






. 

~:r 7f.f5, : ivy 



':J X’v r 


. 



■ ■.ii’7... -o ; i\ 





„ ': ; ? O ; 


l) : 7 


i.j.. !!■ 7 ': :. . 1 '7, 7 77 : : ; ii< ,i.t 

,;.K; 7 


' 

■' . .77 ■ f f 7i 


' 






. • x O 


• 7. 

- 


.i ? P, 

. 

'.'no .7 


• 7 n 














. 

■ 



"7 - : 7:'i • 


■ 7 . 



. 


?r r 

n <■ 

X V'7 7 ’).■ !■ >7 , 



7 H <:, 


-j: > J* -J r j 7. 1 - j ; f 

■ L 7 


:i:o 

: i ; ir .X'7 

. 



7 : jro.'iu••codvi.t Txivvx jtX 

id AIKd. 

70 

77 7 ■ ; 

'7 7 7’7' .''7-. 



• 


,f. ' \ v ; . 7 : ; r J7V7.rI.7‘l 7' r 7.7) 


7.' : j.*7:c.7 i ,i:x 

.- >.; 7 77 i .,7"'C 

3 

' . ' 

5 

7 ' s 

■; :'•"•/i.’iji ( ocx,) (VVx) --"l. 7 7> 



:<;v 

' 

7:' ; XV-77 •' 

rrQ ■' '7 



* ( 


e..- ■: v ‘ .J: : • ;• ' rd:vxL lo nc JJo^hirr ,i-.y 

’ . ' ' : : 1 ' t; r . B ! . j : j: . .. ■ 7 ; *IC": 

.v: >. v [-» . yv;-. 7 xl'-• 7 • xb Oi b,f t (,Vyj ofri.'JOiO \:l b 7 77 777 • fiend 

■ ' . ,7 ' V, . . 7 ' & 7 , . V - 

7 • 7yj :j 1 ' 7 ■;y'7 , 77v.\-l‘c v ;' dr ' ::cx odd , 77,7 y-oih xvxu xx.r x/ricxxt no.LJ 


117 


compensated for by a gain in sodium (387)• Further low potassium diets 
have been shown to protect rats against audiogenic convulsions. 

Although no comprehensive statements concerning the role of 
the adrenal cortex in electrolyte and water metabolism in the various 
convulsive states can be made as yet, the possibilities are intriguing. 

This is particularly true in view of the accumulating evidence that the 
cortical hormones have important functions in regulating the electrical 
activity of the brain (126). Desoxycorticosterone glucoside (DCG), an 
active water soluble preparation of desoxycorticosterone, has been shown 
to reduce the electroencephalographic abnormalities of epileptics (388). 
Further Klein et al (405) have shown that DOGA and AGTH have similar 
effects on the electrolytes and encephalograms of patients subject to 
convulsive seizures. Considerable electrographic improvement was ob¬ 
served by these workers following the use of these agents. 

In view of the paucity of clinical material reported and the 
increasing interest in the neurophysical and biochemical mechanisms in¬ 
fluencing convulsive activity, tais investigation was undertaken. 

(b) Special Methods. 

Several specialized techniques, not previously described, were 
used in this case. The electrolyte composition of feces, a full day*s 
diet, and sweat samples obtained from the hand and forearm were determined. 
The sweat was collected using a modification of the technique used by Conn 
(144 )t and the diet and feces specimens were treated in the manner of 
Wallace et al (337) • Flame photometry was used for the sodium and potassium 
determinations, and the chlorides were measured using the method of Schales 
and Schales (332), as modified by Schales and Schales (406). A cellular 


. 


ovvt 

fir 

' ■ 


; - 


* 

■ ) 

rfU 



f j ' ' 

-.3 oc-b b-'j 

■ • 




. - 

• 






=.toT'-_ od* 00009 r. 

i -J 

•" ■ 











•7 






.* r 


b - ' " 







• 




, 7X00 






: « 





• -t ; ro 


' 









. 




’ 







••r <■ 



;• '•b' 1 • V 

;• d'oV'.-rrv 


. 


■ 







o*> 



4 

Vi 

■ • ; f b 1 lo 



HOC J 

;o Gti o , 

O.. '■ o' 








-<Z : 'l •]• 


Vb’o 

■ 



* 





■ ' ot 

- • o 

■G-td*!’! " I 0 jit i 


■ 








0 : 


V . 


■ 



p.t 




o 








• ' :r •> O' ' 70 "t 




. • til / : 

■ V ' 










l .. . 



• 


. ' 




• 



o'. • ", ’O' :b 

Glut 

O' 

bob’- 




■ 






be oo 'v o 



• • si ' O-" ' 


I 




007' 





' D ' 



no: V'O 

bo : ■" ; ; 

‘ 





Jo t < 



' ' ‘ . ' v re o ' 


' 


. .• or b ( ) 

OHO'sr » bio ..boo 30 b ■ :c V." o . too bo.Ooj V.-t:' Vo v '■ ’ o : -o-b 

b / . o b 'u ■ b V ■ ••• ' o - ' : . 

jena.f-’jso ro o ;.v oob ;o ■. bob I - o ■ b r : V b- " oo ! 0000 ’ f ’ ..too 

‘ 

ucO b o' bi ■> / bt ' o o. ' b o VI t go : '"O / oo b ooltco - ’o irvi of 

Vo •: V. -.-.jo. 4 :;; oob oroooob booot •' • •: tott fi V Vo , , 

oVOo bo b • ’-Vo ■ V'y; o *:<■ oo- o ".0 V. V Gor bo - ono.lt. o: b o to 

OO O ■ ' ; ■ ■ Oo • ^ : / ' ' •! : ' . t. ) O •' ■: '• ' " '• 



118 


potassium determination was performed on centrifuged erythrocytes, which 
had been hemolyzed in sodium free distilled water* Electroencephalograms 
were recorded at appropriate intervals during the investigation of this 
patient, and at least one hour post cibo to avoid the possibility of 
hypoglycemia* 

(c) Case History #81123. 

The patient, Mr* M. A., age 49? gave a history of convulsions 
at age 1-J, following which he was well until the age of 24 when he was 
thrown from a horse and dragged some distance* Following this episode, 
which according to the patient resulted in a fractured skull, he re¬ 
covered and remained well for a period of six years at which time he had 
his first epileptic seizure. Two more similar attacks occurred during the 
ensuing year, and gradually throughout the next seven years their fre¬ 
quency increased. At this time the seizures occurred at regular inter¬ 
vals of ten days when he would have four to five seizures on a single 
day following which he would be seizure free for another ten days, when 
the cycle would be resumed. This pattern continued until four years 
prior to the present admission, at which time he was hospitalized and 
treated with dilantin. Following his discharge at this time the attacks 
became progressively less frfqueni over a period of seven months. He 
was then free of seizures for eleven months after which his attacks 
again returned four to five times a day at two week intervals, and to date 
this cycle has persisted* 

The onset of an attack was usually heralded by a frontal head¬ 
ache which occurred from twelve to twenty-four hours prior to the convul¬ 
sion. His aura varied, but usually consisted of a sense of constriction 


, ■ :■ ' J ' -■ ' 7 T.‘ •" '/ 

.. • . : .;i : f-'J • - ■ ;■ , ' 1 ' ■ 7 7 ■ ^ ‘ "j ■> ' r " ' ; r 7 • 

: .. /. ’ . . / 'l ■> ■: ' *v • sir, ' • •;.©•? . 7 ott 

' < v '■: x l ■ / ... ■. • J ' ■ r» ■ . • l 1 

• ^'.iO , 

... ; ' ; • J : : i *, 3 ' J (*>) 

r r - .... 

.7 rtfr'iw ; V 7 \U ' \ ■ - .1 /' '/t; .U •: ' •• 7.7'.. !f±' ’0LC0I ,vl Wr. .J,.'; 

r . • ... . v . • • ' • ! • • !"'. 

■ ..i ; ■: : » \ . . 1 ’. ' ' ' ' ' . ' • ; 'roror * ■ 

777 off (;;•<!'.M 7.77.77 ■ v f 'fit' ■ ;U; . . ■ : ■ 71 T rr V. ; , y‘o'> 

OfiJ- ; 77T7) OC r,r ■■■ 7 : rb'k'^IXL>r‘ ■■ Ti:l 7 .; 

'll iTMid jv: n ■ i‘,' irc;*ral•> \i-i f *x$©Y. Srtlus- 0 

.'j. ,; i \ 7 ■ 7- • ; I 5 . . • ■ r , ■ T¥ r 07 > 

ol nil (to ■••7 M'.'o.r •• • ! ;t- -:o 

rr : . " n v -c> i‘ "■ • 

. . a 

,t a ■ t i ; • ■ : ’ ■ . . . ' ' ■ • ' ' "t V : 

■; .To ' . ,,' £ i Jv - v ' : '. . ’ '/T 

oK . ,;?ij ■ a v . : .■■; ; - . rr. • ' ' '/‘ c: 1 ' f -.i‘ 

eio riji) rb\ •: n^v-lr -tel T: •:.lo rtoild* r v.r 

•. / . • : ; . ’J' •¥■ r-,.:, ; ■ t ■ •, : • /' . 0* ‘txrel ; >rr 7 '..i fr.’vr^ 

/ ,L0 0 T .* ; ,J 

•••[)••) 3ii .i...; 4 ; n'oT';. •> f rl-:n>L 'v 1 'i??•,,; :J-j ;J J- *, HT lo i^anro orfT 

* 

-J.:. 7-':t" vuroA o-i evlvw ,f f ■■•i:’.':- bs^rnroo© xf:.>l.,r[-.v orlo 3 

'> ' : J: ; . -.ry, - ■; .• ';/> : ' •• t ijij . ■ .77 v \ 


, 




119 


in. either his chest or "stomach” followed by a pain at the back of his 
head, and a "burning sensation" at the back of his nose. Often he 
managed to grab his nose with his left hand before losing consciousness. 
His head, eyes and the comer of his mouth have been observed to twist 
to the right during a severe seizure. The convulsions were generalized 
and lasted for about five minutes, during which time, until recently, he 
lost all sphincter control. The post~ictal depression was characterized 
ty weakness and a headache of two to three hours duration. 

The patient gave a history of nocturia and a siBceptibility to 
infection, having had pneumonia, six times, peritonitis following an 
appendectomy and frequent occurrence of "sinus trouble". In addition he 
claimed to be allergic to cattle and dust and to have "asthma", which 
was more pronounced during wet weather. The family history was non¬ 
contributory. 

On physical examination Ihe patient was suspicious and moder¬ 
ately paranoid, but was co-operative. He weighed 57 kgms. There was 
slight injection of the phamyx, tenderness of the right maxillary and 
frontal sinuses and moderate turbinate hypertrophy, although no post 
nasal drip was observed. The thyroid was slightly enlarged, but was 
freely moveable. The chest was normal, and on percussion the heart 
showed enlargement to the nipple line. The blood pressure on admission 
was 142 / 104 , and the fundi showed some arteriosclerotic changes with 
venous dilatation and slight A.V* nicking. The heart sounds were of 
good quality and the pulse regular and full. The abdomen bore a midline 
scar, but was otherwise normal. The left ankle was inverted slightly 
and shoved marked limitation of movement as a result of damage incurred 


f y. '• . ' • '■ ■ • ' c : ; " v. •-.u< n ?. ■>: \ . 

■ ' ' ' :■ • - . J ' •' >: ! 

J ’ .. • ■ -j b.-V’’- '■>. '■ .. ,'V •: : f. . > v ii 

" > -• .. ■,'■■■: • . . • r. • • ■ ' / . ■ . ! . :l do i.-u 

, •: r; : ' - f : ' . ' : ; .:>• ' w '■ to’; ')•: t•: :I " ft-*. 

.] ■• 'c ..i ; v; ■. i \• .j ’’ . -i • v :• T-^ch. ~<hk 2 IL:' 

, :r. , r cJ' ov 1 ' • ; ■. ■/' ■ br-n 

c ■ I ■ • ' ’ • . ' -• ■ ■ ■■ • rr 

: i ' < . ' ' ' . ' J j ' r . ‘ ' ! 

I, '-■ ? . . ■ 

!h‘::w f :l ■ " -v.-. . / ., ! ,■ * ■. :-.i 1 J .. ’ •*, '-j.' *r,r 

. : act 

. ■;*}0-y •o 

‘ ■' .'b’Ol J^ctq f.[0 

- ■. V . • ' : : ■ . • . : , v • / J • 

h.-i ' h : ; • : . .^.rr.c C c nc-rjoftf/ - t -U r: 

o. if il 1 ‘ .T. ■ . ’ i ^ ‘jsry\i 

' ■ ■ ' , ' ■ ■ • .[ ":■! •: 

r . ■ 

,, w ;; » v - < C . ' -• H . ' )S 1 ■ ‘111 ho' VC'fe 

: : ■ TV ;■ I ■ : • • •./ v ■ ■ . ' "• r 'i ''XCi\l.'..! .■ 

: ' \ 

■ » t 

• ' . 1 . . ’ -i r .• ‘/v; 

b ■ ■-» v ' ■■ -f J b':' ; ',’i I):.: : r { , :l> 




120 . 


when dragged by a horse. No neurological impairment was noted, although 
all reflexes were hyperactive. 

Routine urinalysis and the hemogram were within normal limits. 
X^rays revealed no abnormality of the skull. The electroencephalogram 
showed a fairly pronounced generalized cerebral dysrhythmia, which was 
most severe in the right posterior head region. A pneumoencephalogram 
series done two years previously was essentially norms,!. The patient 
continued on dilantin (ij- grains t.i.d.) and mesantoin (100 mgm. t.iid.) 
throughout the entire investigation to obviate the possibility of status 
epilepticus occurring. 

(d) Proceedure. 

The investigation to be described (vide infra) was carried out 
in three stages during which the effects of pitressin, diminished water 
intake and cortisone were observed. Initially it was intended to repeat 
the work of McQuarrie (37*)) following which it was hoped to observe ike 
effects of cortisone in epilepsy. To this end the patient was studied 
for a six day control interval. The observations made during this 
period suggested that the patient had diabetes insipidus. To rule out 
this possibility, studies with DOGA were postponed and the patient was 
observed further with no change in therapy. Because of persistant 
polyuria, it was decided to observe the effects of pitressin on the urine 
output. The results of this test suggested that the patient was not pro¬ 
ducing sufficient enddgenoug anti-diuretic hormone. 

During the second period of investigation the pitressin test 
was repeated with essentially the same results as before, Although 
oliguria was observed, there was no alteration in the patient 1 s desire to 


. 0£ 1" 

■ ■ 1 • ! . > .‘V c>]i 4 • y;.' h ■ ..vr : t ov 

. 7 / ' ■ :■■“:[ r,i '• : L ; 

‘ 1 "V ‘ : ’ ‘ 

ii i ! ' • ; r ' . i. : ‘ ' '.o . ■' ' ,.r' V' 'vyv. 

’ '• ■ . ' : J. ) ' > i ' i..)I 

i LfOJ '■ ■ . t ■ 

■ • ' - • ” ' : . 

i 1 « ' Z ' i ’ ' ' ■ i - J V 0 , U ' HI i . • ; \ ■ ’■ 

. • o 15 ; > •. - 

. ■ .“OO'ti ( •■}■*-- 

:;o btri’izo \r>„r uvAv) ■, ' o-'' rx icf r: i ad r £ 

* ■ Ictxnl ■ ri . I >' 03 *' < >1 $l ' . i • f : i 

i x :.0 :• ' v . . • ■' : !\ ■: ■ 1 

fuJ' cv.;'-a io •' ./ s) h :: ’• : : ■ ’ ' 'o.Qx'i (' ; 'ic ;,K'- '. - 'J" 

j O' .I j •' 0 ; ’j J ‘ ;:1’ C fi:7; id'XO 0 -G ;-C J 0 lYlC ' 

' ' ' i' : ' ' ‘ ' ■ - r . ii'.' , J..: 7 ■ j l o ; • :'' ■ 1 

’ '..cl; 


- 

7> : J- Jjj.;.'.; Jy -v 

A 

:yr.+ : 

i -7 : 1 ii;’ 

■ U i ; 

f X3q 15 OCjrnoi;! 


. t. 

■;:o >ii' :"l v ■: aco 

U :,fl- no 7 

■ J 0 

ii.:!' v . :: cd' r 

h07.,' 

': . •' • • 


: 7: •; i - ' ‘ : J : " ;jV . • y. y 

. ' J ' ' rc vs., j ; j r ' . ‘.'i.r.ci " ::J :j r '; 


" y ■ :.y v". y.'.yyr; i; ; . .; -y J ..!.y ;r . 

- .. t .vT ■■■•"/. iy.'. r;i;j -;) J. j 7 y ; y? ; ; r .yy • J' \y.:' -t rv3V 

77.;. , •. . : ■ r , .7 '. CJi 7 7;.J‘ , 7;V.:._ J '■ • 7 '7 'j. -'.T ; X.Lo 



121 . 


drink water. This suggested that this was not a true case of diabetes 
insipidus, but that habitual intake of excessive amounts of water re¬ 
sulted in Hie observed polyuria. To test this hypothesis it was decided 
to restriat fluid intake to about 1500 c.c. per day (including water of 
oxidation and pre-foraed water of food). Observations were carried out 
with this regimen for ten days following which the patient was discharged. 

Following a one month period of observation as an outpatient, 
he was re-admitted for study. The low water regimen was continued and 
after a control period of one week cortisone was administered for thir¬ 
teen days. After cessation of therapy the patient was observed for a 
further six days. 

(e) The Effects of Pitressin on Epilepsy. 

(1) A Note of Explanation. 

Usually in studies of the sort described, the urine investi¬ 
gations are performed upon three day pools. It is obvious then that in 
every week, one day could be permitted to pass during which no analyses 
were done. In the previous studies the dietary intake and therapy re¬ 
gimens were maintained constant throughout this day, so that the balances 
would be unaltered when measurements were again begun. It became appar¬ 
ent when the data described (vide infra) was studied that some additional 
intake of the measured elements was interfering with the establishment of 
a balance. Careful questioning revealed that the patient had been fed 
routine hospital diet on these days, thus accornting for the peculiari¬ 
ties of the curves obtained. However, the data resulting from this per¬ 
iod of study is reported, as it is believe that the effects of pitressin 
were unaffected by this error. To confirm this belief, however, the pi- 


. il 


■ 

' 

. ■ . ' . ' ' ■ , v ; o \ [ • !b rd > ■■ ■■:•. 

bo T J ; - ' 1 ; . • . ■ •: o' ' ' ■ 1 ■ ! ' I. O'' •C-j 

brio; • - . (boo' . ■ ■ 

V000.0 ■: •: bn , V ■ ■ : .0'' ; V n • 0 ■ »‘c.' V . •; V.b ;<j / ■ 

■ .cl ■ V ! ? ■ 

■ ' . ’ • ■ ' ' ■ >.? ■ exi 

’led ib' 5' ; i . I I ■■ * ( .. •' V ■ 1 ■ M 



In v : 


' •/ ; Oi’ j ; ‘O. : 





•X9vf 1.,'' 

• O' V 









• 

i d ■ : r b 




. 





•? . , ' VO. 1 

V w- ? .... 

: oiT (?•)) 









0 be- H. 

A (X) 

- Wo ov; 

'd oni’xu ( 

..:;'■ ,'V:,.' 

•bo-.; V. ■ 0 ,; 

1.0 




V Lar- 


ill 0.[«.)' 

s&esfj guv-.: 

K'Td 0 ' J; 

, 

it 





i • ■ 0 zaoi&ns 

joviV:’r>.: 

3. on iio b v 

;■ ■oo.V-.U't 

) fOOO. ' .’J.i ■ 


' iB 


V- r - r oo % 

•b oao 

r b VOOVO 

-■>o: O' 0 

■ 



. O-fe 



■ :r ■ 

mb! rxl 

« 


a;3 k j c': o;;oj o.b.b V OvV ;;r ■ •. J j-;:b - ; ■(-> vo'. bob ;.o. rooo nrio/.u:x 

■ "‘..C bb id. iy : } • ;• . "•;...‘X9d'Iruicr 0 ; JbltSOW 

1 '£>:v. o'; boob V: V ', i bobob -hs.v) 'V box ; 001 dj rid r led: cfoio 

: i'j ' ' ' i B I i . . 

' ' V • . 1 ' ■'/ J r, O' i ■ 

• • ' ... Vbn.no. . ; 0 rb n.V nooo •. nvo: ,nn;ob 0 0 lj o;, b.bn- : bo n:<b onbb.'O 0. 

- 

■ ■'.'.'-O'; Vo:: 00>o‘ Vo '. .i.iV d' 0 b' "V ’. ,:V 'V. -VV 0 0 bvXi" '>. 0 o' vVooh'! ’10 box 

! ■ V V t on v u.; 0 ;: ■ •■ obob' <■■■ '' o c/d ,/-< \ • . , on h-\tooT.rmf Mon. r 



122 


tressin test was again repeated at a later date. Further, some of the 
electrolyte data is of interest when considered as an adjunct to similar 
data reported later in this paper. 

(2) Kesults. 

a. The Effects of Pitressin on Electrolyte Metabolism (Fig. 28). 

i. Sodium Balance. 

Throughout the control period there were no pronounced 
disturbances in the sodium balance, with the exception of those attri¬ 
butable to the excess dietary sodium obtained at the beginning of each 
week. 'Where daily balance determinations were done during an interval in 
which convulsions occurred, there were no significant changes in the 
sodium balance. During pitressin administration, however, there was a 
marked diuresis of sodium, which was greater than any sodium loss observed 
during the previous three weeks. After cessation of pitressin therapy 
there was a positive sodium balance for one day following which there 
was a slight diuresis of the element. 

Serum sodium levels (Appendix III, Table 5) were elevated 
throughout the study except during the initial control week and the day 
following the pitressin test. 

ii. Chloride Balance. 

The chloride balance closely followed that of sodium. 
During the control all changes observed were attributable to the error 
previously mentioned (vide supra), Convulsions in the third week resulted 
in a diminished output of chlorides, and on the day following there was a 
slight positive balance of the element. Pitressin administration re¬ 
sulted in a pronounced diuresis of chlorides following which there was 


) '..Li.- ' . \h, ■ • t " '' ! ':J • • ' r*. T :■ 

•f - ." , j j ■; : b ' . ■ 7 vi • ■■ j .7.7 " -J . L • - \U<’c-io >JC •; 

. . ■ 

, 

. 

- - j i.;:. m t (•.< •: * ra .• I" r : - ‘' f/ > J'L-J ■ d; 

• i'i .'.J ./ r - 7 *: - c; • . ,r n.f j. ‘-i b 

j ■; ■ L'o '. 7.i ; b •> :> ’ v. - r\.v' ’ \ L r D 3 oiC ( ■./ . 

. 

■■■ik’j n-r 1 .:; . ; ' : oo :-;nc.' 'i.b.Vf.;: o . " 

: ■■ ■ -.. . „ ■: .- . . ' • " ' . - . . • L r;; ■, ;■ 

;0:.V'::.,:V-0 77,;7l >7.7 7 •. : • > '. i " ' • • i • ;. x7; L, o:. ‘ l > ;Y.'f 

. 

■ 

‘ ’ ' ’ 

r )60';.v;; : .LO ■[ ; : •• .-V , :/L. /-I i ribo* 

7bb b.i ■ :■[•:. , ' b .■:» . ' i -f : xio-.xbr 

•. n.fc-,0 

.. 

.• . • ■ 

•• b-.y■ 7 ■ .b 7 iff go 73.777 -1 

...■ . : . : : . i -L ■ / 

ob . i,-- i';; <; ,_'i i'jX"Tu..b : o To bx.'ii'.. : i. ■■ " . 

. - 

■....,7 .' .. L ;:. J. - ' '.c , ..-n.i- x ■ ;:i b- .-b 














MR. M.A. 81123 
EPILEPSY I 



Figure 28. Metabolic data on Mr. M. A. #81123 
with epilepsy to show the effect of pitressin. 


C C C C C C C pitressin 



Figure 29• Idiopathic epilepsy #81123 showing 
the effect of pitressin on the urinary output of cortin 
and 17~ketosteroids, and on the circulating eosinophils. 

















































































































































123 


a considerably diminished loss of the element. During the last day of 
the study there was a moderate diuresis of chloride. 

Serum chlorides (Appendix III, Table 5) were within the normal 
range throughout the study. 

iii. Potassium Bdanee. 

There was a marked and persistant retention of pot¬ 
assium throughout the entire study. An even greater positive balance 
was observed during and following seizures. Pitressin produced no sig¬ 
nificant changes in the potassium balance, although the urinary excre¬ 
tion was slightly less than the mean for the three day period in which 
the pitressin test was performed. Following the pitressin test there 
was increased retention of potassium for a day after which a slightly less 
positive balance was observed. 

b. The Effect of Pitressin on Nitrogen Balance (Fig. 28). 

During the control there was a slightly negative balance of 
' nitrogen at the beginning of the first week, following which a balance 
was established for seven days. Thera was a slightly negative balance 
again during the latter part of the second week on no therapy. Seizures 
on the fifth day of the third week produced a negative nitrogen balance, 
which was slightly greater than any previous nitrogen loss observed dur¬ 
ing the control. 

Following the pitressin a diuresis of nitrogen of approximately 
the same magnitude as that observed during the seizures was noted. A re¬ 
tention of nitrogen occurred two days after the pitressin test. 




' 


X0U 


c; j. j; ! d vi . t. j; 


a,f 


Vi 




. 








j ij; • 


r -j; 


1ll ; fJ 


... •;,) v-r hxr.aj ■: & 


JJ lU 


0 




rfoi .. ' x 


D 


no id 


‘10 


tOXJ j ' - 


f 


. 


o 


(. ‘l. 


GO f : 


u 


0 iff, :j' 


.J .O. 




i& ; 


Of. xo . I V 


j ...; . J- J- 1 ii,i 


:oj 5 n 1 f ; v' r 


ID 


V 


) 


no 


-VL'J.0 




. IOO 


; t< 


if j lic/i 




. J : J 


U 


jo if ;CxJd 











124. 


c. The Effect of Pitressin on the Urinary Excretion of Cortin and 

17-Ketosteroids, and Circulating Eosinophil Levels (Fig, 29). 

Throughout the entire study there were no marked changes in the 
excretion of 17-ketosteroids, and all the values remained within the nor¬ 
mal range. Likewise the eosinophils showed no marked change, either dur¬ 
ing seizures or the administration of pitressin. The cortin values re¬ 
mained fairly constant (1.4 mgm, per twenty-four hours), until the third 
week during which the excretion dropped to less than 1 mgm. per twenty- 
four hours. The lowest value (0*54 mgm. per twenty-four hours) was ob¬ 
served following pitressin therapy. 

d. The Effects of Pitressin on the Electroencephalogram (Figs. 37-39). 

Throughout this period of investigation little change was ob¬ 
served in the electroencephalogram. The diffuse slow-wave cerebral dys¬ 
rhythmia (notably 4 second and reaching 120 microvolts) (Fig. 37 Tr. 

5 & 6) was not made more pronounced by pitressin administration, although 
the right sided parietooccipital localization of the disturbance was 
slightly less evident during pitressin therapy (Fig. 39 Tr. 17 8c 13), than 
in the previous records (Fig, 37 Tr. 1 & 2). Abnormal electrical activity 
was observed on the left side (Fig. 33 Tr. 13 8c 14) on one occasion due 
to release of the suppression normally present resulting from anticonvul¬ 
sant medielation, which was omitted by the patient prior to making the 
tracing. 

e. Other Effects of Pitressin (Appendix III, Table 5). 

The administration of pitressin produced an elevation in blood 
pressure from a pre-treatment mean of 125/39 to 131/93 9 and a marked re¬ 
tention of water which resulted in a weight gain of apporiximately 1.2kg. 




; i ;.r : 

. ’ 1 

. ; . ‘ ■. v. . : 

:■ •: . f :• - ■; • ./ ; ' : • '■ : . -a ;1 

. v. r i v 'io r:o-td'.''.T0X9 

. ■ V- ' . .! • ' ’ Cr.-; ' : '• ’.Y. - ' If: ’ 

• ' . ‘ " ‘ ‘ ' ' ' ' 

. ‘ . . * 

’ H;.M ' ' ' . . I ' - 

' fa : 

) ' . . 

• • ■ ■ : .i..•; 'J 1 < j ■ - . . ‘: \ O' V J 

,■ T Y '■ ' ■ ' ' . ' f.Y Vi " 

; ■■ ,j \ v, , ' • • -'■/ : ' Y • • C.. ■:' -■ : " .• 

'd\i\ r r'■ Yr ; . f : j.’r'^oY YoocJ <: bf-iY.’ -' ■ YY 

, *r' 

. ■ . 1 1 ■ ■ ■ ’ ' ■ : 

■ ^ ' a ■ v ; ,Yr . 

■ roY ■ Y; j;;: Y:; - •/ - '.liwrxoa orld* lo e ' yY oY 

<YJ • Y:•’ '. i - Y Y Y • • \ YY ‘;:-c ;v'. r YYifvr t xroi'u-ioiben drtsa 

. 

. ‘ Y c ■> ‘V'" ■■ YYO . 

j . . • 

' : oJ ■' lo. r 1 ) : ■. J : ' 

. . ■ ■ . 




125. 


(3) Discussion, 

Although the electrolyte data was difficult to interpret due 
to imperfect technique (vide supra), it was interesting to note that 
results similar to those reported by McQuarrie et al (377) were observed 
following pitressin administration. The diuresis of sodium and chlorides 
(Fig, 28) is particularly noteworthy in view of the fact that the effect 
is opposite in direction to that observed when DOGA is used (407). It was 
this observation that led McQuarrie (377) to the clinical trials of DOGA 
in the therapy of epilepsy. The retention of potassium observed has also 
been reported (377) to follow pitressin therapy. That this occurred at 
a time when there was a loss of nitrogen suggests that these two actions 
were independent. A similar independence was observed during the occur¬ 
rence of seizures, and is at present unexplained. Further the retention 
of potassium observed during seizures is incongruous with the findings 
of Gicardo ( 404 )? who noted an elevated serum potassium during a seizure. 

The drop in cortin (Fig. 29^? which occurred following the use 
of pitressin, suggests the possibility that this drug inhibited certain 
functions of the anterior pituitary. However, the results are incon¬ 
clusive as the depression was not marked and, in view of the previous 
downward trend, may have occurred in spite of the use of pitressin. 

Pitressin was employed t o determine whether production of the 
posterior pituitary anti-diuretic substance was adequate in this individ-, 
ual. The retention of water accompanied by an increase in weight sug¬ 
gested that the production of this substance was inadequate. However, 
the possibility that an excessive water intake was perhaps responsible 
for the large urine output initially observed still existed. Further in 


* f?'.. : •a/’DXXCI (:') 

: J‘ 3 • : ■ f ' ■ ' x x ; .• .• J' c-Cs i ; xjxc.f'o' TA 

u - '• "/ « (.v.r-,;. t; ;AJ:v} o>-- i/xoi-A d'o r^rc/i: rA 

■■■ ) .. ■ / • 

’ i ' •' '• • .• . : ’ : .■, ' v v ‘ ; \: ' ' • • • nA; <-' r 

, 

* { 

a.OC'Ci. lo 1 JAx x ; .A. <J (VY \) xj'f'.r oY : Y ■: • jYv no id' ivvt^oo A 

fi ’■ ■/-’/■ :■■■' A ' •• ' i-" r " . .Y ■ Yo f f.J rj. 

x ■ • .'. . . •; •. ■■ ' ■, ‘V ; !./ * :• ■■ /•; x ; ' •' • ' 

rU' r OJ.>^3 .. j ::C; M J- x.' ; : jj < 'i j It Yc 3 3 3'.,! fX xx . fxYY JS 

' !. ' ■ >r ' '/ ' If 1 x ■ x\ ." ; ,r ; : t v 1 

f . < v..f t . lo ,©0H II 

. .. 3 r :ra : 1 ’iid" AY; roi ■ ' ' :;" : /fx.' ■ : r. ; : **v : ■?, o «.'J ‘ O 

- ■■ 

: > ' • - i. t : . io 

■ '.'J X/oJ'.-'r . ' - ' ■ , 

i . ' 

,, r ; ,J v ‘'ir.:.": a.o 'Xo 3:"C J ' 

■ 

art XV;:-'fC ' •: - ' , ' . /(‘ '. >h H 35 V XV y. r: i 

. . .. ’ ■ ' ■■ - ./:.:o . 

• 'Xi iS i 3'.-’ 3 rx'f.,:.;- i; : ■ ; J .. • c 3 fix ; 

-X Oif-i; r.s ’ • : ; ' , . .'if. oJ,v| xjrxi;--id'f:x,; ' “" ■ x 

■ 

. . : ,i ' ; : 

' ■■ x 1 ;■ '. 'X . : f >■ x - ;' '. j"iV : x. > . i -x 

. • ’ '.' ' : > " X i.r X ■ ■ ■ ' ■ _■ • ■ x" ".I • ; x 


126 . 


view of the faulty technique employed in this investigation, it was de¬ 
cided to repeat the pitressin test. If the results remained unchanged, 
it was hoped to prove or disprove the hypothesis that a habitually ex¬ 
cessive intake of water was responsible for the increased output, which 
was suggestive of diabetes insipidus. To test this thesis, a markedly 
reduced water intake was established and water balance studies under¬ 
taken. 

(f) The Effects of Diminished Water Intake and Pitressin on Epilepsy, 
(l) Results. 

a. The Effects of Reduced Water Intake and Pitressin on Eledtro- 
lyte Metabolism (Fig. 30) 
i. SodiaM Balance. 

During the control period there was a retention of 
sodium of the magnitude of about 11 meq. per day. Administration of pi¬ 
tressin resulted in a pronounced diuresis of sodium following which a 
positive balance was established. The low water intake initially re¬ 
sulted in an even greater retention of sodium than was observed during 
the control. Gradually, however, the urinary output of sodium increased 
and five days after inauguration of a diminished water intake, the patient 
was in balance with respect to sodium. 

ii» Chloride Balance (Fig. 30). 

During the control interval a diuresis of chlorides was 
noted. Pitressin caused a slight reduction in the urinary loss of 
chlorides, although a negative balance was still observed. Following the 
reduction in fluid intake, the chlorides closely followed the changes ob¬ 
served in the sodium balance. There was a pronounced retention of urinary 


: V : ■ ' * fc? 

, ; r 3; .. ■ . > *'a <a<:t VI aae nj ; iVaeae.a:. obi Vaac ear oV VoVIo 

~ ’ 1 ’ '■'■■■ ‘it VC ‘ ! V J" ■ . : 

I'. L-. ' , a ■/•:< ■ ' 1 'Wane, o' aa r V, ■ Wo c.J slrrl . a. o 

1 i a , : ,.y ■J V I , . . :a '• .V J •: r '■ j a •’ Vr c vaa ;• 

jxri.r e Woe' " os • aeaV a.'W': a vvhv. 4 a eV oaeV vod .-v x : x .ar 


. 

, Vooe.j-VcvV fjo rVao .m II Vai m. V , V; Vi;eV.. Vo .Va'VVa' oVV (';:} 

,R«U0O (I) 

craVoolV' rev;'.:; aeWv' ' oa • V a: V • ^ j • • oa o . lx, " 1 v ‘ .‘IV' ■ ifT . a 

. " ; * ■ ■ a 

:i j 

X olo lit. J.u'rr .a,---,: *, aav a: a'a Vojear; Cc*id* -zoo obd' ^xsxnV'/I 

■* • V.-; ■ ; 0 V ■ „ . V • -a O . a V ;■ : V V ' / ■ a i o' 

f : ; o yjiM:c£So‘ i Lfx><i & ' i i v v 5 ' V 

■ ■ r.ui I ■ i l • 

' vman:r.o loVveavvo a a; lear’I raa 'oa Vo isf :i aVar Woo veV //tv novo no sea b^aj'Inr; 

• ' '. . ’ ' V:o V ' ’ . ... a , v. . Vee ■ Vi 

Vaa. 'V oiio oVV-V ' • .• V a V ; ■ a;: ’ I VU neeV *:a: x/.a; ‘ a:... I a a a ; V vj.V .aa- 

. V • V V ' 

: 'V; :aai.i-V;,;o. r a:./ Va :a VV I -vvoaaa.a VoaVaoa' ntJ ;; r: *' r ar.;VV 

. 

’ - : a ■ 'V. . V- s ■ =■ .• 1 •, - vl :■ a ■ s ' ;a :.,,a V . a ■. V a V Va 

" .'.a "a. ;.a o.iVVaV ■;! k,.« ■ : V. ; aiasvafaa:» o/.'.a oaa. a' . 'r raa aoiVva o 

: a ■ a ■ ■: a 1 . a■■ . a i/V ..-a-j . .a . ' : a i < \ ;.V ;.j. ; 'V"a- 








In.M A. 81123 



Figure 30. Metabolic data on Mr. M. A. #81123 with 
Epilepsy to show the effect of lowered water intake and 
Pitressin. N.B. C - convulsion. 


Mr. M A 81123 





TIME IN DAYS 


Figure 31• Chart showing the effect of Pitressin 
and lowered water intake on cortin excretion, and urine 
volume and specific gravity. 






















































































127 


chlorides, which gradually diminished during the first five days after 
the low water intake was begun. 

iii. Potassium Balance. 

Again a retention of potassium was apparent through¬ 
out the entire study. During the three day control period an average 
of 70 meq. per day were retained. Pitressin altered this state very 
little producing no marked change in the potassium balance. The restric¬ 
tion of fluid intake was followed by an increased loss of urinary potas¬ 
sium, although the positive balance persisted. 

(b) The Effects of Diminished Water Intake and Pitressin on Nitrogen 

Balance (Appendix III, Table 6). 

There was no appreciable change in the nitrogen balance through¬ 
out this period of investigation. 

(c) The Effects of Diminished Water Intake and Pitressin on the 

Urinary Output of Cortin and 17-Ketosteroids, and Circulating 
Eosinophil Levels. 

Circulating eosinophil levels and urinary X7-keto steroid 
output were unchanged by either the administration of the pitressin or 
the alteration in fluid intake, tieir mean levels throughout the study 
being 85 cells/ cu. mm. and 7.3 xngm. per twenty-four hours respectively. 

A very slight decrease in the excretion of Cortin was observed f allowing 
the administration of pitressin. There was a slight increase in Cortin 
output prior to beginning the restricted fluid regimen, and during the 
seven days following water restriction the cortin values were slightly 
lower than those observed during the control interval. 


77' '7 i 

' 

- . : ■ ' 

m>%(;; ' : ' s 

iifox-';! <>onr 

■■ ■ >' j i i. 

: ' ■ 

' 

VJ -L 

. 

niiv.oO ‘ 


■ ]'• ; r ”.; ' • oi " Noli 

. • ' ' a ' r • r • !- 

«■' \ - ' '■, J :7 

S:i-ycx.:> • -: ;• Gfioq to qobtnht.{?-% 2 r V 

■ . ;• • I - 9‘Tic.i‘frs t\dd 

' - ' ‘ „■■■■■ v vs-’, « ( V ' c. 

, ■ ■■ " •• ’ 

i | <»'.•'£•* GOf'ii .( ' . ij 7 C j 1 .'' . i bXXf .C I SO IfoJN 

, •-•Mj ,•/ ' 'J i.^ironcNn 77.1 ■; 

• • ■ : -• . : • ;; ; ' : yr * xi ( ■) 

. ( • ? ir , ': I II.7I7.: • .) fiors-'S . 

7 : , = •; ■ ‘ ;/ / ‘ • ' ' . J • : ' v': ' ( ! 7 ' :•* Gi 

. TV',.: c y * j ; . f 

; 5 . ' :! 'U: •" N T '• "V- • . ; 

.V ■■ „ ' • • •• j •: - • ’ : -r ‘ . j >■ ■ ‘ -.i 

e ‘.70 

' ■ ■ • ■ -/ J. 777 ■ . J ■' 

: 

. 

: 

. : i - a . 7 ■ - : •' zi i ;T $s?£. ; :c n $ 1 q ' 0 fro id' :$'< li u ■ 5 ■ Id 

: . • : ; : iii;, '7 i'. 77! •7:d ';r:J %\oo • • •' ^r’..-rs ' 7 77 

Id i ' - ; J1 0 * ;.3 

' ' ■ ' ■ ■' 

, -/ ' A ' ■ : , : ;7 r< ' *;; ■ : '7 . r C , v G fIG'k ' ' ' ' v 







EFFECT OF PITRESSIN ON FLUID BALANCE 



Figure 32. The effect of Pitressin on fluid balance, 



Figure 33* The effect of reduced water intake and 
Pitressin on fluid balance. 





































128. 


(d) The Effects of Pitressin on Fluid Balance. 

During the four days prior to the administration of the cumu¬ 
lative water balance was calculated at two hour intervals and a mean 
curve constructed from these values (Fig. 32). Similar balances were 
calculated for the day of the test and the day following. A marked re¬ 
tention of water (2.5 litres), paralleled by weight gain of similar mag¬ 
nitude, was observed following the administration of pitressin (0.1 c.c. 
q. 2 h.) over a twelve hour period. A loss of water which approximated 
the retention induced by pitressin (Fig. 32) occurred. During the day 
following the test studies comparing the urine output with the intake of 
beverage water, and the total water intake (sum of beverage water, HpO 
oxidation and pre-fomed HpO of food) also indicated retention of water 
during the administration of pitressin, which ms followed by a prompt 
diuresis of similar magnitude during the twelve hours after cessation of 
treatment (Fig. 33) • Comparisons of day and night urine volumes with 
-water intakes throughout the study revealed that the day urine volumes 
(8:00 A, M. to 8:00 P. M.), for all practical purposes, were identical 
with the amount of beverage water ingested over the same interval. The 
amount of water ingested during the night, however, was considerably less 
than the amount of urine formed during that period. Presumably the water 
of oxidation and pre-farmed water of food contributed to this loss. Such 
fluids lost in excess of the urinary output comprised the insensible 
water loss, which occurred through the lungs and skin. On a low water 
intake this relationship was unaltered, although the daily urine volume 
dropped from a mean output of 4500 c.c. to 1500 c.c. per day (Appendix 
III, Table 6), and the specific gravity of the urine rose from a pre- 
treatment mean of 1.006 to 1.014 (Fig. 31). 


. ' 

• :■* o,. ■'> : •: 

■ v; ■ J d". ori; o:: ( ‘T-d’vi; ( v; 7 \L 

r. :: • id ro--": Led': . w : < v 770 

- ' ■ : . r. ■ ■ • *vc 1 ./ d' i , --.o 


'-'■ S. ,. , (o .1 : i . £} ':•• o' : : lo no J: j;: ’ 





,'J 7. V • ' 

fo fCiiodlD 


'T.7W V ■ '• 


v : rvlo wd ., 



. 

1" 

i VO 7 ' >IXJ 

noi Jr(7 d'r-rx oiid" 

ic ■ •; , 



7 • 7 ... '. ■ ’ .' J ! ■ 

. i 



■' 

■•'i. . * 

7 'd' >V .(J 


' (.IV 

• 

C.--U . 

' 




nc ’• • 

J • 1. 7,7 ; f’/' -r :h 

'dr ir Ld' 


' 

• 

' 




. 

; d ’: ' V-. t 


-. . ,0 '. .-J 



. t M V • 


... 7 . 1 ... ; : ; 

«r v-..; . . rjii w •... •V 7 , , ; .r v;-rj lo .' orJ yLKiw 

■r-; K : ■ . J '■ :...i ■.tedrM lo 'oforofjjB 

. 

. "!. . . o ■- \:r n. • ' ^ •':c ‘.a.) 

• • d . .. ... :..o ...) . r ' " cv 7vi7f,i.7 

. ' • 7.7 ■ . . • ;c.' • • - ' 

. iC-.'. rl ‘ ! : ’ ■ i 

, * * , ■ 

• < ’ i v ... • f-o , ( ; '> ' Ji : •, DI 

, . . . C ' 



129. 


(e) The Effects of Lowered Water Intake and Pitressin on the 

Electro encephalogram. 

During the control period of this investigation there was 
little substantial change in the electroencephalographic pattern from 
that observed during the previous period of observation. The slow- 
wave dysrhythmia remained diffuse (Fig. 39, Tr. 24), although voltages 
were slightly higher and more pronounced in the right occipital region 
(Fig. 39 Tr. 19). Pitressin aggravated the abnormality only slightly, 
and no seizure was observed in spite of the slightly increased electri¬ 
cal activity, which was apparent in the tracings (Fig. 40 Tr. 25 & 26). 

Restricted fluid intake, however, resulted in a pronounced 
improvement in the electroencephalogram (Fig. 40 Tr. 27? 28, 31, 32). 
Delta wave voltage dropped from 80 microvolts to 40 microvolts and 
fewer delta (4 per second) waves (Fig. 40 Tr. 28) interrupted the nor¬ 
mal alpha (10 per second) rhythm (Fig. 41 Tr, 34, 37, 3-3). The improve¬ 
ment in the electroencephalogram continued through this period of in¬ 
vestigation. 

(f) Other Effects of Reduced Water Intake and Pitressin. 

Before pitressin therapy the patient was having seizures 
similar to those described in the history, approximately every two 
weeks. Usually the post-ictal depression was marked and the patient 
complained of pronounced weakness and was quite content to remain in bed 
following the seizures. During this pitressin test he complained of ex¬ 
treme weakness, which became progressively worse as the water retention 
increased. At the time of his final weighing (Fig. 32), immediately 
after the last injection of pitressin, he was unable to stand, on the 


. 


■ 7 ' f-; '■>. ’■ ' ' ■ ' ■' - ' i V* 1 "TOi ’ \o ■’ ■■ ) ‘Vi ' ill ("•' ) 

. r •' r f ■ ■ 

■■■ \'L .* ' ..7 \7 7o 'r' J •„ • < V > :> •• : ■ n "‘T it: i 

■ t' fil 

-V ■ I ■ 1 < 

; ’ I V . ' : V |' 

i ■■■ .. ' '• • j .V' ' • 7 7 . ; c-zi+r 

" . 

. ' : . ' ’ * : ' - - • .7 •• t ” ..V vi ! > • 

• > :fi' v : •• 7 . ' ■ - ■ ■■Vt ' ■ ’ ’’: ■ V ^7 

• ' . . . . 

-Om ' i v; '• i < i ■ 7.. 7. : '.< ■ 7 ^ ■ V v ovrp •'' ' 

.. : > V :• . .' ' - (’ = '-k; ' j -J.. ■■■;.’ 7. 

- 0 V v ,* . 

c. r .;uVs>0.':.. ovtfov J7;. arlci oi-7nor:- 

' 

. noi i r - ' 7 '■.■■v 

. ■ 

' 

¥ . • ; 1: ' . ' i: 

. : 

7:.k L’’: / 7 Vo.' 7' : ' •; c'-ir ■■ o oofoooov/ boofuioxio'i'• 7c 7br.l'7; r:co 

'v • - ‘ . 7 . . .; • o' t I7o‘ 

■ : ■ :• .7 ■ ' ’ , V'7 •/ 7') / i7V . « ?, 'O O. l.OO' ‘OlOO'V 

. ' ' 

• • - . 77’ * :7 V : 


130 


scales without help. During the latter part of the afternoon he com¬ 
plained of a headache, which persisted throughout the remainder of the 
day. After the diuresissbegan he became progressively less weak and trie 
following day was clinically the same as before the test. 

Following the reduction in beverage intake, the patient com¬ 
plained less frequently of weakness. He reported that he was able to 
return to his work shortly after a seizure with little feeling of weak¬ 
ness. Following his discharge, the patient undertook to perform very 
heavy work such as clearing land and cutting cord wood. He reported at 
a later date that although his seizures were as frequent as before, they 
bothered him less and the feeling of weakness was much reduced. 

(Z)Discussion. 

Unlike the first pitressin test (Fig. 28) no marked chloride 
diuresis was observed when the test was repeated (Fig. 30), and inter¬ 
estingly enough there was no marked change in the nitrogen balance dur- 
‘ing the therapy. Seasons for the differences between the two tests are 
not clear. However, the dosage may have been a factor. A dose of 2 
units q. 2 h, was used in the previous test and may have accounted for 
the response observed at that time. The possibility that the “milieux 
interior” was not precisely the same during the two tests also must be 
considered. Variable responses to cortisone and ACTH have been explained 
in this manner by Ingle (^0, and such a possibility must not be omitted 
in these studies. 

The diuresis of sodium, however, was a common factor observed 
during both pitressin tests (Figs. 28 & 30) and would suggest that DOGA 
and pitressin were aifcagonistic. Such a possibility hqs been entertained 






131. 

by Gaunt et al (I 46 ), who also pointed out that the retention of water 
observed when DOCA is used is secondary to the retention of sodium pro¬ 
duced by DOCA. They reported that DOCA acts to produce a water diuresis 
in animals on low salt diets. 

Following the reduction in the fluid intake, the specific 
gravity of the urine was observed to rise (Fig. 21) indicating that the 
kidney was able to perform work. This suggested that the low specific 
gravities previously observed were due to excessive ingestion of fluids. 

The fact that pitressin produced a retention of fluid (Fig. 32) suggested 
that the patient had diabetes insipidus. However, failure of the patient 
to stop drinking usual amounts of water during pitressin therapy was 
evidence that the patient was accustomed to taking large amounts of fluid. 
This hypothesis was confirmed when a striking reduction in urine volume 
occurred following reduction of water intake (Fig. 33)« The improvement 
in the electroencephalograph!e pattern (Fig. 40 Tr. 27 Is 28) was encourag¬ 
ing, and the subjective improvement later reported by the patient paralleled 
similar observations by other workers ( 408 )( 409 )« 

It was decided to keep the patient on a low fluid intake for a 
month, following which a new control level would be established and be 
sufficiently stable to permit studies with cortisone. The proposed DOGA 
experiment was dropped at this time due to the pressure of time. 

(g) The Effects of Cortisone on Epilepsy. 

(1) Procedure, 

Following a control interval of one week, cortisone (200 mgm, 
q.drf I.M.) was administered for two days. The dose was reduced to 100 


':o r . :'v : : d' 3 ;IX duo :>.• jr c ) X3 J- 3 rr ••; j r O 

-'etc;* mjz'ho?, J. ' ' - . 

■ \ i J.' 1 ■ :■ k V • d ‘ : ' • ' ' : 

. ■ • ■ ■ • - 

, 

t ... -J ’ f v . v : v .1 . - . ■ - . ; . - • ; ■ - 

■ 

do !. ■/ . ' 'o' v ror- • - 0 o v o-n J v 0 v -..;q 

. ' rcci 

d: .""J 'io <1 .C'i. .i J d v :.)■ j do jj, • ,;i 

:1 • r 7/co. •! s.u -ovrv lo : ;nl..drdu‘b qodr: o& 

. di.;;. d ' .V’ -I ;;,/..Uod' 0 ■ ‘..oorjoi; job • :rrc. /■ -dd ,y \’v;> 

. 

' r J. • ■ ’ . . ' } . 1 • 

■' ; ■ .• V ’ • •• C ■ ;\l: * • ' - -' 

x; d'rsoJd' ' r :•'0 y .d :.I .:!- > I: ■ V c \or.' j qdr yr ri: 

. i ' , ( ■ ’ ; i( ■ ■ ■■ ' '■ 

i::T r fi ' ' ' rod. 3 no drud j - iq wi# qer.zl O'f Cfl 

• y".! - ■>: *. i.jo,'. 1 J. \ ’k']. 1 3 : >! r • cr-.-r d';y/ 3 l Xo^irroD *3.3 • , /*:>.X;- 1 r iiX 'oh 

■ 

:j3'k .o 1 ■ iX * 

. 3 yii.j Xy '.rr: .... ush j>. X r i.y •. r i::rp:^ 

■- • 

. ; i • f £ 3 . ;>.h;oY. 

. *'.£ 5 I 3 U 0 V!.'... 

. ' i ' ' , i1 :o ) , » t - •. v r ‘ c-i ; yiX o. . d d; 

. •: . ' • * . 






132 . 

mgm. q.d. for an additional day, at which time *018 patient complained 
of extreme pain at the injection sites. In view of the possibility of 
infection (410) , the drug was administered orally and the dose elevated 
to 150 mgm. q.d. to overcome the expected difference in potency (4H)(412). 
This was carried on for four days at which time it was noted that there 
had been a rise in the eosinophil count. This was found to be due to 
inadequate dosage, so the dose was doubled, and oral cortisone (300 mgm. 
q.d.) administered for six days, following which the patient was observed 
for an additional six days before being discharge. 

(2) Results. 

a. The Effect of Cortisone on Electrolyte Metabolism (Fig. 34)* 
i. Sodium Balance. 

Boring the first three days of the control there was 
a negative balance of 75 meq. per day, following which the patient was 
in balance for three days. Immediately before commencing cortisone there 
was a slightly positive balance of about 10 meq. per day. Intramuscular 
cortisone produced a marked retention of the element for three days, 
following which the patient began oral cortisone, and fee urinary output 
of sodium increased. The patient remained in balance until the dosage 
was doubled, when a retention of sodium was noted, which persisted until 
cessation of therapy. During the first three day period with no therapy 
there was a prompt diuresis of sodium following which the patient remained 
in balance until discharge. 

Throughout the study the serum sodium levels were subnormal 
with values of 124 meq./l. being recorded. During the control on cortisone, 
however, the serum sodium levels rose steadily reaching 132 meq ./L. during 


... 

'A,.' \ • . .X Po ' , . XX. -.pX; ■■ qX: f.-X, s •• rJ:/q -.o.v Jp:o Xe 

.• .[;• . ..X.~ v.- vi : \::o :o:,;l , (Xlp) tfoX^otXifdr 

. . 

;:»? c t i JqC'j'A.’-iO ,nl c ;V.P 

' i r X ] ■ ;i- 1 r . : ■ ' . .... '■ 

. . . 

- ■ ' : " X ■ :i ■; .X .iSi : ■ 1 

. . 

y !■' :A i. 0 = : • • ‘ P ■, j: + -.a./J A.O XlftYtX B&lf , ,J 

. 


. c.vr.,' A.• XX • - . ,•‘ ;• qro. p .XX,:X. . q 

■ 

.. 

, :: q X .. A ,X : r.•,J • . A 

' ' ' I :V 

' . 1 ' ' ' ■ i.;,W 

% 

O U : i ' . . . b • ■ I J1 t 

/ ." . OP PCi'.’ hoi-lOi SOI' 


. .■•’■I.'.’ ‘co : :vo-.'X.;J i..v. r j pqoq B 
: 1 v OO^IiSCf fiA 

. 

... . ■>*; ' fteOO.U. V C Oil"'A. j'JOO 

!•. '■ •r!--. tr*.iX-',q ;;pX ooi::X; :pqqvoXloi 

. . i c 

V ■■ ' . -5 Ot.JCJ * PoLlPC o i JTw 

. " B ' 1 

1 -". -X :.-pXo j-q ;0 uow ' r .t XJ 
. • , Xi Xl'P ' J :X ; .' 


XX* .X' . ' ■ .'.C.v. ! .' !iP.:X OpA .''A • . i.;X OOO. {’O/C/.i ..'C 

' : :' . ' ‘.i 1 ' ■ . ■ ■ . ■ pi A ‘.U ■; ' -■ -XX. 


- 


. ■; - -j ., . 'J , 












MGMS /24 HRS 


RESTRICTED 

WATER 

THROUGHOUT 



X HRS 

1 


^7////7 /A±_ 




& 


_/y „ L .T 


20 23 26 


TIME IN DAYS 


Figure 34. Metabolic data on Mr. M. A. #81123 with 
Idiopathic Epilepsy to show the effect of Cortisone. 



Figure 35. Idiopathic Epilepsy #81123. Metabolic data 
showing the effect of cortisone on nitrogen, potassium and 
water balances. 












































































































133. 

the sixteenth day of therapy. A pronounced drop was noted three days 
later when the serum sodium was 128 meq./l. and the level remained un¬ 
changed until discharge. 

ii. Chloride Balance (Fig. 34). 

In most respects the chloride balance followed the 
trends indicated by the sodium balance. During the first two days of 
the control, there was a negative balance of about 38 meq./l, following 
which the urinary output was diminished resulting in a slightly positive 
balance for two days. Prior to beginning therapy there was a slight 
diuresis of chlorides. Cortisone resulted in a prompt and pronounced 
retention of the element, which persisted until oral cortisone (150 mgta. 
q.d.) was begun. At this time the urinary output increased and the 
positive balance was about 12 meq. per day. The retention became more 
pronounced when the cortisone dose was doubled and continued until cessa¬ 
tion of therapy, at which time there was a prompt diuresis of chlorides 
for three days. The patient was in balance prior to discharge. 

Serum chloride values remained within the normal range through- 

_r y 

out the entire study. During cortisone therapy the values dropped to 90 
meq./l at which time there was a marked urinary retention ©f fee element. 
There was no other pronounced changes observed in the serum chloride 
levels. 

ill* Potassium Balance (Fig. 34) • 

A persistant retention of potassium was noted during 
this study. Initially there was retention of potassium of about 40 raeq. 
per day, but during the remainder of the control the urinary output of 
potassium increased resulting in a slightly diminished positive balance. 



■ ■ r 

♦ ‘• 

i ■■ ' ' ”f 

‘ r ' , , lo ■ I' : ?•: .A 

: • ! ■ \ 1 

. . . ■ - ' ' : 

„ )'•; • : • ■ h •" • )< '• ■ 

. 


• ; 


(& 

.. 

■■ ■ . ■ : ; : 5 BJ3 t . } 

Itih'iJ.i) •' . : ;o «n"- : „<■ oiytw 

■ ' . ■ : '■ 1 "* ■ : . :■ .f.' 

' • ’ ' ’ 

A'H C :• ; ) 'I; ■ t ■ ■: ' 

A; A I. 3 i/.dj- A:-' -C At iv A TZ 

-nj bn--' berv'/vi-m s. &u .■*:?< 


tv ro. :: wmoo’i m : ::u'S? 

, r . ■ ic d *• i-w r . a r r vJ -.1 j: -to 

'>S 3 © ? s i 

; ■. ' f\... . •.' : n&r ; ■ -/LiOfiO". 

i 

-■ . Ar ■•ui.J.y • ■ ■ ', vcr-'.'-cxJu Mo ao.i«t 


. 

■ ■ \ . *, • ; 

■ ■ r- ■ i .U x 

0'/' (. :• w.r ; . •• 

: ■ ' _r'- /'v ‘f-: 


y 


• :■ ■ "::y- ■ ^:x:/ :•••••• ,tc Off 

. ' . ■ : • 1 • Jt.-S. , J. 

;4?jJ ■* .6'Jd'ca s.iv; ; J 

• ’ r ' VI "i A 


r, ;„: " ‘ J V'. i ‘ ■ ;>•; ' A ' ..A . : 


Ao \'A' HtHu t-tii Fcwr 

» 


1 5 1 ■ ' 



134. 

Cortisone induced a greater retention of the element when administered 
intramuscularly than during the first four days of oral therapy. How¬ 
ever, the increased oral dosage caused a slightly greater positive bal¬ 
ance, which persisted until three days after cessation of therapy. Dur¬ 
ing the three days prior to discharge the retention of potassium was 
minimal amounting to about 12 meq. per day. 

Serum potassium values remained unchanged and within the normal 
range throughout the study. 

(b) The Effect of Cortisone on Mitrogen and Water Balances, and 
Weight (Fig. 35 )* 

The patient was in nitrogen balance during the first two days 
of the control following which there was a persistent negative balance 
throughout the duration of the investigation. There was a slight in¬ 
crease in the urinary output of nitrogen during cortisone, and following 
cessation of therapy the urinary output diminished resulting in a nega¬ 
tive balance of about 1 gnu per day. 

Fluid balance established early in the control ms upset by 
cortisone (I.M.), which resulted in a retention of water (500 c.e. per 
day). The change to oral cortisone resulted in a decreased positive bal¬ 
ance of only 150 c.e. per day. Doubling the dose produced a slightly 
greater retention of water f following which cessation of therapy caused 
a slight diuresis of about 100 c.e. per day for three days and then a 
slight retention of similar amounts of water for three days. 

The body weight rose slightly drawing the control to 56 kg., and 
after cortisone was begun there was a drop of about 1 kg. during the first 
three days. This was followed by a gradual increase la body weight until 


vrr-i ' i . . • ■' ' 


. . 

wV".r 1.. .r '‘if'-,, d^Oyl*.. xnoic'otai: 


: .’>?v . ;nb doXC 8'. MOfO;. ’ J oo- OX 

--"• ■-a o; o • . , f. 


' U ! 

■ 1 ^ oo \<:c>fric ooki' ,>rri. 

• i 

0 .} . ■ : l; 0XG8xUx : ; 

. ‘i d i ..or- ,.d :\; n oo; 

. 

• - - 

■ 

o -o o' v ;->.*■ x d • •.. eil'i 


ox : oxlo o Jdortiaco a S lo 

- j o •/,?: ■ .. ' ■ -oo:7 . . i i 

: .•/ ;.o ; . ord .O/or i.o..o .go- 

i/o U 

. ' ' s- c X.- J-sjC: o. / n.i o.GOO'iy 

■■ ■ ‘ : ' ■; >; • -‘ ' ' 

f r >i x ■ gtoj# *k • xxv;r;e^ 

* 

'v/T .■■■:■' 0 . ;j. ooor &iU o’ /.I 

• a Id s s ■ I 1 . 

. 

. oil . : ., i 


: ' ’'.'"-if':;: >•, . .x. ; C:j- ad? . (oo.o 


-,f r ..••XIOXXO OBCio 

» * - . . . ' 


■ ■ o/ - : ' '/o : /• K\ x -^,krz o 


. 

• v o ;;J- .; r o:o : ‘z/'.U- x: "O':;,:.OuV- : r ; i. ±J>o 

V. ' . . . • ■ ... 

Lv-i! ,/ ; 'o o);-,oo: J o, o-,i’ v;:,o , 

- . ' .[ r ,; ■: 0 , • 



: 1 : ' o \ .v . •■V;, oooo.i 8,-O' .xo;; '0:r j 





MGMS / 24 MRS 



Figure 36 . Idiopathic Epilepsy #81123. 

Chart shoTdng the effect of Cortisone on the urinary 
output of cortin and 17-ketosteroids, and circulating 
eosinophils. 











































135. 


cessation of therapy, •which resulted in a fairly prompt loss of 
about 1*5 kg, 

(c) The Effect of Cortisone on the Urinary Output of Cortin and 

17-Kstosteroids, and Circulating Eosinophil Levels (Fig, 36). 

Cortisone resulted in a very slight elevation of the 17-5ete¬ 
ster olds during the first three days of therapy, after which the urinary 
excretion was increased from a pre-treatment mean of 9 mgm. per twenty- 
four hours to 25 mgp. per twenty-four hours. Following cessation of thera¬ 
py there was a prompt decrease in the urinary excretion of XY-ketosteroids. 

The urinary output of cortin on the other hand showed a more 
prompt response to cortisone therapy rising from a pre-treatment mean of 
1,3 mgm, per twenty-four hours to 2,6 mgm# per twenty-four hours, during 
the first three days of therapy# There was also a prompt fall in eortieoid 
excretion following treatment. Changes in the route of administration or 
the dosage produced no si^iificant changes in the cortin level, while the 
17-keto steroids showed the most pronounced increase during therapy with 
oral cortisone (150 mgm, q.d«). Urinaay excretion of 17-ketosteroids was 
diminished slightly when the dosage was doubled during the last six days 
of therapy# 

The eosinophils showed a characteristic drop from a pre-treat¬ 
ment mean of 80 eeXXs/eu. mm# to a mam of 20 cells/cu# mm* efairisg the 
administration of cortisone* Following therapy the level of circulating 
eosinophils again rose to pre-treatment levels* 

(d) The Effect of Cortisone on the Electroencephalo^am* 

The improvement observed after instituting the low water intake 
was not maintained during treatment with cortisone. There was a general- 




*:'u> 01 jqoo-v-r .tiHU 0 : : ''.V :.;a.y“£ i ■•}.;. Ov: ,vqi?'lSi A V ; 3c V : :>■;■' 0 

? ,..f 

0 ; "•<:/ '■ o V f'cj 'A 'O. s : : : V ''"O OOf- i I 1 '.; :■.!]:■? ( o ) 

» ■, . V ■ ' ,1 ;• .!■ ■ . r V o' '■ - / , ; 

— : V ‘ ,--V O • f(: W ■ ~3. j.3 , 'q'iOO ;.i ? -V,, f OOOOI Jo'oO 

: v - V . ■ wo: A. . . /' ' ■ {■ o " : ■; j ;■ ■ •; ' ■ ■" -;h. 

■ ’• v.. . ■ * ■ ' ’ r . . ,V O; o • ■ " ‘ 3" - V 0 > : 3 

. .. . - fOi ilc'j 

V V • ,oV . woo • . q v..’ w ‘ • oV 3 : : ■. •■■■.■ • ■ o •>./: - ": o o .:.o qo 

. ■ :: .3OO'O:"' ori.?0;. ' ■" 3'; ■ . .t 3' : 3i t: J'. . > ' ' ■ J'.',' O'O* V; ' Oi ■' V3 : i\2 

xo V ■ . . ' w\V~o\o w oV row Vi.; o .Voxo • •• • Vc;.c.o ■ 

« ... 

■).' , CIO - ■ : • ■ . 3j V V 

ti i • : v: 

;3 j owo-o' ,.V v- -■ Vi f . ■ i f ; . . . v.;... '. . ;.;V 

.. W'. g m 

vV v ... . . , . ; 

3;-kV :::V 3/ • * ; V ;3 - r ' V r, ,c; -',i 3 V '3\;V,/ '}!£.; 

V' 'Vo 

, yVo. : v3i..! .0/vi ' -ou f,.Vy : - •• • o.'Vo 3.1JVtr^onVooo ■•iVV 

.V • . ; . -■ A; o-V o.. ?.■ . '• ( . V:o f • J .30.: 

- I 00 V. 

„ .v..:' V - • .V oo.:h~o ^ : o o oV. ulii :\o t ^Voo;., 

o •; :o.r;or V » ! . : ;•*.(.? - ■ ^. ;.V.>.vV r.. .V.vV.VV r.'VV: ( ) 

o:Vovii'J: -3-:Jv;o :o V ojA : : ;a.fd";.;d'VV:;i-X ',.od"xo IXTXc-.'Bvfo V'O): ovr'.;:,: o.i.’T 
••V>-\.:. .;:.:o ; v '^ofoVv .o.iOi:; .VV 3oo rtf hr .x A- : ; .xv Vo .j :V, Vo/ .V-icVol mji Vox roox 




136. 

ized increase in abnormal electrical activity (Fig. 41 Tr. 33 & 34) and 
high voltage delta waves (notably 4 per second reaching 90 microvolts) 
were seen appearing frequently in the alpha rhythm. The abnormality was 
diffuse, but remained more localised in the right occipital region 
(Fig. 42 Tr. 35 & 36). 

(e) Other Effects of Cortisone. 

Accompanying the electroencephalograph!© changes were some 
changes in personality. The patient became slightly more paranoid, al¬ 
though at times he exhibited a greater sens© of well being than usual. 

Ha was frequently bothered by headaches and complained for some time of 
pain in the hips, although oral cortisone was used throughout the greater 
part of the experiment. 

(3) Comments. 

Urinary retention ©f sodium and chlorides has been observed by 
other worker (147) • However, the fact that cortisone is a shit-retaining 
hormone in the absence of any other adrenal hormones (345) would suggest 
that there may be a deficiency of BOCA-Xike substances in this patient. 
The fact that there was persistent retention of potassium throughout the 
entire experiment would seem to substantiate this hypothesis, for DOGA 
if present would cause retention of sodium and a diuresis of potassium 
rather than a retention of the element like that observed. 

Loss of urinary nitrogen and potassium usually follows the ad¬ 
ministration of cortisone (153). The sii^it loss of nitrogen in this 
case was similar to that observed in debilitated individuals. However, 
it was not paralleled by a corresponding increase in urinary potassium. 
Body weight was noted to diminish slightly after the initial treatment 


. A A ■ ' I ’ 

. . ■ >,m Oi 8€ v • .\ ( ■ ' 

■ 

■ •, " r ■" ■. . - : ' . v ' g • ■ ■; 

n< ; g- A-g;X gg .A. vv^.v ifj. I.. • go:. -g ’ ■ '• :A > v «vr,.^:xfc 

. ; 

,g;< A •- ' •*:. ' V- ■ vAO X-A 

s ,r^rh : A'Ag" cl .< Ag\M fivfvr-t - ■ ■, ' jr >A 

„X ■■ ■■ .■ ■ ;; ;• ' ... •, • . ' J •• " ' •' G 

‘ ' : ■ 

•. j- '; gX-T AG'.: \G'-\GG •;ggg- f ... X : . C:i G.i GG' 

: i .1 l.G T: -’.q 

. gO { '} 

~: jjb’VGG. G:Jo GGG .r " :G • X y X.X ' ■ ‘ Ac f'G • X' gX .'GGgX/AJ 

A.-"--.jA>'; ■ . gggg.Ag ’• X . ' g.^: g ; X »A / ' ■■ 

J .ggg, ; (AX;; gghgig■: .X,- : ’■ Xc g: ; ,:G 

. : si ~AGI ’ 

r - . ' ■ ■ . . I . ■' ‘ 

AOOC ■•.cA. ggA •:rA . gy.g ■ G:A'G-Xv : !'r" -.-A ,.•••*••. i X.gc - j- ■ g’g' g :g c • v‘ g- 

iv-;: . ■■ \ggg "I* ■ gAv-';.:'- v, ^ A • • - g. gX ''G.-go Ag ' tg : -cgv-g.., X.j: 

. ggggAg g:gg _.Ag GGT i;: ■ g:A A - :.;,Ag: ..;g-■ gg : 'iogA]'.gg: 

' : b/5t I 3 8 

• - G; ..A; '"\rj GvG ' -t ' .A GGG' » . A; IV- ... A' - 'A/ G. :;G .. "G 

■V'GG'. A' yAA;j A; -X :.tl ; j - V.. ; A A gg .. g 

*i.: : ■ : - A. J : ; g;' umuA ■ :";G’g;. > •" ■' ...A . •'.! >r. ggg A' 

a a ; ■, ■ . i A I : • .. i ■. 










Idiopathic Epilepsy #81123® Hectroencephalographic picture 
with no therapy and water ad libitum* 





















I £ 





5 


i 

P*4 





O' 

cn 


w 

i 

•H 


Idiopathic Epilepsy #81123* The effect of Pitressin and restricted water intake on the 
electroencephalogram» 





































Idiopathic Epilepsy #81123* The effect of restricted water intake and Cortisone on the electroencephalogram 




































RESTRICTED WATER INTAKE-POST CORTISONE CONTROL 



Figure 43* Idiopathic Epilepsy #81123. 

The effect of Cortisone on the electroencephalogram. 


GMS. / 24 HRS. 




Z77V- 


7 - 7 

URINARY POTASSIUM 




\ 


» ¥ZZZZ± 


URINARY NITROGEN 

T 

~r 


^ZZZZZ 


Figure 44* Chronic rheumatoid arthritis #27645* The 
effect of Dilantin and Mesantin on the sodium* potassium* 
chloride and nitrogen balances. 

















































137. 


with intramuscular cortisone, presumably because of the slightly in¬ 
creased output of nitrogen. With the retention of water that occurred 
later in the treatment period, there was a gradual increase in weight 
even though loss of urinary nitrogen continued. Following cessation of 
therapy and in spite of the diminished nitrogen loss, there was a di¬ 
uresis of water, which accounted for the loss of weight. 

The changes in the urinary output of corticoids and 17-keto- 
steroids observed during therapy with cortisone were characteristic 
(52) (147), although it was noted that the rise in 17-ke to steroids was 
more pronounced following oral administration of the hormone. This may 
have been due to the more rapid rate of absorption of the oral pre¬ 
paration. The fall in eosinophils which occurred has been described 
(147). 

More high voltage, slow-wave electrical activity appeared in 
the electroencephalogram during cortisone therapy. Similar observations 
have been reported (413) with both ACTS and cortisone, although some in¬ 
vestigators (126) (405) have noted an improvement of the electroencephalo¬ 
gram following treatment with cortisone. 

The possibility of abscess development made it desirable to 
change the route of administration of the drug in thie case. It was 
found that the oral route required about twice the dose ( 41 !) ( 412 ) that 
was needed intramuscularly to produce responses of equal magnitude. 

The persistant retention of potassium observed throughout all 
phases of this study proved the most outstanding feature of the case des- 




v. '■ - ; x xx: .r f .;...' . yj ! xx.nx • . ■ x.' ; xx 

>ix.x 

x; ‘ ■ X - ' ' ' - . . . ; ' • ' ■ x. • t ;■■■• X :. 


:■ • ' 


xv x.: x..' . • • '.'■■■ . .■" : ; : : x ..x x c J . qxx. x xx / . 

-i:.x xxv- 

.. ; ■. . . ... ' .x, x r j. xxx- • -. x 


~*CJx:, -V'l GXij’XXX 7.0 vX ,/X vlXT VX UI xx ;jXxX xxii' 

* ■; i ;■ ) •••:•; X ■ j / ■ . v ' X X ' '‘." .X . X " X V V "C'vJ , 

x xx . -xxv . . ■ 'XX.. J .XX hv- X X ,.xxx/: ; . I.) 

' '.X',. 


- 

'• x v x.v :x; x; , , ... ' ;; ■ w>0 CV xii 


ftltti ' * 


. (V; I) 


, : irv. xi x v -'-xx * ,jJ c v cncl 

' XX' : ■' : X • ■ C ' 

' - ' « . . : ' X’.: x •> ' - ■. :.t 


--'' ■ i. XV “ : X ;J<x X: 1 i . .X XXX.;. XX .• - X ] V -X , ,’x ,.X'. x x'v X ; fxv; j'TOQ/, 1' XvXX WX 

'X 1 • x . x • ... : x ...V' x ■ - .x x-rod. \ rJ xxv 

. xxx" x ■ '. - ■' ■ x-j ixx. .X. c;l xxxx, 

< '' .x x ‘ . :xx . ■ . xxxx-' '• x v:x:,- :.xxx • ... '' : xxxo xu r T 

. . ' ■ n ; . i 

. v x • , •, ■ . xxx.x-xxw • X-. ;. X X .WO . :.J W.Xi XXXX 

, ■ • - ' XV' XV. ' ( XXXX XxvXXX.lxX/ XXX,:XXJX X •••..-• 

1...C.X xx'xi ,;xcx .xvx-xv.:/ /xrxL. xrvloq lo rvoxovix,vv.xxtxJxxjxv ©ixT 


138. 

cribed. Since the patient first entered hospital for investigation it is 
estimated that he has retained approximately 270 grams of potassium with 
no ill effects. An electrocardiogram failed to reveal any evidence of 
disordered potassium metabolism, although there was a slight bradycardia. 

That such a massive retention could possibly occur without any 
marked physiological changes seemed most improbable. However, to gain 
some knowledge as to the fate of the potassium, a series of preliminary 
tests were carried out. A determination of intracellular potassium per¬ 
formed upon hemolyzed red blood cells which had been separated from the 
plasma by centrifugation was normal (93 meq./l) ( 414 ) 9 and suggested 
that the element was not being retained in the intracellular spaces. As 
the serum potassium levels had been normal throughout the stuc^r, it was 
thought that the ion was being excreted in some abnormal manner and in 
excessive amounts. It was postulated that excessive amounts were being 
lost in the sweat or feces. However, flame photometric studies (337) 
revealed the excretion by thesd channels to be normal. Thermal sweat 
contained 49 meq./l of potassium, and the fecal loss 11.4 meq. per day, 
both of which are noimal losses (414) • 

The possibility was entertained that the calculated diet figures 
were in error, but determinations by flame piadbometry indicated a dietary- 
intake of 84.2 meq./ day for the test day, as compared with the calculated 
intake ©f 87.4 meq. par day. 

The retention of potassium next was thought to be linked in 
some way with the anticonvulsive therapy of the patient. In order to 
test this hypothesis, a preliminary balance study was carried out on a 
non-epilptie patient. 



, 


' 

^ . v ; *■ \ -S;■ ' ' ij 1 '• • i • oji w U boo 

. - ■■■■"’• r ix 

• ■ ’ ■ . : ■■ 

: . wri ss u - 

; . . •: V. .. , • : ; . ." ••>£ •: i'.c ‘ • • ofaoni 

j; ‘,,OI . ' '.J . 1 ..' : 'b 9 i>$ . 1 ‘ ’J* 'Oi i> ?> ! Ok' 


y : o’.: : .' -SX 

hr 

' r.0i-i'y f:J. ,vi ; 

'■cu.Ui hi ox h&sxSmz-r'- xkv.x. 


> .' : ' 


. .1 No-v 

< ' . • J ;.fh>0 v ; 

r BS8 BX(T 

.2 

' 

J ' :: •. rc.;. ■' 0 : 

■ 1 , • ; Jof' ’10,; j-foi " i,}j f:>; '■$ J'.’O.i 

fjr4 

r . 

f airtoix at»eJ 

£ ■ ■ ■ • 


e| 1 ■ " ' • 


.' ■ : J ■ ■ 

Bi 



: - . " '• J b • -1 ’ ‘ J O. .9 '' '' v ' '9 

(V ' :• ) ’ ; r .. . : V/.-' • .v . . . 'V; : VP ^ 9 •’ 9 : v VI &VO?. 

■ . , ■ ' foW 

. : .. : r . » .* 'V • • i ' ■ n 

* ; ;■ /. . ' ' o i 1.Q : O’ ■ 


i;r/-i'Z j ; ::>■ i.io.v‘ob u lr j •••jit .of Svj "■ -v "J l .xJlr'- oc- pop' 

. ‘ J . ■ : a ' ■' ' ■’ ’ 1 


. 


.£ a o s:> i Ki x r b o ' t iq ox >:) 


, .. ■ j o-v .. i'ri ' u - i 


. o -x . - it V' xj .. .: 

■ j . j d ; ■ ■■ . . 3 ' ’ ■ 


.' r -■ - . ' •: : u,'. )r or r' X XV VO ' o ' . ■ j X' iit X ' ;' : ■:'0 1 

• : .... : . -i .1 o o ■ - D0,,i.o v ..lo'r; /■- .-iJ a 'o: - 


.joo j.i : ' 1 .1J ■ f.i 


139 


The patient, Mr. F., age 67, was afflicted with chronic rheuma¬ 
toid arthritis and had been on no therapy for a considerable time prior 
to the test. He was fed the same diet as was being given t> the epileptic 
patient tinder observation. Following a four day control interval, anti- 
convulsive therapy identical to that received by the epileptic was ad¬ 
ministered for an additional four days* 

During the first two days of the control there was a retention 
of potassium (Fig. 44), following which the patient was in potassium 
balance until the anticonvulsant therapy was begun® The retention of 
potassium was similar to that observed in the ease of the epileptic 
studied and persisted until cessation of therapy* 

While the data presented is not conclusive, they suggest that 
the mechanism responsible for the observed retention of potassium is 
mediated through the anticonvulsive therapy. It has been recognised that 
patients and experimental animals depleted of potassium become alkalotie 
(344) and that alkalosis results in lowered convulsive thresholds (377) 
(387)* It is suggested that the anticonvulsives induce a retention of 
potassium and an acidosis which is known to elevate the seizure threshold 
(387)® Much more work along this line is required to account for such 
contrary facts, as the protection against convulsions afforded by low 
potassium diets given to rate (387) and the beneficial results obtained 
in epilepsy with BOCA therapy (377) (388), which is thought to act by re¬ 
ducing brain potassium (403). Further it is suggested that future studies 
should include the study of the effects of DOCA on an epileptic patient 
loaded with potassium salts. Certainly in the light of the poor results 
obtained with cortisone in this case, a trial with DOGA is warranted. 




v ■' r; ' rr]:) 'I.;'I-"' . V X';x , \'n .xJxx ; T 

: . L"’ ;,r ■ : : ; ,X r • 'X • • • ro'l Y '": ’.xl o«T i'-0 x • . ‘ : xx ’ ’lixf ixTfiltte S v > X 

.xxx’J. . ’ i x vj ■■ i ' vx Y - x . ■ i • ' : : ’ 

■ j .. , . , ■ .■ }. , • ; .:-:/x ' 'Mr.- • • ; : -x 

■ v' ' . . ' • ■ ' y rD 

. ' ■ d'i ■' ■: ' 

■■ s...Imlrx'O e:.J- lo er'zh -hl. x;x 

xx; tnl* »•[ .X xx; j xx XX x , 'f:Y..x xv. J; 'Y-.T r -.Mr J : J j;ul vx xixl * : 

' fo * 

. 

j ‘-.l'- X'Xco'xxrx x/.,i f r ,vYl XY'xxcx u'Ox ,.l x YXY/'x./ y xh ,.ir Y'Jl'f 

■■x xx ' • •/ o 1, xx vx- > J *. x,’ ■ I-, 'ykxxxx J r'■•ryr;f era 

,', r ' i'L \ : 

■ xxxx : :.\ J x lx . . :x. • X x./’ ; ; xX.i xx xx / X ' x : 'x 

ov.v-: Xrv;rco r'i $. r .;r'.o- :• ' '!o ■ ■ r ' r ■ \ 

' - * . 

•; •. • i ,c 'x-J .r ;; ': > r ftx f: : : , xxXi< ; 

' ■ •:/. : ' ' i. * . ' ■> , 

; .. : r • - -;.i. v r i..y j ^ -x . ;'i '-.•/: iv.-o 

x i I.'-.’’,:-:- xx. 1 ' x ; ■_ 'X,x., <.\t xvx; :xx: - x'Jxx- 

' . ■■ x: . ,■ I x-',x/ . ■ V ) xx ' - - x • 

■ .x.rxx; XXX x ;■■■* xx xx XxX,: u . ^jxxl^x xx/X' 'ko vx.xjx; x;.,x .! - xxx. x,x. xxxx: 

" ' ' ; : , ■ .. J XX.. ■ X . ,i J ■ ' ■ X. 

xdx; x x:'X' ' iidl’r IbJx.xx .6 xixx*!' /xl' j ul.lv; uxrx? xJxo 


140, 

Apparently cortisone acted like pitressin to produce no clinical or 
electroencephalograph!c improvement, although it was reported to be 
three times more effective in protecting animals against water intoxi¬ 
cation (3S5). 

(h) Summary. 

A case of epilepsy treated with cortisone is described. By 
means of a pitressin test a polyuria, at first attributed to inadequate 
production of anti-diuretic substance (diabetes insipidus), was found to 
result from a habitual intake of excessive amounts of water. 

Pitressin administration to this patient resulted in water re¬ 
tention, a diminished urine volume with increased specific gravity, a 
diuresis of sodium, increased weakness and an elevated blood pressure. 

The effects on chloride and nitrogen excretion were variable, and no 
changes in potassium balance, urinary output of cortin and 17-ke to steroids, 
or circulating eosinophil levels were observed. 

Clinically a diminished water intake produced no change in the 
frequency of the seizures, but they were much less severe, and the elec¬ 
troencephalogram was significantly improved. Lowered chemoeorticoid ex¬ 
cretion and gradually increasing urinary potassium and sodium outputs 
were observed following the lowered water intake. No change in the cir¬ 
culating eosinophil level was noted. 

The metabolic response to cortisone administration were normal, 
although no electroencephalograph!c or clinical improvement was observed. 
There was retention of sodium, potassium, chlorides and water, a slight 
diuresis of nitrogen, increased urinary cortin and 17-ketosteroid output, 
and a depression of the circulating eosinophil levels. 



■.v XX. v -v Xv, • X ' vXX-- -Xv '-a- :■ .* j re o .., w v: X 

X V .V L' X V,XXX‘ X' . V X ; , V- V VS : V 'V ;/V) ?V VlJO J 2 

-X.:CCu:d v ’ ' dx X . v : . X V,:; v. <\± sv ] !;•} w v;: : !' v •• • i 

. / •; ; : ’ i) 

' / ■ . v. ■;' : wvw X ‘-v.:'' "v " bib . -p ?:o so a 

■ ■ ' , 5 Gtl to S3 

i lb] • ■■ ■ 

X . '' ■ X ■ o ‘ v lv J ■ ix ■ ': r - ;• 

- vi Xv / i J: w . vXXv; . :j.rX v * ' • Xr.lrX : -XrvTTV 

Pi ,--Xx v •. ; • v'XXvv . v. 'v..v. I. XX' • Xv vxv ovivXvvX , vX XvX 
. v. • . ■ 1 fc 

tu . &hl*XQ . ’ ®s$£ 

. d:;•>•••. J.J- . X-X'X vv rXXvo : Xv Xv v.X .■? , • • , - X.;.. vv. "X-, • ;X. 'X 

:X ■; :;3v 'J • • • vX..rc X; XX, -/'.I-' \v 

oXX X vv Xo on Lvov gv.;; v:v -.vV,v ’’j vvXXvXX z 3 

w> ,v vv: v. ,ci'd d v , vv.;v ? o?5 oXi lo v,ona.rr;e r j:‘i 

: . > v-.;".- . '. ■ ; iv;.-"v.r■ i . c-Tv 

■ : j vs ’ -" ■ , ./' /IIvvdBT^ TO 

v- s ;? . .• ; :".:v b'r;;: -ax:! vd" j-;v/al’v 4 . b ./v i\r 

. - ■■ v :X X; X. >.s: X:r :v: i r.;.:o 

Ton ucA ■ j i * od»sk1 

,X- v■; v- v..." . .;X-..:X XXv - c 0 ..XX■,;'T.;v. b.Aj-ryy ;I." < : ivy/oriXIo 

. tv X .■ , vs "v :: j'.o-.t t XX 

. f ■ & ■ t i < ■ 5 ■ 

, ; " v X XX: ■ :-y ‘ -J b ■ X-: v i s \"v 



U1 


It is estimated throughout the entire study 270 gms. of po¬ 
tassium were retained. Preliminary studies suggest that the retention 
of the element was caused by the anticonvulsives used by the patient. 

It is suggested that this phenomenon may be linked with the mechanism 
of action of the anticonvulsive drugs. 

It is suggested that DOGA would be beneficial in this case 
because cortisone and pitressin acted in a similar manner to slightly 
increase the electroencephalograph!e abnormalities. Future observation 
of the effect of potassium salts in this case with and without DOGA may 
be of interest. 

F. A Comparison of the Metabolic Effects of AOTH and Cortisone. 

I. Sodium Balance. 

Cortisone was observed to produce a diuresis of sodium -when 
administered in relatively low doses, but when used in high dosage 
(300 mgm. per twenty-four hours) in a single ease, a retention of the 
element occurred. ACTS also produced a diuresis of sodium.,, which oc¬ 
curred following a slight retention of the element which was observed 
during therapy. 



| Sodium, Meq ./Day 

j Potassium Mef ./Day 

Treat- 

Control 


Control 

Therapy 

Control 

ment 

Pushing® s 

+ 36.4 

+ 2.09 

- 13.12 

+11.13 

- 4.62 

+ 16.49 

Cortisone 

Adreno- 








genital 

- 8.35 

- 34.34 

-54.74 

+ 8.82 

+ 3.38 

+ 0.95 

Cortisone 

Adreno¬ 








genital 

+ 1.26 

-10.07 

+12.9 

+ 17.97 

+18.03 

+ 8.9S 

AOTH 

Allergic 








Urticaria 

+ 5.23 

+ 6.93 

- 2.9 

+ 24.15 

+U.20 

+17.20 

ACTH 

Epilepsy 

- 20.74 

± 15^6 

-22.44 

+27.98 

+34.31. 

+22.09 

Cortisone 


Table I. Comparison of the average daily sodium and potassium 
Balances oc curing before, during spad after therapy 
with AOTH or Cortisone. 





















■' • Ltp 

. 


.. 






:• ■ 


■ ... . ■ - ijrr-bsd 


j ;•. 


:»f U 




[■: ; c: ' : 'v ■ , ■ ' / • j- r: - . ' '' . 

■ 

. ' - 

(j ■ . ■ ■ "/ - 

' 

. ; 


bf, v)o<,: 




;■ --a:;. V,-rT 
.... . ..... . •- 


KTOx { 










Ji: 




.t 





r.b.^,5 -kh, 

• vcajuxj' 




• '7 l > 

.e ' -• J. 3' 

’ 












142. 


II. Potassium Balance. 

Potassium loss followed therapy with cortisone in two of the 
three cases studied. One case, however, receiving 300 mgm. per day of 
cortisone showed a retention of potassium. ACTH administration was fol¬ 
lowed by a loss of potassium in one case, and a slight retention of the 
element occurred in another instance, although in both cases the dosage 
was the same. 

III. Chloride Balance. 

A diuresis of chlorides was observed to follow administration 
of ACTH in both the cases described, whereas only two of three cases 
showed a similar diuresis of chlorides when treated with cortisone. 

Again the large dose of cortisone used was believed to be the factor re¬ 
sulting in the retention of the element observed in the other case. 



Chlorides Meet • 

Nitre 

>gen &n./Day 

Treat- 

ment 


Control 

Therapy 

Control 

Control 

Therapy 

Control 

Cushing* s 

— 3 •/2 

- 8.6a 

-31.21 

- 0.05 

-1.45 

-3.9 

Cortisone 

Adreno¬ 








genital 

-12.2 

-41.0 

-61.55 

- 0.9 

-5.03 

-5.3 

Cortisone 

Adreno¬ 








genital 

All ^ 

-12.08 

-31.31 

-30.17 

+ 1.27 

+ .45 

+ .43 

ACTH 

allergic 

Urticaria 

-13.30 

-17.05 

-30.S8 

+ .74 

-1.08 

+0.5 

ACTH 

gpilepsy 

-13.77 

+17.36 

- 5.71 

- 0.91 

-2.53 

-1.43 

Cortisone 


Table 2. Comparison of the average daily chloride and nitrogen 

balances occurring before, during and after therapy with 
ACTH or Cortisone. 

IV. Nitrogen Balance. 

Nitrogen loss was consistently observed t o f ollow the admin is- 

% 

tration of both cortisone and ACTH in all of the cases reported. 




















• •>: ; ,ir'. . ;.J 

y./.-.cf '/O OV J w •* O0 i f 1. V 7 / -T' ' ' J :)<• ’ v C‘J J'.cl I^G-l f ;XfiX'I V 

. t . Jb/l&o. . • • 

• i.c"’ ■' : "’ ■ ' • ’ ; ‘ J' • :■ ' . ' ‘ * ■■■ ■:ci ' V 'J J' 

3XiO r- ,! - • J-' ; • . - ■ t .-.j* y - ' V,. ‘,o \o •. . vV Qi 

ljuJ 'V'vv /-/J o-.> ........ , •. * ; v:J! *£.• ::c;'o*‘i‘]:. r .iVGO Ji.J. 


vfollul Ou IjSV'Y.Oad'o 


p,oa.fii> 


:oa©£> 




£iar c-;\ 





- 

i 


"VI.: iVVVViO ; 


. ' ' 



. : o ■ > V . "V: 


■ O' j 1 i ■ ■ 


ill 


A . 
■ • -J 

'Vi’'..- .va'vcv; ,‘iwCv’ i'"-’ ri: 


.U; 







143 


V. Eosinophil Response. 

ACTH and cortisone depressed the circulating eosinophil levels 
in all cases except one. In this case the dosage of ACTH (25 mgm. b.i.d.) 
was believed to be inadequate, although the possibility is entertained 
that there was a transitory fall in the eosinophils, which remained un¬ 
detected due to the length of time between determinations. 



Eosinophils Cells/cu.mm. 

17-Ketosteroid M&./24 Hr.Treat- 


Control 

Therapy 

Control 

Control 

rherapy 

Control 

ment 

Pushing* s 

lio 

27 

33 

X3-9 

23.9 

*~K776~ 

Cortisone 

adreno¬ 








genital 

165 

37 

55 

77.1 

27.6 

11.9 

Cortisone 

Adreno¬ 








genital 

150 

180 

330 

45.1 

48*4 

39.3 

ACTH 

Silergic 






7.6 

ACTH 

Urticaria 

160 

32 

136 

8.81 

11.5 

Epilepsy 

77 

8 

74 

7.19 

18.4 

7.55 

Cortisone 


Table 3. Comparison of the average daily urinary output of 17-keto- 
steroids, and the mean daily level of circulating eosino¬ 
phils, occuring before, during and after therapy with 
ACTH and Cortisone. 


VI.Urinary Output of 17-Ketosteroids• 

Both ACTH and cortisone resulted in a rise in the urinary out¬ 
put of 17-ketosteroids, except in the case of the adrenogenital syndrome, 
which was treated with cortisone. A prompt and prolonged fall of 17- 
ketosteroid excretion was seen in this case. 

VH Urinary Output of Cor tin. 

The urinary excretion of cortin was elevated in all cases 
studied, presumably because ACTH stimulated the production of increased 
amounts of the 11-oxysteroids, which hormones are reflected by the cortin 

















. 

. r::>: ■ XC’lT.*' o ' : . 

' . • . ff-.M-.:,. ■\J i ■ .:■> I..'' : yj TOO -T. bu’i'i .r". '"’0 J-L'lOA 

. ... . . 

'.' t it 

'.'..r... V : • ‘ , ; .Mo o*' ; ' ; ■ -’k. • *" k , •; ,i 

, 


f '.OiOX OX ' > • 

' 

HTOA ; 
j 




■ 




r - j. fr : or 


yf 



ill 


j ?dt 
! cy.r 
Oal 



• " 1 ”' * 


t v * 

-oisooyy] 


! 




i y t 




■ . ; - ‘ - 1 

•c j . ' ' : f. i . '■ « '' o* 

f ! •: . 1 t '■ . • • 

« :xc i;' . .'k 4 


■ x . ' ' ' 

—Ti lo .• j,- ! 


. y y o'ToJ- i V'i ' o c;; : . ■; mi. lx kv 

• ■- l ■'f -' mimm (" r . ’ >A XX'Ol: 

. •. ■ y.; : t : :• :v'’ ■ X '.1 "l . ' , X: *-v. : X •' O'XO koy 

. ,: • : I ■ x m 1 ' ■ ; • mi o: m k X" 


. : :j • J ./ . ':. r x;O' .,..* ' x :■ J . 

. - j: j 'jo ■ ■; yy f <v•:; ■ C ';: * r Jh: U V 

, ■ ■ ■ 

■ y;• _ : .r r,-; -vr. "7 X 

— • . •. ■( , •xyr:, ■; ry. - o • rkk ’>o tJ-oo-ho 


X- 





excretion* Administration of exogenous 11-oxysteroids (cortisone) of 
course increased the urinary output of cortin. 



Cortin Msm./24 Hrs. 

Blood Pressure u 

im./h£* 

Treat- 


Control 

Therapy! 

Control 

Control 

Therapy 

Control 

ment 

Cushing*s 
Adreno¬ 

1.69 

4.97 

3.69 

132/91 

133/39 

158A02 

Cortisone 

genital 

Adreno¬ 

1.02 

2*44 

1.32 

125/73 

126/75 

124/74 

Cortisone 

genital 

Allergic 

Urticaria 

0.64 

0.70 

0.63 

101/69 

112/73 

111/77 

ACTH 

0.33 

1.52 

0.57 

112/79 

112/72 

109/75 

ACTH 

Epilepsy 

1.1 

2.54 

1.06 

135/95 

134/91 

125/89 

Cortisone 


Table 4» Comparison of mean daily cortin and blood pressure deter¬ 
minations obtained before, during and after therapy with 
ACTH or cortisone* 


TO'Blood Pressure* 

The effects upon the blood pressure were variable* Two cases 
in this series showed an elevated blood pressure following therapy. 
Apparently both ACTH and cortisone are capable of elevating the blood 
pressure, although the mechanism of this response is not well understood 
at present. 



Urine 

' alume C , 

C. 

Spec! 

.fie Gras 

Ity 

Treat- 


Control 

Therapy 

Control 

Control 

Therapy 

Control 

ment 

Cushing* s 

1070 

1146 

1240 

1.017 

1.017 

1.018 

Cortisone 

Adreno¬ 






1.016 


genital 

1190 

1317 

1739 

1.016 

1.019 

Cortisone 

Adreno¬ 







ACTH* 

genital 

546 

571 

552 

1.03C 

1.030 

1.029 

Allergic 






1.014 

ACTH 

Urticaria 

1365 

924 

1310 

1.014 

1.021 

Epilepsy 

1661 

1244 

1601 

1.012 

1.016 

_ 1»Q12„ 

Cortisone 


Table 5* Comparison of mean daily urine volume and specific gravity, 
before, during and after treatment with ACTH or cortisone. 














































II DSKAHWC. 


.0 IKS 


, . 


Jfio 



:•)••• r : ) ; • ■ r.o.-u • 

■ .. 1 . / . ; 

• 1 ;i ' J x 


■"< iV r >y\TOi : P. SKriCZ r;J: 

■■■ U. ' ■ o-ij f" h? i&Itff;: K'KT;: 

■>ur .y ■ ■ r’o : • ' - I ":c. .1. ,\:;: r c ; I ■; t ---v v 






o-urxr 












145. 

K Urine Volume and Specific Gravity. 

The effects of ACTH and cortisone on the urine volume and 
specific gravity were also variable. In low dosage cortisone appar¬ 
ently causes an increase in urine output accompanied with no marked 
changes in specific gravity. High dosage of cortisone resulted in a 
retention of water that was coincident with an elevated specific gravity. 
ACTH resulted in a decreased urine volume in the case of allergic urti¬ 
caria, whereas little change was noted in the other patient receiving 
similar therapy. 

It was noted that the responses to ACTH and cortisone varied 
even though similar dosages of these substances were used. A dose, 
which was pharmacologic under certain conditions, was seen to be in¬ 
capable of producing the same response at other times and in other 
patients. It has been suggested (415) that the wide range of responses 
observed is due to the varying needs of the tissue, which fluctuates 
with the activity and environment of the organism at the particular time 
of study. That the same hormone can induce retention or diuresis of 
sodium, chlorides or water; be anabolic or catabolic; or promote or de¬ 
press glucose utilization can only be explained on the basis that the 
functional status of the individual cell is not static. It is obvious 
then in the light of these observations that no fixed amount of a hor¬ 
mone such as ACTH or Cortisone constitutes a physiological dose, and that 
the effects observed with their use are determined by conditions existing 
within the cell at the time of therapy. One would concur with Sayers (195) 
who points out that further studies of the adrenal hormones demand a wider 
application of such concepts concerning dose and response. 


!>:.»• ’ o: ;7.1o .•■■o r,r.; ■ 7 • , .T '■ 7r j y T- .oiT 

■ r-I 0.; , 0 .". ' o ■■■/ •’ 

cb r>s ; i i ! ■ g , 1 

7 o'C r:.: *■ : o y\ ' ■■ n r : o. . 7/ V1 • 0.0 

, -or r oj ec : ±;Ly 7 , 77 , ; v -,c r> rsl U>& Z;n- r :;, o'Y'DA. 

' .77 o': 0 o • 7 ; : 7 7 7 - Do ■ :;D 0 .!. Dr o .iJo.U • "-io•: 

- 

D J:"' "7 t=-- .Do; 07 . ;D o 7 -7 .; > 0 .; 

1 7 . i: .V. ■777.V ; ■: ■ ;i? *:l ..1 TiO -.7 • ' 7 7; 1 ,07 . 0 '7V.‘ 

■: ■ 7 7 ■■■ -- , ■ • )' o 77 ■ 00770 r ;-/o .-[■ o;.; 

7?..7ro iix u. 7? 7:..7t o. .777' ‘ • . 7 '.-r; ... : ; : 7 .. .■ 770:7 lo o.oi'ocroo 

v : r ■: • V : ■■■.". 7 .0 - . ■ oi • . 

"r-7 . . 07 .. : , 0 - 7:0 7 . ; • ' ;V: ■ 77 ' 0 7 oooooro . : o 

' 

. 

.ro ::o : -.777 kvv ; 7.0 'jo.'.-uv! •re oiriooi ouo 70 ;• 7 . 7:0 y-ihrioiZxo t ooilror: 

07 / •• • 7.::D ■’ : . .r 70 ‘v oorurrc . rf ~rl:i o a-'O no oDoorDoD.;:/ ■ •• v - o' ?. oooto 

77 D: . 7 .. £ ; . : .o .7 \jj ;ro.' ' fui& oD X. 

\ t o toi if ^ lo : ■ l fioi&fr 

' tDoi • h toai oD *: o . o o ; a< 

. 7 . . 7 . • .1 D' • : : oro 7.Do;o .• ' x:V..: :?,J ;.). '> ■ D 

7 • , . 0 . ;vc 7. ./ . : " .D.' r . .) : or al 5 

• -■ : r. ; ■ or'O- r ;7 o 00-7 o'; 7 .g 0h){oj77 ; 07, V J.D'. D : :i/ -7 JC, ' 7 _ : 77 

' ' - ■. 77 r; o o;r 7; n-. or o' \ .0 • 



SUMMARY 


1. The historical background concerning investigation of the physio¬ 

logy of the adrenal cortex was described. 

2. A review and evaluation of some of the literature on the subject 

was presented. 

3* The methods and procedure for performing metabolic and biochemical 
studies were outlined. 

4* The results obtained from studies of patients with Cushing® s Syn¬ 
drome, Adrenogenital Syndrome. Allergic Urticaria and Idiopathic 
Epilepsy were presented. 

5* The significance and possible explanation of some of the results 
observed were discussed. Probable lines of future investigation 
were indicated. 

. The metabolic effects of the adrenocorticotrophic hormone (ACTH) 
and cortisone were compared. 


6 



jo , [, 

' 

■ ■ . 

' 

' 



,1J . ■ ' ' t. ■ ■ ’ •. j.. ' 

.; - oo •• ' .■ ■. ; J : . ; r -Ovo .. / j.u \ ol 

: '• ' : : . c / ' 7 i 

bc&r : ■' •, ’ r 

.. .. : ‘ .7' ■ <;.j o' : .j < 77 : * ‘7 7 -r. • o J . ■ ' . j 

. ■■ > r: : 7• j : J-' 

: ■ ' ■ : V ' 77:.' j : ' - . j 

Lb; . 3 ' J 1 . J . ■ 7 7 , : 7 . 

7 7 1 ; c \ o II: 

' 

' ■ , 7 C: •: ... ( ; 1 f J J 7 : ■ ' . 77 ''7 ... 7 J ' ! j. ; , 7 

j’ / ' 7' ' . 7 ' ' Q* / : 

j . <• r ■. • r -; : 

'} 0 7Xj-r ■: i 7;l '7! ! ■ /.']'7.7' f ' V. 7: '.7 7/7 ' X'.C ’ '7-,7/ :7.d 

-r ' v o/iooj ,/7O0 ; 












H - APPENDICES 







i. 


APPENDIX I. 

Flame Photometry. 

(a) Principle. 

The principle of the flame photometer, which was devised to 
measure low concentrations of sodium and potassium in solution has been 
described by Barnes ©t al (416)• The solution to be analysed is dis¬ 
charged -through an atomizer in a fine mist into a mixing chamber, whence 
along with a combustable gas it is drawn into a flame. The light emitted 
by the excitation of the elements in the vaporized solution is conducted 
through an optical system to a photoelectric cell. By the use of lenses 
and appropriate filters, the light emission of particular elements may 
be isolated and measured. Light striking the photoelectric cell produces 
an electrical impulse, the magnitude of which is a function of the amount 
of the element in the sample. This electrical response my be utilized 
in two different ways for measurement purposes. 

(1) The Absolute Method. 

When using this method the current output of the photoelectric 
cell is measured directly by having it flow through a galvanometer, -here 
the galvonmeter is used as a micro-ammeter. The method is fairly accur¬ 
ate under ideal circumstances, however serious errors may result from in¬ 
terfering substances in the sample, variations in flame temperature, or 
fluctuations in gas or air pressure. 

(2) The Internal Standard Method. 

The errors which may be encountered when using the Absolute 
Method may be el i minated in large measure by the use of a balance circuit. 



jbwajr/cjy aow doxxfv? .7.3;?obo.o ; 1 - ox&t to * loiov.-v; •; • l? 

■ . 3 ' j - : ‘ 

.... •/'.■•■'.■••'• .-a .:• ■ 

so,u ft ? ; -rfi ■.io 1 : ; 1 o; i '. ».< fc i / . :, Jb 

.boJ'd'J ’ . ■ 1 ' 

. .j , ■ bxtoo : I ■ : . - ' i > . f 

; ; 1 ) .' . ... - ‘ ■ " m d 

v-v: br-jr.-v. i:ro ftr ..*..1' •• j r V : ' J \ tor 

..; ■ :/< ; u .. . .. 0 0 r V . O ■ ■' A ' ■; •. . ■.: : .' ' * o , 

L ,f fi/',-,: o '.r: M '.3 va'.J/ V ■ -voo;:;;. v ..o' 1 .. ' ’o , r . ;n 

- - .' ' ; •: ■. ■ ■■ 1 _.: .■ I' ■ ■;.' ;• V V .’ ' i ; - ‘ ':.' 0 . 

' ■; . or ■: ■; A . ■ 

• 01 ■ • . 

o.:J od ; xo Jvroo-xro J Arvoo o , 'b o cioic 1 ' 'ir asnti ■ 

v'X-ji-y t'Z'tjopunxrvi xj .olV: ,-J: oii/.voi oxviusaoui >h LU<0 

■ .' ■ 

■■ •• •: : • .' ; ,. . r j 0 j. •: j. •.£ ; / ' 

•;c > ■ - ... ; . . . ’. £ ( . . : . / , ' .../ sd .. '• : • vixr-; :.i'n b.. 

' ' .' • O ’ -J - r 

.• 

.;{■ f*, : .r • .:•••* oo r/ ■, roo;'.) ;o ecf \m dohfvr ::r.( 0 ''*i© oaY 

. . " . , . ■ . . , : l . . j . j>'d 3 ' : ' C 



ii 


A fixed quantity of Lithium, a substance not normally found in urine or 
serum is added to the sample. The output of a photoelectric cell acti¬ 
vated by the Lithium is balanced against that of a cell responding only 
to the light emitted by either sodium or potassium. Most factors which 
influence the light intensity emitted by sodium or potassium will influence 
that emitted by Lithium in the same manner and to the same degree. In this 
method the galvanometer is used as a null instrument, and is returned to 
zero by the use of a potentiometer. The potentiometer reading, therefore, 
is a measure of the concentration of sodium or potassium in the solution, 
the actual concentration of which is obtained from a calibration curve. 

(b) Apparatus. 

During this investigation two flame photometers were used - a 
Barclay Flame Photometer and a Beckman DU Spectrophotometer equipped with 
a flame photometer accessory. In the former instrument three channels, 
each of which is fitted with appropriate lenses and filters, directs the 
light to three balanced photoelectric cells sensitive to sodium, potassium 
and lithium respectively. Such an arrangement permits the use of both 
the Absolute and Internal Standard Methods of analysis. The Beckman in¬ 
strument on the other hand has but one photocell, and utilizes the prin¬ 
ciple of the Absolute Method of analysis. With the superior optical 
system of the spectrophotometer, however, most errors are el imin ated as 
only the intensity of the spectral band characteristic of the element 
under observation is measured on the galvanometer. The accuracy of this 
machine, therefore, is comparable to that obtained with the Barclay in¬ 
strument. The glass parts of both instruments were cleaned regularly 
with a detergent (Haemo-Sol) and sodium free distilled water. Filtered 


. n 

...c • ■' or ton '••o:, 3 J J ‘lo ur.! ow *, 

v v. u ,\L .. ■ ■-..7 i.?nr ■> ■ • j. : - v ' 

’ 

•'. :r.rnj-..LxL . ;.L • : - v . ;; e-i •. .• ;r > L' ’ ' 

. 1 . : '.>• • .' ,• ■;" : Ji. ■ J . '/ 

■ .. ■ a 84 ' n - ■ 

. :L ". . ■ - ' •; ...... 

. }{\ •' : 7 *;■■■•..■• ■■■;.- : ; ...v ;^ :,t r: . •• .-r: ‘ v,.: 

Li ' 1 ’ . ■ '. : 

' 

b - s e,'i:<h:,xo&o£iq s»amJ. 0 1 .■ a J . • . : ,vtx < 

BJX-r Lx/ ; r •.: -o L/. ■ ;. ■ ■ .* 1/7 ' : t -. •.• .' '*n. 

. 

-.o' j- 'lib . y.roLQl 'xr; a ^ •/' - L? L L dxLL '>o . r L -o' 

■ . 1 ivl 

, 1 cl . ' ' " ' ■■ •• . . v ■■ ' v r : : ■ 

’ 1 . . '• ' 5 

L •’ : , . x/ ! . ro X; J -' 

.v:oi.j • •.■;;* L; ' l-. '' .v --: .. : iL ic r.Calo 

■ ■ ■ • ' ' • ;i •■■■: » ' • , c i :)•:.> 's.c it rsr-, 

■ i . . i ■ 

.• ■.= r 5'/ ;vLu n:• it;; ;■-x^f-rur 

-•/ '' . .i . ‘ ‘ '• ■ 

• .. ' .. rMsthoi:, bm (S.o ■ ;-L r- .: riJ.x. 


r 


iii. 

air under pressure was used to vaporize the solutions, and the flame 
was fed by natural gas or propane of constant composition, which could 
be burned at any pressure by means of reducing valves on the instruments. 

(c) Preparation of the Material. 

Urine specimens were diluted one part to fifty of sodium free 
water, while the blood was first allowed to clot, centrifuged, and the 
serum diluted to one part in three hundred of the sodium free water. Di¬ 
lution of specimens was necessary to bring the concentration of the ele¬ 
ments being measured into the range which was optimum for accurate 
analysis. 

(d) Procedure. 

Calibration curves were constructed from readings (Table 6 for 
sample calibration data) obtained from a series of stock solutions con¬ 
taining sodium or potassium of various known concentrations. Four or 
more points were used to establish the slope of the curve. After stabil¬ 
ization of the curve, the unknown solution was introduced and the rad- 
in gs recorded. These were checked a second time, following which the 
standards closest to the unknown were re-checked. If the curve obtained 
during the calibration of the instrument remained unchanged, the read¬ 
ing for the unknown was accepted as valid, and the concentration of the 
element determined from the calibration curve. 

The accuracy of the method compares favorably with that obtained 
from the most superior chemical methods (417)* 


♦ . I 



’ 11 . ■; :■ . ■ : 1 l.l: : .,>1 ' " f 0,1 ' . ;.r v;;' ■ : ■ *. y.-t; yJI; 

1 lj.ro 0 : 11 ■ 1 r • i- ,. r . ;Cy vj t/\'X •: T 

■ j . . % . v ■ • • .. . 

• . 1 ‘ <■)] 

r yxIItt; c.; cl 1 . .v :--c -yttI. o t-o >y i 

■ / . • " ' 

« 1 ' : . ’ . t : ; . b 

-sia ::. lj I;,-- '. 1 ./ • :t! (1 vrcoer-o^ff v, : ?.r ■ J ^ ‘in fxoi\l r Jl 

of :■ ; :JJ 'il..o "■v.r . 1 . :r • 1 > 1,1 tyyt • -j.,: . It;;- 



. :: 1 ; 

. 


•to'): 1 \ It’} o rrl. ; v.: toy! o.l *= ;r , v . .t ooIIyt 1; . : 1 ) 


rr 1:1.'Ion loo .7 ; 1 . 10 .' - ■ 5 ■ ■ . r.l ••1 .V ' ■ ttt ■ 1.' ■ rlil ;n aio'cma 

. 

■ ; 1\: oolx- . ' n -.'I •■■■■;'. o : 1 1 . 1 ;y.,o : "■ i'.'-o.v t • 

- . . . ' I ' ; ' '• ' 


. ' , ■ '■■■■. •' 3' . 1" V; 1 

.. :/ :■> : ! . ■ ;■ 0 ■ ■ ;t ■ • 1 ■; u • ;, • "", 

no * ; ; r ■;.. • :.o' t ;; ’ . • .0 'to -olloo1 M r. -vuj nlon'l 

.1 \o . 11 .J • . 1' 1! . , :1 •. "I-'to-.V:. ' r oyo-'to 3 0 1 o 

. v . •' 11 :■ : ' . •■£ • M. j- ; 1 

■ 1 ’ ? > . • ■ 

- 






Absolute Method 


- 

internal Standard M 

•sthod 

St. 

Concentration PPM 

Gal. 

St. 

Concentration PPM 

Roten 

Sol. 

K 

Na 

Reading 

Sol. 

Li 

Na 

Reading 

1 

0 

0 

0 

1 

50 

0 

0 

2 

0 

5 

11 

2 

50 

5 

87 

3 

0 

10 

22 

3 

50 

10 

177 

4 

0 

15 

32 

4 

50 

15 

260 

5 

0 

20 



50 

20 

340 


Table 6. Sample calibration data for both the Absolute Method 
and the Internal Standard Method. 


(e) Difficulties Encountered During the Investigation Period. 

When this series of investigations was begun, the Barclay 
Flame Photometer operating on natural gas was used for urine and serum 
sodium determinations only. Potassium determinations on this machine 
were very unsatisfactory due to the difficulty experienced in estab¬ 
lishing reliable calibration curves. For that reason potassium de¬ 
terminations were performed using a Beckman DU Spectrophotometer equip¬ 
ped with a Flame Photometer Accessory. This arrangement existed through¬ 
out the investigation of Mrs. R. C. and Miss C. W., following which the 
Barclay Flame Photometer was returned to the manufacturer for repairs. 
Before it was returned another project was begun and the Beckman ma¬ 
chine of necessity was used for all sodium and potassium determinations. 
Some months later, and too late to be of use in the remainder of the pro¬ 
jects described, the Barclay Flame Photometer was returned. It became 
of interest, therefore, to determine whether the two instruments dif¬ 
fered with respect to sodium values, so a small series of serum specimens 
were tested on both machines. Comparison of the results (Table 7) re¬ 
vealed no significant differences. 


















f.'J'.t ( 


VVJ 

{'.- 3 ; , 

J..3 -• 




' #:i”r 







xrxi ■ xx\ X : 



V X 


■ -i ■ J X X. . ■■ 


' . ' Fitl 

v. ■: i'.oxx t ii.i , X ,x. Xx : . -XX. I .it v.'jXxec! ~X 'X . XX 

. ! i •■ t ■ ■ c < oi 

■ ' ■ ' i - X wJLei . • . ■. f - - 

-XxXx. •' oi x-jx,xy ; x x r; v:e;; xx.x: 

■ . . ■■ :.X .o' . x '/ rx; ' . ’..x;- ; ! ’X X. xxyx-iX. 

".x;. m'. j.-rv j"ixxx.jx ' X Xx. .. 1 . ' • •: X xx • ■}': £ ' r-'XWl BXTX x.-x B-X'x .? 

. .■ • . &®q 

.XX. ‘ . ,X . . - . - ' x 

„ i i: xX: ’•.. f :; ■ n arfj oX xx x v xxX x.xx x-Xxr s Xoxx o.fx/vrX v\Bloy.^S 

- v "s • x' XU 3.3x J. • • ’;;x r: • rX' ; - - xx ;rx;x xXX: xxo'X; d 

..■x xx ‘.. x"- :■= x r . /.X,, rx. Ix/GX: x:o’. sj 33V? x. : i ixxd^x Xg xr : 'i.:'; 

--oxx: XX,' ig x ; : X • \t ;j x-’xx ‘io ox oX xx‘x X cc.t .Xxx x'x-X xf x xxnoo 

■; tj 4 x x.; ; x' •Xgj.XX x.<X '.x/xv-: :>iXJ' . .'xrxx:x 1 -X^ 

-‘xXX ■ XXX ' I •: X 3,X ■ . : ■ iX XX ‘.''X X : . XXCX. ■ • X; X , ’ ‘••'Xi ' X ’it 

' ' ■ :■ ■ x. • , ;XJ.- -v ; t . .•" 

• o 

„ ■ . X : 









V. 


Material 

Photometer 

Absolute 

Change 

Percent. 

Diff. 


Beckman 

Barclay 

Serum 

154 

153.9 

0.1 

.06 


Serum 

143 

147.3 

4.3 

3.0 


Serum 

141 

140.3 

0.2 

.01 



Table 7. Show comparison of values for serum sodium 
obtained on the Barclay and Beckman Flame 
Photometers. 

As potassium determinations had been impossible previously, 
attempts were again made to calibrate the recently repaired machine with 
respect to that element. However, several weeks of experimentation re¬ 
vealed that the potassium cell was still defective, and it was returned 
to the manufacturer. 

Erratic drifting of the galvanometer needle became increasing¬ 
ly apparent during the ensuing interval, during which attempts were made 
to calibrate .the machine for determinations of sodium. It was decided 
that the n draft IJ was due to contamination of the air, so use of the 
machine was discontinued pending the availability of new space free of 
such contamination in which to insta.ll and operate it. 

Throughout the course of the studies reported it was necessary 
to re-check several potassium and sodium determinations. Frozen speci¬ 
mens were used for this purpose, and there was found to be no changes 
in the values obtained in such repeat studies, which were attributable 
only to freezing. Data illustrating this point is presented below. 










7 


-vr. -v • - *t 


u 


JX ' v. : ; " -T ; O * 

.. i... 

• C- j : . , ; 

. 


. ... 




; ■ .„.r : 


liU\ • 


i;i V' 


; : v • : ■ .. :■ •• v i ■ 

. 


,V eidsT 


. 

r‘ i; ,V'. .• » ■ v. , ■ . v.*: * . ^ :‘i,r 

. 

' v.U 6 ■ 

.' . ■ • ? : >'• : ■■ 

e>\oju' i-si&v . }.!,rl> ^al+wb , v ,, ? j/;?.««■ bxU \7 

. ' ' 1 > • 

. -V •' ■' v . ; "■ ; \ r,: , ■ -vr 5 T .r*::.“.*.i : J.: $ 

’;.0 • ' 7 ' O' \o \j f' -.ft or :.',-h ' 

. • ■ ■ :l ■ ■ ■ ' ' . ■ X ■’ 

v' xx o^.a " •• &J~ h '<'/'■ t'■ :/t r-xrlVr.rj - j 'it, v-njo'? -xlt jr^od^ttavMT ' 

'' . X-i n ' X: •')-•• 

r 

■ - ■ 1 

. c I 




▼i. 



Determi- 

Before 

Freezing 

(Mea.). 

After 

Freezing 

„.. 

Percent. 
Change 

Number 

Days 

Frozen 

[Jrine 

r k 

77.7 

75.1 

3.4 

65 

Urine 

K 

64.I 

66.6 

3.9 

49 

Urine 

K 

80,3 

78.7 

2.0 

103 

Urine 

K 

74.3 

77.5 

4.3 

98 

Serum 

K 

4.8 

4.5 

6.2 

103 

CJrine 

Na 

22.1 

22.3 

1.0 

105 

Urine 

K 

54*0 

51.3 

5.0 

35 

Urine 

N 

12.6 

12.2 

3.2 

35 

Urine 

K 

36.3 

39.3 

8.2 

30 

Urine 

Na 

46.38 

42.0 

9-5 .. 

J 5 


Table 8. The effect of freezing on urinary and serum 
potassium determinations performed with the 
flame photometer. 
















■ ■: ; • : '■ 

' 

.. 


■ 




?:'<f r 


:n.r ■;.? 
i:t I:, ... s /'■ 


. 













vii. 


APPENDIX II. 

Factors Affecting the Determination of Urinary Cortin. 

(a) Conditions of Storage. 

Circumstances sometimes result in considerable delay before 
the extraction of a urine pool is begun. It was of interest, therefore, 
to determine the effects of storage under varied temperature conditions 
for relatively long periods of time prior to extraction. 

A single urine specimen was used for the determinations des¬ 
cribed. Three aliquots (200 c.e.) were measured out and acidified to 
pH 1.7. The first and second specimens were stored at room temperature 
and at ice box temperature respectively for forty-eight hours prior to 
extraction. The third specimen was extracted immediately, and the cortin 
assays of all three extracts were determined in an identical manner. 

The results (Table 9)» although not statistically significant, 
indicate that refrigeration is necessary when conditions demand that the 
urine be stored prior to extraction. 

Time Cortin 

Specimen Stored Temp. Mgm./24 Hrs. 

1 IS Hrs. Room 0.39 

2 IS Hrs. Refrig. 1.11 

3 Zero - 1.24 


Table 9. Table showing the effect of storage tempera¬ 
ture on the determination of urinary cortin. 

(b) The Effects of Freezing Prior to Extraction. 

Sometimes it is desirable to repeat a cortin determination 

long after the specimen was collected. In such cases specimens which 








c 



• 1 • ' • tfl 


• J j • c. • ■; fj'-. • •• r/iriiO 


■ i * .. . 

' : • ; -.••• X*. : . 


. 

i ' . '■ M a'. c.." ;.r.•: ■' j.c'i 


: • •:> • _ • • * 

. j l'j.. " 0 :;i'; ;i’ ; . >'■ ' v 

. . 


♦ . 

" - i . - • “ .• .. f f v r:v. ^0: 

oo • ' 

'..7‘ill V-.-Jv ' • . :• • 0 ■ 


« ’ 

vtoi - t.. »>T) -■ . ‘ 

& 1 

■" - • -.1 :• • ■: J ■: J I 


. >. •• :j- • • ■ : •; c• r :/ ' • ’ 


. 

. _ : _ ... . ‘ . , _ ; j ; ./. 


. . 

. ,/ J 

, 

> 

::r. ; : r^V.-r 



. . ■ ■ tlm 

, ■ :t . r\V : ■ *f. \c ru L ■ : V ' 


l. ; o ' 9 b ■ ' ti 

. • •*;;;• - 1 . : : .. n . do \ JljEl ^nol 





viii. 


were preserved by freezing are used. It was necessary, therefore, to 
determine the accuracy of such repeat determinations performed on 
frozen specimens. 


Urine 

3 Day 

Mgm./24 Hrs. 

Before 

Mgm./24 Hys. 
After 

Days 

Actual 

Percent. 

Spec. 

Vol. 

Freezing 

Freezing 

Frozen Change 

Change 

1 

1530 co 

I .30 

1.42 

175 

+0.12 

9 

2 

3300 " 

•94 

•74 

170 

- .20 

21 


Table 10. Table showing the effect of freezing on the determi¬ 
nation of Urinary Cortin. 


The data presented indicates that although there may be 
some change in the values obtained after freezing, such are not sig¬ 
nificant in the light of the experimental error of the method itself. 







.. ■ . .• .j-■■■;.:-V i \ 

ih\[. o oq ^J ' • J yh : rr. do.y:nvrx:.vo/', vou'vo;: o •/;- 

. 


- ' • • • . ... • 

. . . 

. 0 . . ,-1 :• \v:*o ■. • !.-: ? 

. - . ... f3 

r . .:. i : .; ;• ; : • - : r u , : ; .. •. 

• -■ ; " ' :. ■ C . : 

.' ■; ■ - ,i ‘ -iti \.o ijc i '■ \;n 


ft<3 :. : . ' . V M.’O,' r O • * v.j- • jOF 

"J • .•••••0 0 ' a .” -*V tu.' 0.1 CO.ftV.tirj ■0/00 0 

, ... ... ; ■:. •' jo . ;c / '• o' vo: .'.■ ■ oi <. o 







Appendix III 

Tables of Metabolic Data 




BIOCHEMICAL DATA 
SHOWING EFFECTS OF CORTISONE 


CCt <3 OVJi fO H 


OHVOMMVOVOOCX 
O O VO TO TO VaJ TO 00 


H H H 1 H H 1-* I-* 
oi o O' vr* 4>- vo MVjO 

°V\VV-V>VV 

KD H H H sO »»vO 
VOQOOOOOCTv-3 
_ 


H* H H* M H H H 

vr» vn ux vo vn vn 4>* 

+*■ ocoo 




^SO vO 

U 


09 (XX OCX vn -V2 V.O O'Vrt 
OQ-VnOtUtVOOTOav 

88883888 


TO TO TO TO TO ?0|0 TO 


M VO 

loo 


9 


^voso o 


OX KJX \Jt Vft VJt 

• # # • 

vo v* 


vn 


f 8 

£! TO 


H H H H H H H 
HOOHQHHO 
OV^'JO^HOvS 
• •••»«*« 
-3 vn vQ JO v ft TO 


H H H 
vn ut 
O H 

TO TO vO TO O Vo TO 


N k K. is. vn Vft is. m 

To o To o To o h To £ 


p*\n ro vo vft 
• ••••••• 

vO TO VO TO CO 00 Vft 
Ox TO VO TO 


.00- **3 0Q vO vO M3 *sl G> 
COOOH -3 4^ M3 


• ••••••• 

No OM‘DHMOM 


VO VO VO 4>- 4^- Vo 4^ 

• •••••«• 

TO *V3 OX vft O M3 O 

TO TUTO JO Tv$* TO M K3 


000070000 
OOOOOQOO 
3333043 B 
<M* c+ c+ c+" cf* e+ c+ 
? H 4 1 B H-4 5 
oooocraceoo 
H H H* Hi © H H 

• 3 
CD 

& 

• 

Hu 


X o 
0 T H 

© • 


JB 


g: w 

d> 

n 


& a 


P? 

CO *13 


H3 Q 
M 
O 


8 

« 

n> 

<! 

• 

5 

<D 

• 

OCX <3 O'vn 4 s. VO TO H 

hj Gj> 

Is 

« 




TOTOTOTOTOIOTOTO 
• ••••••• 

O vn O^-fs Ts M 

OxTOOTOM^vOQn 
vftvn<xxvftT 04 ^' 00 ' 

a 

[SODIUM 



TO TO Vo Vo HViJHIO 
• ••••••* 

OivQOOCDH^O 
VO Vft 4 ^ Vft MD 

1 

p 

01 



+ 8 1 1 + 1+1 

H^V)VTt.J^CDH 
Ui OnC 

Ox Ox TOO* TO O'M 3 4 ^ 

Od 

$ 

• 



VO VO VO VO VO TO TO VO 
• ••••»•* 
OTOTOTOTO*'« 3 'OvO 
Ox VO (XX -s! TO VO 

Js^^TO-JVOvOO 

a 

3 

£ 

CO 

09 

P 

TjQ 



TO TO TO TO VO Vo TO VO 
• «•••••• 

4 ^^CXJOHVO^TO 
VO VO VO O' 

8 



+ + + + + 1 + + 
• •••&<»<» * 

<jsca|>-OHv*HO\ 

s 

• 



vovovoVovovoVo-i^ 
»•••••*• 
so ^3 ax ax O' -a h 
h O'M 3 vo ocun- o oa 

TO H ^3 Vft 0 & HVO 

a 

0 

B 

1 

S 

D 3 



UJ £>- Vlx Ux VO I?** TO 4 ^! 

OJMOHHOOJM 
H TO ->3 0 » O' O' 

1 



+ 8 8 8 + 8+1 
H H H 

• »«•••»• 

H ^0 H Vo Vo <# v n 
S-»^ p 03 - HVO^ -J 
ropvovovn TO M « 0 ! 

td 

& 

« 



hmhhhhhvo 

kO TO Vo TO TO TO TO o; 

a 

SJ 

H 

1 



PfKfGPPK 

b b -b b 4 b '0 b 1 '- 

s 

i -3 

1 

ff 



1 1 J 1 8 I 1 + 

VO VO ^ VO TO 

1 

♦ 

TO 

• 



Control 

Control 

Cortisone 

200 mgm. q,d. 
Control 

Control 

Control 

Control 

TREATMENT 



? g- 
w 5* 


• oct 
O CO 



& 


a 


id <3 to 
n> js H 

4 H H 

p. fd 
O CD < 
O, to p: 

• H 

Hj £ 

O CD 
4 CO 

CD CO 

95 tr 
o o 

cft 

3* po 
4 4 
CD CD 
CD 

95 

a < 

95 CD 

X 4 

95 

OQ 

CD 








































































































ro 

s- 

a 

§ 

• 

<T 

$ 

P 

5 

CD 

Oa>J U) M H 

0 e 

o 



M MM M M 

TOvQ-P- MOJ-NsO M 
Oi -4 .JS- vO k) n£> 

U)O-OO)?OOVjJ0a 

URINE ! 

VOL • 

i 


MMMMMMMM 
• •••••«« 

oooooooo 

MMMMMMMM 
O'M-vlOOU) 'JO 

SPEC a 
GR. 

o 

2 

U> 

M 

& 

M M M M M M M 

OOOOMOMOM 
W0)H WOOkk 

CREAT¬ 

ININE 



OiuiVJt On On <Jn On On 
OOnOnOOMMMM 
• ••••••• 

-O 00 vO vO 4^ vn MM 
O O O O O O 

m o 
oi rn 



MMMMMMMM 
fc- -S COnOU)JS-U)^ 

• ••••••a 

O vn O CD M *sl vd V.«i) 
OJ 

5 s 

♦ « 

m 

• 



M Mk k- Ut MM 

os 

a- 



Control 

Control 

Cortisone 

200 mgm. q.d. 
Control 

Control 

Control 

Control 

TREATMMT 


■ 1 





CO **5 


nO 

O 

ON 

vO 

O 


s 


a 


< Jt> 
® P H 
4 M M 
H* £ 

O (!) <4 
0.0) P 
♦ M 
H> p 
O CD 

fi to 

§ & 


P 

a> cd 

(D 

p 

O. <J 

P CD 


TO 
































CO 

c+ 

! 

<r 

HP 2> 

HOvOW>3 Osvn U> M H 

3 DAI 

PERIOD 


- 


m ro ro ro ro h 

vnvn oovjjOfooooO' 
snot co Oj sO on OsO M vn vn 

§ 

CO 

a 

• 




HHHHHHHHHHH 

rororororororororororo 
^OOO Oon Oj on on Qs ro 

HOOj -<l 4>- Vo vn 00 O 00 M 

txf 

• 

y 

I 

a 

•+ 

o 

=* 

H 

VH 

• 

ro 

HHHPPHPPHHH 
Oon Vo vn is. vn 4 s. 4 s. vn oson 

ro’ go bo bis- os b b ro is- 

• 

ro 

• 

00 

vn 

fe 

« 

00 

Vhjs. on V>.'Vn'iv* 4 s- .is-- 

Vn O' O Vo O-'Oon 00 00<!00 

^=-* 

1+ 

00 

H 

• 

as 

i 

k Oro oi-'HononCs-oasOs 
4^-VjoroOOon->300Vjj 
OOOvnOH£*-OOOvn 

ooooooooooo 

d 

o 

l-t 

o 

os 

ro 

ro 

o 

00 

rororororororororororo 

oo 00 '^ on on as os as co as os 

ro b os - o h b b h 

® o 
q ro 

> 



HH H H H H H H H M 

OOOOsQOOOOOO 
roM HHOITI 0& is- <2 -0 Vo 

bs‘ * Co Co H b 

S o 
0 H 
o 

• 

> 

g 



HHHHPHHPHHH 
i-i- ^4s.4^4r~vn.fe-vnvn|s, 
VO>- OSOO --0 VO VO £"• \J0 O VjJ 

^<JO*t>'VjJ+-\0=>avO vn 

S? 

Q 

• 

H 




£s4S- 

jt - • • 9 •.<»-• • * » ® 

roroas^ n vo vn ->3 vo a* 
vnvn O 00 U) OSOO osvn ro 

s w 
© 

£J 

• 

> 

1 

r+ 

• 

00 

o 

$ 

00 

ro 

0000 00 vD 00 00 00 00-000 00 
*>3-0 ^300-3700s-0s0 0^ 

&a 

- 

• 

v*> 

00 

vn 

ON 

V*J 

-0 -0 Qs 00 <2 Ofc' 

vj -0 v£> is- 00 4r- Ut -0 Os O 

oi hd 

• * 



rs.^- ^vn4^£-vnvn4s»is.is. 
0’s os wow b b a b b b 

MUMUWMMWMMU 

b b b b b b vn b b Co \) 

►-a o 

M 

o 



Control 

Control 

Methyl Tes- 
osterone 

40 mg./24 Hrw. 

Control 

Cortisone 

100 mg. 

/24 Hrs. 
Control 

Control 

s 


ICO 

r 

o 

< 

a 

* 

♦ 

H H 

HOOO»>J Qs vn 3S- VjO ro H 

0 

,a 

1 ^ 

!s 

1 


TABLE OF METABOLIC DATA ON MISS C. W. #96696 WITH ADRENOGENITAL SYNDROME SHOWING EFFECT OF CORTISONE. 

L,.. , -- - - -- .... ■ . ... . . . . .. ..... . --... . -- ■ . . . ------ 



to ro ro ro ro ro ro Ki'WK) ro 

• •*•••«•••• 

i" Osvn osvn Os ^ Gs 4 s. 4 s.v 9 
OOU\ OsioOO/OQnOH 
ro vO H 0Q. vn CO vn vn OOK) 

a 

8 

O 

s 

TO 

! 



vovovnrovororovorv>?v>vo 
...*«..«.•• 
vOv3000W»HvO>10 
gs ro -F- so vo vo ro 

a 



+ . 

fo'So^'^vo^o'biavoS 

PHnOWO) WUiUi H CO 

• 



vovovovovovovovo ro ro vo 
«•••••••••• 

ovoHororovoroojvOso 
00 vo vn vo is. ro 00 vo ro 0 
M VO U&4>- 4>- 4s- Qs->34^-sO-<! 

a 

hd 

1 

cn 

? 

a 

r 



vovo'ojrovorororororovo 
• •••••••••• 

so O 0 s is. O SO 014 :- -^a 

vo Vo O 0 os 




1 + 0 + ”»* + + + + + + 

• ••«»••»••• 

rovoi^csrovovnocTH h^! 
as|s. osvn 0 4 "- ro vn vo roi>> 
sovo ro 4 s- i-^ b- os-vJi^sO-'J 

• 

j 


VO VO VO Vo VO VO VO VO VO VO is 

asCobCobbbCobsbb 

UtHsDVoOssDOaoroOH 
W ro H ro H- 3 v£l OSVO H H 

a 

1 

| 

1 

Ui 

i 

. 

w» 

52S 

H 

rl 

8 

I 



Osvn -=avovn4s»^vnis.4s.vn 

b b b vn ro Co b O vn: 0 

Vo H v0 4s ro VO io 00- is* vn is- 

§ 

► 

1 1 



1 1 1 + 1 1 II 1 II 

MHO H H 

b bCoi-bCobbbos 

-5\OsOsOvnVOVO«q HiN.ro 
K> OQsO <0 vO vo -*4 sO sO' 

od 

& 



Ihhhhhhhhhhh 

'hhhhhhhhhhvo 

rororovorovororororoo 

a 



HHHHHHHHHHH 

ut-asovnvoroHOo ro ro 

os is. osut -o ro 0 ro ca V) vo 

a 



^ is b ro 0 S h S h S 
isro^rovnsoroo^- h-o 

g 

m 

V 

i 


Control 

Control 

Methyl Testosterone 

40 Mg. 

/24 Hrs. 

Control 

Cortisone 

100 mg. 

/24 Hrs. 

Control 

Control 

TREATMENT 


VjJ 


►d Cb ir> 
(DPI-* 
4 p. H 

< 

& 

p d 

H CD 
pi to 
CD 

to to 

Hj o 
o 2 
4 B 

(T> P 
P ^ 
O (5 

£? CD 
4 4 
CD P 
CD (TO 
CD 

£ 

P 

*<5 











































































































Diet: Carbo-hydrates 225 gras 

Proteins 70 gms. 

Fat BO gras. 

Calories 1900. 


oa 


• 

lAv. 

(—* M 

H0\O (Xi -<i O'' vn 4N- VoJ JOH 

TO 

9 0 

D ^ 

Z) 



H H M H H H H M H M 
-<1 <T' \0 H h J 1' VjJ a> C# vn 
vO(»n0v£)O''^HvCUU)H 
10^^0^0^1-5 0 HM 

< s 

D M 
T* g 



HHHHHHHHHPH 

oobboooobob 

SPECIFIC 

GRAVITY 

7T 

O 

b 

Ur* 

H 

k 

9 . 

JO vi wi \£> 04 ; - r- 1 Vj 

H O 

II 

l 



oSSSSSSSSSS 

JO Vn VjJ G* Ut WO 

w § 

tj H 



| H 

HHHH4^-*3Q£0$O-<Is 0 
O W <1 vO O'* ~>2 '^3 CO O <1 

0 oa o^vo ohoj^U) wo 

Bw 

» » 

CO 



HMMMWHHOOHH 
@ ® « • ».»»»•» 

^3 MvOWOOOvDOOUim 
^WUiUjHMWsO WWW 

fl 

s 



Control 

Cohtrol 

Methyl Testosterone 
40 Mg. 

/24 Hrs. 

Control 

Cortisone 

100 Mg. 

/24 Hrs. 

Control 

Control 

§ 1 






N.B. All values shown are avera 

Adrenogenital Syndrome TABLE II (C) daily values for each thre 

A period. 

Miss C. W. #96696 cont'd. 





























y;s't 
: * ic X 













T^O*-* 8000*t£8-9St 3C*0j : sHp . t 6*TiP|A9p «is! 


OH 


p-p“P“ 


■<3 

O' 


M M M M M M M M 
OOHHHOvOOvOOO 
JivO w WWUV«OHOJO-^ 


O' -4J -4 -4 -4 Oson (>Ui O'' O' 
09 on OaP~ ro OssO oo so ro> oa 


uJjVuO OOOOSX>Ox>OoOdOOOdSjJ 

ro m m m ro ro ro ro> ro ro ro> 
O^OaOJ.HH O w M M O' 

oj o oa Osoa 


o-ionononononomonon-4on 
O n Osp- vOutp-^-Hp-W W 
l> ro w w o O' cr-on U)\ji qs 


p- on on Oo oo Os Os O P~ Oa 
Os P- ro ro ro p- 


MsO Oa-4 Oonp-Oo ro 

o 


OOOOMOOOOO 
-4 OaOvO OUl O'so Osn 

0 9 0 0 0 0 0*0 

WHWvOvOVi -4 ro on 


p-Sx>p-OOOnp-p-p-Onon 
OvOO oaso> Qsp-p- ro ro 

OOOO0OO0O# 

oaon oarosoo-4-4Csos 


p-p~ononon 


HHHHHHHHHH 

0OO0009*# 

oooooooooo 

rororooosx>oovorororo 

vOvOOO-MOOOsOvOvO 


-M- 


•HH 


0*0000009 

VOsOsOOsOvOsOOrOsO 

WWOOiOiOiHWHH 


p- Oo p- p~- p- Oo p- onp- 
O sO O Oson uivdOHW 

000000090 

UtMM'-HHPH Oaon 


000000900 

OsO'-'4 O' Os Os on OssOOo 
O -4 on Osp- P~ O' 0'P~ 


Oo | M M M M M ?OP- 
oo i oaP~ on CO-on o ro 
O I O Osp- -43sOsOsO 


O O > > O O 3 3 OO 

O O O O O O 0 0 OO 

3 3HH{3P(tct3 3 
ft c+ ffi ffi ct ct t 0 <+ €+ 

*1 1 11 11 

o o o o o o 


S3 


353 

<DD5 

h& 


CD 
*Q 


W 


-< 

OO 

1H 

H*C 

3 3 
CD CD 


0 D 
13 


S 3 

C+0 


td 

M 

o 

o 

a 

m 

s 

M 

O 

> 

t"* 


o txj 

> 

*-3 
> 


is; 

0 

Cd 

0 

I 

3 

9 

ct 

o 


ct 

£T 

*<! 


-4~-0-4-4-4-4-40a Os on 
00- 00- M M ro CP-4 OO-On VO 

0090000000 

vnp-p-rororoonp- ooo 
Os on Oa-4 M Os O' so M sO 


O Os OO- oa-4 -4-4-4 OaP“ 

Hsoo w wro HsOkOW 
000000*000 
-01 on Oo OssO so 0*-Jon O 
>3-0H O' 


* 4* I I I +• + + I *t- 

m ho ro M 

OS 00- 00- M O SO OS 00 -Vjk) -4 

00009900*0 

OO-SO 00 -oo -o ro on -4 sOOo 
Qssn ro Oo OssO on so on \0 

Oa-4-4-4 41 Os-4-4-4 Os 
p- WvOHOiOo-vlH M Os 


M vO O 0 --O Os on p-0o j\j M 
O 


oaM-4 43 CP-4 oaon HP 
O' -4 on sOP“* OasO 


-4 O' Osp- ononp-oo oaon 
WUionsOHH OasO OaM 

000000900 

onpn 0aOs-s3-*0-v30op-0o 

sO on 


4 4-4-4 + -* *4-14 

h w ro h row m m 
m osoo Mojo io> vo ro-4on 
000000900 
W'JsOHsOOHWfOH 
-4 -4 onsOP“-40a 


Os on Os on Os O' Os-4 Os on 
M Qsoo p- O CP ro 43 -4 Oo 

09*0000000 

ro rop-oo o^oo-Jhuj 
ion rosoon ro ro 


OsOoO 05-414] 4143 Oa Os 
sOOaHsOononp-oo Qs-4 

09090*000 

soon OHpp oaon-4on 
ro sOsO M 


3 I 


3 13 3 1] 

On ro W H 3 M M M 
oa?o43onp-sorop-sop- 

• 0 0 0 0 9 0 

OWOsQsOPfOWHH 
lion ro Os-43 Mon so oa 


HHHHHHHHHO 


Soon oaoaoaoaoaoaoa-4 
M Oson P^OPP vOO ro 


HOHHOOs04PW 


oa oaoj on os os os on so ro 
osso 


4 44-4*+*-* S I 

OOOOHHrOpWH 


Ms -4 on oo ro roMooMp- 
M oson p- SO P- oa Os oa 


o o > > oo3 3 oo 

0000009 * oo 

ct ct SS EC ct c+ 0 0 ct ct 
11 11 11 

o o o o o © 

M MM MM 


s 

CD 

IkO 


U 

o 

> 

co 

Cd 

M 

§ 

? 

lo 


o 

EC 

M 

§ 

M 

a 

w 

Cd 

S 

CD 

LQ 


55 

0 1 

CD 

t« » 

• o 

otft 
0 CD 
£> 

=^,H* 
sO ct 
sO Do 
rs> M 
O 

on Cd 


M 

1 

O 

3 

CD 


Cd 

o g 
sC J 33 

M M 

a z 

o 


s 

M 

►4 

Cd 


D 

> > 


sn 


ss; 

9 

od 


a a > 

D) DO M 
H* M 


id ^ 
CD 
1 
M 

o 

a 

o 


< W 

&& 
C ct 

CD CO 
CO 

CO 

H> cr 
o o 
i s; 


D3 D> 

O 1 

tr a> 

ct D5 

cr < 
1 ® 
CD 1 

(D dj 
oq 





















































































CO 

c+ 

• 

a 

CD 

<3 

• 

> 

<3 

CD 

4 

5D 

TO 

CD 

OaOOoip VO DO H* 

0 a* 5D 

0 • • 

tM 

?d 

xa 

zx 

3 ) 





H M MM 

909# *••<»•: 

-O VO 00- M POMvO-VI 
OVDVD O VD -vj DO-P- DO 

0 

3 O 

3 po 

3 t-3 
- M 

a 





M M 

oa OK) 0 vn oa^a oo-vO 

0*9* 9*009 

p- vovn vn VOHP'^V) 
vo 

17-K.s.! 

m enu * 




DO H M M M M M 

0 VDVO vop- O DO vn DO vO 
\0 00 O VOVO OOO--P" JO 00- 

EOSIN 



M 
H- 1 
M 

-0 

vn 

M MM M M M M M M M 
O OMOMMMMMM 

\0 0^^ M^MM OP 
-0 - 0-0 0-0 - 0 - 0-0 * 0-0 

0 vo OVD vo oaoo-oo-^ovo 

w 

• 


i+ 

9 

O 

O 

sjJ 

03 

■P- 

0 

M 

O 

-0 - 0-0 -0 -0 -0 -0 -0 -0 -0 

DO vo-p- vo p- p- p- -p- -O vn: 

oo»*«*o* 0* 

Ovn DO -0 00 -OO Ovn O 
HVnMvn DO 00-00-00-vOvO 

re M 
0 Q 
► ffi 
*-3 




M h-M m m m m m 

HPO 00 DO M DO M O 
Ovn H vo HHM OVo 

-OVocaO vovovo O O 

<3 Sj 

D M ! 

► W 




M MM M MMMMM 

0090 *0*9# 

OOOO OOOOO 
M MM DO H M M M M 
vn rooo-P- vovo vovn do 

SPECIFIC 


I* 

O 

f> 

O 

wO 

O 

M 

0 

VO 

H 

M MM M M M M M M 

*09* *0*0® 

DO DOVO VO VO VO VO vo VO 
OOOvn -0*s3-4MP 

CREAT- 

IMIM. - 



Control NA 
Control NA ! 

No NA ! 

No NA 

No NA 3 

Menstruation ; 

ACTH (no NA) 
ACTH (no NA) 
Control(noNA) 
Control (no NA); 

TREATMENT { 



tc 

M 


olw 

> 

i-3 

> 


a 

w 


i 

a 

> 

n 


3 

CD 

O 

P) 

3 

c+ 

CD 


Ore 

5D 


3 


05--4 CDvnp- 


o cr jd 

0 0 9 


VO DJ |_J TCj 

to a 
> 
o K 
a 


OOOOOOI—' O0-0 

Oui ro okmxi. Ovo oo--o 




O^VjOHHOI 00-vn H* M 
OOMv£)vOWWHW>3 


vo vO 
Op- 


vn 05- 

OO 


Vn O 

vo Vo J 3 

• • O 

OO 
OP“ c 

H 


vn P—0 vn -0 
DOVo 0a\O vn 

£»♦*<** 

mp- Dop-p- 

-o oo-oro o 


+ i + + 

do do 

VOv£> 


Vnp- 

OO 


oavn 

o ♦ 

-O M 
DO vn 


4* l l 4* 4* 

M 

H WO 

oooaoo-M 

» • « o « 

0 0 - 0 - 0*0 

on Ovn 0-0 


-0-0 OOOl 0-0 0-0-0 

O oavo viOhvivi 00 --o 


<0VjJVjJH*O-P-|- , -O-OV j J 

o o oo-\o o -p~ o -o vo oo 


•O-p-vn-p- pb^OOP 

oo-ro oo oo- povov>)p 

;o*o« {3 o • * ♦ 9 

oroH*oo o oovo P- p- 

000-0 oovn-oo 


4. 4 + PS 4- I I 4 . 4 


p-p-p-vn vn 
oaoo 00 --OP- 


VO j_j j_j *3 1 DO VO I—* VO 

H OHO ^ Ovn vovn DO 

o« * « • • 

«WH 00-^OUn VO vO 

OO oaro p- o 00 do oo 


nw 


1 


“T 3 

vn O vn vn O 
vO vn vn vo O 

• •000 

03- O 00 -vn DO O O-P" M H-* 
O O vn 0^0 HH O 00-p- 

vn 00- 
ODOp- OVO 


vn \D 0-0 
vO vO vO O 

• £3 • • « o • 

00 Vo OmD O vn COvn Vo O 
0-0 O-P- DO 

0 


1 1 1 *i 

HVt WH H- 
M O O Vo p 
• « « CD 
0 03-0 VO 
0-0 vn O 


4 9 110 

hp o ro 

VO O VD VO VO 
« 9 4 o a 

Mvn O HP 
H 1 vO-P~-P“ O 


HHHHHHHHHH 
HHHHHHHHH 

a*<»<»*9** 9 

-OOOO 0-0 Ovn OO^o 
DO }— 1 -p- vn Ovn vo vo vn 


HHHH M MM 

OHHV) vOH WWvO 

jo*#* £4 © 0 • o o 

-p- OO-vO-P- O OapOOH 

O O Ovn OOOOO 


+ I I I -f 4. I I A 

hoohh-pohOw 

©0©0£4<>«®*9 

DO DO VO 00 0 vO WOO W 
PPVDH ovn-O-Ovn 


ooP->lp:aaaoo 
0000 


3 3 M »-3 S3 

3. 3. 

!c+ ci* ffi Cd 0) 

a a a n- c+ 

4 4 c+ > > > 

O O *-5 

0 0 

HH3 P f 

M M 

p-'-- ' O O 5D 


bp e* 

a a 

0 0 a a m 

> > 

> > 0 



a 

CD 

►O 


(ft 

E 


TABLE IV A 

N*B* All values shown are 

URINARY BALANCE DATA average values for each three 

llergic Urticaria SHOWING EFFECTS OF ACTH day period. In period 3, the 

rs. J*W• # 99254 daily results are tabulated© 














































































<> o 








03 

<* 

• 

S' 

£ 

4xg. 

00-4 On UT P" Vo ro H 

PERIOD 



H 

a 

• 

—3 

HHHHHHHH 
OOOOOOOO 
Vo OnP"—3 P" On VO Vo 
• « » « » • 

On P“ UT OO On —3 

Cl 

Meq./l 

pj 

to 


H 

• 

Vo 

HHHHHHHH 

p-'UTUTUTUTUTP'p- 
On On O O p“ CD Vo H 

Na 

Meq./l 



P- 

» 

ur 

H 

p" P" P" P" P~" P" P” P“ 

On H UT CD —3 Coro ro 
ro prVo p- On 

♦ 

> 


H* 

• 

Vo 

ro 

—3 

• 

ro 

rorororororororo 

Qn On CO CO CD UT—3 OO 

• • • • 

-3 Vo Vo UT 

K O 
CD -©r 
oro 

• 

> 



H 

IS) 

NO 

HHHHHHHH 

rororoHrorovovo 
ro o o vo Vo ohp 

CDOOOOOOOOCD'O'vo 
Oop- On On VO VO p" —3 

• 

TJ 

• 


ro 

UT 

ro 

Vo 

OO 

CO 

ro 

UVopppVo Vop 

On CD HO O UT UT H 
On Vo On— 4 UTVO -o On 
V o CD Co Vo O O O —J 

Volume 

Urine 


»4 

• 

o 

e 

H 

• 

O 

o 

UT 

HHHHHHHH 

• •••••a* 

OOOOOOOO 
OOOOOOOO 
-4 OnP-UTUTUTOnOn 

C/3 

d 

• 

9 

• 

URINE 


H 

£ 

HHHHHHHH 

urProurPPPP 
P“ CD-4 O VO H O Vo 

? 

CD 

% 

• 

UT 

-4 

UT 

-3 

• 

H 

Ul UT UT UT UT UT UT UT 
Ov—3-4—3 On —4 On- 3 
• •«••••« 
vorooruvoHboVo 
ro onUt oo ro cd -4 

Kgrri* 

Weight 

H* 

VO 

• 

H 

g 

H H H H 

O vo CO On H —4 —1 H 
O Vo CD On O —3 On O 

Eosin 

• 

On| 

O 

H 

• 

O 

H 

H H H H H 

• ••••••* 

UT Q —3 On ro 'OT P" On 
P~no On —3 VQ -4 Ov VQ 

Mgm 

Cortin 

H 

• 

ro 

vo 

CO 

1 

UT 

VO 1 

H CD VO CD Ov—3 —3 

oo* » • » • • 

• • vo CO UT —3 CO o 
-3 ro —3 CO 

H K 

X? 

• 




Seizure (2)* 
Seizure (1) (3) 
Seizure (2) 

2 Seizure (2) (3) 

o 

1 

1 



& 

O H 
H> C+ 
ps 

Uo H 
H* 

a. o 

ps H* 
^ 64 
CD 

*d a 

CD 

US 

a & 


a 

3 


p'p-p-p-prprp-p' 
VO VO Vo WVjJ \jJVa>P- 


v/T UT -O P" p- UT On M 
ro ro —4 —4 oovn 


ur p- oo ur vn ro co 

OH h-nI^o cd oo 

• f • • 

UT CD-3 p- ro OO ON On 
do vrip-vn^o no 


oo-o out p"V jo ru H 


S' 


iL^AhL 

3 VD DO VQ VO 


O wo O-j M'ovn 
co cd ro ur-3 oovop- 


i 4- i 

sfe 


ijvOHO H'O tv) 

HMD-JpOOVAVnU) 

O vo ro o ro -3 —3 P" 
* * ro P" H -4 O VO 


t)NUT—3 —0 —3 <5 n -4 O 

U\NO HO Q\p" —0 H 

OO CO OO P~ v O H ~4 UT 
ro 


VAOVAPHH Oo H 
*«»»••»» 

ro H P" On Vo on O v O 
UT On VQ 


p-VoVaVop-p-p-Us 
to CO VO VO CO—4 H —3 


utovtouth'Out 
p” o Vo -4 M H UT 0 


COCO-4 O OOPO 
H’OTHP'O OO ro On 


pr Vo Vo p" ro On —j oo 


i i i 8 i i | i 

Vo p“ 'oO On ro On ON 
VO -4 HUT O H vo 

co ro -4 ur On p--4 ro 

Qn p" —4 Vo vo VO UT P" 


££££££££ 

UoVoVoVoVopr'JTUJ 

vo Vo ro —3-4 ro O vo 


HHHHHHHH 

fOP**GNVn-Op-U)-4 


—3 ro vo vo ro co vo ur 


1*1-8 I I 3 I 

H (O H ro O O Vo 
»»»•••!• 

On H OUT GO Vo On H 
OO 


ro 

03 

CD 

H* 

N 

n 

CD 


VO 


03 03 CQ 
CD CD CD 
H* H- H- 
N N N 

% ^ H 

CD CD CD 


VO 


TJ Vo 

fcd 


H- ♦ 

■§ 5> 
<<! • 

M^te 

oo 

H 

H 

ro 

Vo 


—4 

♦ 


W 


<* > 


& 


c 

CD <\ 
CD PJ 

O CD 
CD 

CD CD 

§ g- 

c+ 

CD CD 
CD 

PJ 

a <- 

p> CD 
PS 

d on 
CD CD 
1 
H* 

O 

a. 






































































Calories- 2100 
CHO - 250 gms 
Protein - 90 gras. 
Fat - 80 gras. 


i 

(u 

(D 




w 

s 

CO CX> OO 

o O' P> 

So 

• 

GA 

VO 

rrr 

uo Go Go 

• . . 

p-Grur- 
NO fO 00 

VA 

ON 

• 

GO 

—4 

fr- H 

go ro O 
• O -P" 

fr- . • 

-0 OO -0 

-o oo 

ro 

* 

GO 

-4 

f H 

ro Os 
ro M 

• • • 

O On Go 

ro vn. o 

H* 

*-* 

H 

* 1 

O 

VD to P 

VO Go O 

. . . 

H H On 

ON 

ro 

« 

w 

On Vn. On 
--3 VO O 

♦ • • 

ro vago 

£ 

GO 

. 

—0 

Go ON UT. 

(NO Go O 

• • • 

ro On GO 

ro 

. 

U1 

£r 

l r-£~Go 

Go o-o 

-o H -"J 
VA-J O 

ro 

s 

OVA VO 

OO O ON 

• • • 

g:°2« 

VO 

• 

NO 

^ 

4=-^r-vo 

• • • 

£ 

• 

u> 

£££ 

• • t 

f Go GO 

e 

t 

ON 

H 1 H H 
ro ova 
• • » 

O rv> H 

1 

GO 

ON 

1 

• • • 

■NlO 03 


J* 

? 

(D 

0) 

CO 

H* 

3 



DAILY BALANCE DATA FOR PERIOD 6&8, 














































•} Hr f b b ■ : 
. 



. 



. ■ *■ f 4; !• ’ 

] i " ‘ j :j 












—“■— • r^r~f 

§ t 

^ MjJ MH 0 i 

Si 

XJ 

3 

H 

D 

OF DAYS 

3 

4 

3 

4 

3 

i 

H H H H 1 — 1 O 

O Q O O O I - 1 

-o cS ox ox to • 

» » t * 

TO Ox CNCQ 

SERUM 

H H H H H* 52! 
J 1 UlUlUlUt P 
uj oj ox ox 4 s. • 

CQ 

M 

g 

P" ■£- 4>“ 4>~ -P- W 

• • . • * • 

w un ro 4>~ 4>~ 
ox 


TO I\) N) fO M2 1 
<l'j*4MNiro < 

• >£>T\: 

sO > 

CQ 

D 

> 

H H H H Hjttf 
VjJ TO VjJ VjJ TO • 
WvO O 

vO vO ^ l^vD 
->3 ox ox O ox 

H 


H H U) ^ ^ < ; 
OX Ui VjJ -N OX O ! 
H H»(»HH 
VjJ OX VjJ O <2 • ! 

1 URINE' 

GRAVITY 

1.006 

1.006 

1.007 

1.014 

1.0U 

i SPECIFIC 

HHHHHH 

• O • 9 9 J25 

or 4 >> Ox 4-"* M 

0 s Ox O^U 3 g 

0 

f 

ui utut ox 0 * 9? 
->3 -»3 ^*3 -«4 TO 1 

» ...» CD < 

r-» TO VjJ Ol • 

00 VjJ OX ->J 

5 

• j 

E0SIN 

99 

SB 

66 

77 
| 77 


0 

■» * • • * , 0 ( 

fL CQ. NO 4>* VjJ *-3 

a 

i 

oa -3 oe <i 

b b ox on h § 

• 

117-KS 

CQ f 1 CQ Q 

CD Q CD Q 

H* *! H* S 

N . N S 

£ 5^ £ g 

4 p 4 25 

© <+ CD H3 

'“'n CD ,CQ 

H *i H 

OJ w 

ra 

vo 



txJ 


W 


h *n 

VjJ 

Is- 

c+ &. 

H* 
<Q O 


& 


P* VO M H 

period : 

NUMBER ; 


oJ VjJ VjJ 

NUMBER 

OF DAYS 1 

■■ ! 

fs-^4^^4^ 

oJ VjJ VjJ VjJ VjJ 

• • © • • 

la va ut vjx Vjj 

■p- 

M 

2 ! 

CQ 

O 

a 

N W H VO VjJ 

F'-MfOO H 

• • * • • 

O 'JI w 4 - 

TO H ox 

S 

h3 

? 

2 M 

* Q 

w it 

! + + + + 

TO 

HHVjJHH 
» • H Vo H 

• • 

TO vO O OJ 00 
vO 

• 

M H H H H 
M O O M M 
IsVjJvOOO 

« • . . • 

H OftOVO O 
TO 

M 

25 

POTASSIUM (Meq 

WOO out 
O -P" -<1 H O 
• . • • « 

VjJ VjJ vO Ox H 
P- Ox 

8 

+9 

+ + + + + 

■Jo fe fe b 
© • • • 

CQ.p- OCX 

s 

• 

© 

P'--P'"-P"4^-P- 

vjJ OX OX OJ TO 

• ® ® 9 * 

H VjJ TO 4>- v£> 
ON 

M 

5£ 

: rrss£xa~TV-z^s^ft 

CHLORIDE (Meq.) 

VjJ TO H ->3 ->3 

H O ->3 O -O 

© © © # © 

0 -^2 VjJ TO 

P** TO VJi 0& 

a 

»-3 

+ + + 1 J 
H TO TO VjJ VjJ 
TO -P- -3 VjJ -P^ 

• • ® • . 

HV^ WHiO 

oa oa^- 

W 

• 

H H H H H 

M 

2 ! 

NITROGEN (sms.) 

H H H H H 

oJ 4^ VJ^ O' On 
# © • • • 

v£> -P- TO TO ON 
VjJ OX 

a 

+ 1111 

M TO 

• 9 • • 4 

Ox O 00- -O TO 
VjJ VjJ \0 

1 

• 

CQ IT 1 03 

Q O CD 

H* < H* 

W N 

£ < £ 

4 P nl 

© c+ © 

*->N © 

H 4 H 

OJ TO 

y 

VjJ 

0 

i 

CQ 



C?d 


^ M 


TO 

VjJ 


1 

< 


vO 


+1 <J > 
® P H 
4 H H 

H . jS 

O CD < 
&m P 

• H 

Hj £ 

O CD 
4 CO 

CD 00 

p nr 
o o 
nr £ 


tr p 

CD CD 
CD 


a> 

P3 


TO 






























































































Thermo-sveat contains 49 meq./l of potassium, 


vO 

o 

I 

43 


> 

O 

r 

H 

O 

c** 

JB 

in 

to 

H* 


& 
H* 

CD 

of 
O 
£ 

c«* O 


00. 00 

f" 7^ 

ro !>- 

B B 

CD CD 
hQ >n 


33 

m 

03 

CD 

P> 


sO 

4>- 

B 

CD 

43 


H* 

c+ 

Hi 

CD 

O 

c+ 

P3 

m 

m 

H* 


M M M M 

a* o a* 

• • • (0 


U> VO VO VO 

• • • • 

4^ 4^- v.n o 

O <3 M Vo 


CO H h- 1 


+ + I + 

MMMH 
faJUl H >3 
• • ♦ • 

CO OM'O 
O 4^- O 00 


00 


4^ vn 00 

Oi OJvO^ 

^ O O VO 


+ + + + 
ovn vn m 
Kn vn ->4 -v3 

• • • • 

£- H O O 

MK 


• • • 

4>- O 'Jt 
'o Vo 4 > - 


O TO 
v£> 4 ^ vn 


O 00 <2 On 

vo 00 vn 


HHHH 
H O M H 
OVJ0VH 

• • • • 

00 H O VO 

?>- ** ro 4>- 


-3 -3 Vn 00 
O CO CO 


O O'jJ '£) 
-VI <2 is. 


£ 



H H H M 

fe (5 vO 


HHHH 
4>- vn vn .£•- 
► • • '£> 
O '£> Vo 

rrr i 


o 


W W 


!XI 


M 


I 

tl 

Kl 


o 


H* 














































To 

o 

• 

< 

• 

F 

6 

vo cd — <j owa -P vo ro h 

PERIOD 

NUMBER 




HHHHHH H H 

rororoODOjro roro 
->J >J->J Ito O VA -P-P* 

♦ • 

va \a 

© p 

• 

H 




pp-vopp-Vo PP 

• »»*•« •• 

va o vo va H vo op 

VA OP Oo CO 

K W 
a> 

P 

• 

> 

s 

| 



HHH H H H H 

OOOVOOO oo 

-OOOVOpoo VO VO 

• ••••» » • 

ro PP rv> O O O'O' 

m o 

CD H 
P 

• 

> 


>4 

ro 

• 

va 

ro 

• 

VA 

KS ro ro ro ro ro roro 

VA -4 -4 VA NO VO VA H 

••♦••• 9 • 

VOH-4VACOH vo Vjo 

K o 

CD O 
p i\> 

• 

p 



aoovMOfoorovoui 

CD o H O ro VO VA 

w 

o 

© 

S' 



H 

Os H H M O S! Os O 

♦ CO vo vo Oo 9 • • ♦ 

VA • • • » U> -4 VQ CO 

H 0-4 VO VA VA VO (O VA 
O VA 

H 

“4 

& 

• 




H H ro M i\) w H H 

O H CMrvnvnvrUAH 
hh HvnrirH co h 

o 

o 

<4 

H- 

3 

H 

§ 

v+ 

o 

va 

H 

5 

• ••♦*»<»••• 

VAVAVAVAPvAVdOOP 
H H H VA O ON On vo H 

O 

CD 

P 

t 

14 

rv> 

Vo 

l\> 

Vo 

t J HHHHHHHH 
P-4 U> O P* Q OVA CO 
CD fO VA Vo vo v5 rOOVA 
o rovo-o CD o vo VA VA 

Volume 

Urine 

t* 

s 

H 

• 

& 

HHHHHHHHH 

ooooooobo 

HHHJOHHHHH 
tOUlOP-O IN) W fO 

CD 

• 

9 

# 


ts 

VO 

ro 

HHHHHHHHH 
ro ro Vo u> vo U) wwp- 
U)-n3 COW M WV)-0 O 

00*00 vo*V 0 * 'go VO^VO* H vo 
vovoroHcoVDroovD 
H 

Cd 

• 

• 

3.1 

B-* 

c+- 

9*f 

• 

P" 

VA 

VA 

• 

On 

VA VA VA VA VA VA VA VA VA 
PVAOVAVAVAVAVAVA 

»•«•»♦»*♦ 

-000-4 CO O —V) VO -4 



Control 

Control 

Cortisone 

Cortisone 

Cortisone 

Cortisone 

Cortisone 

Control 

Control 

TREATMENT 


td 


ft 

o 

> 


VO CD-4 OsVAPU) l>0 H 

PERIOD 

NUMBER 


Vu jujvjUj frV*j Vo ro ro 

NUMBER 

OF DAYS 


ppppppppp 

VdVoVdVoVOVoVoVoVO 

jrr hjppprmos 

-4 CO-n}-0 Os VO VA -4 VO 

IN 

CD 

§ 

M 

P” cd ro vo h 

ro vo -4 ropro OPH 
♦ • • o roH‘ Vo vo 

VO VA O • • • P • • 

Vo vo ro --4 Vo o VA 

vo ro P os 

OUT 

? 

£> 

• 

t 1 4 4 4 f 1 4* 1 
PH M ro H —4 

H On CN Vo i\> Vo VA 

hohh-^ihovacd 

-4VAp*CDpNOVAVo 



coOrovooHrovoH 

CO On Vo pp-4 O CD ro 
GOH H'Ovo H (V) OsVA 

a 

TJ 

1 

CD 

W 

00-4 On- 4 CD Ov OO OO Qn 

o CO OO ro ONVO -4 H O 

CoVAVAPO-4 ro VA VA 

8 

»-3 


4 4 4 J- 4 t* 4 4 J- 
HVoVjoVoivSp-HroP" 
ro rouj-4PHPCoO 
• »•«••••• 
HO CDOPV3 OO VO —3 
H CO H -4 —4 IVO Ov VA 

P 

r 

O 

• 

pppwppppp 
P O ro covainoowo ro 

• •• 

CO VA H —4 vo ONp* ro vo 

On ro vo Onvo pro w H 

H 

o 

p 

8 

H 

i — l 

vo vn ro ro vo hvavo-4 
-4 co vo Vo vo covn cqvo 
«««•«»••• 
vocorooroovVAVAro 
VA Ov p" OO Vo VA 

OUT 

i 

? 

4 - i 4 4 4 !» 3 4 I 

On OO OO VA ro P * p" On 

V) w» VO -4 4 O CD -4 VO 

HP-vo ro H H ro P 

1 

• 

• 

£££££££££ 

frvo Os P" ro P P* p* ro 
HVo H -4 vo vq H VA On 

H 

s; 

M 

i-3 

P3 

O 

HHHHHHHHH 
VA VA -4 —4 O ' On ON On VO 

—4 VQ VA P" GO VA sO OVA 

On 

OUT 

S 

t?3 

ro VA CO VQ VA o vo VA —J 
VO -4 vo Vo H H VA VA On 

p 

H 

» 

0) 

• 

Control 

Control 

Cortisone 

Cortisone 

Cortisone 

Cortisonw 

Cortisone 

Control 

Control 

TREATMENT 



•S'* 

P* 

3 r 5 

% r 

M ^ 

H CD 

no 

VO 


s° 

■8 

4 p- h 

H- H 

o V! < 

£ 

£ CO 
CD 

CO CO 

8 § 
8 S 

o © 

cr 

P 

<j 

P CD 

ft >1 

H (to 

<« °£ 

© 



































































N.B. All results shown are average 
daily values for each two 
day period* 





ltd 


a 

GO 

» 

I 

o 

H- 

M 

S3 

cf 

H* 

3 

3 

£3 

P- 


? 

CO 

3 

3 

c+ 

O 

H- 

3 


[f'DWH 

2 DAY 

PERIOD 



M 

CO 

OJOJOJ,p- 

a 

o 

• o • • 


o 

M 


M 

oooaw 


g 

M 

o 

g 

HW WO 

<3 

a> 

'vO-p- 03-p~* 

• • o • 

00.0 oj.ro 
ro vo 

*-3 

£> 

4 4- 4 1 

fOHHO 

v*> oo~p- o 

BAL 


• • • o 

o 03 on o 
0op~\O 03 

• 


MHH 

M 

3) 

vO O O M 

a 

O 

O x ro on ro 


t-3 

o • • • 


> 

oao o m 


CO 

oj ro on 


CO 

M 

G 

O' O' VO 03 

o 

g 

03 -F- cm- 1 

G 

> <* o » 

t-3 

g 

O-P-Va; 03 


CD 

oa v/i 


£1 

* 4 * * 

GO 


rooo 

> 


oa-<j cxj-o 



« • c o 

-0} 0->30J 

On-P~ CO o 

• 


£“ ■£“ *P“ 

M 

O 

on on o M 

2 

G 

o • « o 


G 

I 


O 

: oiun-vj 03 


PC 

M 

O 

M 

O 

K 

Hrouio 

G 

CO 

■p-.p- of«oj 

•"3 


• » • • 


g 

rooj-e^on 


CD 

vO-p-U) M 


.Q 

4. 4 I 1 

GO 


oj ro m 0 s 

> 


HH^ t—* 

tr* 


• o o • 

jOJ 0-0 

CM- 8 OOJ 

• 


M M M M 

M 

a 

-P“-P" ■£'" 

a 

M 

0 9 9* 



OJ OJ OJ OJ 


PC 

H* 03 M 03 


o 

o 

K 

HHHH 

o 

M N)-p- M 

G 

a 

• • 9 • 



Mon CO 03 


g 

CD 

£5 

f fe> *T 

OHOfO 

0 0 9 0 

BAL 

ro 03Mon 

• 


M 03-0 03 



o a o o 



• • o o 

PC 


3 3 

fcG 


8 ? fc 5 ct ct 

> 


3 3 

o S . S ^ 

1 

a 

H 1 


E 




• 3 

O 

3 

♦ H- 

o 

fO PC 
3* 
OCD 


On 


ct 

O 

H- 

CL 


> 

3 

c+ 

3* 

3 

H* 

ct 

H* 

CO 



to 


ro 





































































I - BIBLIOGRAPHY 





BIBLIOGRAPHY 


1. Eustachius, B.: Opuscula Anatomica, Venice 1563, as cited by 

A. Grollman. The Adrenals; Williams & Wilkins Co*, Baltimore, 
1936, page 1. 

2. Bcker, A.: Der fienere Bau der Nebennieren beim Menschen und 

den vier Wirbelthierklassen, Braunschweig I846, as cited by 
A. Grollman* The Adrenals; Williams & Wilkins Co., Baltimore, 
1936, page 5. 

3* Koellikerr Microscopischen Anatomie oder Gewebelehre des Men- 
schens, 1854# as cited by S. H* Willaims. Textbook of Endo¬ 
crinology; W* B. Saunder Co., Philadelphia, 1950, page 248. 

4. Addison, T.: On the Constitutional and Local Effects of Disease 

of the Suprarenal Capsules, London 1855# Medical Classics, 

2: 244, 1937. 

5. Brown-Sequard, E.: L 9 importances des fonctions des capsules sur- 

renales, J. de Physiol., Is 160, 1858, as cited by H. Selye. 
Textbook of Endocrinology (2nd Ed.), ACTA Endocrinologies 
Inc., Montreal, 1949# page 88. 

6. Biedl, A.s Inner© Sekretion, Berlin 1913# 1916, as cited by 

A. Grollman. The Adrenals; Williams & Wilkins Co., Baltimore, 
1936. 

7. Vulpian, A.: Quelques reactions propres a la substance des cap¬ 

sules surrenals, Compt. rend. Acad. d. Sc., Paris, 43: 663, 1856, 

as cited by A. Grollman. The Adrenals; Williams & Wilkins Co., 
Baltimore, 1936, page 6. 

8. Oliver, G. & Schaefer, E. A.: Physiological Effects of Adrenal 

Extracts, J. of Physiol., 18: 230, 1895. 

9* Henle, J.: Das Gewebe der Nebenniere und der Hypophyse, Zeit. f. 
rat. Med., Dritte Reihe, 24: 143# 1865# as cited by A. Grollman. 

The Adrenals; Williams & Wilkins Co., Baltimore, 1936, page 71. 

10. Abel, J. J.: On a Simple Method of Preparing Epinephrin and its 

Compounds, Bull. Johns Hopkins Hosp.# 13: 29# 1902. 

11. Takamine, J.j Adrenalin, the active principle of the Adrenals, 

Am. J. Pharm., 73: 523# 1901. 

12. Aldrich, T. B.: Adrenalin, the active principle of the Adrenals, 

J. Am. Ghem. Soc«, 27: 1074# 1905. 

13* Jowett, H. A. D. i The constitution of Epinephrine, J. Chem. Soc., 
85: 192, 1904. 







J. . 

' ' 


: n.; v .f* : Kt .b'" f > : r " ; ■ ■: .if 1 ‘ i : ■. 

. : , ■ '' ' '■•'T', ‘ ■ ■' ■ '■ . ' r 

, .o ■' i. b J s : : . b . -1 -i • j b ..• •• . 

. 

.:: >M r,s ■ •; bbb-:b ■'■■■■’ ' r yb'"; ■ .1. <: ' •• ■ .: b 

■' < . b... . ' b b . . ' h ’ . .b r . ."■) 

K '■ ' • . ' • 

;; ■ ... : ' 'll • ' . bbr .' 1 - y.- v : . : 

, ‘ ; b ■ a’ < . ' ' - . ■ r . , :• b. ' ■' . 


•' '' f . , • L ’’ 

; , . 

. If rd'.rooi .":b to .o< " ' T 


.' J i V ' } r’,-3.0 . > U 

. . , b x 

svj.. k borb y j■ bbb , ;.... 




, I 

, ■ . IS.'.S’. , 1 . • ' ' • ' 



b-q.co bob oomu-acfi/a &X o *'i <:/ 

. b , ’>y : ■'' f -j./i I . . . . . 

■ ■ / ; b oy bb J b" ;ob • *. 





: 

T 

. ■ 

,;yb.; 


t r: .n:d *;cob b>w ■■ '‘p. : ' ;I 


. J..: . 


. 

. . b • ? ' . 

. • 

• 

. ' j : '/.'b'. ..' ■ ; 

A iiJ 1 : , '. 

Xv\. iIT 

bn 

■; J v.d ?■£-x < !V ‘ r 'v lo be 

.b(X : ,. , < : , b 

j 

• . 

w b, .i., r. 
■; jrzjjwd' C'O 


£ 

. . : '■ , . . . 


t . - 

. .. toi : . . . 

. 



. 


* u U 








14. Stolz, F.: Adrenalin und Alkylaminoacetobrenzcatechin, Ber. Deut. 
chem. Gesell, 37: 4149, 1904, as cited by A. Grollman. The Adren¬ 
als; Williams & Wilkins Co., Baltimore, page 76, 1936. 

15* Dakin, H. D.: The Physiological activity of substances indirectly 
related to Adrenalin, Proc. Roy. Soc., London B., 76: 493, 1905, 
as cited by C. K. Best & N. B. Taylor. The Physiological Basis 
of Medical Practice; Williams & Wilkins Co., Baltimore, 1950, 

(5th Ed.), page 795* 

16. Friendmann, E.: Die Konstitution des Adrenalins, Beitr. Z. chem. 

Physio. U. Path. 8S 95, 1906, as cited by H. Selye. Textbook of 
Endocrinology (2nd Ed.); ACTA Endocrinologies Inc., Montreal, 

1949, page 87. 

17. Boruttau, H.: Erfahrungen uber die Nebenniere, Arch. ges. Physiol. 

78: 97, 1899, as cited by A. Grollman. The Adrenals; Williams & 
Wilkins Co., Baltimore, 1936, page 123• 

18. Blum, F.: TJeber Nebennierendiabetes, Deut. Arch. klin. Med., 

71: 146, 1901, as cited by A. Grollman. The Adrenals; Williams & 
Wilkins Co., Baltimore, 1936, page 131. 

19. Mann, F. C. & Magath, T. B.r Die Wirkungen der totalen Leberex- 

stirpation, Ergeb. der Physiol., 23: 212, 1924, as cited by A. 
Grollman. The Adrenals; Williams & Wilkins Co., Baltimore, 1936, 
page 131. 

20. Cori, C. F.: Mammalian carbohydrate metabolism. Physiological Rev. 

11: 143, 1931. 

21. Gannon, W. B.j The emergency function of the medulla, Endocrinol. 

& Metab., 2: 171, 1922. 

22. Crowe, S. J. & Wislocki, G. B.: Experimental observations on the 

Suprarenal gland with special reference to the functions of their 
interrenal portions. Bull. Johns Hopkins Hops., 25: 287, 1914* 

23. Wheeler, T. D« & Vinct, S.: The question as to the relative im¬ 

portance to life of the cortex and the medulla of the adrenal 
bodies, Trans. Roy. Soc. Canada, 11: 125, 1917. 

24. Stewart, G. N. & Rogoff, J. M.: Studies on adrenal insufficiency; 

Influence of extracts of adrenal cortex (sheep and cattle) on 
survival period of adrenalectomized dogs and cats. Am. J. Physiol. 
91: 254, 1929. 

25. Houssay, B. A. & Lewis, J. T.: Relative imp» tanee to life of 

cortex and medulla of the adrenals. Am. J. Physiol., 64 : 512, 1924 

26. Hartman, F. A., Hartman, W. E., Dean, G. A. & MacArthur, C. G.: 

The hormone of the adrenal cortex. Am. J. Physiol., 86: 353, 1928. 




: A. 





JX> 









rss&jftn 



:U I 

;J ;• 

; I/.;' 



» .'V . . : ul ■ ,■ ■ • . ) e ’ 

.. . tu: 




LU ■ 



c 1 v i a 

iO ' XKXVChX T f 'x 



j* iXO'L'riqifc 


■~rl :• 


. 



'pis&uLi 






■ . 


. ■ , L 

: -J .VO f'.ixj. Of OQfZ-yJ TOX? 

. . : t v- 




xit-SG I LvxaG 







T'*0VU)'0,,i 

' 


j 


. -j ■ n L v '-j'‘ V 

.. u lo ■ i: yj{ :■>. fT 












27. Swingle, W. W. & Pf if filer, J. J.: Studies on the Adrenal Cortex; 

Further observation on the preparation and chemical properties 
of the cortical hormone, Am. J. Physiol., 98 : 144 , 1931 . 

28 . Grollman, A. & Firor, W. M. : Studies on Adrenal; Preparation of an 

active extract of the homone of the adrenal cortex, J. Biol. Chem., 
100s 429, 1933. The Adrenals; Williams & Wilkins Co., Baltimore, 
page 234 . 

29. Kendall, E. C., Mason, E. L., McKenzie, B. F., Myers, C. S. & 

Koelsche, G. A Isolation in crystalline form of hormone essen¬ 
tial to life from suprarenal cortex; Its chemical nature and 
physiologic properties, Proc. Staff Meet., Mayo Clin., 9: 245, 1934* 

30. Win ter steiner, 0. & Pfiffner, J. J,: Chemical Studies on the Adren¬ 

al cortex; Isolation of several physiologically inactive crystalline 
compounds from active extracts, J. Biol. Chem., Ill: 599, 1935* 

31. Winter steiner, 0. & Pfiffner, J. J.: Chemical studies on the ad¬ 

renal cortex; III. Isolation of two new physiologically inactive 
compounds, J. Biol. Chem., 116: 291, 1936. 

32. Beichstein, I. T.: Cortin, the adrenal cortical homone. Helve 

Chira. Acta., 19? 29, 1936. 

33* Kendall, 1. C., Mason H. L., Myers, C. S. & Aliens, W. D.: A Physio¬ 
logic and chemical investigation of the suprarenal cortex, J. Biol. 
Chem., 114: Lvii, 1936, May. 

34. Mason, B. L., Myers, C. S. & Kendall, E. G.: The chemistry of 

Crystalline substances isolated from the suprarenal gland, J. Biol. 
Chem., 114? 613, 1936. 

35. Mason, E. L., Hoehn, W. M. & Kendall, E. 0.: Chemical studies of 

the suprarenal cortex. IV. Structures of coumpounds C. D, E, F 
and G., J. Biol. Chem., 124? 459, 1938. 

36 . Steiger, M. & Beichstein, T. : Desoxy-cortico T steron (21-oxypro¬ 

gesterone) aue 5"3-©sy atio-cholensaure, Helv. Ghim. Acta, 

20: 1164, 1937, as cited by L. Goodman and A. Gilman. The Pharma¬ 
cological Basis of Therapeutics; MacMillan Co., New York, 1941, 
page 1229. 

37. Beichstein, T. & Euw, J.: V. liber Bestandteile der Nebennieren- 

rinde. Isolierung der Substanzen Q (Desoxycorticoeterone) und 
B Sowie Weiterer Stoffe, Helv. Ghim. Acta., 21: 1197, 1938, as 
cited by L. Goodman and A. Gilman. The Pharmacological Basis of 
Therapeutics; MacMillan Co., New York, 1941, page 1229* 


\wO' rr o : J J. > r *i 


■ 






I ; .. : n- 


v.y:iDA ;-i\/ -jo ■vj.i: -m-; 
erij:lledv 10 ov .'..to 

-:-.o r ? », , r» ' 


a 


-I 


: V .... , .. ... ' 


. 


. 


.0 :;.r. 


. 


xo ::: j. 


I :?•'< {D 


lU —. > ■ XOJ *v 

,V 


. - 


: ’ ; 

. 


n-:;o 


•-.one 


^crr ■ ol ;0J'< ■ ; 


. « 

; : • ■ ‘ • 




0 X^ol 

. 


. . , . 


■ arit 


. 

■ :o—?~ci Qifjs 

: , , .... . J. I 

V;.,:;: . *\ “ I ‘.0.1, oioD 

v:; t w 


. . 

. ; 

‘ , • J£/ .vx Qo 

. . cc:, . -T -f 

. : ( " : . T 


O.- : .i ■■■. 









38. Lardon, A. & Reichstein, T.: Constituents of the adrenal. 

LXII. Cortex and related substances, partial synthesis of 11- 
dehydrocorticosteron, Helv. Chim. Acta., 21: 747, 1943. 

39. 2uw, J., Lardon, A. & Reichstein, T.: Constituents of the adrenal 

cortex and related substances. LXX. Partial synthesis of corti- 
costeron, Helv. Chim. 4cta., 26: 1287, 1944. 

40. Sarett, L. H.: Partial synthesis of pregnen-4-triol-17 (b), 20 

(b), 21-dione-3, 11 and pregnene-4 diol-17 (b) 21 trione, 3, U, 

20 Monoacetate, J. Biol. Chem.j 162: 601, 1946. 

41. Hench, P. S.: The Potential reversibility of rheumatoid arthritis, 

Proc. Mayo Clin., 24: 168, 1949, end Ann. Hheumat. Dis., 8:90, 1949. 

42. Hench, P. S.: Analgesia accompanying hepatitis and jaundice in 

cases of chronic arthritis, fibrositis and sciatic pain, Proc. 

Staff Meet. Mayo Clin., 8: 430, 1933. 

43. Hench, P. S.: The analgesic effect of hepatitis and jaundice in 

chronic arthritis, fibrositis and sciatic pain. Aim. Int. Med., 

7: 1278, 1934. 

44- Hench, P. S.: Effect of spontaneous jaundice on rheumatoid (A trophic) 
arthritis: Attempts to reproduce the phenomenon, Brit. Med. Jouro., 

2: 394, 1938. 

45* Hench P. S.: The advantages of hepatic injury and jaundice in cer¬ 
tain conditions, notably the rheumatic diseases, Med. Clin. N. Am., 

24: 1209, 1940. 

46. Hench, P. S.? The ameliorating effect of pregnancy on chronic 

atrophic (infectious, rheumatoid) arthritis, fibrositis and inter¬ 
mittent hydrarthrosis, Proc. Staff Meet. Mayo Clin., 13: 161, 1938. 

47. Smith, P. S.: Hypophyseetomy and a replacement therapy in fee rat, 

Amer. J. Anat., 45: 205, 1930. 

48. Gollip, J. B., Anderson, I. M. & Thomson, D. L.: The adrenotropic 

hormone of the anterior pituitary lobe. Lancet, 225: 347, 1933. 

49. Li, C. H., Evans, H. M. & Simpson, M. E.: Adrenocorticotrophic 

hormone, J. Biol. Chem., 149: 413, 1943. 

50. Sayers, G., White, A. & Long, C. N. K.: Preparation and proper¬ 

ties of pituitary adrenotropic hormone, J. Biol. Chem., 149: 425, 

1943. 


•ivij:-. c-.; 



, 



' ..r • 


* 





' 


>„t*T r 
lu CT‘,' r ?, 


x>xsS - Y: . -r 

' *": : . ... 




V ; - j "V ■ ' ■ : •' 






.' h) . . 

. . . ■' . f '. 


) 11 uJ t : t I ■ ’ ' ■ ' ' : ■ 

i 


o L'ro'txJo no' ^au •-H""' •; ' ■■-V' 1 $r-JJ^rrc IIq a ?s 

■ J ; '.r' : : :, ’ \1 [ .. \ ' Y'■ ’ ' a. ''' 

” ■ ■ 

' ' - -■■ .. . ;■ ■■■ . r . '• «■ ' « • ■ 

f ' . ' • , : 


.. . . v/.C m? 

' 

. 





‘fisd'no"?. 

i' 0v' : 






51. Selye, H.: General adaptation syndrome and diseases of adaptation, 

J. Clin. Endocrinol., 6s 117, 1946. 

52. Bench, P. S., Kendall, B. C., Slocumb, C. H., & Policy, H. F.s 

The effect on a hormone of the adrenal cortex (17-hydroxy-ll- 
dehydro-corticosterone: Compound E) and of pituitary adreno- 
corticotrophic hormone on rheumatoid arthritis; preliminary re¬ 
port, Proc. Mayo Clin., 24: 181, 1949, and Ann. Rheumat. Dis., 

8s 97, 1949. 

53* Abelous, L. E. & Langlois, P.s La mort des grenousilles apres la 
destruction des deux capsules surrenales, Compt. rend. Soc. Biol., 
43: 855, 1891, as cited by A. Grollman. The Adrenals: Williams & 
Wilkins Co., Baltimore, 1936. 

54* Gourfein D.s Recherches physiologiques Sur la fonction des glandes 

surrenales. Rev. med. de la Suisse remand©, 16s 113, 1896, as cited 
by A. Grollman. The Adrenals; Williams & Wilkins Co., Baltimore, 
1936. 

55- Fir or, W. M. & Grollman A.s Studies on adrenal; adrenalectomy in 

mammals with particular reference to the white rat» Am. J. Physiol., 
103: 686, 1933. 

56. Rogoff, J. M. & Stewart, G. N.s Studies on adrenal insufficiency in 

dogs. Control animals not subjected to any treatment, Am. J. 
Physiol., 78: 683, 1926. 

57. Elliott, T. B.: Some results of excision of the adrenal glands, 

J. Physiol., 49: 38, 19U- 

58. Rofoff, J. M. & Stewart, G. N.: Studies on adrenal insufficiency; 

Survival period ©f untreated adrenalectomized cats, Am. J. Physiol. 
88: 162, 1929. 

59. Jaffe, H. L. ? Effects of bilateral suprarenalec temy on the life of 

rats. Am. J. Physiol., 78: 453, 1926. 

60. Brown-Sequard, ELa physiologic et la pathologic des capsules 

surrenales. Arch. gen. &© med., 8: 385, 527, X 856 , as cited by A. 
Grollman. The adrenals; Williams & Wilkins Co., Baltimore, 1936. 

61. Sisson, E. D. & March, B.: Some factors influencing length of sur¬ 

vival following bilateral suprarenalee t omy, Endocrinology, 19: 

389, 1935. 

62. Grollman, A.: The adrenals; Williams & Wilkins Co., Baltimore, 

1936 , page I 46 . 

63 . Martin, S. J. & Maresh, F.: Temperature studies in normal and supra¬ 

renal ectomized rats. Am, J. Physiol., 105 : 273, 1933- 

1 







Qirc, 


















( 


it 




. 




1 


h r 










64 * Harrop, G. A., Weinstein, A,, Soffer, L. J. & Tresher, J. E.: 

Studies on suprarenal cortex; metabolism, circulation and blood 
concentration during suprarenal insufficiency in the dog*, J. 

Expert. Med*, 58: 1, 1933* 

65 . Aub, J* C., Forman, J. & Bright, E. M.: Effect of adrenalectomy 
upon the total metabolism of the cat, Am* J. Physiol., 61: 326, 

1922. 

66* Nicholson, W* M. & Soffer, L. J.: Cardiac arrhythmia in experimen¬ 
tal suprarenal insufficiency in dogs.. Bull. Johns Hopkins Hosp., 

56: 236, 1935. 

67. Corey, E. L. & Britton, S. W.: Blood cellular changes in adrenal 

insufficiency, and effects of cortico-adrenal extract. Am. J. 

Physiol., 102: 699, 1932. 

68. Zwemer, R. L. & Lyons, C.: Leucocyte changes after adrenal removal, 

Am. J. Physiol., 86: 545, 1928. 

69 . Marvel, L. de: Sensibilite au froid des rats decapsules, Compt. 

rend. Soc. Biol., 95s 1087, 1926, Rev. Soc. argent, de Biol. 2: 

226, 1926, as cited by A. Grollman. The Adrenals; Williams & 

Wilkins Co., Baltimore, 1936. 

70. Hartman, F. A., Lockwood, J. E. & Lockie, L. M.: Lowered resistance 

to heat in adrenal insufficiency, Proc. Soc. Exper. Biol., 29: 

409, 1932. 

71. Crivellari, C. A.: Sensitiveness of adrenalectomized rats to certain 

toxic substances. Am. J. Physiol., 81: 414, 1927. 

72. Lewis, J. T.: Sensibility to Intoxication in albino rats after 

double adrenalectomy, Am. J. Physiol., 64 , 506, 1923* 

73* Torino, A. & Lewis, J. T.: Morphine intoxication in adrenalectomised 
rats. Am. J. Physiol., 81: 405, 1927. 

74. Harrop, G. A. & Weinstein, A.: Studies on suprarenal cortex. Corti¬ 

cal suprarenal insufficiency and the action of the cortical hormone 
upon normal and suprarenalectomiged dogs, J. Exper. Med., 57: 305, 

1933. 

75. Maim, F. C.: A study of the gastric ulcers following removal of the 

adrenals, J. Exper. Med., 23: 203, 1916. 

76. Banting, F. G. & Gairas, S.: Suprarenal insufficiency. Am. J. Physiol., 

77: 100, 1926. 

77. Star, P.: An unusual case of Addison* s disease; sudden death. Lancet, 

1: 284, 1895. 















7£G 








78, Jaffe, H. L.: Suprarenal gland. Arch, of Path. & Lab. Med., 3:414, 
1927. 

79* MacMahon, H. E. & Zwemer, R. L.: Pathological histology of adren- 
alectomized cats. Am. J. Path., 5: 491, 1929. 

80. Moore, B. & Purinton, C. Q.j Effects of adrenalectomy in goats. 

Am. J. Physiol., 5: 182, 1901. 

81. Loewi, 0. & Gettwert, : Die Folgen der Nebennierexstirpation, 

Arch. ges. Physiol., 158: 29, 1914, as cited by Grollman. The 
Adrenals; Williams & Wilkins Co., Baltimore, 1936. 

82. Selye, H.: Textbook of Endocrinology (2nd Ed.); ACTA Endocrino¬ 

logies Inc., Montreal, page 122, 1947. 

83* Williams, R. H.: Textbook of Endocrinology; W. B. Saunders Co., 
Philadelphia, 1950, page 283. 

84* Loeb, R. F., Atchley, D. ¥., Benedict, E. M. & Leland, J.: Electro¬ 
lyte balance studies in adrenalectomized dogs, and with particular 
reference to the excretion of sodium, J. Exper. Med., 57: 775, 1933* 

85* Harr op, G. A., Soffer, L. J., Ellsworth, R. & Trescher, J. H.: 

Studies on suprarenal cortex; plasma electrolytes and electrolyte 
excretion in suprarenal in sufficiency in the dog, J. Exper. Med., 

58: 17, 1933. 

86. Harrison, H. E. & Barrow, D. G.t Renal function in experimental 

adrenal insufficiency, 2m. J. Physiol., 125 : 631, 1939. 

87. Baumann, E. J. & Kurland, S.: Changes in inorganic constituents 

of Blood in suprarenalectomized cats and rabbits, J. Biol. Ghem., 

71: 2®=, 1927. 

88. Best, C. B., Taylor, N. B.: The physiological basis of medical prac¬ 

tice (5th Ed.); Williams & Wilkins Co., Baltimore, 1950, page 459* 

89. Ueraey, E. B. & Win ton, F. R.: Action of caffeine on isolated kidney 

of dog, J. Physiol., 69: 153, 1930. 

90. Hastings, A. B. & Compere, E. L.t Effect of bilateral suprarenal- 

eetomy on certain constituents ©f the blood of dogs, Proc. Soc. 
Exper. Biol. & Med., 28: 376, 1931. 

91. Tmszkowski, R. & Zwemer, R. L.: Corticc-adrenal insufficiency and 

potassium metabolism, Bioehem. J., 30: 1345, 1936. 

92. Wilder, R. M., Kendall, E. 0., Snell, A. M., Kepler, E. J., Rynearson, 

E. H. & Adams, M.: Intake of potassium, important consideration in 
Addison 8 s disease; metabolic study. Arch. Int. Med., 59: 367, 1937. 



■!\1 \ 




. 

.'?■ I 


■: ■ \ ‘ i. [ ■ r • 

•. ; . : 

«. oj r ' '. 1 ' :. 


► ■■‘T, - ".Lr. t • . . C , ' ' 

.. i. ...... . \. . r 

, ' . . - . : .. -L 

. . . .. . ' 

, « . .j. • ■■ 




-■C . , . -' . 

% ■ MO ' 1 . ’ . 3 '■ f.£ , , • . I 

: . . ' 


. • , ■ . ... * . ..... 

• i :Jj . „ ■' o/ . *. : J'• ./c r . v v ■ r .' : 

* » o. ' . B .VJLBij l i i ■. ijz r ' -r. 


." /■' .. ' : . . . . . ' 

. • .. . . . 

. '■ jj B ' J... :■ . ■■ B ■ ■' ; B ". .' • . . ; ‘ . 

, . ■ . B ■ \j .■ .1 1 B 

. 

••I :• ; 0. ' : . .. . , i ... . , •' ’ . BB 

. ' ; B : ' . / ) ■' ■ v 

...... . . . . . ' 

. B- . Bo,l:o>B ■ . ■ . a Bo 

; . . , ■: . ; C ■ * 

. oo : 'j . ■;o'.r': , ■; o.; 'in kx\B.; \BB lo i .o'.i. r r : pJLccH'ers no vniowD 

. , . : ■ .. . . . . 


. 


, . . . Jl ' ' 

; , ■ : . . I- -r o-: * 1 B o- ■ . . ri:. ; ;• o 


15.0 ■' '' 


... , . . 

c-or: ;; , B s 


, ■ . 


.■ • • : 









93* Darrow, D. C., Harrison, H. E. & Taffel, M.: Tissue electrolytes 
in adrenal insufficiency, J. Biol. Chem., 130: 487, 1939. 

94• Landau, M.: Die Nebennierendrinde, Jena, 1915, as cited by A. 

Grollman. The Adrenals; Williams & Wilkins Co., Baltimore, 1936. 

95* Marshall, E. K. & Davis, D. M.: Influence of the adrenals on the 
kidneys, J. Pharacol. & Exper. Therap., 8: 525 , 1916. 

96. Lucas, G. H. W.: Blood and urine findings in desuprarenalized dogs, 

Am. J. Physiol., 77: 114, 1926. 

97. Rogoff, J. M. & Stewart, G. N.: Study on adrenal insufficiency in 

dogs; blood studies in control of animals not subjected to treat- 
ment, Am. J. Physiol., 78: 711, 1926. 

98. Wyman, L. C. & Walker, B. C.: Studies on suprarenal insufficiency; 

blood sugar in suprarenalectomized rats.. Am. JJ. Physiol., 89: 215, 

1929. 

99* Swemer, R. L. & Sullivan, R. 0.: Blood chemistry of adrenal insuffi¬ 
ciency in cats. Endocrinology, 18: 97, 1934* 

100. Bieny, H. & Malloizel, L.: Hypoglycemic qpres decapsulation, 

Compt. rend. Soc. Biol., 65 : 232, 1908, as cited by A. Grollman. 

The Adrenals; Williams & Wilkins Co., Baltimore, 1936. 

101. Porges, 0.: Hypoglykamie bei Morbus Addison sowie bei nebennieren- 

losen Hunden, Zet. klin. Med., 69s 341, 1910, as cited by A. Grol¬ 
lman. The Addrenals; Williams & Wilkins Co., Baltimore, 1936. 

102. Goodman, L. & Gilman A.? The Pharmacological Basis of Therapeutics; 

MacMillan Co., New York, 1941, page 1229. 

103* Schwartz, 0.: Ueber Stoffwechselstorungen naeh der exstir pat ion bie 
den Nebennieren, Arch. ges. Physiol., 134s 259 , 228, as cited by 
A. Grollman. The Adrenals; Williams & Wilkins Co., Baltimore, 1936. 

104. Boggild, D. H.: Die Bedeutung der Neberrieren fur die Blutzuckerregu- 

lierung. Acts.. Path. Scand., 2: 68, 1925, as cited by A. Grollman. 

The Adrenals; Williams & Wilkins Co., Baltimore, 1936. 

105. Loeb, R. F., Atchley, D. W. & Stahl, J.: The role of sodium in ad¬ 

renal insufficiency, J.A.M.A., 104: 2149, 1935• 

106. Marine, D. & Bagmann, E. J.: Duration of life after suprarenalectomy 

in cats and attempts to prolong; it by injections of solutions con - 
taining sodium salts, glucose and glycerol. Am. J. Physiol., 81: 86, 
1927. 

107. Rogoff, J. M. & Stewart, G. N.: Studies on adrenal insufficiency. 

Influence of intravenous injections of Ringer’s solution upon lie 
survival period in adrenalectomized dogs. Am. J. Physiol., 84, 649 , 1928 



- •:/’ ' ' ' ; . ' . . ' . , , / 

: <. 

• • . , • , . . r . : , , . ■. 

• i . ' ’ - " • , ' Li . : t ■ • • }. . • 

" r , : :• ; > L: -V I : , . . . /■; ' • 


» " : r , • ’ . ’ ' i , . . ■ 

I --’- 1 t .: . 

■ L " ' ’ \ ' • ; . . , -■ , 

c\~'f v.|': ; .?j' - J' bo _U. .o , v. '' L./.i ; L.; JL' N;' o/> 


' ’ '/O.'OL '.' . r '. ■ r; . ■■ ■ ... r : .' • .... 

- ■■ L; 2 — ' ■; ■ . • . , . ■ ' ••• 4. o 




unoTb 





' 


,xioi-.t..^.D.raqao't «a 1 

, 


1 




, 


1 Z>TQ J 

. . > , . .... 

' ■ ' ■ ■ ■: • ■ ; . . . 

■: . . ' 

i-i/.f rtolootrLL ; : 'too xir> \o m~\ airiod*£!•• • *« 

' : ■ O •' ' ■ . ;<:vi 

* cJ" I !" : ■ : • ■■■ b : •! ; I;j'■ •.: ■ ... 

-’-jt briL-I oib> oLi iioi&knsd-sM 'too fe**L o.! 

. ; , .f. , ,'t& rl&I ■ ,. -. J jaxiliV : 

; . • . ' I 

. : ! - . ...... . • .; , r ■ 

: . ■ . . ; . ■ . . : v J 

, 

:. J . 

* • " ‘to :i ■; r ,;.vi auoxi^V- vfbab "c vor:;/.!T'..'j 

. ' . X:-7‘ 


: . 

.. * 

. 




X/sm'z-A> 


108. Thom, G. W., Garbutt, H. R., Hitchcock, F. A., & Hartman, F. A.: 

The effect of cortin on sodium, potassium, chloride, inorganic 
phosphorus, and total nitrogen balancd in normal subjects and in 
patients with Addison*s disease. Endocrinology, 21* 202, 1937 and 
Endocrinology, 21: 213, 1937. 

109• Selye H.s Textbook of Endocrinology (2nd Ed.); ACTA Endocrinologica 
Inc., Montreal, 1947, page 118. 

110. Britton, S. W. & Silvette, H.: Effects of cortico-adrenal extract 

on carbohydrate metabolism in normal animals. Am. J. Physiol., 

100: 693, 1932. 

111. Best, C. H. & Taylor, N. B.: The physiological Basis of Medical 

Practice, (5th Ed.); Williams & Wilkins Co., Baltimore, 1950, 
page 807. 

112. Selye, H.: Textbook of Endocrinology (2nd Ed.); ACTA Endocrinolo-. 

gica Inc., Montreal, 1947, page 121. 

113. Harrop, G. A. & Thom, G. ¥.: Studies on suprarenal cortex; the 

effect of suprarenal cortical hormone upon the electrolyte excre¬ 
tion of intact normal dog. A proposed method of comparative 
assay, J. Exper. Med., 65: 757, 1937. 

114. Hartman, F. A., Lewis, L. A. & Toby, C. G.; Effect of cortin on the 

excretion of electrolytes. Endocrinology, 22, 207, 1936. 

115* Thorn, G. W., Ingle, L. L., & Eisenberg, H.: Effect of corticosterone 
and related compounds on renal excretion of electrolytes, J. Exper. 
Med., 68: 161, 1936. 

116. Hawk, P. B., Qser, B. L. & Summerson, W. H.: Practical Physiologi¬ 

cal Chemistry (12th Ed.); Blakiston Co., Toronto, 1947, page 693* 

117. Long, C. N. H. & Katsin, B.: Effect of adrenal cortical hormone on 

carbohydrate stores of fasted hypophysectomized rats, Proc. See. 
Exper. Biol. & Med., 36 : 516, 1936. 

118. Long, C. N. H., Katzin, B. & Fry, E. G.: The adrenal cortex and 

carbohydrate metabolism. Endocrinology, 26? 309, 1940. 

119. Groilman, A.: The Adrenals; Williams & Wilkins Co., Baltimore, 

1936, page 235. 

120. Haines, W* J., Johnson, R. H., Brunner, M. P., Pabst, M. L. & 

Kuizenga, M. H.; Study of the carbohydrate regulating hormone of 
hog adrenal extract. Federation Proc., 8: 203, 1949. 

121. Selye, H.: Textbook of Endocrinology (2nd Ed.); ACTA Endocrinologica 

Inc., Montreal, 1947, page 48 . 



ol ' ' , . I - i I r ■ r f ± ' '■ • : i ' / *3 

'■1 v: : y.i'o I ’ j r. o* r. "" o r r >.v: :.r „ l is r '~o it ’!< i'r 


«■*:.» r.'p! 


, ■ ; i 1 : . ‘ 




■: • . :■ ,\ ■ ' ; c * .• 

. :• r r - - 


* . 

. v. 


“•rrr'r..:* loro: r.v^-ooi^'ino To 


■ ■ v . 

1 - 

o m 




. :• -• 


. 

. 


' : : ... . •.: ■••x " x ; •, ; ■ ; . . . 

C. V . ‘ < 1C ' -V ' . . 

. 


. 

'.-c ,:x: VV:o 
or ' r cr 


M K ' - . 30 ' LC ■ J ■ 


, j . . ,. c- 


. 




. : 


I 


xuxrt 


V. , • XX ( 


■ x r * d 

' j 


. . 

vr.^xL <oi!0 i'ro 


. :& . • • •' . ' .j : * c J'O. • .r ■• ■■.- :i •: 

. : 1 . j 


rr 


J rx:o 

. . ’ : . . 


bdo ;r r* 


toaxxo 


. 


OJ ■. 




: . , :: 


- 




o si 


- . ‘ < •; .■ '• . ; ' , or . I...*. - r c .: 




. 


o:rxr; 



122. Selye, H.s Textbook of Endocrinology (2nd Ed.); ACTA Endocrinology 

ica Inct., Montreal, 1947, page 71. 

123. Albright, F.: Cushing’s Syndrome. Its pathological physiology, its 

relationship to the adrenogenital syndrome, and its connection with 
the problem of the reaction of the body to injurious agents. (Alarm 
reaction of Selye). Harvey Lectures; The Science Press Printing Co., 
Lancaster, Pa., 33s 123, 1942-43* 

124* Kendall, E. C., Mason, H. L., Hoehn, W. M. & McKenzie, B. F.s Studies 
in the chemistry of the suprarenal cortex: the probable position 
of the undetermined atom of oxygen, Proc. Staff Meet., Mayo Clin., 

12: 270, 1937. 

125. Williams, S. H.: Textbook of Endocrinology; W. B. Saunders Co., 

Philadelphia, 1950, page 253* 

126. Forsham, P. H., Bennett, L. L., Roche, M., Reiss, R. S., Slessor, A., 

Flink, E. B. & Thofn, G. ¥.: Clinical and metabolic changes in 
Addison’s disease following the administration of compound E acetate 
(ll-dehydro-17-hydroxycorticosterone acetate), J. Clin. Endocrin¬ 
ology, 9s 660, 1949. 

127. Sprague, R. G., Power, M. H., & Mason, H. L.: Physiological Effects 

of Cortisone and pituitary adrenocorticotrophic hormone (ACTH) in 
man, J.A.M.A., 144s 1341, 1950. 

128. Ingle, D. J., Pres trad, M. G., Nezamis, J. 1. & Kuizenga, M. H.: 

Effect ox adrenal cortex extract upon tolerance of eviscerated cat 
for intravenously administered glucose. Am. J. Physiol., 150: 423, 
1947. 

129. Ingle, D. J. & Prestrud, M. C.| Effect of adrenal cortex extract 

upon urinary non-ptrotein nitrogen and changes in weight in young 
adrenal©ctomized cats. 

130. Kendall, 1. G.: The function of the adrenal cortex, Proc. Staff 

Meet., Mayo Clinic, 15, 297, 1940. 

131. Oberdisse, K. & Werner, R.: Sugar formation and protein catabolism 

under influence of adrenocortical hoxmone, abstr. J.A.M.A. 139/ 1113, 
1949. 

132. Selye, H.: Textbook of Endocrinology (2nd Ed.); ACTA Endocrinolog- 

ica Inc., Montreal, 1947, page 159* 

133* Council on Pharmacy a nd Chemistry: Desoxycorticosterone acetate 
U.S.P., J.A.M.A., 140: 539, 1949* 


. ; ; . • 1 ■ 1 ■ : ? • «. ■ VJ - 


. 


, 


. 

L'wi •. f , ; J . •' ' X ■ i'vX/' r ^ OJ.:it • • 

. : - 


r ;) 


. 




'!■ I..- 




Hi - 


> • ;c 1 K'*- r :. V. 


. 


. . . . . -. ..... . • - • - ' 

. 

. 

. 




' ■ D 


:* • »£>J 

b . 


■j-y jr 

X -,;X :> :■ X '.j:usc‘:;p.ov X ' •' ’ •' X. X - ’• nX vn<:wo.l '^ 

. : ■: ' ’ ,X - • 


. 




. . , . * ' v 

. 




: ■ • ■ .. . x x , x .x , . 

f : .* (n'iXX‘0 ;.:!■>{ -icn oXX- c ' :J 0 f ■ . ozi>’ 

. . . 


j;o . ■■■ X.o ■.•X.J- hom/ . "-X ; :-y£‘';C'~ ' 

• " ■ ' X.::Xr: ; .o ' ' ; - 


•v •• 


■ 1 . ' S . * r • 

X. :' •: cr- M.:'i aJte$C' 'vCr-HCXX Yyit'K 

r 


. 

, ‘;' 

.\"X I 

. 




f - ;X-' • j 

* . 


:: ■: • . ■ "» 
« . ' X 


Y . r. 


, 




l. ' J! 




:OXcv 


y ,■ ' ■ ' 




\ X 


i ■ 




X ■' *’■ TiU bn . : YO ■: /; v 


yy:ixy 




134* Thorn, G. W. , Engle, L. L. & Eisenberg, H.: Treatment of adren¬ 
al insufficiency by by means of subcutaneous implants of pellets 
of desoxycorticosterone acetate (a synthetic adrenal cortical 
hormone), Johns Hopkins Hosp. Bull., 64 : 155, 1939. 

135* Perera, G. A.: The effect of continued desoxycorticosterone ace¬ 
tate administration in hypertensive subjects, Proc. Soc. Exper. 

Biol. & Med., 68 s 43, 1943. 

136. Ferrebee, J. W., Ragan, C., Atchley, D. W. & Loeb, R. F.: Des¬ 

oxycorticosterone esters. Certain effects in the treatment of 
Addison’s disease, 113: 1725, 1939* 

137. Thorn, G. W. & Eisenberg, H.; Studies on desoxycorticosterone, a 

synthetic adrenal cortical hormone. Endocrinology, 25: 39, 1939. 

133. McGullagh, E. P. & Ryan, E. J.: The use of desoxycorticosterone 
in Addison’s disease, J.A.M.A., 114: 2530, 1940. 

139* Thom, G. W. & Firor, W. M.: Desoxycorticosterone acetate therapy 
in Addison’s disease, J.A.M.A., 114: 2517, 1940. 

140. Thorn, G. ¥., Howard, R. P., Emerson, K. Jr. & Firor, ¥. M.: 

Treatment of Addison’s disease -with pellets of crystalline adrenal 
cortical hormone (synthetic desoxycorticosterone acetate) implanted 
subcutaneously, Johns Hopkins H©sp. Bull, 64 : 339, 1939. 

141. A ird, R. B.: The effect of desoxycorticosterone qeetate in 

epilepsy, J. Nerv. and Ment. Dis., 99: 501, 1944* 

142. Anderson, J. A.: Desoxycorticosterone acetate and water exchange, 

J. Clin. ItodoeyimolGgy, 3: &X5, 1943* 

143. Wilder, R. M.t Progress in treatment of Addison’s disease, Proc. 

Staff Meet. Mayo Clinic, 15: 273, 1940. 

144* Conn, J. W.s Electrolyte composition of sweat; clinical implica¬ 
tion as an index of adrenal cortical function. Arch. Int. Med. 

83, 416, 1949. 

145* Kuhlman, D., Ragan, C., Ferrebee, J. ¥., Atchley, D. ¥♦ & Loeb, R. F. 
Toxic effects of desoxycorticosterone esters in dogs. Science, 

90s 496, 1939. 

146 . Gaunt, R., Bimie, J. H. Sc Eversole, ¥. J.s Adrenal cortex and water 

metabolism. Physiological Rev., 29: 231, 1949. 

147. Sprague, R. G., Power, M. H., Mason, H. L., Alberta., A., Mathieson, 

D. R., Bench, P. S., Kendall, E. C., Slocumb, C. H. & Polley, H. F.: 
Observations on the physiologic effects of Cortisone and ACTH in 
man, Arch. Int. Med., 85: 199, 1950. 






143* Kendall, E. C.: Hormones of the adrenal cortex, Endocrinology, 

30 : 353, 1942. 

149• Reinecke, R. M. & Kendall, E. C.: A comparison ofoihe influence 
of some crystalline hormones in the adrenal cortex on the de¬ 
position of glycogen in the liver. Endocrinology, 32: 505, 1943* 

150. Mason, H. L.: The chemical nature of the hormones of the adrenal 
cortex, Proc. Staff Meet. Hayo Clinic, 15: 239, 1940. 

151* Ingle, D. J.j The production of glycosuria in the normal rate by 
means of 17-hydroxy-ll-dehydrocorticosterone, Endocrinology, 

29: 649, 1941. 

152. Thom, G. W*, Bayles, T. B., Massell, B. F., For sham, P. H., 

Hill, S. R., Smith, S. 4 Warren, J. E«s Studies on the relation 
of pituitary-adrenal function to rheumatic disease, New England 
J. Med., 241: 529, 1949. 

153* Ingle, D. J. & Thom, G. W.: A comparison of the effects of 11- 

desoxycorticosterone acetate and 17-hydroxy-ll-dehydrocorticoster- 
one in partially depancreatized rats. Am. J. Physiol., 132: 670, 

19 ^. 

154* Wells, B. B.s The influence of crystalline compounds separated 
from the adrenal cortex on gluconeogenesis, Proc. Staff Meet. 

Mayo Clin., 15: 294, 1940. 

155. Lewis, R. A., Kuhlman, D., Delbue, C., Koepf, G. F. & Thorn, G. W.: 

The effect of the adrenal cortex on carbohydrate metabolism, 
Endocrinology, 27: 971, 1940. 

1 56 . Wells, B. B. & Kendall , E. C.: The influence of the adrenal cortex 

in pfolorhizin diabetes, Proc. Staff Meet. Mayo Clinic, 15: 565, 1940. 

157. Grattan, J. F. & Jensen, H.: The effect of the pituitary adreno¬ 

corticotropic hormone and of the various adrenal cortical prin- 
cioles on insulin hypoglycemia and liver glycogen, J. Biol. Chem., 
135: 511, 1940. 

153. Ingle, P* J*, Sheppard, R., Ivans, J. S. & Kuizenga, M. H.: A com¬ 

parison of adrenal steroid diabetes and pancreatic diabetes in the 
rat. Endocrinology, 37: 341, 1945* 

159. Herring, V. V. & Evans, H. M.: Effects of purified antero-pituitaiy 

hormones on the carbohydrate sfcdres of hypophysectomized rats, Am. 

J. Physiol., 140: 452, 1943. 

160. Wang, F. G. k Verzar, F.t Comparison between glycogenetic property 

of desoxycortico star one, ll-dehydro-! 7 ”hydro:xycorticosterone (com¬ 
pound E) and adrenal cortical extract, Am. J. Physiol., 159 : 263, 
1949. 




0 J.i 


. • ' 


j J..Q ' C'. '■ O0 A 
•/ ii:o J '*o . viv/ihi: . j 

■ : , ■ ,'i'- . 


• OOTM.Ti j'.O {(?>. 



• ' 0 J.1 ' 


‘ a. 


r' lo no J j.1.. ( 

♦ • o :o >t * jv<v ■- ■ 





* • * . . • . ■ - 
, ; E * . . . . : 

. : ' noli' ; J i: ’ 



\ 


0 [iiir/.tioo 


m .-ch*oj j. .■-r'.Lir*. y-c/xJ. 



wo iJwsfi'jvV, ?.o sol 




■'"-••“i;.; ■ !;iic.K'jv jjfiit y.o ont:> om 

;,; ; ooTJ.:g 'it-vli. ,ck,a' 


■ i la 




... 

•}fr&*iJC*:J ‘ic IX TS.S:\L 

r.'l-zrd 


' • ' s. A , 

- '.V' J'0,. Vi ! ' tc ~fiU • f' >0 -j • ■ . l&flOt. ?roil 

t ■ 7 ■ . . . . , 

v.'.v 7 ■ A: -C • .\>Vi : ■ . r.-0.'d , J • ; ‘.i O 

- * " ' . . " • . "£ i • ( • I. ' - 


161. Chiu, C. Y. & Needham, D. M*: Effect of adrenal cortical steroids 

upon the formation of carbohydrate by rat liver slices, Nature, 

164; 790, 1949. 

162. Thorn, G. V*, Koepf, G. F., Lewis, R. A. & Olsen, E. F. s Carbo¬ 

hydrate metabolism in Addison*s disease, J. Clin. Investigation, 

19s 313, 1940. 

163. Sprague, tt. G., Gastineau, C. F., Mason, H. L. & Power, M. H.: 

Effects of synthetic ll-dehydrocorticosterone (Compound A) in a 
subject with Addison*s disease, Amer. J. Med., 4s 175, 1943. 

I 64 * Hench, P. S., Slocumb, C. H., Barnes, A. R., Smith, H. L., Polley, 

H. F. & Kendall, E. C.: The effects of the adrenal cortical hor¬ 
mone 17-hydroxy-ll-dehydrocorticosterone (compound E) on the acute 
phase of rheumatic fever: Preliminary report, Proc. Staff Meet. 
Mayo Clin., 24s 277, 1949* 

165. Kendall, E. C.: The adrenal cortex. Arch. Path., 32: 474 , 1941 . 

166. Wells, B. B. & Kendall, E. C.: The influence of corticosterone and 

C-17-hydroxy-dehydrocoriicosterone (compound E) on somatic growth, 
Proc. Staff Meet. Mayo Clin., 15s 328, 1940. 

167. Ingle, D. J., Higgins, G. M. & Kendall, E. C.s Atrophy of the ad¬ 

renal cortex in the rat produced by administration of large amounts 
of cor tin, Anat. Rec., 71: 363, 1933. 

168. Heilman, F. R. & Kendall, E. C.: The influence of ll-dehydro-17- 

hydroxycorticosterone (Compound E) on the growth of a malignant 
tumor in the mouse. Endocrinology, 34s 416, 1944* 

1 69 . Murphy, J. B. & Sturm, E.: The effect of adrenal cortical and pi¬ 

tuitary adrenotropic hormones on transplanted leukemia in rats. 
Science, 99s 303, 1944. 

170. Ingle, D. J.: Diabetogenic effect of some cor tin-like compounds, 

Proc. Soc. Exper. Biol. Med., 44: 176, 1940. 

171. Ingle, D. J.; & Kendall, E. C.s Influence of amorphous fraction 

from adrenal cortex on efficiency of muscle, Proc. Soc. Exper. 

Biol. & Med., 45s 692, 1940. 

172. Ingle, D. J. & Kuizenga, M. H.t The relative potency of some ad¬ 

renal cortical steroids in the muscle-work test. Endocrinology, 

36: 213, 1945. 

173* Boland, 1. W. & Headley, N. E.: Effects of cortisone acetate on 
rheumatoid arthritis, J.A.M.A., 141s 301, 1949* 

174* Wilson, D. R.: Personal communication. 



’ ■ 


xic' <*:• f-o 


. 


t 






iTOi 






■ c"'7 7 7l7.i' I'A \ 77'.■ } W 0 "''; ‘l:: . • . 

. J\ ' . - ' . : ' 7 


: "7 ' r ; , * 

*.i.d'7o77 7 l d7-;" «-fo ( ; ; '■ :'. r o(!"' 777 ".i-, J7:7:X<J"''<7 7 . 

» . ; : * . . 

... . . . 

sd’iiyofiLa 77 -?;• hvos^.K ■ 


. ; . 

u:.i. ■/-( • : ' 

. \. V : ' / . 

; ’ . ' . : c ; « . ■■ 

53 J ■ 1 

1 ■ ' i ■ ' . j ’ 

. ... . • . 







. 



' 7" ' ■ . 

. . • . : , ■■ 


.... 

c j' 5 ih 'fl 
, : :U7 : ; : . <■ ; 


X 7 :MU 


, 7grfOo7i:>: 7 ■' . , V I , ■ 

. .. : : 7 ' 7 \;"'' ' 7 . 7 :.■> ■' . 

. . , : ■; 



■ 


. 





175* Recant, L., Ott, W. H. & Fischell, E. E.: The antipyretic effect 
of cortisone, Proc. Soc. Exper. Biol. & Med., 75: 264 , 1950. 

176. Frebor, R. H.: Effects of Cortisone and ACTH in rheumatoid arth¬ 

ritis, Bull. N. Y. Acad. Med., 26: 206, 1950. 

177. Selye, H.: Textbook of Endocrinology (2nd Ed.); ACTA Endocrin¬ 

ologies TJniversite de Montreal, 1947, page 212. 

178. Albright, F.: Recent Progress in Hormone Research. I.; Apple- 

ton-O e ntury-Crofts, Inc., New York, U. S. A., 1947, page 293* 

179 • Albright, F. & Reifenstein, E. C., Jr.: Parathyroid glands and 
Metabolic bone disease; Williams & Wilkins Co., Baltimore, 1943* 

ISO. Reifenstein, E. C., Jr., Forbes, A. P., Albright, F., Donaldson, E., 
& Carroll, E.: Effect of methyl testosterone on urinary 17-keto- 
steroids of adrenal origin, J. Clin. Invest., 24: 416, 1945* 

181. Deane, H. W. & Creep, R. O.s A morphological and histochemical 

study of the rat * s adrenal cortex after hypophy sec tony with com¬ 
ments on the liver. Am. J. Anat., 79: 117, 1946. 

182. Swann, H. G.: Pituitary-adrenocortical relationship. Physiological 

R 8 v., 20s 493, 1940. 

183. Creep, R. 0. & Deane, H. W„: Cytochamical evidence for the cessa¬ 

tion of hormone production in the zona glomerulosa of the rat’s 
adrenal cortex after prolonged treatment with desoxycorticoster- 
one acetate, Endocrinology, 40: 417, 1947. 

184* Dgane, H. W., Shaw, J* H. k Creep, R. 0.: The effect of altered 
sodium or potassium intake on the width and cytochemistry of the 
zona glomerulosa of the rat’s adrenal cortex. Endocrinology, 

43s 133, 1943. 

185. Ingle, D. J., Prestrud, M. €., Li, G. H., & Evans, H. M.: Relation¬ 

ship of diet to the effect of adrenocortico trophic hormone upon 
urinary nitrogen, glucose and electrolytes, Endocrinology, 41: 170, 
1947. 

186. Bergner, G. 1. & Dean, H, W.: Effects of pituitary adrenocortico¬ 

tropic hormone on the intact rat with special reference to cyto- 
chemical changes in the adrenal cortex, Endocrinology, 43 : 240, 
1943. 

187. Ingle, D. J., Li, C. H., & Evans, H. S.: Effect of adrenocortico- 

trophie hormone on urinary excretion of sodium, chloride, potas¬ 
sium, nitrogen and glucose in normal rats. Endocrinology, 39: 

32, 1946. 

188. For sham, P. H., Thorn, G. W., Prunty, F. T. G. & Hills, A. G.: 

Clinical studies with pituitary adrenocorticotropin, J. Clin. 
Endocrinology, 8: 15, 1943. 

















vti r 



•■j HO 




~0 01 ' 





0000 .) 0 00 
€ ’ 




, 





.u , . 

:0 loll OJIflt O’Xs 


■v0,;0":i;c<)Oj 


SO 

■c$l 





139. Mason, H. L., Power, M. H., Rynearson, E. H., Ciaramelli, L. C., 

Li, C. H. & Evans, H. M.: Results of administration of anterior 
pituitary adrenocorticotropic hormone to a normal human subject, 

J. Clin* Endocrinol., 3: 1, 1948. 

190. Sayers, G.r Progress in Clinical Endocrinology; editor S. Soskin, 
Grune & Stratton, New York, 1950, page 124. 

191 • Sayers, G. & Sayers, M. A.: The pituitary-adrenal system. Recent 
progress in hormone research, 2: 81, 1943. 

192. Mason, H. L.: Isolation of a urinaxy steroid with an oxygen atom 

at carbon 11, J. Biol. Chem., I 58 : 719, 1945. 

193. Lieberman, S., Dobriner, K., Hill, B. R. & Rhoads, C. P.: Studies 

in steroid metabolism. Identification and characterization of 
ketosteroids isolated from urine of healthy and diseased persons, 

J. Biol. Chem., 172: 263 , 1948. 

194. Sayers, G., Sayers, M. A., Fry, E. G., White, A. & Long, C. N. H.: 

Effect of adrenotrophic hormone of anterior pituitary on choles¬ 
terol content of adrenals with review of literature of adrenal 
cholesteroll, Yale J. Biol. & Med., 16: 36 I, 1944* 

195♦ Sayers, G.: The adrenal cortex and homeostasis. Physiol. Rev. 

30: 241, 1950. 

196. Sperry, W. M.: Misero-method for determination of total and free 

cholesterol. Am. J. Clin. Path., Tech. Suppl., 2: 91, 1938. 

197. Hechter, 0., Jacobsen, R. P., Jeanloz, R., Levy, H., Marshall, C. W., 

Pincus, G. & Schehker, The bio-oxygenation of steroids at Cll, 

J. Am. Chem. Soc., 71: 3261, 1949* 

198. Sayers, G., Sayers, M. A., Liang, T. Y. & Long, C. N. H.: Cholesterol 

and ascorbic acid content of adrenal, liver, brain and plasma 
following hemorrhage, Endocrinology, 37: 96, 1945* 

199. Sayers, G., Sayers, M. A., Liang, T. Y. & Long, C. N. H. Effect of 

pituitary adrenotrophic hormone on cholesterol and ascorbic acid 
content of adrenal of rat and guinea pig. Endocrinology, 38: 1, 1946. 

200. Dougherty, T. F. & White, A.: An evaluation of alterations produced 

in lymphoid tissue by pituitary-adrenal cortical secretion, J. Lab. 

& Clin. Med., 32: 584, 1947. 

201. Dougherty, T. F. & White, A.: Influence of hormones on lymphoid 

tissue structure and function. Role of pituitary adrenotrophic 
hormone in regulation of lymphocytes and other cellular elements 
of blood, Endocrinology, 35s 1, 1944* 

















202* de la Baize, F. A., Reifenstein, E. C. & Albright, F.: Differ¬ 
ential blood counts in certain adrenal cortical disorders 
(Cushing*s Syndrome, Addison*s Disease and Panhypopituitarism), 

J. Clin. Endocrinol., 6: 312, 1946. 

203. Hechter, 0.: Lymphocyte discharge from the isolated rabbit 

spleen by adrenal cortical extract, Endocrinol., 42: 285, 1943. 

204* Dougherty, T. F. & White, A.: Pituitary-adrenal cortical control 
of lymphocyte structure and function as revealed by experimental 
x-radiation, Endocrinology, 39: 370, 1946. 

205. Dury, A. & Robin, E. D.: Urethane induced lymphopenia in normal 

and adrenalectomized rats, Endocrinology, 42: 320, 1943. 

206. Hills, A. G . f Forsham, P. H. & Finch, C. A.: Changes in circu¬ 

lating leukocytes induced by the administration of pituitary 
adrenocorticotrophic hormone (ACTH) in man. Blood, 3: 755, 1948. 

207. Thom, G. V., Forsham, P. H., Prunty, F. T., Bergner, R. E. & 

Hills, A. G.: Clinical studies in Addison*s disease, Ann. New 
York Acad. Sc., 50: 646 , 1949. 

208. Davis, M. E. & Hulit, B. E.: Changes in circulating eosinophils 

in women during menstrual cycle and reproduction, J. Clin. Endocrin¬ 
ology, 9: 714> 1949. 

209. Godlowski, Z. Z.r Eosinopenia caused by adrenalin infusion and by 

insulin hypoglycemia, Brit. Med. J., 1: 46 , 1943. 

210. Recant, L., Forsham, P. H. & Thorn, G. V.: Observations on the 

pituitary-adrenal response following epinephrine infusion in man, 

J. Clin. Endocrinol., 8: 589> 1948. 

211. Altschule, M. D., Altschule, L. H. & Tillotson, K. J.: Changes in 

urinary uric acid-creatinine ratio after electrically induced con¬ 
vulsions in man, J. Clin. Endocrinol., 9: 548, 1949* 

212. Thom, G. V., Forsham, P. E., Prunty, F. T. G. & Hills, A. G.: 

A test for adrenal cortical insufficiency; response to pituitary 
adrenocorticotropic hormone, J.A.M.A., 137: 1005, 1948. 

213. Long, C. N. H. & Fry , E. G.: Effect <f epinephrine on adrenal 

cholesterol and ascorbic acid, Proc. Soc. Exper. Biol. &Med., 

59: 67V 1945. 

214. Thom, G. Forsham, P. S. & Emerson, K.: The diagnosis and 

treatment of adrenal insufficiency; Springfield: Charles C. Thomas, 
1949. 

215. Baez-Villasenor, J., Rath, C. E. & Finch, C. A.: The blood picture 

in Addison*s Disease, Blood, 3: 769* 1948. 





. '.( 
















I'Hcrj - ' ' 






216. Venning, E. H., Hoffman, M. M. & Browne, J. S. L.: The extrac¬ 

tion of cortin-like substances from, human post-operative urine. 
Endocrinology, 35: 49, 1944* 

217. Venning, E. E., Boffman, M. M., Browne, J. S. L., Kazmin, V. K. 

& Bell, J. C.s Biological assay of adrenal corticoids, Endo¬ 
crinology, 38: 79, 1946. 

218. Shipley, R. A., Dorfman, R. I. & Horwitt, B. N.: The presence in 

normal urine of cortin-like material which is active in the 
muscle work test. Am. J. Physiol., 139s 742, 1943. 

219. Shipley, R. A., Dorfman, R. I., Buckwald, E. & Ross, E.: Effect 

of infection and trauma on excretion of urinary cortin, J. Clin. 
Invest., 25: 673, 194&. 

220. Schiller, S. & Ddrfman, R. I.; Influence of urinary cortin-like 

material on water intoxication in the adrenalectomized rat. 
Endocrinology, 33: 402, 1943- 

221. Venning, E. H. & Kazmin, V. E.; Excretion of urinary corticoids 

and 17-ketosteroids in the normal individual, Endocrinology, 

39: 131, 1946. 

222. Venning, E. E. & Browne, J. S. L.: Excretion of glycogenic corti¬ 

coids and of 17-ketosteroids in various endocrine and other dis¬ 
orders, J. Clin. Endocrinol., 7: 79, 1947. 

223. Heard, R. D. E., Sobel, H. & Venning, E. E. ? The neutral lipide- 

soluble reducing substances of urine as an index of adrenal cor¬ 
tical function, J. Biol. Chem., X 65 : 699, 1946. 

224. Talbot, N. B., Albright, F., Salt man, A. H., Zygmumtowicz, A. & 

Wixom, R.r The excretion of 11-oxysteroid-like substances by 
normal and abnormal subjects, J. Clin. Endocrinol., 7: 331, 1947. 

225. Heard, R. D. E. & Sobel, H.: A colorimetric method for the esti¬ 

mation of reducing steroids, J. Biol. Chem., 165 : 687, 1946. 

226. Lowenstein, B. I., Corcoran, A. C. & Page, I. E.: Determination 

of corticosteroids in urine (abst.), Endocrinology, 39: 82, 1946. 

227. Daughaday, ¥. H., Jaffe, E. & Williams, R. H.: Chemical Assay 

for "Cortin” ; determination of formaldehyde liberated on oxida¬ 
tion with periodic acid, J. Clin. Endocinology, 8s 166, 1948. 

228. Corcoran, A. C. & Page, I. E.s Methods for the chemical determina¬ 

tion of corticosteroids in urine and plasma, J. Lab. & Clin. Med., 
33: 1326, 1948. 

229. Holtorff, A. E. & Koch, F. C.: The colorimetric estimation of 17- 

ketosteroids and their application to urine extracts, J. Biol. 
Chem., 135: 377, 1940. 






olon 


m 














230. Callow, N. E., Callow, R. K. & Emmens, C. : Colorimetric determ¬ 

inations of substances containing the grouping -CH 2 -CO- in urine 
extracts as an indication of androgen content, Biochem. J., 32: 
1312, 1938. 

231. Fraser, R. W., Forbes, A. P., Albright, F., Sulkowitch, H. & 

Reifenstein, E. C., Jr.: Colorimetric assay of 17-ketosteroids 
in the urine. Survey of use cf this test in endocrine investiga¬ 
tion, diagnosis and therapy, J. Clin* Endocrinology, 1: 234, 1941* 

232. Mason, H. L. & Engstrom, V. ¥.; The 17-ketosteroids: Their origin, 

determination and significance, Physiol. Rev., 30: 321, 1950. 

233. Forbes, A. P., Donaldson, £. C*, Reifenstein, E. 0., Jr. & Al¬ 

bright, F.: The effect of trauma and disease on the urinary 17- 
ketosteroid excretion in man, J. Clin. Endocrinology, 7: 264 , 1947. 

234* Venning, E. H. & Browne, J. S. L.: Urinary excretion of adrenal 
cortical steroids, Ann. New York Acad. Sc., 50 ; 627, 1949. 

235* Thorn, G. ¥., Prunty, F. T. G. & Forsham, P. H.: Changes in urinary 
steroid excretion and correlated metabolic effects during prolonged 
administration of adrenocorticotrophic hormone in man. Science, 

105: 528, 1947. 

236. Landau, R. L., Knowlton, Anderson, D., Brandt, M. B. & Kenyon, 

A. T.: The effect of starvation on urinary 17-ketosteroid excre¬ 
tion, J. Clin. Endocrinol., 8 : 133, 1948. 

237. Ingle> D. J.: The time for the occurrence of cortico-adrenal hyper¬ 

trophy in rats during continued work. Am. J. Physiol., 124: 627, 
1938. 

238. Kinsell, L. ¥., Li, C. E., Margen, S., Michaels, G. D. & Hedges, 

R. N.: Metabolic effects of a peptide mixture derived from ACTH 
(li) in comparison with those resulting from whole ACTE. Adminis¬ 
tration to a human subject; Proc. of the First Clinical ACTH 
Conference, J. R. Mote, Editor, The Blakiston Co., Philadelphia, 
1950, page 70. 

239. Li, C. E.: The chemistry of hormones, Ann. Rev. Biochem., 16: 291, 

1947. 

240. Jones, I. C.: The relation of the mouse adrenal cortex to the 

pituitary. Endocrinology, 45: 514, 1949* 

241. Sayers, G., Bums, T. ¥., Tyler, F. E., Jager, B. V., Schwartz, 

T. B., Smith, E. L., Samuels, L. T. & Davenport, H. ¥.? Metabolic 
actions and fate of intravenously administered adrenocorticotrophic 
hormone in man, J. Clin. Endocrinology, 9: 593, 1949. 



r 


. 



242. Gordon, G. S., Li, C. H. & Bennet, L. L.: Effect of adrenocortico- 

trophic hormone on urinary nitrogen excretion in normal rat, Proc. 
Soc. Exper. Biol. & Med., 62: 103, 1946. 

243. Evans, H. M., Simpson, M. E. & Li, C. H.: Inhibiting effect of 

adrenocorticotrophic hormone on the growth of male rats. Endo¬ 
crinology, 33: 237, 1943. 

244. Becks, H., Simpson, M. E., Li, C. H. & Evans, H. MEffects of 

adrenocorticotrophic hormone (ACTH) on osseous system in normal 
rats. Endocrinology, 34: 305, 1944. 

245. Li, C. H., Kalman, C., Evens, H. M. & Simpson, M. E.: Effect of 

hypophysectomy and adrenocorticotrophic hormone on alkaline phos¬ 
phatase of rat plasma, J. Biol. Chem., 163: 715, 1946. 

246 . Browne, J. S. L,: Conference on Metabolic Aspects of Convalescence 

Including Bone and Wound Healing, June 11-12, 1943, New York, 
page 88 . 

247. Sayers, G. & Sayers, M. A.: Regulation of pituitary adrenocortico- 

trophie activity, Fed. Proc., 5 : 200, 1946 . 

248. Sayers, G. & Sayers, M. A.: Regulatory effect of adrenal cortical 

extract on elaboration pituitary of adrenotropic hormone, Proc. 

Soc. Exper. Biol. & Med., 60: 162, 1945* 

249* Carr eye it, R. A., Golla, Y. M. L. & Reiss, M.: Action of gonado¬ 
tropic hormone and of pituitary corticotrophic hormone on choles¬ 
terol content of the adrenals, J. Physiol., 104s 201, 1945* 

250. Editorial: Some aspects of adrenal cortical function and pituitary- 

adrenal relationships, Ann. Int. Med., 31: 925, 1949* 

251. Taylor, A. B., Albert, A. & Sprague, B. G.: Adrenotrophic activity 

of human blood, Endocrinology, 45 : 335, 1949* 

252. Ingle, D. J. & Kendall, E. G.: Atrophy of the adrenal cortex of 

the rat produced by administration of large amounts of cor tin, 
Science, 86P 24, 1937. 

253* Selye, H. & Dosne, C.: Physiological significance of compensatory 
adrenal atrophy, Endocrinology, 30: 581, 1942. 

254* Wallach, D. P. & Reineke, I. P.: The effect of varying levels of 
thyroidal stimulation on the ascorbic acid content of the adrenal 
cortex. Endocrinology, 45: 75, 1949* 

255* Woodbury, D. M., Cheng, C. P., Sayers, G. & Goodman, L. S.: 

Antagonism of adrenocorticotrophic hormone and adrenal cortical 
extract to desoxycorticosterone: electrolytes and electroshock 
threshold. Am. J. Physiol., 160: 217, 1950. 









256. Sayers, G. & Sayers, M. A*: Regulation of pituitary adreno- 

corticotrophic acitivifcy during the response of the rat to acute 
stress, Endocrinology, 40: 265 , 1947. 

257. Long, C. N. H.j Conditions associated with the secretion of the 

adrenal cortex. Federation Proc., 6: 461, 1947. 

258. Long, C. N. H.: Recent studies on the function of the adrenal 

cortex. Bull. New York Acad. Med., 23? 260, 1947. 

259* Gellhorn, E. & Frank, S.: Sensitivity of the lymphopenic reaction 
to adrenalin, Proc. Soc. Exper. Biol. & Med., 69 : 426, 1948. 

260. Kohler, V. & Fleckenstein, A.: The effect of the synthetic adrenal 

cortical hormone (percorten) on the diabetogenic S&aub effect, 

Klin. Wchnscbr., 20: 844, 1941> as cited by G. Sayers. Adrenal 
cortex and homeostosis. Physiol. Bevs., 30: 241, 1950. 

261. Kohler, V.: Die Stellung des Desoxycorticosteronacetats im normalen 

und pathologischen Kohlenhydratstoffwechsel; Desoxycorticosterona- 
cetat und Adrenalin. Deutsches Arch. f. klin. Med., 194: 268, 1949, 
as cited by Sayers, G., Progress in Clinical Endocrinology, S. So skin 
Editor. Grune and Stratton, New York, 1950, page 128. 

262. Cheng, C. P. & Sayers, G.: Insulin hypersensitivity following the 

administration of desoxycorticosterone acetate. Endocrinology, 

44: 400, 1949. 

263. Woodbury, D. M., Emmett, J. W., Hinckley, G. V., Jackson, N. R., 

Newton, J. D., Bateman, J. H., Goodman, L. S. & Sayers, G.: 
Antagonism of adrenocortical extract and cortisone to desoxy¬ 
corticosterone: Brain excitability in adrenalectomized rats, Proc. 
Soc. Exper. Biol. & Med., 76: 65 , 1951. 

264 . Cheng, C. P., Sayers, G., Goodman, L. S. & Swinyard, C. A.; Dis¬ 

charge of adrenocorticotrophic hormone in the absence of neural 
connection between tie pituitary and the hypothalamus. Am. J. 

Physiol., 158: 45, 1949. 

265 . Uotila, U. U.: On the role of the pituitary stalk in the regula¬ 

tion of the anterior pituitary with special reference to the 
thyrotropic hormone, Endocrinology, 25 : 605, 1939. 

266. Cheng, C. F., Sayers, G., Goodman, L. S. Sc Swinyard, C. A.: Dis¬ 

charge of adrenocorticotropic hormone from transplanted pituitary 
tissue, Am. J. Physiol., 159: 426, 1949* 

267. Hume, D. M.: The role of the hypothalamus in the pituitary-adrenal 

cortical response to stress, (abstr.), J. Clin. Invest., 28: 

790, 1949. 





268. Babes, V. & Jonesco, V. M.: Etudes sur la diminution de la 

graisse surrenale dans des etats pathologiques, Compt. rend. 

Soc. de Biol*, 65: 267, 1908, as cited by Recant et al, J. 

Clin. Endocrinology, 10: 187, 1950. 

269. Vogt, M.: Observations on some conditions affecting the rate of 

hormone output of the suprarenal cortex, J. Physiol., 103: 317, 

1944. 

270. Hungerford, G. F.: Effect of epinephrine in decreasing number of 

circulating mononuclear leucoytes in the rat, Proc. Soc. Exoer. 

Biol. & Med., 70: 356, 1949. 

271. Spiers, R. S. & Meyer, R. K.: The effects of stress, adrenal and 

adrenocorticotrophic hormones on the circulating eosinophis of 
mice. Endocrinology, 45: 403, 1949. 

272. Hechter, 0.: Corticosteroid release from the isolated adrenal 

gland, Fed. Proc., 8: 70, 1949* 

273. Nickerson, M. &■ Goodman, L. S.: Pharmacological properties of a 

new adrenergic blocking agent; N, N-dibenzyl-B-chlorothylamine 
(dibenamine), J. Pharmacol. & Exper. Therap., 89: 167, 1947. 

274* Teppennan, J. & Bogardus, J. S.: Attempts at pharmacologic 

blockade of the secretion of adrenocortieotrophin, Endocrinology, 

43? 448, 1948. 

275* McDonough, F. K.: Homeostasis in the sympathectomized dog. Am. J, 
Physiol., 125: 530, 1939. 

276. Ingle, D. J. & Nezamis, J. E.: The effect of adrenal cortex ex¬ 

tract with and without epinephrine upon work of adrenally in¬ 
sufficient rats. Endocrinology, 44: 559, 1949* 

277. Seeker, J.: The role of adrenal cortex in maintenance of sciatic 

pressor reflex, J. Physiol., 109: 49, 1949* 

278. Means, J. H.: Clues to etiology of Grave*s disease, Lancet, 257: 

543, 1949. 

279* Ingle, D. J. & Kendall, E. G.: Weights of the adrenal glands in 

rats fed different amounts of sodium and potassium. Am. J. Physiol., 
122: 585, 1938. 

280. Gaunt, R., Ever sole, W. J. & Kendall, E. C.: The influence of some 

steroid hormones on lactation in adrenalectomized rats. Endocrin¬ 
ology, 31: 84, 1942. 

281. Tuerkischer, E. & Wertheimer/ &: Adrenalectomy and gastric 

secretion /.Endocrinology, 4s 143, 1945* 


■ jjnJUiii i j.. • a V - 1 . . b 

. : ' 7 • Jgj 1 

■ ■■..!■ • : c 

. ;' , v : . . , 7 : I c : 7 . 7. [ ) 

. - , . f 

: xo; ■ 

. /' / ' /■ 

■ - i i ' sj ' ' ' • , , , • - : 

. ; . 7 ; : :■ .. : • * ; ; 


: . 

■ ■■ li . ’ e a 5 ' >.i i s . I : ■ ' o' id ij 


• t D -3 


.17 


Ii.‘IT 3 'IBS 7 ) 3 J* f 


7 


' 

.r. t CV : . . "-1 


. : c L: v, 7 ■ - . 7 ? 7 


<M±:COO 

o -•'-.1:.; 




ol^clcD " "" -dq ! 1 : . o 

,oXo!Ti:x;oo,,n7. „ ox/KioxJxoIjxcoc; g-xV: 7o ooi j’oxo:* ' 




f ,o > 7 j ' 






• oxo ; ■ r. x ■ xc 7o 7T :, , .j t • 

.ni 7 .;:t "to hxxr ncox .'n:.xi:7count, ji/o77.'.' 

7 7. „ ; , • ' /. 


<vl7ffl 

; 




10 


. i J. , . , ■■■■■ ■ T v ■ j ; ;■ . ;j.7; : 


r .,) . 

. • . . , "7 . vl ■; O'.' lo :,7- X. ' 


»"ol. ;. u 


: O' ;; . / . , . . . . , . - ' 

;J-.'vr -^r.hdo&o^y. ;,:io\7u ru vS ciq g^cKW.tn;: ojV;or v >7o 

; ' .7 


. 


. 

: o f ' : ' CO ' ' t"' ■ » . 7v . ' •' 




282. Thomsen, V.: Studies of trauma and carbohydrate metabolism with 
special reference to the existence of traumatic diabetes, Acta. 

Med. Scandinav. Suppl., 91: 1, 1938. 

283* Kelley, V. C. & McDonald, R. K.: The effects of acute exposure to 
simulated altitudes on dextrose tolerance. Am. J. Physiol.. 152:, 
250, 1948. 

284* Lewis, R. A., Thom, G. W., Koepf, G. F. & Dorrance, S. S.: The 
role of adrenal cortex in acute anoxia, 21: 33, 1942. 

285. Ingle* D. J., Ward, E. 0. & Kuizenga, M. H.: The relationship of 

the adrenal glands to changes in urinary non-nitrogen following 
multiple fractures in the force-fed rat, Am. J. Physiol., 194: 

510, 1947. 

286. Noble, R. L. & Toby, C. G.: The role of the adrenal glands in pro¬ 

tein catabolism following trauma in the rat, J. Endocrinology, 

5: 303, 1948. 

287. Levin, L.: Physical stress and liver fat content of the fasted 

mouse. Federation Proc., 8: 218, 1949. 

288. Selye, H. & Dosne$2; The influence of traumatic shock on the blood 

sugar of adrenalectomized rats treated with adrenal cortical extra¬ 
ct, Proc. Soc. Exper. Biol. & Med., 48: 532, 1941. 

289. Bergman, H. G,, Rosenfeld, D. D., Hechter, 0. & Prinzmetal, M.: 

The ineffectiveness of adrenocortical hormones, thiamine, ascor¬ 
bic acid, nupercain© and post-traumatic scrum in shock due to 
scalding bums. Am. Heart J., 29: 506, 1945* 

290. Ingle, D. J. & Kuizenga, M. H.s The survival of non-adrenalect- 

omized rats in bum shock with and without adrenal cortical hor¬ 
mone treatment, Am. J. Physiol., 145: 203, 1945* 

291. Pinchot, G. B., Close, ¥. P. & Long, C. N. H.: Adrenal changes 

produced in rats by infection with B. tularense and B. coli. 
Endocrinology, 45: 135, 1949. 

292. Kottke, F. J., Taylor, C. B., Kubieek, W. G., Erickson, D. M. & 

Evens, G. T.$ The adrenal cortex and altitude tolerance, Am. J. 
Physiol., 153: 16, 1948. 

293. Swingle, W. W. & Remington, J. W.: The role of the adrenal cortex 

in physiological processes, Physiol. Rev., 24: 89, 1944* 

294. Lithander, A,: Acute adrenal insufficiency in rabbits produced by 

some bacterial toxins, Acta Med. Scandinav. Suppl., 160: 1, 1945* 


/ ... • - ■; ' -V : : 

.. : '‘v* ,vri *:o vm o,f oo-o^ f i 

, 'i? 







V:-; 


, 






-Jo .\i‘ •.: -:: v " ' 

c•.. ij-^-trcoo X or. .■■■■: ■ > 

. 





; J' * 


. . ’ 

■ r .. . .r-\<c 

, V ■ ' '' - ' ,f„ . 



, . . t :T ■ 

/ • " 


OSS 




..:a- ';y r j' CrOh. eJ.o.r*;viaq- 



t. 

■... ,•_ - . '* -v'03 



295# Kepi, M. F. & Pearson, B.: Adrenal cortical changes after ad¬ 
ministration of adrenal cortical extract in guinea pigs receiv¬ 
ing M.L.D. of Clostridium welchii toxin. Bull, Am, Coll. Sur¬ 
geons, 30: 60, 1945* 

296, Brown-Sequard: (1890) as cited by H. Selye; Textbook of Endo¬ 

crinology (2nd Ed#); Acta Endocrinologica Inc., Montreal, 1949, 
page 113. 

297. Rose, B.: The effect of cortin and desoxycorticosterone acetate 

on the ability of the adrenalectomized rat to inactivate his¬ 
tamine, Am. J. Physiol., 127: 780, 1939# 

298# Wilson, A.: The effect of adrenalectomy on the blood histamine 
of rabbits, J. Physiol., 99: 241, 1941# 

299# Rose, B# & Browne, J. S. L.; The effect of adrenalectomy on the 
histamine content of the tissues of the rat. Am. J. Physiol., 

131: 5S9, 19a# 

300. White, A. & Dougherty, T. F.j Pituitary adrenotrophic hormone 

control of rate of release of scrum globulins from lymphoid 
tissue. Endocrinology, 36: 207, 1945# 

301. Dougherty, T. F#, Chase, J. H. & White, A.: Pituitary-adrenal 

cortical control of antibody release from lymphocytes. Explana¬ 
tion of anamnestic response, Proc. Soc. Exper. Biol# & Med., 

58: 135, 1945# 

302. Murphy, J. B. & Sturm, £.: Lymphoid tissue and antibody formation, 

Proc. Soc# Exper. Biol. & Med#, 66: 303, 1947. 

303# Li, C# H. & Reinhardt: Electrophoresis of rat plasma; effect of 
adrenocorticotropic hormone, J. Biol. Chem., 167: 487, 1947. 

304# Gordon, A. S. & Katsh, G. F#: Relation of adrenal cortex to struc¬ 
ture and phagocytic activity of macrophagic system, Ann. New York 
Acad. Sc., 52: 1, 1949# 

305# Selye, H.: Production of nephrosclerosis by overdosage with desoxy¬ 
corticosterone acetate, Canad. M. A. J., 47: 515, 1942. 

306. Selye, H. & Pentz, E. I.: Pathogenetical correlations between 

periarteritis nodosa, renal hypertension and rheumatic lesions, 
Canad. M. A. J, 49: 264, 1943# 

307. Selye, H., Sylvester, 0#, Hall, G. E. & Leblond, C. P.: The hor¬ 

monal production of arthritis, J.A.M.A#, 124: 201, 1944# 

308. Carnes, W. H., Ragan, C., Ferrebee, J. W. & O’Neill, J.: The effects 

of desoxycorticosterone acetate in the albino rat, Endocrinology, 

29: 144, 1941. 




? Od 


















309* Harrison, R. G.: Relation of the adrenal cortex to arthritis. 

Lancet, 250: 815, 1946. 

310. Knowlton, A. I., Loeb, B. N., Stoerk, H. C. & Seegal, B. C.: 

As cited by G. Sayers. The adrenal cortex and homeostosis, 

Physiol. Rev., 30: 241, 1950. 

311 • Eisenhardt, L. & Thompson, K. W.: A brief consideration of the 

present status of so-called pituitary basophilism with tabulation 
of the verified cases, Yale, J. Biol. & Med., 11: 507, 1939* 

312. Chute, A. L., Robinson, G. C. & Donohue, W. L.: As cited by 

Sayers, G. The adrenal cortex and homeostosis. Physiol. Rev., 

30: 241, 1950. 

313* S e lye, H.: Conference on metabolic aspects of convalescence 

including bone and wound healing, October 13-14, 1944, New York, 
page 71. 

314* Hall, C. ¥., Dontigny, P., Beland, E. & Selye, H.: The role of the 
adrenals in the production of nephrosclerosis by anterior pituitary 
preparations. Endocrinology, 38: 296, 1946. 

315* Ingle, D. J.: As cited by G. Sayers. The adrenal cortex and homeo- 
statis. Physiol. Rev., 30: 241, 1950. 

316. Simpson, M. E., Li, C. H. & Evans, H. M.: Absence of renotropic 

effects on administration of pure adrenocorticotrophic hormone 
(ACTH), Endocrinology, 39: 286, 1946, 

317. Doughterty, T. F.: Factors Regulating Blood Pressure; Zweifach 

and Shorn, Editors, New York: Josiah Macy, Jr. Foundation, 1948, 
page 17. 

313. Woodbury, D. M., Rosenberg, C. A. & Sayers, G.: Antagonism of 

adrenocorticotrophic hormone (ACTH) and adrenal cortical extract 
(ACE) to desoxycorticosterone (DCA), Federation Proc., 9: 319, 1950. 

319. Selye, H.: On the production of malignant hypertension by chronic 

exposure to various damaging agents. Rev. canad. de biol., 2: 501, 
1943. 

320. Dougherty, T. F.: As cited by G. Sayers. The Adrenal Cortex and 

Homeostasis, Physiol. Rev., 30: 241, 1950. 

321. Opsahl, J. C.: As cited by G. Sayers. The Adrenal Cortex and 

Homeostasis, Physiol. Rev., 30: .241, 1950. 

322. Ragan, C., Grokoest, A. W. & Boots, R. H.: Effect of adrenoeortioo- 

trophic hormone on rheumatoid arthritis, Am, J. Med., 7: 741, 1949* 










' M 


V 










4 . 







, . . , ■ - . » » 

f ■ : ' 1 ■ • , ■ ‘ ‘ : ■ 

:*l . ,oo--: ' . (■■.0..;) rrc o& {\ 

o.L'i' • . . . .■ ,1 

' : . 

. 


. 

... 



•■•cc.-ti'" 


■ s • 


. 

. : : 


. c 

i/o ywLy-'vti r 









323. Turner, D.: Handbook of Diet Therapy, The University of Chicago 

Press, Chicago, Illinois, 1946. 

324. Watt, B. K., Merrill, A. L., Orr, M. L., Wu, W. & Pecot, R. K.: 

’’Composition of Foods - Raw, Processed, Prepared”, United States 
Department of Agriculture; Agriculture Handbook Ho. 3, Washing¬ 
ton, D. C., June, 1950. 

325. Cooper, L. F., Barber, E. M. & Mitchell, H. S.: Nutrition in 

Health and Disease for Nurses (3rd Ed.), J. B. Lippincott Co., 
Philadelphia, U. S. A., 1930. 

326. Randolf, T. G.: Enumeration and differentiation of leucocytes in 

the counting chamber with propylene glycol-aqueous stains, Proc. 

Soc. Exper. Biol. & Med., 52; 20, 1943* 

327. Randolf, T. G.: Differentiation and Enumeration of Eosinophils in 

the counting chamber with a glycol stain; a valuable technique 
in appraising AGTH dosage, J. Lab. & Clin. Med., 34: 1696 , 1949. 

323. Bonsnes, R. W. & Tans sky, H. H.: On the colorimetric determination 
of creatinine by the Jaffe reaction, J. Biol. Chem., 153: 531, 

1945. 

329. Hawk, P. B., Oser, B. L. & Summer son, W. H.: Practical physiologi¬ 

cal Chemistry (12th Ed.); The Blakiston Go., Philadelphia, 1943, 
page 314. 

330. Harvey, S. C.: The quantitative deteimination of chlorides .in the 

urine. Arch. Int. Med., 6: 12, 1910. 

331* Hawk, P. B., Oser, B. L. & Simmer son, W. H.: Practical Physiologi¬ 
cal Chemistry (12th Ed.); The Blakiston Co., Philadelphia, 1943, 
page 393. 

332. Schales, 0. & Schales, S. S.i A simple and accurate method for the 

determination of chloride in biological fluids, J. Biol. Chem., 

140/ 379, 19a. 

333. Hawk, P. B., Oser, B. L. & Summer son, W. H. Practical Physiological 

Chemistry (12th Ed,); The Blakiston Co., Philadelphia, 1943, 
page 625 . 

334* Weichselbaum, T. E.: An accurate and rapid method for the determina¬ 
tion of proteins in small amounts of blood, serum and plasma, 

Am. J. Clin. Path., Tech. Sect., 10: 40, 1946. 

33&* Hawk, P. B., Oser, B. L. & Stumers on, W. H.: Practical Physiologi¬ 
cal Chemistry (12th Ed.); The Blakiston Co., Philadelphia, 1943, 
page 524. 

336. Hald, P. M,: The flame photometer for "the measurement of s cdi i m and 
potassium in biological materials, J. Biol. Chem,, 167: 499, 1947. 







, •. • 









• - . 












A;'r 







337• Wallace, W. M., Holliday, M., Cushman, M. & Rlkinton, J. R.: 

The application of the internal standard flame photometer to the 
analysis of biologic material, J. Lab. & Clin. Med., 37: 621, 1951. 

333. Walker, H. M.: Elementary Statistical Methods* Henry Holt & Co. 
Inc., New York, 1944? page 119. 

339* Mason, H. L. & Sprague, R. G.: Isolation of 17-hydroxycorticoster- 
one from the urine in a case of Cushing's syndrome associated with 
severe diabetes meilitus, J. Biol. Chem., 175s 451? 194S. 

340. Yater, W. M.: Fundamentals of Internal Medicine (3rd Ed.); 

Appleton-Centuiy-Crofts, Inc., New York, 1949? page 650. 

34^* Lewis, R. A. & Wilkins, L.s The effect of adrenocorticotrophie 
hormone in congenital adrenal hyperplasia with virilism and in 
Cushing's syndrome treated with methyl testosterone, J. Clin. 
Invest., 23: 394? 1949. 

342. Wilkins, L., Klein, K. 8c Lewis, R. A.: Hie response to ACTH in 
various types of adrenal hyperplasia. Proceedings of the First 
Clinical ACTH Conference* J. R, Mote, Editor, Blakiston Co., 
Philadelphia, 1950, page 135. 

343* MeQuarrie, I., Johnson, R. M., Zeigler, M. R. t Plasma electrolyte 
disturbance in a patient with hypereorticoadrenal syndrome con¬ 
trasted with that found in Addison's disease. Endocrinology, 21: 
761, 1937. 

344- Willson, D. M., Power, M. H. & Kepler, 1. J.: Alkalosis and low 
plasma potassium in a case of Cushing's syndrome. A metabolic 
study, J. Clin. Invest., 29: 701, 1940. 

345* Thorn, G. Proceedings of the First Clinical ACTH Conference* 

J. R. Mote, Editor, Blakiston Go., Philadelphia, 1950, page 139* 

346. Soffer, L. J.: Proceedings of the First Clinical ACTH Conference* 

J, R. Mote, Editor, Blakiston Go., Philadelphia, 1950, page 137. 

347. Blackman, S. 8., Jr.: Concerning the function and origin of the 

reticular zone of the adrenal cortex* hyperplasia in the adreno¬ 
genital syndrome. Bull. Johns Hopkins Hosp., 73: 130, 1946. 

348. Soffer, L. J., Gabrilove, J. L., Jailer, J. W. 8c Jacobs, M. D.: 

Recent Progress in Hormone Research, Vol. ¥., G. Pincus, Editor, 
Academic Press Inc., New York, page 416 . 

349. Yater, W. M.: Fundamentals of Internal Medicine (3rd Ed.)* 

Appleton-Century-Corfts Inc., New York, page 649* 





; 






350. Reilly, W. A., Lisser, H. & Hinman, F # : Pseudosexual-precocity; 
adrenal cortical syndrome in pre-adolescent girls; report of a 
successfully operated case, Endocrinology, 24: 91, 1939. 

351* Wilkins, L., Fleischmann, W. & Howard, J. Macrogenitosomia 

precox associated with hyperplasia of the adrogenic tissue of 
the adrenal and death from corticoadrenal insufficiency. Endo¬ 
crinology, 26: 365, 1940. 

352. Young, H. H.: Genital Abnormalities, Hermaphroditism and Related 
Adrenal Diseases; Williams & Wilkins Co., Baltimore, 1937. 

353* Wilkins, L., Lewis, R. A., Klein, R., Gardner, L. I., Grigler, 

J. F., Rosemberg, E. & Migeon, C. J.: Treatment of congenital 
adrenal hyperplasia with cortisone, J. Clin. Endocrinology, 11: 

1, 1951. 

354* Wilkins, L. & Lewis, R. A.: The renal excretion of steroid hormones 
in pseudohermphroditism, and male sexual precocity associated with 
symptoms of Addison®s disease. Tr. 17th Conference on Metabolic 
Aspects of Convalescence, March 28-29, page 168, 1946. 

355- Wilkins, L., Lewis, R. A., Klein, R. & Rosemberg, E. C.: Suppres¬ 
sion of androgen secretion byoortisone in a case of congenital 
adrenal hyperplasia, Bull. Johns Hopkins Hosp., 86: 249, 1950. 

356. Helper, H. N., Lubsches, R., Hain, K. & Wilson, M. G.r Proceedings 
of the First Clincail ACEH Conference; J. R. Mote, Editor, 
BXakiston Co., Philadelphia, 1950, page 4X9. 

. 357. Bartter, F. C., Albright, F., Forbes, A. P., Leaf, A., Dempsey, E. 

& Carroll, E.: The effects of adrenocorticotrophic hornone and 
cortisone in the adrenogenital syndrome associated with congenital 
adrenal hyperplasia: An attempt to explain and correct its dis¬ 
ordered hormonal pattern, J. Clin. Invest., 30: 237, 1951. 

358. Stebbins, R. B.: Cytochemical changes in the adrenal cortex of 

the rat following the adainistration of cortisone, Federation 
Proc., 9: 345, 1950. 

359. Yater, W. M.: Fundamentals of Internal Medicine (3rd Ed); Appleton- 

Century-Crofts, Inc., New York, 1949, page 1113. 

360. Selye, H.: Effect of ACEH and Cortisone upon an "anaphylactoid" 

reaction, Canad. M. A. J., 61: 553, 1949* 

361. Long, J. B. & Favour, C. B.: The ability of ACTH and Cortisone to 

alter delayed type bacterial hypersensitivity. Bull. Johns Hopkins 
Hosp., 87: 186, 1950. 







362. Nelson, C. T*, Fox, C. L. & Freeman, E. B.: The inhibitory effect 
of cortisone on anaphylaxis in the mouse, Proc. Soc. Exper. Biol. 

& Med., 75: 181, 1950. 

363* Dews, P. B. & Code, C. F.s Effect of cortisone on anaphylactic 
shock in adrenalectomized rats. Abstracted from program of the 
fall meeting of Am. Soc. for Pharmacol, and Exper. Therap., 

1950, page 33. 

364 * Shwartzman, G., Schneierson, S. & Soffer, L. J.: Suppression of 
the phenomenon of local tissue reactivity by ACTH, Cortisone 
and Sodium Salicylate, Proc. Soc. Exper. Biol. & Med., 75: 175, 
1950. 

365 * Kandolf, T. G. & Rollins, J. P.: The effect of cortisone on bron¬ 
chial asthma, J. of Allergy, 21: 260, 1950. 

366 . Rose, B .2 Studies on the effect of ACTH on eosinophilia and bron¬ 

chial asthma. Proceedings of the First Clinical ACTH Conference; 
J. R. Mote, Editor, Blakiston Co., Philadelphia, 1950, page 491. 

367. Bordley, J. 1., Carey, R. A., Harvey, A., Howard, J. E., Kattus, 

A. A., Newman, E. V. & Winkewerder, ¥. L.: Preliminary observa¬ 
tions on the effect of ACTH in allergic diseases, Bull. Johns 
Hopkins Hosp., 85: 396, 1949. 

368. Thorn, G. ¥♦, For sham, P. H., Frawley, T. F., Hill, S. R., Jr., 

Roche, M., Staehelin, D. 8c ¥ilson, D. L.: The clinical useful¬ 
ness of ACTH and cortisone. New England J. Med., 242: 824, 1950. 

369 . Carey, R. A., Harvey, A. M., Howard, J. E. & ¥inkenwerder, ¥. L.: 

The effect of adrenocorticotrophic hormone and cortisone on the 
course of chronic bronchial asthma. Bull, of Johns Hopkins Hosp., 
37: 387, 1950. 

370. Samter, M.: The eff ect of ACTH on patients with allergic diseases; 

facts and speculations, J. of Allergy, 21: 296, 1950. 

371. Franklin, ¥., & Lowell, F. C.: Treatment of bronchial asthma. 

Am. Practitioner and Digest of Treatment, 1: 1161, 1950. 

372. Carey, R. A., Harvey, A. M., Howard, J. E. 8c Wagley, P. F.: The 

effect of adrenocorticotrophic hormone (ACTH) and cortisone on 
drug hypersensitivity reactions. Bull. Johns Hopkins Hosp., 87: 
354, 1950. 

373. Tulipan, L.: Failure of ACTH in the treatment of a case of mycosis 

fungoides; report of a case, J. Invest. Dermat., 15: 349, 1950. 

374. Bartter, F. C., Fourman, P., Forbes, A. P., Jefferies, ¥. M. 8c 

Dempsey, E. A.: A quantitative analysis of the effects of ACTH 
on potassium and phosphorus metabolism. Forty-first Ann. Meet. 

Am. Soc. Clin. Investigation, May 2, 1949, page 7. 









arr- 




.a 





: ; J 

ydl 


. 

... *. • ;• r i oj • o;: •atiXGa.j'o; 

aaou Ic .II-; i , , : ' a 


:)Oj; - •. '\o ''a.. ’•: yr i’ 

: T nlaa/ana a.o a -a . a o 





. . 

, fa..;..' - ' f • ■ * : • ' •' ■' '■ ■ '■ a.a ■■■•„ 








' 



. .oc 


aaorif 


■.a.-i 


a Cl 


Oftf £ 


P ; 





375 • For sham, P. 9., Thorn, G. W., Frawley, T. H. & Wilson, L. W.: 

Studies on the functional state of the adrenal cortex during and 
following ACTH and cortisone therapy. Program 42nd Annual Meeting 
Am. Soc. Clin. Invest., May 1 , 1950, page 22 (advance abstract). 

376. Yater, W. M.: Fundamentals of Internal Medicine ( 3 rd Ed.); Apple- 

ton-Century~Crofts Inc., N e w York, 1949, page 1024. 

377. McQuarrie, I., Anderson, J. A. Sc Ziegler, M. R.: Observations on 

the antagonistic effects of posterior pituitary and cortico- 
adrenal hormones in the epileptic xubject, J. Clin. Endocrinology, 

2: 406 , 1942. 

378. McQuarrie, I. Sc Peeler, D. B.: The effects of sustained pituitary 

anti-diuresis and forced water drinking in epileptic children. 

A diagnostic and etiologic study, J. Clin. Invest., 10: 915, 1931. 

379* Swinyard, E. A., Toman, J. E. & Goodman, L. S.s The effects of body 
water and electrolyte shifts on experimental convulsions, Fed. Proc., 
5: 205, 1946. 

380. Ziskind, E., Somerfeld-Ziskind, E. Sc Bolton, R.: Hydration studies 

in epilepsy, J. Merv. & Ment. Bis., 89* 52, 1939* 

381. Davenport, V. D.: Relation between brain and plasma electrolytes 

and electroshock seizure thresholds in adrenalectomized rats, Am. J. 
Physiol., 156: 322, 1949. 

382. Swinyard, 1. A.: The effect of extracellular electrolyte depletion 

on brain electrolyte pattern and electroshock seizure threshold, 

Am. J. Physiol., I 56 : 163, 1949* 

383* Ward, J. R. Sc Call, L. S.: Changes in the blood chemistry in rats 
following electrically induced seizures, Proc. Soc. Exper. Biol. & 
Med., 70: 381, 1949. 

384* Swingle, W. W., Parkins, W. M., Taylor, A. R. & Hays, H. W.: A study 
of water intoxication in tie intact and adrenalectomized dog and 
the influence of adrenal cortical hormone upon fluid and electro¬ 
lyte distribution. Am. J. Physiol., 119s 557, 1937. 

385. Eversole, W. J., Gaunt, J. R. Sc Kendall, E. C.: The effect of adrenal 

steroids in water intoxication, Am. J. Physiol., 135s 378, 1942. 

386. Woodbury, D. M. Sc Davenport, ¥. D.: Brain and plasma cations and 

experimental seizures in normal and desoxycorticosterone treated 
rats, Am. J. Physiol., 157: 234, 1949. 

387. Golfer, H. F.: Studies of the relationship between electrolytes of 

the cerebral cortex and the mechanism of convulsions. Assoc. Res. 
Nerv. Sc Ment. Dis., 26 : 98, 1947. 











■oo 


hn 








338. Aird, R. B. St Gordon, G. S.: Anticonvulsive properties of desoxy- 
corticosterone, J.A.M.A., 145: 715, 1951. 

399* Spregel, E., & Sycis, J.: The anticonvulsant effects of steroids, 

J. Lab. & Clin. Med., 30: 947, 1945. 

400. Selye, H.: Antagonism between anesthetic steroid hormones and 

pentomethylenetetrazol (metrazol), J. Lab. & Clin. Med., 27: 

1051, 1942. 

401. Swingle, ¥. ¥., Remington, J. ¥., Hays, H. ¥. & Callings, ¥. D.: 

The effectiveness of priming doses of desoxycorticosterone acetate 
(DOCA) in protecting adrenalectomized dogs against water intoxica¬ 
tion, Endocrinology, 28: 531, 1941. 

402. Gellhom, E. & Ballin, H. M.: ¥ater intoxication and the electro¬ 

encephalogram, Am. J. Physiol., 146 : 559, 1946. 

403. Ziegler, M. R., Anderson, J. A. & McQuarrie, I.: The effects of 

DOGA on water and electrolyte content of the brain and other tissues, 
Proc. Soc. Exper. Biol. & Med., 56 : 242, 1944* 

404. Cicardo, V. H.: Physiochemical mechanism in experimental epilepsy, 

J. Nerv. & Ment. Dis., 101: 527, 1945. 

405. Klein, R. & Livingston, S.: The effect of adrenocorticotrophic 

hormone in epilepsy, J. Pediat., 37s 733, 1950. 

406. Schales, 0. & Sehales, S.S.: Importance of controlling pH in the 

Schales and Schales method of chloride determination, J. Biol. Chem., 
168: 779, 1947. 

407. Thorn, G. Engel, L. L., Eisenberg, H.: The effect of corticos¬ 

terone and related compounds on the renal excretion of electrolyte, 

J. Exper. Med., 68: 161, 1933. 

408. McQuarrie, I.: Epilepsy in children; relationship of water balance 

to occurrence of seizures. Am. J. Dis. Child., 33: 451, 1929» 

409. McQuarrie, I.; Manchester, R. G. St husted, C. G.: Study of water 

and mineral balances in epileptic children; effects of diuresis, 
catharsis,phenobarbitol therapy and water storage, Am. J. Dis. 

Child., 43: 1519, 1932. 

410. Selye, H.: STH, ACTS, cortisone and resistance, Canad. M. A. J., 

64: 439, 1951. 

411. Kuzell, ¥. C. 8c Schaffarziclp, R. ¥.: Oral administration of corti¬ 

sone acetate, Stanford M. Bull., 8: 212, 1950. 

412. Boland, E. ¥. & Headley, N. E.t Oral use of cortisone acetate, 

J.A.M.A., 145: 3, 1951. 












--- 3 © 0 $ 







■:,rW5l£ r 'Cf X- : 

X"CCt ;^ 1 : .X • '• 












413* Boland, E. W. & Headley, N. E.: Effects of cortisone acetate on 
rheumatoid arthritis, J.A.M.A., 141s 301, 1949. 

414* Sunderman, F. W. & Boerner, F.: Normal Values in Glinical Medi¬ 
cine; V, B. Saunders, Co., Philadelphia, 1949. 

415• Ingle, D. J.s As cited by G. Sayers. The adrenal cortex and homeo¬ 
stasis, Physiol. Rev., 30: 241, 1950. 

416. Barnes, R. B., Richardson, D., Berry, J. W. & Hood, R. L.: As cited 

by P. M. Hald. The flame photometer for measurement of sodium and 
potassium in biological materials, J. Biol. Chem., 167: 499, 1947. 

417. Hald, P. M.: The flame photometer for measurement of sodium and 

potassium in biological materials, J. Biol. Chem., 167: 499, 1947. 


- ... • •' : . .. . 6 . <, 

• ’ • “ - r . : 

•• . ■ J ; , ' ' r 

* ... ' ... ... ... „ ,.. 

i , . . 

• 

• * * ■ , . .. ' ,, 

; ■ ’ ■ .7 , .' „ 

• .• - : „ 

' * • * • * 





















